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                                                               Abstract                
                                                                                 
Scleroderma has been studied extensively with much known about onset and progression, and 
the relationship with psychological aspects such as coping, depression and anxiety. However, 
there is limited knowledge about how the development and progression of scleroderma is 
related to personal stress experienced at an early age (psychological injury) and the emotional 
regulation strategies such as self-compassion used to help in coping. This may be important 
information for the treatment of scleroderma and related illnesses. This thesis addressed this 
relationship over more than ten specific studies that examined how different forms of 
scleroderma (diffuse and limited sclerosis), different symptoms (such as  
Raynaud’s phenomenon - the first sign of scleroderma onset) and age of onset were linked to 
psychosocial experiences; particularly examining stresses experienced, and levels of self-
compassion or kindness to oneself (self-kindness). The research questions raised were 
whether psychosocial variables involving early interpersonal experiences (early life stress and 
insecure adult attachment) and emotion regulation strategies (levels of self-compassion and 
emotional suppression), would be related to physiological responses (levels of hyper-arousal) 
- in scleroderma symptoms and onset. A within groups and between groups design was 
utilized. Three major different samples were recruited to enable attention specifically and 
first, to individuals with scleroderma, and then, following the scleroderma studies and to 
enable comparisons, second, to individuals from a general community sample (‘normal 
population’), and third and finally, to individuals with breast cancer. When comparing groups 
it was hypothesised that individuals from the scleroderma sample would report lower positive 
early life experiences and levels of self- compassion in their emotional regulation, than the 
community and breast cancer samples. Participants (129) in the first study were recruited from 
national and international scleroderma organisations and invited to complete either an online 
or hard copy survey. The findings supported the hypotheses and revealed that negative 
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nurturing experiences in childhood (low in early memories of warmth and safety: EMWS) 
predicted, elevated pain in scleroderma, depression and anxiety; and was significantly greater 
when comparing groups for those with more severe skin involvement (a general gauge of 
overall disease severity) and those with Raynaud’s phenomenon, when compared to those 
without this condition. In addition in this first study (of scleroderma) insecure adult 
attachment with significant others also predicted elevated pain, and depression and greater 
skin severity when comparing levels of skin involvement. Difference between the major 
subsets of scleroderma (diffuse and limited sclerosis) were found for pain: with EMWS and 
dismissive attachment, being significantly related to elevated pain for limited sclerosis; 
whereas emotional suppression was significant for diffuse sclerosis. Emotional suppression an 
emotion regulation strategy was also significantly related to anxiety and greater skin severity 
when comparing levels of skin involvement. Hyper-arousal predicted more severe Raynaud’s 
phenomenon, and was related to level of scleroderma disability, the early age diagnosis with 
scleroderma, and low self-compassion. Other relationships with attention to whether self-
compassion helped as a strategy for coping with scleroderma, demonstrated that low self-
compassion was significantly related to an earlier onset of scleroderma and Raynaud’s 
(diagnosed up to decades before the onset of scleroderma itself) and predicted more severe 
Raynaud’s symptoms. Low self-compassion (low self-kindness) and hyper-arousal (reactive) 
predicted more severe Raynaud’s phenomenon for diffuse sclerosis; whereas greater self-
judgment (a subscale of self-compassion) was significantly related to elevated Raynaud’s for 
the limited sclerosis group. Results generally supported the hypotheses and demonstrated that 
early life stress involving experiences low in warmth and safety, an insecure attachment style, 
inadequate emotion regulation/coping strategies (low self-compassion and suppression) and 
hyper-arousal, predicted or were associated with psychological or physiological variables such 
as depression, anxiety, pain, scleroderma and Raynaud’s symptoms and onset.  
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  Participants in the second and third comparison studies completed an online or hard 
copy survey and were recruited through breast cancer organisations and community 
organisations such as sporting clubs; and also included university students. Community 
members mainly from South East Queensland totalling 106 people, were recruited for the 
community study. Breast cancer organisations from around the world were involved in seeking 
participants for the study with 31 involved in the final numbers. Results suggested similarities 
and differences between groups; with significantly greater early childhood stress and lower 
self-compassion reported by individuals diagnosed with scleroderma when compared to 
community participants and significantly lower self-compassion for scleroderma participants 
when compared to breast cancer participants. Some similarities were found between illness 
groups. For depression, low self-compassion was significant for both groups; however, lower 
EMWS (scleroderma) and dismissive attachment (breast cancer) also predicted depression for 
the respective groups. For anxiety, emotional suppression was a significant predictor in both 
the scleroderma and breast cancer groups; however, lower EMWS, elevated pain and hyper-
arousal also predicted anxiety for the scleroderma group, but not the breast cancer sample. 
Demonstrating that EMWS was more likely to predict experiences of depression and anxiety 
for scleroderma participants than breast cancer participants. No other variables were significant 
for breast cancer. Findings generally supported the hypotheses and demonstrated that an 
inability to engage compassionate soothing emotion regulation experiences to reduce arousal, 
was likely to increase the vulnerability of scleroderma and breast cancer participants (to 
developing conditions such as depression).                
  Differences between those with scleroderma and breast cancer were also found for the 
variables that predicted age diagnosed with the illness. Greater hyper-arousal predicted an 
earlier onset of scleroderma; whereas greater self-compassion (which was predicted by low 
hyper-arousal) predicted a later diagnosis of breast cancer. Findings demonstrated a more 
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positive outcome for breast cancer participants who reported a greater capacity to engage in 
self-compassion as an emotion regulation strategy to reduce arousal; as results suggested this 
way of relating to the self was more likely to predict a later, rather than earlier onset of breast 
cancer. Conversely, low self-compassion was related to a diagnosis of Raynaud’s phenomenon 
at a younger age for individuals diagnosed with scleroderma (first study); suggesting that levels 
of self-compassion (e.g., high: later onset of breast cancer; low: earlier onset of 
Raynaud’s/scleroderma) may have consequences in relation to onset of disease. Greater early 
childhood stress and lower self-compassion were reported by scleroderma participants when 
compared to community participants and lower self-compassion was reported by scleroderma 
participants when compared to breast cancer participants; these experiences also predicted 
elevated pain, Raynaud’s symptoms and earlier onset of Raynaud’s phenomenon. Thus, in 
relation to scleroderma (the main focus of the study), these experiences are seen to impact on 
levels of arousal and the course of scleroderma, resulting in an earlier onset and exacerbation 
of symptoms. The findings suggest more beneficial results come from strategies that are related 
to lower arousal: such as greater experiences of self-compassion.                                                      
  Limitations include a smaller sample size for the breast cancer group than anticipated. 
This occurred as breast cancer organisations expressed concerns about exploring members 
early childhood experiences due to factors related to blame for the development of the disease. 
Post-hoc calculations, however, indicated adequate power in the numbers involved, allowing 
for confidence in the comparisons made. Further research that involves identifying levels of 
self-compassion and hyper-arousal when people are first diagnosed with Raynaud’s/ 
scleroderma and providing education and therapies that teach patients to engage in self-
compassion and arousal reduction techniques; may provide beneficial outcomes in reducing 
symptomology and possibly leading to an extended life expectancy (as thirty per cent of 
individuals diagnosed with scleroderma die within the first five years of diagnosis).      
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         The major contribution of this series of studies was the finding that greater self-
compassion may be a determining factor in predicting lower hyper-arousal and a later onset of 
disease. This study demonstrates the importance of providing individuals (children) with 
adequate experiences of nurturing and feelings of safety and the development of effective 
emotion regulation strategies such as self-compassion to reduce negative arousal. Providing 
children with positive nurturing experiences and the capacity to engage in self-compassion may 
be a protective factor for reducing arousal and delaying the onset of disease.     
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                                                     CHAPTER ONE                                                                                           
Research Project Overview  
       Psychosocial stress is recognised as significantly contributing to the development of many 
psychological conditions and diseases (e.g., Ackerman et al., 2002; Arnetz & Ekman, 2006; 
Boscarino, 2004; Da Costa et al., 1999). The potential for stress to impact on an individual’s 
physical health has long been known to depend on an individual’s physiological response to the 
stressor (Selye, 1950; Seyle, 1976). A number of physiological systems such as the 
neuroendocrine and immune systems respond to psychosocial stress (Lekander, 2002;  
Maier & Watkins, 1998). Psychosocial stressors include interpersonal violence (e.g. Stein &  
Kennedy, 2001), attachment interactions that fail to reduce arousal (Bowlby, 1998; Schore,  
2002) and cognitions and emotions associated with stress and distress (Lekander, 2002; Maier 
& Watkins, 1998). Individuals who lack the capacity to effectively manage stressful situations 
may as a consequence suffer from excessive arousal reactions (Selye, 1950; Seyle, 1976), 
augmented inflammatory responses, dysregulation of the immune system (Arnetz & Ekman, 
2006) and psychological conditions such as depression and anxiety; experiences that are risk 
factors in the development of autoimmunity (e.g., Boscarino, 2004; Schore, 1994).   
 Although stressful experiences are common and can occur over the lifespan, early life 
stress may have long lasting detrimental effects on the developing limbic and immune systems; 
and an individual’s capacity to adjust to adult stress situations and develop a secure attachment 
style (relationships with significant others). Negative appraisal of self and others can result 
from early stress events and can impact on psychological and social maturation that may lead 
to depression and anxiety disorders (e.g., Schore, 1994). For example, Briere (1995) identified 
a number of major psychological and physiological responses to childhood stress/abuse. These 
responses included anxiety, posttraumatic stress and hyper-arousal, cognitive distortions such 
as depression; altered emotionality, such as defensive avoidance  
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    16  
  
(an emotion regulation strategy that influences cognitions and behaviours); and impaired self-
reference, such as a limited capacity to provide self-support.         
  Adverse childhood experiences have also been found to affect brain physiology by 
interfering with normal brain wave development. In this study higher levels of brain-wave 
abnormalities were found in individuals reporting early trauma when compared to those 
without trauma experiences (Teicher et al., 1997). Stress leads to arousal of a number of 
interrelated neurological systems (e.g., hypocampal-hypothalamic-pituitary-adrenal axis) and 
when severe, repeated or prolonged, the neurological systems involved in the stress response 
may become dysregulated (Van der Kolk & Greenberg, 1987). Dysregulation of neurological 
processes resulting from stress can involve immunological responses and excessive 
inflammatory reactions (e.g., Crittenden & Claussen, 2000; Van der Kolk & Greenberg, 1987), 
involved in autoimmunity (e.g., Schore, 1994) and the development of scleroderma  
(Bolster & Silver, 2008).                
  When individuals are exposed to an early life deprived of warmth and safety, they tend 
to lack experiences of positive affect and compassion. Gilbert and colleagues suggest that these 
experience’s result in the infrequent activation of the soothing/safety system and the capacity 
of an individual to self-sooth and effectively regulate emotions (Gilbert et al., 2008). Gilbert 
suggests there are a number of emotion regulation systems, which include the soothing/safety 
system and the threat/protection system. Limited exposure to positive nurturing experiences 
and few early life experiences of feeling safe are likely to stimulate the threat system and 
develop a tendency to view others as potentially threatening (Gilbert, 2000;  
Gilbert, Clarke, Hempel, Miles, & Irons, 2004; Gilbert et al., 2008).     
  These strategies condition the individual to utilize a range of negative emotional, 
cognitive and behavioural approaches that are self-critical and more likely to result in the 
development of defensive strategies (Gilbert, Baldwin, Irons, Baccus, & Palmer, 2006; Gilbert, 
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McEwan, Mitra, Franks, & Richter, 2008) such as avoidance behaviours and emotion 
suppression (Gross, 2002), to prevent engaging in the threat situation (Langens & Morth, 
2003). Researchers have identified a number of variables that suggest individuals with 
scleroderma have a tendency to view others as threatening and engage in avoidance 
behaviours. Behaviours such as defensiveness, interpersonal sensitivity (Angelopoulos et al., 
2001), fear of negative evaluation and social anxiety (Richards et al., 2004) have been reported 
in a number of scleroderma studies. These behaviours suggest individuals with scleroderma 
may be hyper-sensitive to threat and may utilize avoidant emotion regulation strategies such as 
suppression to manage threatening experiences, factors yet to be investigated and therefore 
explored in the current study.                    
  Gilbert’s social mentalities theory suggests that individuals who function in the “threat 
mentality” tend to have experienced critical early environments deficient in compassion. 
Gilbert (e.g., 2000; 2002) postulated that in the absence of compassionate soothing experiences 
the internalisation of these early external threat experiences, may impede the development of 
the self-soothing social mentality. This may lead to an inability to self-sooth and use effective 
emotion regulation strategies to manage distress. Engaging defensive strategies to avoid 
internal and external threat experiences may increase self-critical cognitions (Gilbert et al., 
2004; Gilbert et al., 2006; Irons et al., 2006), susceptibility to conditions such as anxiety and 
depression (Gilbert, 2007; Gilbert, 2012) and physiological responses such as increased 
sympathetic nervous system activation (Campbell-Sills, Barlow, Brown, & Hofmann, 2006) 
and immune dysregulation (Schore, 1994). Experiences involving threat and the capacity to 
reduce arousal, through the utilization of effective emotion regulation strategies have been 
under-investigated in relation to scleroderma (a complex autoimmune disease). To determine 
the relationship between these psychosocial factors and immune related symptoms, the current 
research project investigated negative early life experiences, levels of self-compassion, 
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emotion suppression and hyper-arousal, and scleroderma onset and symptoms.    
 Gilbert’s social mentalities theory (e.g., 2000; 2012) examines interactions between 
biopsychosocial and evolutionary adaption to threat and safety in social relationships. Gilbert 
suggests these interactions have the capacity to influence cognitive, emotional, motivational 
and behavioural development and involve evaluating potential threat, creating safe 
environments and regulating emotions associated with feeling safe or threatened. Gilbert 
(2002) suggested that inner compassion and the ability to self-sooth are strategies capable of 
down regulating the threat system and are generally developed through early nurturing 
experiences that engender feelings of warmth and safety. Gilbert’s theory describes processes 
involved in the development of either beneficial or detrimental approaches to regulating the 
threat response and was utilized in this thesis project as a basis for exploring early threat 
experiences, emotion regulation and the relationship with immune related symptoms,  
particularly scleroderma.                
  Psychosocial stress is widely acknowledged as being associated with the onset and/or 
exacerbation of many immune related conditions such as breast cancer (Luecken, Dausch,  
Gulla, Hong, & Compas, 2004; Palesh et al., 2007) and autoimmune diseases; for example  
Crohns’ disease (Garret, Brantley, Jones, & McNight, 1991), systemic lupus erythematosus (Da 
Costa et al., 1999; Pawlak et al., 2003), multiple sclerosis (Ackerman et al., 2002), 
hypothyroidism, rheumatoid arthritis, psoriasis (Boscarino, 2004) and scleroderma (Chen, 
Huang, Qiang, Wang, & Han, 2008; Hui, Johnston, Brodsky, Tafur, & Ho, 2007).   
 Autoimmunity occurs when the bodily processes responsible for differentiating between 
the self and pathogens fail to perform this function, damaging healthy tissue. Scleroderma (also 
known as systemic sclerosis) is described as a multistage, multisystem, chronic autoimmune 
disease that is characterised by progressive vascular disorder, immune activation and extreme 
tissue fibrosis (Smith & Kalhaleh, 2008). This disease develops when an individual’s immune 
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system attacks healthy tissue impeding normal functioning of the skin, joints, blood vessels, 
lungs and internal organs (e.g., Etkins, Lenker, & Mills, 2005; Varga, 2004). Despite research 
that has been conducted in this area, there remains no known cause for scleroderma and only a 
limited understanding of the factors that may contribute to the development of this disease 
(e.g., Etkins et al., 2005). There is as a consequence no known cure and although stress is 
reported as a risk in the development of autoimmunity  
(e.g., Boscarino, 2004; Schore, 1994), a paucity of research has been conducted with regard to 
stress and scleroderma. Therefore the current study explored stress from a threat-arousal- 
management perspective and the relationship to immune related symptoms in scleroderma.  
 Researchers have focused mostly on psychological factors in relation to aspects of the 
disease such as pain, coping with and adjustment to scleroderma, body image satisfaction and 
illness perception (e.g., Angelopoulos, Drosos, & Moutsopoulos, 2001; Richards, Herrick, 
Griffin, Gwilliam, & Fortune, 2004; Roca, Wigley, & White, 1996); with a few studies 
demonstrating an association between physical and emotional stress (Freedman & Ianni,  
1983; Hui et al., 2007) and stress events occurring before scleroderma onset (Chen et al., 2008; 
Hui et al., 2007); however, these events were not examined in relation to disease symptoms. 
Therefore the current study investigated the relationship between biopsychosocial stress 
aspects and the onset of scleroderma. Factors associated with experiences of stress and threat 
including early life experiences and the ensuing physiological, cognitive and emotional 
responses, such as hyper-arousal, emotion regulation strategies (suppression and self-
compassion) and insecure attachment styles (dismissive and fearful) have not previously been 
examined in relation to scleroderma symptoms and onset. Stress/threat experiences have the 
capacity to impact on an individual’s physical and psychological health (e.g., Bowlby, 1998; 
Every & Lating, 2002; Gilbert, 2012; Gross, 2002; Neff, Kilpatrick, & Rude, 2007); and were 
therefore explored further in the current study in relation to scleroderma.   
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Aims and Proposed Methodology               
  The literature suggests that psychosocial stress has the potential to influence the 
development of many physiological and psychological conditions (e.g., Ackerman et al., 2002; 
Arnetz & Ekman, 2006; Boscarino, 2004; Da Costa et al., 1999). This potential is generally 
dependent on an individual’s capacity to manage stress through early relational experiences 
(e.g., Gilbert, 2006; Gilbert, 2012), that promote the capacity to develop positive relationships 
with self and others and experiences that foster effective regulation of emotions and arousal 
reactions (e.g., Gilbert, 2002: Neff, 2003a). The development of chronic arousal reactions 
involve inflammatory responses, limbic and immune system dysregulation (Arnetz & Ekman, 
2006); risk factors in autoimmunity (e.g., Boscarino, 2004; Schore, 1994), the development of 
Scleroderma (Bolster & Silver, 2008) and mental health conditions (e.g., Boscarino, 2004). 
Despite biopsychosocial research that has been conducted in relation to scleroderma, there 
remains no known cause or cure and only a limited understanding of the factors that may 
contribute to the development of this disease (e.g., Etkins et al., 2005). The focus on stress-
arousal as a factor that may precipitate or exacerbate symptoms has not been explored in 
scleroderma research and requires investigation.         
  Stress-arousal and disease research demonstrate a link between early relational 
experiences and an individual’s capacity to manage the psychological and physiological 
reactions involved in managing threat experiences. Stressful interpersonal and intrapersonal 
relationships that have the potential to elevate arousal, as well as factors previously explored in 
scleroderma studies were drawn on to develop the hypotheses for the current study. Findings 
from a number of scleroderma studies have identified behaviours such as defensiveness, 
interpersonal sensitivity, fear of negative evaluation and social anxiety. These studies did not 
identify significant factors from a stress-threat-arousal perspective or suggest that individuals 
with scleroderma have a tendency to view others as threatening. Conclusions drawn from these 
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studies generally referred to psychopathology when discussing findings. Drawing on these 
studies it was hypothesised that these fear related defensive behaviours suggest individuals 
diagnosed with scleroderma may be hyper-sensitive to threat and respond with protective-
defensive-threat-arousal, in stress situations involving interpersonal and intrapersonal 
communications, ways of relating to self and others, that may have developed in early 
childhood. As the development of effective emotion regulation strategies that reduce arousal 
may be dependent on positive nurturing experiences in early life; it was hypothesised that 
negative early relational experiences deficient in compassion and safety and the utilization of 
ineffective emotion regulation strategies associated with increased arousal and immune 
dysregulation, would be related to onset and severity of scleroderma and mental health 
symptoms. Negative relating to self and others is likely to initiate the stress-arousal response 
for extended periods of time, increasing the risk of autoimmunity, and is therefore explored in 
this study in relation to scleroderma.                                 
 Three main studies and several sub-studies were conducted on scleroderma, breast 
cancer and community samples. The first (scleroderma) study investigated stressful 
interpersonal (early life experiences and adult attachment style) and scleroderma symptoms and 
onset. Intrapersonal relationships (how an individual relates to self and regulates emotions: 
levels of self-compassion and suppression of fear/threat experiences), elevated arousal (hyper-
arousal) and the relationship to scleroderma symptoms and onset. Mental health (depression 
and anxiety) was also examined as the psychosocial variables in this study had not previously 
been explored in relation to these conditions; and may provide further understanding of the 
contribution these factors as well as the level of scleroderma disease symptoms experienced, 
have on levels of depression and anxiety experienced by this population.         
  Several theoretical models were examined in relation to the studies. The 
biopsychosocial model of health integrating aspects related to the area of 
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psychoneuroimmunology, Gilbert’s biopsychosocial theory of social mentalities and model of 
affect regulation systems (such as threat/protection and soothing/safeness systems; e.g., 
Gilbert, 2000; Gilbert, 2001; Gilbert, 2002; Gilbert, 2012) were chosen and utilized in the 
thesis project to capture the relationships of the variables under investigation.                         
Types of Scleroderma - DV’s and Psychosocial - IV’s: The dependent variables for the first 
study were scleroderma, the different types of scleroderma (diffuse and limited sclerosis), 
defined by different antibodies with the more severe form of scleroderma, diffuse sclerosis 
involving a more rapid onset than the limited form of the disease (Bolster & Silver, 2008). 
These major forms of the disease involve symptoms such as Raynaud’s phenomenon, 
breathing and intestinal conditions, ulcers, skin thickening, disability and pain. These 
variables as well as age of disease onset were investigated in relation to the independent 
psychosocial variables; early relational experiences of warmth and safety (EMWS), 
attachment style (e.g., dismissive and fearful); emotion regulation strategies, suppression/re-
appraisal and self-compassion (self-kindness, mindfulness, self-judgement, isolation, over-
identification), hyper-arousal; and depression, anxiety and stress to determine the relationship 
between these variables and the onset and exacerbation (and in the case of greater EMWS and 
self-compassion and lower insecure attachment and suppression, hyper-arousal: lower 
symptomology) of symptoms.          
 The second and third studies examined participants with scleroderma (autoimmune 
disease), breast cancer (depressed immunity) and a sample of ‘normal’ community and 
compared the relationship between the independent psychosocial variables investigated in the 
first study, and the dependant variables; (study two) scleroderma/community and (study three) 
scleroderma/breast cancer; and all groups scleroderma/breast cancer/community. Breast 
cancer was selected as a comparison group as it is more commonly diagnosed in women than 
men and is an immune related disease. The community group was selected as a comparison 
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study to ascertain whether differences occurred in psychosocial experiences between illness 
and non-illness groups (dependant variable: immune disease/no disease). The three groups 
were examined to determine the influence certain experiences may have on psychological and 
physical health conditions in these populations.                                                                      
                Review of the Literature - Disease and Stress                                                               
The Biopsychosocial Model, Psychoneuroimmunology and Psycho-oncology    
  The biopsychosocial model of health integrating psychoneuroimmunology, provides a 
framework to investigate emotion regulation and the social, psychological and immune related 
biological factors explored in the current study. The biopsychosocial model proposes that an 
individual’s health is not only affected by physiological factors but also social and 
psychological aspects (Barlow & Durand, 1999). This model adds a social and psychological 
aspect to the biomedical model (described as the conventional model of health).             
Historical Context: Physical and Psychological Health Models        
  The biomedical model of health and illness that has prevailed since the 19th century, 
suggests a purely physiological understanding of the body’s processes, with molecular biology 
utilized to explain disease and physical health. The biomedical model assumes that health 
relating to the physical aspects of the body is independent of the psychological and social 
aspects of the mind. Although psychological and social factors were not integrated into the 
biomedical model of health, Psychosomatic Medicine (in the 1930’s), Behavioural Medicine 
and Health Psychology (in the 1970’s), recognised the interrelationships between physical and 
psychosocial aspects of illness (Sarafino, 2008).         
  The expanded and more holistic view of health and behaviour resulted in the 
development of a framework that included the biomedical and psychosocial aspects of health, 
referred to as the biopsychosocial model. The biopsychosocial model recognises that any 
particular disease or disorder is complex and therefore is unlikely to be attributable to a single 
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factor, providing a framework to understand the physiological, social, psychological, and 
behavioural dimensions of illness, as interacting to influence behaviour and health. The 
biological dimension of the biopsychosocial model considers aspects such as the functioning 
and interrelationships of physiological systems and gene expression. Psychological aspects of 
this model involve mental processes and behavioural factors that involve cognitions, emotions 
and motivation. Social factors include interpersonal and societal influences on health that 
involve the family, general community and the larger society (Sarafino, 2008).  As research 
increasingly found that emotions affected the endocrine and immune systems, a new field 
emerged (psychoneuroimmunology) that specifically studied the interrelationship of emotions, 
the endocrine and immune systems (Sarafino, 2008).  Psychoneuroimmunology (PNI) is a field 
that examines biological processes involving the neural, endocrine and immune systems in 
relation to disease and psychological conditions. This area of research is interested in the 
bidirectional interactions between human behaviour and neural, endocrine and immune 
processes, based on the theory first postulated by George Solomon in1964, termed 
psychoimmunology (Kern & Ziemssen, 2008). This theory explores the influence of emotions 
in relation to immunity and disease and suggests that immune related changes affect the 
physical body as well as cognitions, emotions, motivation and  
behaviour (Lekander, 2002; Maier & Watkins, 1998).           
  Scleroderma and Psychoneuroimmunology (PNI): PNI views stressful experiences and 
emotional states as factors that have the potential to influence physiological systems. PNI is 
concerned with the hypothalamus-pituitary-adrenal (HPA) axis, an endocrine system that 
responds to physical and psychological stressors. These stressors may potentially initiate a 
stress response that involves the release of hormones from the hypothalamus and pituitary 
gland, including adrenocorticotropic hormone (ACTH) and cortisol. The autonomic nervous 
system (ANS) is also involved in the stress response and communicates with the immune 
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system. The HPA axis, the ANS and immune system are influenced by psychosocial factors, 
particularly positive and negative emotions (Kern & Ziemssen, 2008); for example stress and 
depression from stressful life events have the potential to impair the immune function  
(Marsland, Cohen, Rabin, & Manuck, 2001) and are factors associated with scleroderma (Roca 
et al., 1996; Angelopoulos et al., 2001; Hui et al., 2007); however, there are gaps in the 
knowledge. Therefore scleroderma symptoms (immune dysregulation), such as Raynaud’s 
phenomenon and gastrointestinal dysfunction and psychosocial variables such as early life 
stress, emotion regulation, depression and anxiety were investigated in the current study to 
determine the relationship between psychosocial variables and immune related symptoms.  
 Scleroderma and Psychosomatic Dermatology: Scleroderma is predominately a 
connective tissue disease involving the skin. Psychosomatic dermatology recognises the 
biopsychosocial aspect of skin disorders such as psychosocial variables that involve 
intrapersonal and interpersonal relationships that may influence skin disorders (Gieler, 
Niemeier, Kupfer, & Harth, 2008). Skin conditions are experienced by a majority of  
individuals diagnosed with scleroderma.               
  The relationship between interpersonal and intrapersonal psychosocial stress factors and 
skin related conditions have not previously been investigated in relation to scleroderma and 
were explored in the current study to determine this relationship.                                    
 Cancer and Psychosocial Aspects: The current study also examined cancer as a 
comparison and contrast to scleroderma issues. The scientific field established to explore the 
role biopsychosocial factors may play in the onset or exacerbation of cancer symptoms is 
called psycho-oncology. This field was established in the mid nineteen-seventies when it 
became apparent that psychological, social and biological aspects contributed to the cancer 
experience; and cancer had become de-stigmatised to a level that the emotional affects 
experienced by a person diagnosed with cancer could be discussed and investigated. Psycho-
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oncology developed as a field that conducts research related to the psychological aspects of 
cancer, including behavioural and lifestyle factors and the management of symptoms related to 
the development of cancer such as anxiety, depression, pain and fatigue (Holland, 1998).  
  Psychoneuroimmunology also contributes to cancer research through the investigation of 
connections between psychological and physiological aspects of cancer risk and survival 
(Holland, 2002). Psychosocial factors such as anxiety, depression, attachment style and emotion 
regulation strategies explored in the scleroderma sample (over-responsive immune system) were 
also examined in individuals diagnosed with breast cancer (depressed immune system) to 
determine whether differences and/or similarities occurred in the relationship between 
psychosocial variables and immune related symptoms for these groups.                                                
Biopsychosocial Aspects of Stress                   
  Biologically stress can involve a number of the body’s systems including the central 
nervous, endocrine, and immune systems and can create an abrupt and intense disruption to the 
body’s homeostasis (Kusnecov & Rabin, 1994). Psychologically defined stress refers to the 
evaluation of any particular circumstance as exceeding the capacity of an individual to manage 
an event that may potentially endanger their well-being (Lazarus & Folkman, 1984).   
Physical or psychological stimuli that exceed an individual’s available internal and external 
resources and capable of generating a stress response are described as stressors (Lazarus & 
Folkman, 1984; Selye, 1950; Seyle, 1976). External and internal stressors have the potential to 
injure or impair the biological, psychological and social systems of an individual. External 
stressors resulting from environmental and psychosocial stress and internal stressors such as 
inflammatory responses (a symptom of scleroderma), are therefore capable of disturbing the  
body’s equilibrium (Schore, 1994).                 
  Not all stressors elicit the same (physiological, behavioural or psychological) response 
and the same stimulus generally has a different effect on each individual due to genetic 
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predispositions, age and gender or exposure to environmental factors (e.g., Chapel, Haeney, 
Misbah, & Snowden, 2006; Selye, 1950; Seyle, 1976). It has been understood for some time  
that exposure to stressors and predisposing characteristics may result in inadequate 
physiological responses to stress; for example Selye’s general adaption syndrome (GAS). Selye 
(1950; 1976) described three stages of adaption to stress, with each stage eliciting changes in 
the functioning of the nervous and endocrine systems. The first stage, the alarm reaction stage, 
involves the release of hormones that assists in increasing resistance to the stressor and is 
followed by the resistance and exhaustion stages. Conditioning factors involving internal and 
external factors that differ amongst individuals may considerably alter the stress response 
pattern and the ability to adapt to or tolerate stress; a situation that may be a determining factor 
in the development of disease (Selye, 1950; Seyle, 1976). As the literature suggests differences 
occur in individual responses to stress, the current study explored differences in 
biopsychosocial factors in individuals diagnosed with scleroderma and the relationship 
between these factors. 
  The development of arousal conditions generally result from an individual’s 
inappropriate response to indirect stressors (e.g., Every & Lating, 2002). Arousal is influenced 
by genetic factors and is higher in individuals who are more physiologically and emotionally 
reactive (Pfaff, 2005). Several systems are responsible for controlling the human stress 
response; these include the sympathetic component of the autonomic nervous system (SAM) 
and the hyperthalmic-pituitary-adrenal (HPA) complex. The pituitary gland is controlled by the 
hypothalamus and excretes a number of hormones that are released when an individual is 
stressed, for example corticotropin-releasing factor (CRF) excreted by the hypothalamus 
signals the pituitary to release the hormone ACTH that activates the adrenals. A number of 
hormones such as serotonin, prolactin, oxytocin and beta-endorphines are involved in the anti-
stress system that increases an individual’s stress tolerance. When the anti-stress system is 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    28  
  
effective the individual experiences a state of calm and relaxation and an increase in positive 
social interactions. Strategies that provide an individual with the capacity to self-sooth and 
reduce the stress response were investigated in the current study. Self-compassion strategies 
were explored in relation to psychosocial and biological symptoms of scleroderma to determine 
positive and negative effects of individual strategies for managing stress in the form of emotion 
regulation on physical and psychological well-being.          
 A number of situations that an individual may perceive as painful, threatening, 
overwhelming or that trigger unpleasant memories may activate the stress response. Excessive 
production of stress hormones can trigger excessive production of anti-stress hormones and 
may create health risks; for example excessive excretion of corticotrophin may trigger high 
levels of prolactin secretion associated with the development of pituitary adenomas (e.g., 
Arntez & Ekman, 2006) a condition associated with scleroderma (e.g., La Montagna et al., 
2001). A few studies have reported elevated prolactin levels in women diagnosed with 
scleroderma (Kucharz, Jarlzyk, Jonderko, Rubizs-Brzezinska, & BrzezinskaWcislo, 1996; La 
Montagna et al., 2001). Vera-Lastra and colleagues (2006) identified 80% of scleroderma 
participants compared to 5% of controls with prolactin related conditions such as 
hyperprolactinemia, increased central dopaminergic tone and pituitary microadenomas, 
suggesting that prolactin may be involved in the prognosis of scleroderma (Vera-Lastra, Jara, 
& Medina, 2006). Prolactin performs a number of physiological functions including 
immunostimulation (Vera-Lastra et al., 2006) and its secretion has been associated with 
psychosocial factors (Fava, Fava, Kellner, Serafini, & Mastrogiacomo, 1981). Therefore 
investigating psychosocial factors that may be linked to pituitary adenomas (e.g., Arntez &  
Ekman, 2006) associated with the development of scleroderma (e.g., La Montagna et al., 2001) 
may provide further understanding of the role stress plays in scleroderma.    
 Prolactin concentrations may be influenced by stressful environmental conditions, as 
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prolactinomas often develop after stressful life events (Sobrinho et al., 1998) and were found to 
be more significant in uncontrolled stress events (Sonino et al., 2004). Variation in the 
secretion of prolactin affects the central nervous system, influencing an individual’s emotions, 
mood and behaviour (Sobrinho et al., 1998; Sonino et al., 2004) and has been associated with 
negative experiences such as panic attacks (Fava, Serafini, De Besi, Adami, & Mastrogiacomo, 
1988), rage associated with humiliating experiences (Sobrinho, 2003), parental separation 
(Assies, Vingerhoets, & Poppelaars, 1992), and parental deprivation in childhood (Sobrinho et 
al., 1998). Fava et al., (1981) found that elevated prolactin associated with hyperprolactinemia 
was related to depression and anxiety. Thus elevated prolactin is associated with stressful early 
relational experiences and mental health and is also a precursor to the development of 
scleroderma; however, the relation to early life stress and negative interpersonal and 
intrapersonal experiences had not previously been explored.    
 Therefore, these variables (early life stress and negative interpersonal and intrapersonal 
experiences) were investigated in relation to scleroderma, and depression and anxiety to 
determine the relationship between stress experiences, mental health and scleroderma 
symptoms. Further, stress related conditions include physiological diseases involving 
immunological responses and excessive inflammatory reactions, inadequate emotion regulation 
strategies that create hyper-arousal (e.g. Van der Kolk & Greenberg, 1987; Crittenden & 
Claussen, 2000), immune dysfunction; the development of illness conditions such as 
autoimmune diseases (e.g., Schore, 1994) and psychological disorders such as anxiety and 
depression (e.g., Miller, 2005; Every & Lating, 2002). However, little research has investigated 
stress related psychosocial variables such as ineffective emotion regulation strategies that 
increase arousal and physiological responses; these were examined in the current study to 
determine the relationship and contribution of these experiences to the autoimmune symptoms 
of scleroderma.          
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The Immune System: Depression and Anxiety       
      
 Stress induced depression may also affect the immune system by activating biological  
mechanisms that increase cytokine secretion and hyperactivity of the HPA-axis (e.g., Kiecolt, 
Glaser & Glaser, 2002). Anxiety and depression have been associated with a number of 
diseases including scleroderma and breast cancer (scleroderma, e.g., Angelopoulos et al.,  
2001; Beretta et al., 2006; Roca et al., 1996; breast cancer, Iwamitsu et al., 2005; Khan et al., 
2012 and Vardanima et al., 2010) and are often preceded by stressful events and immune 
dysfunction (e.g., Boscarino, 2004; Miller, 2005). Research exploring depression and anxiety 
in scleroderma populations, has not previously examined the relationship between these mental 
health factors and the utilization of protective factors for managing psychosocial stress. Levels 
of self-compassion and positive/negative childhood rearing experiences, the quality of 
attachment relationships and the utilization of effective/non-effective emotion 
regulation/coping strategies were explored to determine the contribution these variables may 
have on disease symptoms.    
The Immune System: Hyper-arousal               
  As stress may negatively impact on biological, psychological and social aspects of an 
individual’s wellbeing, exposure to prolonged psychosocial stress can create hyper-arousal, 
heightening neuro-immune and endocrine activation, that may result in the development of 
physiological conditions such as autoimmune disease (e.g., Schore, 1994) and psychological 
conditions that involve emotion dysregulation (e.g., Van der Kolk & Greenberg, 1987;  
Crittenden & Claussen, 2000), such as anxiety and depression (e.g., Miller, 2005; Every & 
Lating, 2002). Stressors, such as emotional, immunological and inflammatory responses may 
produce excessive arousal reactions dependant on the intensity of the individual’s response to 
the stressor (e.g., Every & Lating, 2002; Selye, 1976). The inability to adapt to stressful 
situations may produce excessive arousal reactions (Selye, 1950; 1976), dysregulation of the 
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immune system and augmented inflammatory responses (Arnetz & Ekman, 2006); risk factors 
in the development of diseases involving autoimmunity (e.g., Schore, 1994; Selye, 1950; Seyle, 
1976) and symptoms associated with scleroderma (Bolster & Silver, 2008; Freedman & Ianni, 
1983).            
 As excessive arousal reactions (hyper-arousal) have not been explored in scleroderma-
psychosocial research and is a risk factor involved in the (autoimmune) disease process, the 
current study examined the relationship between this factor and scleroderma symptoms and 
onset.                
The Immune System: Scleroderma               
  The immune system is complex and therefore a comprehensive explanation of its 
function is beyond the scope of this paper. A brief description however is provided. The 
immune system is comprised of a collection of cells organized to protect the individual from 
infection. The immune system is designed to distinguish normal components of the body from 
foreign pathogens and therefore differentiation between the self and non-self, through a process 
involving the innate and adaptive immune systems. The innate system identifies signs of 
infection, while the adaptive immune system responds to these messages by producing cells 
that attach to pathogens to eradicate them from the body. The adaptive immune system 
contains specific memories of evolving antigens, generating a vast range of receptors that 
either retain or eliminate molecules depending on reactivity. Generally the immune system 
differentiates between the body’s tissues and pathogens; however, this system may become 
hyper-reactive creating an environment where the immune system attacks healthy tissue 
producing autoimmunity. The adaptive immune system consists of T and B lymphocytes, 
antigen recognition and cell development. The T cell actions the appropriate immune response 
responsible for distinguishing the body’s tissues from pathogens; while proteins found on the 
surface of activated B cells, dendritic cells, monocytes and macrophages are involved in 
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increasing the immune response (Kay & Anderson, 2008).          
 The immune system communicates with the brain through a bidirectional systemic 
network, in which the immune system alerts the brain to events occurring in the body (Maier & 
Watkins, 1998). Neuro-immune interactions involve communication between a number of 
substances, including hormones, neurotransmitters and cytokines (Lekander, 2002). Immune 
cell activation occurs in response to potential injury and functions to protect the body and 
promote recovering. The immune system is regulated by the neuro-endocrine system and 
responds not only to infectious agents and physiological threat but also to psychosocial 
stressors. Immune related changes therefore affect the physical body as well as cognitions, 
emotions, motivation and behaviour (Lekander, 2002; Maier & Watkins, 1998). Changes that 
involve dysregulation of the immune system have been implicated in psychological conditions 
such as depression and immune related diseases (Maier & Watkins 1998), such as  
scleroderma.                      
  Therefore factors that may provide a protective function in relation to the immune 
system (scleroderma symptoms) and psychological conditions (e.g., depression) such as 
elements of self-compassion (e.g., self-kindness, and mindfulness), that may provide an 
individual with the capacity to return the body to a state of calm by reducing arousal, were  
examined to determine this relationship.                                                                                             
Scleroderma: Gastrointestinal Conditions         
  Gastrointestinal conditions have also been associated with autoimmune diseases such as 
scleroderma (Bolster & Silver, 2008) and psychosocial variables that include stress, anxiety 
and depression, (Nietert et al., 2005; Tache, Martinez, Million & Wang, 2001). Tache and 
colleagues suggested that stress can alter gastrointestinal functioning as part of the 
physiological response to stressors and that the brain is involved in mediating the inhibition of 
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the upper, and stimulation of the lower gastrointestinal system in response to stress. These 
physiological reactions to stress were also found to be associated with anxiety and depression  
(Tache et al., 2001) and were factors investigated in the current study. 
Autoimmune Diseases and Psychosocial Stress    
        Research suggests autoimmune diseases such as scleroderma are the result of interactions 
between factors an individual encounters in the environment, such as experiences of stress and 
trauma and predisposing aspects, such as those involving a person’s genetic makeup (e.g., 
Chapel et al., 2006). Psychosocial stress is associated with the onset and/or exacerbation of 
many autoimmune diseases (e.g. Ackerman et al., 2002; Matos-Santos et al., 2001; Pawlak et 
al., 2003). Research has found that systemic lupus erythematosus disability was associated with 
more experiences of stressful life events (Da Costa et al., 1999). Stressful life events were also 
experienced by individuals diagnosed with Graves’ disease before onset (Matos-Santos et al., 
2001). Boscarino (2004) found an association between the development of autoimmune 
diseases, such as hypothyroidism, rheumatoid arthritis and psoriasis in Vietnam veterans 
experiencing posttraumatic stress disorder (PTSD). Some studies have also found that stress 
was associated with scleroderma (Chen et al., 2008; Hui et al., 2007; participants experienced a 
number of stress events before onset of disease) and breast cancer (e.g., Dube et al., 2009); 
however, the relationship between scleroderma disease symptoms and stress was not examined 
in these studies and require investigation.          
 A study conducted in the USA investigated the effects of adverse childhood experiences 
(ACE) such as childhood physical, emotional, and sexual abuse. In this ACE study the total 
number of adverse experiences (ranging from zero to eight), measured cumulative childhood 
stress. The results demonstrated that as the number of traumatic events in childhood increased, 
the likelihood of being hospitalised with an autoimmune disease decades into adulthood 
increased; indicating the likelihood of biological impacts of early life stress on subsequent 
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inflammatory responses (Dube et al., 2009). Female participants in this study were found to 
have a 50% greater likelihood than men for hospitalization with a Th2 category autoimmune 
disease (such as scleroderma). Indicating that the number of traumatic events experienced in 
childhood may influence physiological processes such as inflammation involved in the 
development of autoimmunity. The influence early life experiences may have on the 
development of autoimmunity has been explored through the measurement of number of stress 
events experienced by individuals. The current study explored early life stress experiences and 
this relationship to scleroderma symptomology by measuring an individual’s experiences of 
nurturing and feelings of safety. This way of exploring stress relies on the individual’s response 
to experiences, rather than measuring exposure to an event that an individual may or may not 
have experienced as stressful or traumatic. Dube and colleagues concluded (from the ACE 
study) that experiencing multiple trauma or stress events in early life may impact on the 
developing brain and affect the limbic system, an area of the brain that responds to emotions. 
Frequent activation of the stress response on a young person’s central nervous system, may 
contribute to the dysfunction of the immune system increasing the risk for developing an 
autoimmune disease (Dube et al., 2009).      
  The current study therefore investigated the relationship (not previously explored) 
between adverse childhood experiences investigated as early memories of warmth and safety 
and scleroderma symptoms. These variables were explored to determine the impact early life 
experiences may have had on the development and/or exacerbation of scleroderma symptoms.                                                              
Scleroderma            
  Scleroderma is a rare and complex autoimmune-connective tissue disease affecting 
approximately 1 in 4,000 in the population and more commonly diagnosed in women. It is a 
multistage, multisystem, chronic disease that affects the organs, musculoskeletal and vascular 
systems (LeRoy & Medsger, 2001; Varga, 2004). Scleroderma is generally diagnosed in people 
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aged between 30 to 50 years and has a mortality rate of approximately 30% within the first five 
years of diagnosis. Scleroderma is one of the most complex and least understood of all 
autoimmune diseases. Individuals are afflicted with a range of symptoms that differ across this 
population and include, Raynaud’s  phenomenon, skin hardening, intestinal conditions, 
breathing problems, internal organ involvement and pain (e.g., Etkin et al., 2005; Giuggioli, 
Manfredi, Colaci, & Ferri, 2010; Varga, 2004).                                                                     
Categories of Scleroderma: Scleroderma can be categorised as localised, linear or generalised 
(e.g., Chapel et al., 2006). The generalised form is the most common type and contains two 
major subsets of scleroderma, diffuse systemic sclerosis is present in 35% of individuals 
diagnosed with scleroderma and limited systemic sclerosis affects 60% of individuals with 
scleroderma; other forms of scleroderma such as sine scleroderma, linear scleroderma and 
morphia are considerably less prevalent (Hinchcliff & Varga, 2008). Limited sclerosis also 
known as limited cutaneous disease or CREST syndrome (calcinosas, Raynaud’s phenomenon, 
esophagal dysmolity, scleradactal and telangiectasias), is the most common type of 
scleroderma. Skin thickening of the fingers is a primary feature of scleroderma; the extent of 
skin thickening and pace of disease progression differentiates diffuse scleroderma from limited 
scleroderma (Bolster & Silver, 2008). Skin symptoms are a general gauge of overall severity of 
scleroderma symptoms (Steen & Medsgar, 2001). People diagnosed with limited sclerosis, do 
not necessarily meet the full criteria for CREST syndrome but exhibit skin thickening features 
that may appear on the face, fingers and forearms.        
 Diffuse sclerosis has a more rapid onset than the limited form of the disease; symptoms 
include swelling of the hands and legs, carpal tunnel arthritis, Raynaud’s phenomenon and 
fatigue. Skin thickening is also a feature of diffuse scleroderma with rapid progression 
beginning in the extremities and advancing to the trunk early in the disease course. Both 
diffuse and limited scleroderma subsets have similar gastrointestinal disease and interstitial 
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lung fibrosis symptoms, these symptoms are present in those with anti-Scl-70 (an autoantibody 
used to determine diagnosis; Bolster & Silver, 2008).           
 The two major scleroderma-subsets are classified according to specific autoantibodies. 
The anti-topoisonerase or anti-Scl-70 and AntiRNA polymerase 111 are associated with diffuse 
scleroderma and the anticentromere antibody is present in limited scleroderma, with 
approximately 25% of this population also exhibiting the antitopoisonerase antibodies. The 
presence of anti-topoisonerase increases the risk of pulmonary interstitial fibrosis, renal crisis, 
cardiac involvement and poorer survival. AntiRNA polymerase 111 is an antibody specific to 
scleroderma and present in 28% of this population. It most commonly occurs in diffuse 
scleroderma, rarely in limited scleroderma and is associated with rapid skin progression and 
renal crisis. Survival rates are greater in this population than those with anti-Scl-70 (Smith & 
Kalhaleh, 2008).             
 African-Americans and a Choctaw Native American Tribe have higher prevalence rates 
and earlier onset of scleroderma than Caucasians, with the antibodies associated with more 
severe prognosis occurring more frequently in this population. Scleroderma has also been 
reported in Australian aborigines although a formal study has not been undertaken. Antibodies 
may represent the body’s reaction to different triggers of the disease; however, the varying 
frequency of different antibodies suggests that ethnicity and genetics are likely to be factors 
involved in the pathogenesis of scleroderma (Steen, 2008).                                             
Pathogenesis of Scleroderma                                                             
 The pathogenesis of scleroderma is very complex; genetic variables influence collagen, 
vascular and immune function and are further complicated by environmental factors (Smith & 
Kalhaleh, 2008; Steen, 2008). Antibodies explain differences between presenting symptoms for 
different scleroderma subsets; however what initiates and perpetuates this disease is still 
unclear. Altered functioning of the endothelial cells and immune dysfunction has been 
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implicated in disease activity. Anti-endothelial antibodies are evident in 40-50% of the 
scleroderma population and have been found to positively correlate with pulmonary pressure 
and digital ulcers and negatively with pulmonary diffusion capacity (Smith & Kahaleh, 2008). 
Endothelial cells make up the inner lining of a blood vessel and interact with the circulation 
system to regulate mechanism such as immunological and inflammatory responses (Sumpio, 
Riley, & Dardik, 2002). Neural pathways control blood flow regulation and arterial pressure 
through sympathetic activation of blood vessels; constricting arteries and smaller arterioles. 
This action involves the chemicals norepinephrine, epinephrine and occurs during situations 
such as exercise and emotional stress. Endothelial cell dysfunction occurs in many immune 
related diseases (Sumpio et al., 2002). As emotional stress is involved in immune 
dysregulation, the current study examined interpersonal and intrapersonal emotional stress 
experiences, including childhood stress, attachment style and emotion regulation strategies 
(levels of self-compassion and suppression) and the relationship to scleroderma symptoms.                                
Scleroderma Symptoms: Raynaud’s and Stress        
 Vascular abnormalities are the first symptom of scleroderma with Raynaud’s 
phenomenon affecting approximately 95% of people diagnosed with scleroderma. Raynaud’s 
phenomenon in individuals diagnosed with limited scleroderma may precede the inflammatory 
skin stage and other symptoms of the disease by many years or in some cases decades. The 
onset of Raynaud’s phenomenon in diffuse scleroderma generally occurs shortly before or in 
conjunction with a diagnosis of scleroderma. Raynaud’s phenomenon involves the constriction 
of blood vessels, resulting in arterial closure (Smith & Kahaleh, 2008) in the fingers and less 
frequently the toes and facial area. It is induced by cold or emotional stress (Bolster & Silver, 
2008). Research by Freedman and Ianni (1983) suggests that individuals diagnosed with both 
scleroderma and Raynaud’s are likely to experience heightened reactions to stress. Recurring 
and prolonged vascular constriction often leads to ulcers, gangrene and amputation. Vascular 
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complications are not confined to the peripheral areas of the body, internal organs are also 
involved. The kidneys are affected by vascular complications with renal crisis involved in 
changes to blood vessels which is an early feature of diffuse scleroderma, while pulmonary 
artery hypertension is present in limited scleroderma (Baker & Denton, 2008). As research 
suggests that emotional stress is involved in Raynaud’s symptoms and that individuals who 
experience both scleroderma and Raynaud’s phenomenon, experience a greater physiological 
response to stress; the current study explored early life stress experiences in relation to 
Raynaud’s onset and the relationship between these factors and scleroderma. Determining the 
influence specific types of stress may have on the development and/or exacerbation of 
scleroderma disease symptoms, may inform therapeutic treatment involving the management of 
stress in this population, to reduce symptomology and improve quality of life.                       
Scleroderma Symptoms: Pulmonary/Breathing and Gastrointestinal Conditions  
 Pulmonary disease in scleroderma is the most common cause of death and generally 
includes pulmonary arterial hypertension (PAH; prevalence 12% Mukerjee et al., 2003) and/or 
intestinal lung disease (prevalence 75%: Bussone & Mouthon, 2011; Smith & Kahaleh, 2008). 
In a study in 2003 the three year survival rate for PAH was 56% ( Mukerjee et al., 2003) and 
for pulmonary fibrosis, a study by Steen & Medsger in 2006 revealed the ten year survival rate 
at 67%. Fibrosis also features throughout the body and is the result of a build- up of 
extracellular matter such as collagens and fibros mater in the lower layer of the skin (dermis), 
heart, kidneys, lungs and gastrointestinal tract (Smith & Kahaleh, 2008). Gastrointestinal 
involvement is generally the first manifested scleroderma symptom after Raynaud’s 
phenomenon and is present in most scleroderma patients. The whole gastrointestinal system 
may become involved resulting in conditions such as fibrosis, smooth muscle atrophy, 
gastroesophageal reflux, malabsorption, diarrhoea, constipation, nausea, abdominal pain, 
anorexia and weight loss (Bolster & Silver, 2008). Gastrointestinal conditions have been 
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associated with stress and research has shown that stress can alter gastrointestinal functioning 
as part of the physiological response to stressors. The brain is also involved in mediating the 
inhibition of the upper and stimulation of the lower gastrointestinal system in response to 
stress; these physiological reactions to stress are also associated with anxiety and depression 
(Tache et al., 2001). Gastrointestinal and breathing conditions have not been investigated in 
relation to psychosocial stress and scleroderma and were therefore investigated to determine 
the relationship between interpersonal (early life and attachment experiences) and intrapersonal 
stress (emotion regulation e.g., levels of self-compassion), mental health (depression and 
anxiety), biological responses to stress (hyper-arousal) and scleroderma symptoms. Whether 
some stress experiences were more likely to influence the onset or exacerbation of specific 
scleroderma symptoms when compared to other stress experiences were also investigated.   
Scleroderma Symptoms: Skin and Musculoskeletal Involvement      
 Musculoskeletal involvement is frequently experienced by patients with scleroderma 
and may involve such conditions as arthritis, inflammation, fibrosis, joint flexion problems, 
tendon friction rubs and tendon sheath pain often resulting from fibrin and collagen deposits; 
limiting movement of the tendons. Generally the fingers, wrists, elbows, ankles and knees are 
affected by this condition (Bolster & Silver, 2008) and there is further complication of skin 
thickening. T to B cells are implicated in the disease with an increased ratio of CD4 to CD8 T 
cells. CD8 T cells occur in the lungs and CD4 T cells predominate in the skin (Smith & 
Kahaleh, 2008).           
 The skin tends to progress through three stages of change during the course of 
scleroderma, these include inflammation, skin fibrosis and skin softening. In the initial stage 
the hands and fingers become puffy, sweat and oil excretion is reduced resulting in dry, 
cracked skin, poor wound healing, and ulcers on the digits and joints. This stage may continue 
for months at which time skin thickening begins to occur. Once the inflammation has subsided, 
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a protracted skin fibrosis stage may occur. Thickening of the skin generally begins in the 
fingers and may progress to the elbows, from the toes to the knees and affects the face and neck 
in limited scleroderma. In diffuse scleroderma skin thickening may progress to the trunk and all 
areas of the arms and legs. The third stage involves a softening of the skin typically on the 
trunk and upper arms for the diffuse form (Bolster & Silver, 2008). The level of skin 
involvement is a general gauge of overall severity of scleroderma symptoms (Steen & 
Medsgar, 2001).          
 Therefore the relationship between psychosocial stress variables and severity of skin 
involvement needs to be investigated to determine whether specific interpersonal and 
intrapersonal stress experiences, influence the level of skin involvement and overall symptom 
severity in individuals diagnosed with scleroderma. The current study also examined these 
aspects.                                                                                                                                          
Incidence of Scleroderma                        
 The prevalence rates of scleroderma (also known as systemic sclerosis) vary 
considerably and are dependent on the time period, the disease definition of cases and the 
country in which the study was completed. Chifflot and colleagues (2008) completed a 
systematic literature review and reported prevalence rates of scleroderma from studies 
conducted between 1969, to 2006. These rates varied from seven people per million to 
approximately 500 per million and were higher in the United States of America (276 per 
million) and Australia (233 per million) and lower in France (158 per million) and England (88 
per million). Similar to other connective tissue diseases, systemic sclerosis has a greater 
incidence in the female population with predominance of 3-5:1, and up to 14:1 in some 
populations. The female-to-male ratio is greatest in child bearing years. In the postmenopausal 
age range, the ratio is at its lowest, 2.4:1 and in children; girls develop the disease more 
frequently than boys. Age of onset generally occurs between 30 and 50 years, with a mean age 
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of onset occurring in Caucasian males at 44 years and 42 years of age in females (Chifflot, 
Fautrel, Sordet, Chatelus, & Sibilia, 2008).            
 Prevalence rates are similar for both the major subsets of scleroderma (limited and 
diffuse sclerosis), although patients with limited scleroderma are not usually diagnosed until 5-
10 years after onset of symptoms (Chifflot et al., 2008). Family studies have shown an 
increased frequency of scleroderma in first-degree family members. Prevalence rates for 
biological relatives with scleroderma reported in the United States of America (USA) were 
found to be higher than prevalence rates in the general population. A study by Arnett and 
colleagues (2001) compared prevalence rates of scleroderma in the USA with that of first 
degree relatives; findings revealed that approximately 1.6% of families had members 
diagnosed with scleroderma, which was significantly higher than in the general population.  
These results suggest that having a first degree relative with scleroderma is a risk factor for 
developing scleroderma, although the absolute risk factor for any individual family member is 
less than 1% (Arnett et al., 2001). Therefore genetic factors may not be the greatest risk for 
developing scleroderma.                   
 Stress factors such as emotion regulation strategies that effectively or ineffectively 
reduce stress, that may have resulted from early life experiences (factors explored in this study) 
may play a role in the development of scleroderma; through the frequent triggering of stress 
chemicals involved in autoimmunity. Stress experiences may not only impact on specific 
scleroderma symptoms but also on individual’s experiences of pain resulting from scleroderma 
symptoms. Stress variables such as attachment style, emotion regulation and childhood stress 
require examination in the current study, as these factors have been associated with experiences 
of pain in other studies (e.g., Davies, Macfarlane, McBeth, Morriss, & Dickens, 2009; Thakkar 
& McCanne, 2000) and would provide further understanding as to the influence certain types 
of stress may have on pain, one of the major disease factors associated with scleroderma.                                                                                                                             
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Scleroderma Pain and the Biopsychosocial Model                                                            
 Pain is a common experience associated with scleroderma and is a predictor of level of 
physical functioning (Benrud-Larson et al., 2002), disability (Miller, Rehberger, Gunther,  
& Schmitt, 2012) and psychological factors such as depression (Benrud-Larson et al., 2002;   
Miller et al., 2012). Pain has been described by the International Association for the Study of 
Pain as an unpleasant physiological and emotional sensation that acts to protect the body from 
tissue damage (ISAP, 2012). The biopsychosocial model emphasises that pain is a multifaceted 
experience that may be explained by biological factors such as tissue damage, while 
acknowledging the influence of social and psychological aspects (Keefe, Porter, & Labban, 
2006). Pain is a complex phenomenon and is acknowledged as a sensory, emotional and 
cognitive experience, as it involves attention and interpretation that occurs at a neurological level. 
Pain is more than a sensory experience as the association between tissue injury and the level of 
pain experienced is low. The extent to which tissue is damaged, is not necessarily an indicator 
of pain intensity (Lee-Chiong et al., 2010). As pain is recognized as a private experience that 
differs between individuals (Lee-Chiong, Gebhart, & Mattay, 2010); and as the amount of tissue 
damage isn’t always related to the level of pain experienced; the current study examined the 
relationship between psychosocial stress variables and individual experiences of scleroderma 
pain, to determine the influence early life and attachment experiences and also emotion 
regulation strategies could have on scleroderma related pain.     
           Physiologically elevated or excessive experiences of pain may be the result of nociceptors 
that are sensitive to tissue damage and react to changes such as inflammation, a condition 
involved in scleroderma. This effect may create an over sensitivity to pain due to over stimulation 
or irritation, resulting in a lowering of the nociceptors’ firing threshold, increasing the 
responsiveness to painful stimuli; and in some cases hypersensitivity to non-dangerous stimuli. 
These experiences activate reflexes in a number of structures including the spinal cord, 
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brainstem, cortex and limbic (or emotional) system. These experiences distort the relationship 
between the degree of tissue damage and the extent to which pain intensity is  
perceived by the individual (Lee-Chiong et al., 2010).            
  The emotional effects of pain have been associated with negative emotions such as 
depression, anxiety and anger (Tan, Jensen, Thornby, & Sloan, 2008). Burns (2006) found that 
emotional responses associated with muscle tension were linked to elevated pain. Pain related 
emotions were also found to influence perceptions of pain and physiological reactions to pain. 
Rainville and colleagues found that pain-related anger/frustration and sadness, a desire for 
relief from pain, decreases in perceived control of pain and increases in arousal levels were 
associated with elevated experiences of pain (Rainville, Boa, & Chretien, 2005).   Pain is 
associated with many scleroderma symptoms such as those involving the skin and 
musculoskeletal system (Miller et al., 2012). Pain can become chronic for individuals suffering 
severe complications due to disease symptoms, such as Raynaud’s phenomenon and skin ulcers 
that can become gangrenous requiring amputation and creating further disability (Giuggioli, 
Manfredi, Colaci, & Ferri, 2010). These conditions have also been linked to psychological 
problems such as depression (Benrud-Larson et al., 2002; Miller et al., 2012).  Research 
exploring emotions in relation to how people experience pain in other illness populations has 
found a range of psychosocial variables associated with pain occurrence.  Pain research has 
linked psychosocial factors such as insecure attachment, emotion regulation and childhood 
stress with experiences of pain.                            
             Research suggests exposure to early life stress may influence an individual’s 
developing brain, the capacity to regulate emotions and reduce arousal in stressful situations 
across the lifespan, pain thresholds and the immune system (Depue, & Morrone-Strupinsky, 
2005; Heit, Graham, & Nemeroff, 1999; Schore, 1994). Early life stress including child abuse 
has been linked to heightened stress in adults, physical illness and pain. Research suggests 
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individuals exposed to childhood abuse experienced an increase in physical symptoms that 
include gastrointestinal, respiratory, muscular and other types of pain (Thakkar & McCanne, 
2000) and a greater likelihood of developing serious health conditions such as an autoimmune 
disease, ulcers, cancer, heart disease or diabetes (Sachs-Ericsson, Blazer, Plant, & Arnow, 
2005). Therefore the emotional aspects of pain in relation to the capacity to effectively regulate 
emotions that may be influenced by early life experiences are factors investigated in this study 
in relation to pain associated with scleroderma.     
  Further evidence that pain is influenced by early psychosocial stress was reported by a 
number of researchers. Jones and colleagues found a relationship between childhood physical 
and psychological adversity and chronic pain in adulthood when compared with individuals 
who were not exposed to these experiences (Jones, Power, & Macfarlane, 2009). Greater scores 
were also reported by individuals who had experienced childhood trauma in relation to severe 
pain when compared with individuals without these experiences (Dragkioti, Mavreas, 
Damigos, Kotrotsiou, & Gouva, 2011). Individuals with chronic pelvic pain who had 
experienced past abuse histories and utilized the emotion regulation strategy suppression of 
unwanted thoughts, were also likely to experience higher levels of pain (Thomas, MossMorris, 
& Faquhar, 2006). Emotion regulation and early life experiences associated with stressful 
attachment interactions have also been linked to pain reactions. The development of certain 
attachment styles associated with an inability to regulate stress and emotions has also been 
linked to an increased vulnerability to stress, pain and disease. For example, Davies, 
Macfarlane, McBeth, Morriss, and Dickens, 2009 found that insecure attachment styles, 
(preoccupied, fearful and dismissive) were associated with approximately twice the experience 
of chronic widespread pain as other types of attachment. McWilliams, Cox, and Enns (2000) 
found that individuals experiencing chronic pain due to arthritis and an insecure anxious 
attachment style reported greater pain intensity and disability (Martinez, Miro, Sanchez, 
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Mundo, & Martinez, 2012). Research suggests that increased pain is associated with a number 
of psychosocial stress experiences including regulating and expressing emotions, and also 
factors related to early relational experiences such as an insecure attachment style and 
childhood experiences of stress. However, these factors have not been explored in relation to 
scleroderma pain and disability and therefore, were examined in the current study.                           
Psychological Factors and Scleroderma                                 
  Scleroderma is not limited to the physiological aspects of disease; a number of studies 
have demonstrated a link between scleroderma and psychopathology (Angelopoulos et al., 
2001; Richards et al., 2004; Roca et al., 1996). These studies suggest that people diagnosed 
with scleroderma tend to have a co-morbid psychological status, with depression the most 
studied (Angelopoulos et al., 2001; Roca et al., 1996; Thombs, Hudson, Taillefer, & Baron, 
2008). These psychological conditions create an added burden for people facing adjustment to 
this disfiguring, debilitating and potentially fatal disease. Psychological conditions such as 
depression, anxiety (Legendre, Allanore, Ferrand, & Kahan, 2005), fear of negative evaluation, 
social anxiety (Richards et al., 2004) anxiety, somatisation, obsessive compulsive disorder, 
interpersonal sensitivity, guilt (Angelopoulos et al., 2001), hostility, defensiveness 
(Angelopoulos et al., 2001; Hyphantis et al., 2007), aggression (Hui et al., 2007), self-blame 
and limited social support (Malcarne & Greenbergs 1995), have all been examined in relation 
to scleroderma. Scleroderma researchers have also focused on factors concerning aspects of 
the disease such as coping with and adjustment to scleroderma, body image satisfaction and 
illness perception (e.g., Angelopoulos et al., 2001; Richards et al., 2004; Roca et al., 1996). 
Research has also explored stress experienced by individuals diagnosed with scleroderma. A 
few studies found that stress events, emotional stress and recurrent infections were reported 
before or during onset of scleroderma (Hui et al., 2007). Stress events were also experienced 
by individuals in the year before onset of scleroderma, with scleroderma patients reporting 
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significantly greater scores on measures of stress experiences, than non-scleroderma 
participants (Chen et al., 2008). However these experiences were not directly linked to disease 
symptoms or severity.                                                   
        Notably much of the research on scleroderma has found negative physical, psychological 
and social implications for the person diagnosed with this disease (e.g.,  
Hyphantis et al., 2007; Malcarne & Greenbergs, 2005; Richards et al., 2004). Research to date 
has mostly focused on psychosocial aspects in relation to disease severity and coping with and 
adjustment to a diagnosis of scleroderma (e.g., Angelopoulos et al., 2001; Richards et al., 2004; 
Roca et al., 1996). Although people diagnosed with scleroderma appear to suffer a range of 
psychological problems these factors have received limited investigation, with the exception of 
depression. Several studies have focused on the high prevalence of depression in this 
population, with mixed findings. Studies reported mild to severe depression in 33% to  
65% of scleroderma subjects (e.g., Angelopoulos et al., 2001; Beretta et al., 2006; Roca et al., 
1996; Thombs et al., 2007). Depression is associated with some aspects of scleroderma such as 
pain, illness perception and body image satisfaction (e.g., Angelopoulos et al., 2001; Roca et 
al., 1996). A number of studies suggest that depression is associated with the disease process 
with higher levels of depression associated with more severe disease symptoms (Beretta et al., 
2006; Thombs et al., 2007). Legendre and colleagues (2005) found that scleroderma was 
associated with a high prevalence of depression (43%) and anxiety (83%). Nietert and 
colleagues (2005) found that 36% of scleroderma patients reported experiencing depression, 
with higher levels of depression associated with cardiac involvement and reduced functioning 
of the gastrointestinal tract. Hyphantis and colleagues found that higher levels of depression 
were linked with esophageal problems, while elevated levels of anxiety were associated with 
pain related arthritis (Hyphantis et al., 2007). A study by Benrud-Larson and colleagues found 
that 50% of individuals diagnosed with scleroderma reported depressive symptoms, with 
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higher scores associated with pain (Benrud-Larson et al., 2002). Research to date that has 
focused on psychopathology associated with scleroderma, found that a majority of individuals 
diagnosed with scleroderma experience depression and anxiety related to both disease 
symptoms (such as gastrointestinal, cardiac, pulmonary and arthritis related pain), and 
psychosocial factors (including helplessness, hostility, defensiveness, and interpersonal 
sensitivity) (e.g., Angelopouloset al., 2001; Hyphantis et al., 2007; Legendre et al., 2005; 
Nietert et al., 2005). Depression and anxiety are therefore conditions that are likely to impact 
on scleroderma symptoms and psychological health.  
However; the, origins of depression and anxiety in scleroderma have received little attention.  
 Early life experiences, emotions and cognitions and the physiological impacts on the 
immune system in relation to symptom severity and early onset may influence levels of anxiety 
and depression. These aspects have not been examined in relation to scleroderma and hence are 
explored in the current scleroderma study. Psychosocial variables associated with depression 
and anxiety, such as early memories of warmth and safeness, adult attachment and emotion 
regulation styles, levels of self-compassion and scleroderma onset were therefore explored. 
Physiological disease symptoms, breathing and intestinal problems, Raynaud’s phenomenon, 
finger ulcers, skin involvement, pain and disability also need to be explored in relation to 
severity of depression and anxiety to further inform the literature on predictors of scleroderma 
symptoms. The current study examines these aspects in a comprehensive approach that strove 
to systematically link scleroderma and psychosocial stressors.                                           
Social Stressors, Autoimmune Diseases and Scleroderma        
  A few studies have found that people diagnosed with scleroderma have experienced 
stressful life events prior to the onset of scleroderma (Chen et al., 2008; Hui et al., 2007). Hui 
and colleagues reported that individuals diagnosed with scleroderma experienced stress events, 
emotional stress and recurrent infections before or during onset of scleroderma (Hui et al., 
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2007); while Chen and colleagues found that stress events were also experienced by individuals 
in the year before onset of scleroderma, with scleroderma patients reporting significantly 
greater scores on measures of stress than non-scleroderma participants (Chen et al., 2008). 
However neither of these studies explored stress experiences in relation to scleroderma onset, 
symptoms or disability, examined in the current study.      
  Research that has examined psychosocial factors associated with the onset or 
exacerbation of other autoimmune diseases has revealed a relationship with stress events (e.g., 
Akerman et al., 2002; Da Costa et al., 1999; Matos-Santos et al., 2001). Although stress is 
reported as a risk in the development of autoimmunity (e.g., Boscarino, 2004; Schore, 1994) a 
paucity of research has investigated stress and scleroderma.          
           As experiences of stress are common and the research available suggests that individuals 
with scleroderma may experience stress events as more overwhelming or threatening than 
individuals not diagnosed with scleroderma (Freedman & Ianni, 1983); research is needed on 
how stressful life experiences impact scleroderma symptoms and factors associated with 
coping with stress reactions. Research suggests stress and stressful life events are associated 
with autoimmunity (e.g., Akerman et al., 2002; Arnetz & Ekman, 2006; Boscarino, 2004; Da 
Costa et al., 1999; Heit et al., 1999; Matos-Santos et al., 2001; Schore, 1994; 2002; 
Stojanovich & Marisavljevich, 2008); and scleroderma (Chen et al., 2008; Hui et al., 2007).   
 Stress events can occur at any time across the lifespan and may begin in childhood. 
Adverse early life experiences can affect an individual’s adaptive functioning in adulthood, 
influencing emotional and cognitive responses and strategies to manage stress and distress. The 
relationship between emotion regulation, stress and scleroderma has not been examined and 
these variables were therefore explored in the current study.      
  Gilbert and colleagues have explored early negative life experiences and suggest these 
experiences influence the development of the threat system and negative reactions. Gilbert 
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proposed that early life experiences deprived of warmth and safety, generally stimulate the 
threat system (Gilbert, 2000; Gilbert, 2002; Gilbert et al., 2006) and condition individuals to 
employ a range of negative emotional, cognitive and behavioural strategies (Gilbert, 2002; 
Gilbert et al., 2008; Irons, Gilbert, Baldwin, Baccus, & Palmer, 2006). These strategies involve 
avoidance behaviours and emotion suppression (Gross, 2002), and enable the individual to 
avoid or disengage from the threatening situation (Langens & Morth, 2003).    
 Gilbert (2002) suggested that the development of self-compassion increases the capacity 
to self-sooth and down regulate the threat system. The development of this strategy is generally 
facilitated through early nurturing experiences that include attachment behaviours. Early 
attachment experiences reflect adult feelings of security and emotional responses. Attachment 
behaviours reflect proximity seeking to attachment figures for protection from threat, 
facilitating emotion regulation responses through the provision of distress relief and reduction 
of heightened levels of arousal (Bowlby, 1997). The inability to reduce arousal levels affects 
immune functioning and is a risk in the development of autoimmunity (e.g., Schore, 1994), 
thus linking scleroderma to factors involving elevated arousal and the exploration of variables 
involved in hyper-arousal in the current study.   
  Unlike the inability to regulate emotions associated with early threat experiences, Neff 
(2003a; 2003b) suggested that self-compassion increases the capacity for self-care, reducing 
feelings of isolation by increasing feelings of connectedness to the suffering of other human 
beings. Self-compassion reflects an ability to positively regulate emotions that leads to 
increased feelings of autonomy and the capacity to provide care and compassion for both self 
and others. Higher levels of self-compassion unlike negative ways of relating to one’s self are 
associated with positive health outcomes (Neff, 2003a; Reyes, 2011).     
  Individuals diagnosed with scleroderma tend to have a heightened stress response 
(Freedman & Ianni, 1983), when compared with individuals without scleroderma. This 
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response is likely to be linked to feelings associated with fear or threat and the ability to self 
sooth; and may reflect an inability to regulate emotions through self-compassion. Self-
compassion (low), emotion regulation (suppression) and attachment styles (dismissive and 
fearful) that may invoke a stress response have not previously been explored in relation to 
scleroderma and were therefore examined in the current study.                 
 Psychosocial aspects associated with managing stressful experiences and the related 
cognitive and emotional appraisal that may generate ineffective coping strategies associated 
with physiological arousal, immune dysregulation and psychopathology have not been 
investigated in relation to scleroderma disability and specific symptoms, such as Raynaud’s 
phenomenon and pain. As experiences of stress before diagnosis of scleroderma have been 
scarcely investigated, this study set out to explore early memories of warmth and safeness and 
associated variables, such as how individuals with scleroderma relate to the self (self-
compassion) and others (attachment styles), emotion regulation strategies (suppression, 
reappraisal) and levels of hyper-arousal and anxiety and depression, to evaluate the relationship 
between stress and scleroderma symptoms and onset.                                    
Comparison Study - Community Group: While the study examined scleroderma, a comparison 
with another group of individuals without a diagnosis of scleroderma (study two) will be 
investigated as research demonstrates individuals diagnosed with scleroderma tend to have a 
heightened stress response (Freedman & Ianni, 1983), significantly greater scores on measures 
of stress (Chen et al., 2008) and experience greater levels of depression (e.g., Angelopoulos et 
al., 2001; Beretta et al., 2006; Roca et al., 1996), when compared to individuals without 
scleroderma. As experiences of stress and depression appear to be greater for people with 
scleroderma, exploring differences in psychosocial variables between people with and without 
scleroderma, may provide further understanding of what influences this disease.                                                                                                                                
Comparison Study – Illness Group: A comparison study (3) with a different immune related 
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illness (a depressed immune system: breast cancer, compared with an over-reactive immune 
system: scleroderma) was also investigated to aid understanding as to whether similar (and/or 
different), psychosocial variables investigated in the first study also applied to another illness 
group. Breast cancer was chosen as the comparison group as it is an immune related disease 
that is more prevalent in women than men (as is the case for scleroderma).                                                                                                                
Cancer and Psychosocial Stress         
 Researchers suggest stress is associated with dysregulation of the immune system and is 
associated with other immune related diseases (that do not involve autoimmunity). Cancer 
related diseases unlike autoimmune diseases (that involves a hyper-responsive immune system) 
that attack healthy tissue (Smith & Kalhaleh, 2008) are associated with immune suppression 
(Whiteside, 2006). Biopsychosocial cancer studies have found associations between stress and 
individuals diagnosed with cancer. Research suggests an association with neuroendocrine-
immune changes, psychosocial stress and an increased risk of cancer (Sephton & Spiegel, 
2003; stress aspects are further explored in the literature review in study three related to breast 
cancer and the group comparison study). Scleroderma researchers have not previously 
compared differences in stressors in individuals with different immune responsive diseases 
such as cancer. The current study therefore investigated differences in the type of stressors 
experienced and/or strategies used to regulate emotions; in diseases that involve different 
immune responses (scleroderma: hyper-responsive and breast cancer: suppressed) and whether 
these experiences were linked to onset and increased symptomology of the respective diseases.    
 Breast Cancer: Research suggests that stress and trauma can significantly impact on an 
individual’s immune system and may result in the development of disease. However the 
chemicals involved in the stress response in breast cancer may not always be related to 
psychosocial factors (Abercrombie et al., 2004; Spiegel, Giese-Davis, Taylor, & Kraemer, 
2006). There are a number of known genetic, gender and physiological risk factors associated 
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with breast cancer, such as being female, having a family history of breast cancer, oestrogens 
and age of onset (Mavaddat et al., 2010; Eeles et al., 2004), as well as personal stress 
experiences (Palesh et al., 2007). As stress experiences are involved in the mechanisms 
associated with immune responses and autoimmune diseases, it is possible that different 
psychosocial variables as well as physiological factors may be associated with these two 
diseases.           
 Therefore the examination of difference and similarities in variables that are related to 
stress and disease were explored in the current study in relation to scleroderma and breast 
cancer; to determine the degree psychosocial stress influences onset and exacerbation of the 
respective diseases. Also investigated were more positive ways of relating to self through 
investigation of self-compassion; to determine whether difference occurred between illness 
groups for positive and negative interpersonal relating and the influence these experiences may 
have on disease symptoms and age of onset.                                                                                             
The Current Study                    
 The current study compared immune (hyper-reactive and depressed) and non-
autoimmune related conditions. Therefore the dependant variable across the three groups was 
type of immune related disease/no disease. This variable was hypothesised to account for 
differences between groups for levels of psychosocial experiences/functioning and in relation 
to disease onset and symptomology. This research project therefore investigated differences in 
psychosocial variables in individuals diagnosed with scleroderma, individuals diagnosed with 
breast cancer and individuals from a community sample, to determine stressors associated with 
psychological and illness related symptoms. This was determined by comparing early life 
experiences measured as early memories of warmth and safety and adult attachment style, 
emotion regulation (e.g., self-compassion) and mental health. Hyper-arousal and different 
factors associated with elevated disease symptoms and disease onset were also examined.   
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  As stressors during childhood development can induce biological, psychological and 
behavioural responses likely to impact on immune functioning (for example the development 
of serious illness such as autoimmune diseases; Sachs-Ericsson et al., 2005) and subsequently 
adult ill health, the current study examined early life experiences and emotional and cognitive 
functioning (that may have developed in childhood) in adulthood in immune related diseases, 
scleroderma and breast cancer. These factors were investigated to determine whether 
differences occurred in experiences of stress and the management of stress (levels of self-
compassion); and whether these experiences were related to the onset and/or levels of severity 
of disease symptoms and psychological injury in these individuals.                 
                 CHAPTER TWO – STUDY ONE: SCLERODERMA    
Gilbert’s Biopsychosocial Theory and Model              
  Three studies were conducted in the current project. The first study explored the 
relationship between psychosocial stressors and cognitive, emotional and physiological aspects 
associated with autoimmunity and psychological conditions such as anxiety and depression. 
The biopsychosocial model of health integrating psychoneuroimmunology,  
Gilbert’s biopsychosocial theory of social mentalities and model of affect regulation systems  
(threat/protection and soothing/safeness systems; e.g., Gilbert, 2000; Gilbert, 2001; Gilbert, 
2002; Gilbert, 2012) were utilized to capture the relationships of the variables under 
investigation. The first study aimed to investigate the influence psychosocial variables 
(EMWS, attachment, emotion regulation, self-compassion and hyper-arousal) have on 
scleroderma onset and symptoms, levels of depression, anxiety and stress, and the impact these 
mental health variables (depression anxiety and stress) have on scleroderma onset and 
symptomology. The primary variables of focus (16 in total) are captured within the three 
headings of biological, psychological and social. Biological factors include: hyper-arousal, 
subtypes of scleroderma (diffuse and limited sclerosis) scleroderma disability and pain,  
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Raynaud’s phenomenon, finger ulcers, skin involvement, intestinal and breathing conditions; 
Psychosocial aspects of early experiences of warmth and safeness and attachment style;  
Psychological factors: emotion regulation/coping strategies of suppression, reappraisal and 
self-compassion; and mental health aspects of depression, anxiety, and stress.                               
Gilbert’s Theory of Social Mentalities.               
  Social Mentalities Theory (Gilbert, 2000; Gilbert, 2001; Gilbert, 2002; Gilbert, 2012) 
suggests that humans have a number of “social mentalities” that are involved in the 
development of specific types of relationships; it draws on archetype, modern evolutionary, 
developmental and social psychology theories. This theory also utilizes biopsychosocial and 
neuropsychological approaches to explain the evolution of adaption to threat and safety in 
terms of the interrelationship between cognitions, emotions, motivation and behaviour in the 
social environment, as conscious or unconscious processes. Gilbert suggests these processes 
reflect underlying evolutionary-social systems, involved in both internal and external personal 
relationships involving evaluating potential threat, creating safe environments and regulating 
emotions associated with threat and safety. Gilbert (2012) argued that human beings are driven 
to pursue and acquire certain goals in environments that are often perceived as threatening and 
that these experiences, influence an individual’s perceptions of how they  
experience their external and internal worlds.           
  Gilbert’s social mentalities theory was selected for this research project to explore 
individual’s experiences of threat (self and others), by examining whether limited early life 
exposure to warmth and safety, influenced intrapersonal (e.g., self-compassion) and 
interpersonal (attachment style) relationships and whether these aspects were linked to levels of 
hyper-arousal, psychological functioning and physiological symptoms in individuals diagnosed 
with scleroderma and breast cancer. Gilbert’s theory and research has been applied to 
individuals with adverse early life experiences and the development of psychopathology. As a 
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number of mechanisms involved in the stress response are also involved in the development of 
scleroderma (e.g., inflammatory responses, vascular constriction and immune activation: 
Bolster & Silver, 2008; Smith & Kahaleh, 2008); it was hypothesised that these stress 
responses may also contribute to the development of scleroderma.    
  Gilbert’s theory was therefore utilized in this study to examine and explain the likely 
processes related to early life experiences and the impact these experiences may have on 
emotion regulation and the relationship an individual develops with themselves and others; and 
whether these responses are likely to impact on the development and exacerbation of  
scleroderma and breast cancer symptoms.  
  Gilbert (2012) suggested that social mentalities guide an individual’s interpersonal and 
intrapersonal actions to perform particular social roles that reflect a pattern of emotional and 
cognitive responses that could be described as social intelligence. Gilbert suggests social 
mentalities are implicated in threat focused and attachment behaviours associated with 
receiving and obtaining care. These safety seeking behaviours have the potential to negatively 
affect biological and psychological reactions (e.g., Gilbert, 2000; Gilbert, 2002; Gilbert, 2012). 
Gilbert suggested that early threat experiences may reflect defensive safety seeking behaviours 
(that do not afford safety) and influence defensiveness in adult relationships. He also suggested 
that compassionate care involves creating an environment of safeness and warmth, facilitating 
the development of a secure attachment (Gilbert, 2002; Gilbert, 2012). Therefore in the current 
study these experiences are hypothesised to influence positive or negative interpersonal and/or 
intrapersonal responses, the capacity to self-sooth and regulate the stress experience and the 
subsequent release of chemicals involved in the fight and flight response that can generate 
inflammatory and vascular conditions implicated in the development of scleroderma.   
 Gilbert suggested that secure attachment fosters an individual’s capacity to provide 
soothing experiences and compassionate behaviour to oneself and others, activating the 
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safeness-social mentality. Whereas the threat mentality is activated in situations of perceived 
and actual threat; for example when children experience threatening home environments, 
deprived of warmth and safety, they tend to lack experiences of positive affect and therefore 
the infrequent activation of the soothing/safety system. In this situation the individual is more 
likely to stimulate the threat system and view others as potentially threatening (Gilbert, 2000; 
Gilbert, 2002). These strategies tend to condition the individual to utilize a range of negative 
emotional, cognitive and behavioural strategies such as self- criticism and the development of 
defensive tactics (e.g., Gilbert, 2002; Gilbert et al., 2008; Irons et al., 2006) such as avoidance 
behaviours and emotional suppression (Gross, 2002), to divert attention away from the threat 
situation (Langens & Morth, 2003).     
  As individuals who function in the threat mentality tend to have experienced critical 
early environments deficient in compassion; in the absence of compassionate soothing 
experiences, the internalisation of these early external threat experiences may impede the 
development of the self-soothing social mentality and lead to an inability to self-sooth and use 
effective strategies for regulating the emotional response and cope with distress (e.g., Gilbert, 
2000; Gilbert, 2001; Gilbert, 2002). Engaging defensive strategies to avoid internal and 
external threat experiences may increase self-critical cognitions (Gilbert, 2000; Gilbert et al., 
2004; Gilbert et al., 2006), susceptibility to conditions such as anxiety and depression (e.g., 
Gilbert, 2001; Gilbert, 2007; Gilbert, 2012; Gilbert et al., 2006) and physiological responses 
such as increased sympathetic nervous system activation (Campbell-Sills et al., 2006) and 
immune dysregulation (Schore, 1994). Therefore the examination of factors involving 
interpersonal and intrapersonal relationships, such as early childhood stress (EMWS), 
attachment style (fearful and dismissive) and ineffective emotion regulation/coping strategies 
(low self-compassion and emotional suppression), that have the potential to influence immune 
system functioning (hyper-arousal and scleroderma symptoms and onset), were explored to 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    57  
  
determine the impact negative relational experiences may have on disease symptoms of 
scleroderma; and the influence these biopsychosocial factors may have on the mental health 
(depression and anxiety) of individuals diagnosed with scleroderma.                                     
Affect Regulation Systems                 
  Gilbert’s theory of affect regulation systems was selected as an explanation of the 
underlying emotional and chemical responses that result in certain interpersonal and 
intrapersonal behaviours that involve the capacity to self-sooth and regulate the threat 
response; and therefore the potential to influence immune responses involved in the 
development of scleroderma. Gilbert (2010) suggests there are three dominant emotion 
regulation systems in the brain, one negative type involving threat and two types of positive 
affect: the drive/seeking and self-soothing/contentment systems. The drive/seeking system may 
be associated with dopamine, and the soothing/contentment system with neuropeptides such as 
oxytocins and vasopressin. Gilbert and colleagues proposed that the development of the self-
soothing/contentment system is important as it regulates the threat and drive systems.   
 The development of a dominant threat system is fostered through early experiences of 
threat and affective states associated with feeling unsafe or uncared for. Experiences that 
promote the development of neural networks in the soothing system in this situation are likely 
to be inadequate and may result in behaviours associated with the drive or threat systems.  
Individuals unable to access the soothing system may respond defensively and may have 
difficulty feeling safe or content. Individuals who have early experiences of regular soothing 
generally are calmer and able to regulate emotions when stressed and are less likely to 
experience depression, anxiety, stress, insecure attachment and self-criticism (Gilbert et al., 
2006; Gilbert, McEwan, Mitra, Franks, & Richter, 2008).                                                          
  Self-criticism develops when individuals focus on their own inadequacies and failings; a 
negative evaluative strategy (Neff, 2003a) associated with psychological conditions such as 
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depression (Gilbert et al., 2006; Gilbert, 2007). The development of self-criticism is associated 
with adverse childhood experiences, indicating uncaring, unaffectionate and critical parents. 
Repeated negative childhood experiences may result in difficulty regulating the emotional 
response due to an inability to self sooth and reassure (Gilbert et al., 2004). Individuals who 
have developed without these positive soothing experiences may lack the resources during 
times of stress to regulate negative emotions and feel safe and content; conversely individuals 
with positive experiences tend to be kinder to themselves when faced with adverse experiences 
through the ability to self-reassure and regulate negative emotions (Bowlby, 1997; Gilbert et 
al., 2004). The incapacity to provide self-reassurance and engage in self-soothing strategies 
when stressed may result in ineffective negative emotional regulation strategies low in self-
kindness (Gilbert et al., 2004).            
 Self-kindness (an element of self-compassion) unlike self-criticism lessens the impact of 
negative affective experiences and provides opportunities to develop a more balanced view of 
individuals’ cognitions and emotions. Self-compassion involves engaging in personal acts of 
self-kindness when experiencing adverse situations or perceptions of personal inadequacy by 
providing warm supportive responses rather than actioning self-criticism. Self-compassion 
enables individuals to view themselves from a more human perspective by providing 
nonjudgmental strategies to understanding their own inner struggles and disappointments. It 
also involves being mindfully aware of painful thoughts and feelings, rather than suppressing 
or over-identifying with them and provides a more positive emotion regulatory approach, 
founded not on an evaluative process but on kindness and understanding towards the self (Neff, 
2003a; Neff et al., 2007).           
  Positive early experiences that engender feelings of warmth, nurturing and safety have 
been associated with well-being (Irons et al., 2006; Schore, 1994), while negative experiences 
are associated with the development of insecure attachment styles, anxiety (Mikalincer & 
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Shaver, 2007), depression, stress, self-criticism (Gilbert et al., 2008) and emotion regulation 
strategies, such as suppression and avoidance (Gross, 1998; Hayes, Wilson, Gifford, & 
Strosahl, 1996; Iwamitsu et al., 2005). These negative experiences as well as the capacity to 
provide one-self with self-compassion (rather than self-criticism) were explored in relation to 
scleroderma (and breast cancer) symptoms and onset, to determine whether different 
interpersonal and intrapersonal experiences influence positive and/or negative health outcomes 
for individuals diagnosed with scleroderma.                                                                                         
Early Memories of Warmth and Safeness                             
  Further evidence that supports examining the variables in the currents study in relation 
to scleroderma relates to early childhood experiences. Research suggests negative early 
childhood experiences can have detrimental effects on the social functioning, psychological 
and physical health of individuals. Gilbert (2007) suggests early life experiences influence 
gene expression and the biological and psychological functioning of the brain. These early life 
experiences are expressed as different types of emotion regulation and social communications 
that reflect cognitive and behavioural patterns of threat and safety. Positive early experiences 
that engender warmth and safety have been associated with well-being (Schore, 1994), while 
negative experiences with low self-kindness and/or the development of self-criticism (Brewin, 
Firth, Cozens, Furnham, & McManus, 1992; Neff et al., 2007), are associated with poorer 
psychological outcomes such as depression and self-hatred (Irons et al., 2006). Gilbert and 
colleagues (2008) suggested that feeling safe and content is a determinant of psychopathology, 
attachment style and self-evaluation.          
 Positive nurturing experiences that foster feelings of warmth (such as tenderness, 
kindness and concern) and safeness (feeling safe rather than safety seeking) are associated 
with a lower risk of developing psychopathology (Mikulincer & Shaver, 2007). Whereas 
negative rearing environments where abuse, perceptions of parents being non-caring 
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(FinziDottan & Karu, 2006) and neglect are generally associated with an increase in negative 
affect and a vulnerability to psychopathology (Heit et al., 1999; Schore, 1994). When early 
environments are experienced as threatening and fail to provide feelings of safeness and 
warmth a lack of stimulation of the positive affect and warmth systems and an over-activation 
of the threat/defence/protective systems may occur (Gilbert et al., 2008). Feeling safe and 
content has a significant negative correlation with depression, anxiety, stress, self-criticism 
and insecure attachment (Gilbert et al., 2008) As psychosocial stress, particularly early threat 
experiences have the potential to impact on immune and psychological functioning; the areas 
discussed above provide further support for exploring these aspects in relation to scleroderma 
symptoms and psychological functioning of individuals with scleroderma in this study.      
 The EMWS scale was selected to measure negative childhood experiences, as a lack of 
early positive rearing experiences or memory associated with early threat, may leave an 
individual unable to match negative emotions with specific events. The inability to explain this 
sense of threat or negative affect may result from events that were experienced as subtle non-
verbal communications or as preverbal experiences (Richter, Gilbert, & McEwan, 2009). How 
an individual responds to an event (both physiologically and emotionally) may be a better 
indicator of threat than recall of stressful events, as some individuals may recall parents as 
kind and available, but still feel fearful and lack a sense of belonging. Others may have 
experienced negative events but felt they managed and coped well (Richter et al., 2009).  The 
recall of positive or negative feelings associated with early rearing experiences generally relies 
on the recollection of an individual’s own inner experiences, rather than recalling events 
related to other’s behaviour as an indicator of stress. Recall of affect in relation to childhood 
memories may therefore explain feelings of threat not accounted for by the recall of any 
particular stressful event. This view of exploring an individual’s experience of threat was 
therefore employed in this study to measure (using the early memories of warmth and safety 
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scale) scleroderma participant’s reporting of early life exposure to warmth and safety and the 
influence these experiences may have on scleroderma symptomology and onset.                                                                                                 
Attachment                                                                                                                            
Attachment Style: Attachment theory describes the interactions between a child and his or her 
primary caregiver and the influence these communications have on an individual’s ability to 
regulate emotions and cope with stress across the life span (Bowlby, 1997). Bowlby suggested 
that people are born with an innate psychobiological system that motivates people to seek 
proximity to attachment figures for protection from threat (safety seeking behaviours; Gilbert, 
2012) and in turn facilitates the regulation of emotional responses by providing relief from 
distress and assistance to reduce heightened arousal (Bowlby, 1997). The failure to reduce 
arousal levels affects immune responses, future immune functioning and is a risk in the 
development of autoimmunity (e.g., Schore, 1994). Investigation of the impacts insecure 
attachment styles may have on scleroderma symptoms, levels of arousal and psychological 
functioning in this illness population were therefore explored in the current study.    
 Bowlby (1998) observed differences in attachment figures functioning in relation to 
availability, responsiveness and supportiveness in times of need. The availability and 
responsiveness of attachment figures to act as an emotional regulator, affects a child’s sense of 
attachment security resulting in the development of either a secure or an insecure attachment 
style (Bowlby, 1997; Ainsworth, 1985). Insecure attachment may invoke a threat response that 
produces anxiety, fear and distress in similar future situations due to uncertainty about the 
accessibility and security of their attachment base (Mikulincer & Shaver, 2007). Ainsworth 
described insecure attachment behaviours as a pattern that reflects a defensive response 
resistant to change, due to expectations the child has developed during interactions with the 
parent. For example the development of avoidant behaviours may result in a defensive pattern 
due to experiences around rejection and seeking close contact with the parent. The child may 
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not seek this proximity due to defensive strategies to protect the self from rejection, therefore 
avoiding the experience most desired and reducing the opportunity to change the insecure 
attachment style (Ainsworth, 1985). Defensiveness has been reported in scleroderma research 
(e.g., Angelopoulos et al., 2001) and may reflect insecure attachment styles, early life stress 
and avoidant emotion regulation strategies in this population. Therefore the relationship 
between these factors and the onset and severity of scleroderma symptoms were investigated 
to determine the influence these factors may have on this disease.       
 Bartholomew and Horowitz (1991) expanded Bowlby’s internal working model of self 
and others by developing a model of individual differences in relation to adult attachment. 
These two underlying dimensions that represented positive or negative aspects of a person’s 
internal model of self and others were used to define four patterns of attachment. Bartholomew 
and Horowitz described individuals with a fearful attachment style as cold-passive, who 
demonstrated negative models of self and exhibited high levels of anxiety and arousal. Fearful 
and dismissive individuals demonstrated avoidant behaviours and difficulties in becoming 
close to and relying on others; however, they differed in their sense of self-worth, with fearful 
attached individuals demonstrating a lack of assertiveness and a sense of social insecurity 
(Mikulincer & Shaver, 2007).          
 Dismissive individual’s exhibit independent behaviours and a positive view of 
themselves; however, their underlying insecurity results in avoidance and distancing due to 
their uncertainty that others would assist then in times of need. Fearful individuals have 
negative expectations of both themselves and others and are highly anxious, self-doubting, 
self-conscious and cautious. Dismissing and fearfully attached individuals use avoidant 
strategies, while fearful individuals, exhibit high levels of anxiety (Simpson & Rholes, 1998). 
Insecurely attached individuals tend to lack the resources necessary to cope successfully with 
and adapt to adverse situations (e.g., Bowlby, 1998; Mikalincer & Shaver, 2007). They tend to 
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appraise stressful situations as more demanding and difficult to manage, than securely attached 
individuals and lack the ability to regulate their emotions, as a result of experiencing parents 
that were ineffective in their management of the individual’s distress as a child (e.g., Bowlby, 
1998; Mikalincer & Shaver, 2007). Individual differences in attachment styles were explored 
in the current study as they were hypothesised as possible determining factors in relation to 
coping strategies, the extent stress is managed and symptom severity in individuals diagnosed 
with scleroderma.           
 A number of attachment styles have been described in the literature, for example in a 
(25-year) review of adult attachment measures, Ravitz and colleagues critiqued different 
methods of assessing a range of attachment styles. A number of interview measures of 
attachment such as the adult attachment interview (AAI; developed by George, Kaplan, and 
Main in 1984) assess narrative coherence as an indicator of secure attachment, three categories 
of this measure are similar to the infant attachment categories, secure: (free) /autonomous, and 
insecure attachment styles: avoidant/dismissing, and anxious (enmeshed)/preoccupied 
(ambivalent/resistant in infant category). This measure also includes a fourth category 
“unclassifiable”. Individuals can be classed as “unresolved” with regard to abuse, trauma, or 
loss. Projective tests are also used to evaluate an individual’s capacity to sustain self and other 
boundaries and assess attachment repair. While self-report scales measure conscious attitudes 
and awareness of behaviors related to experiences of trust, intimacy, dependence, separation, 
and loss. Attachment has been described as “state-dependent traits.” Attachment behaviors are 
not always obvious however they are generally activated by negative events such as situations 
of threat or isolation. Trait-like patterns of behavior are also triggered in situations where 
relationship expectations such as others' trustworthiness or one's lovability and can influence 
attachment behavior.          
 Attachment measures involve categories of attachment style or measure various 
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dimensions of attachment. Two dimensions of insecure attachment have been identified: 
attachment anxiety (negative sense of self) and attachment avoidance (negative sense of 
others). Attachment anxiety is characterized by an expectation of separation, abandonment, or 
insufficient love; a preoccupation with the availability and responsiveness of others; and 
hyper-activation of attachment behavior. Attachment avoidance is characterized by 
devaluation of the importance of close relationships, avoidance of intimacy dependence, self-
reliance, and relative deactivation of attachment behavior. Categories can be derived from 
dimensional scales such as Bartholomew and Horowitz's four-category model which 
reconciles dimensional and categorical models by identifying categories on the dimensions of 
attachment avoidance and attachment anxiety. Secure attachment is defined as a relative 
absence of attachment anxiety and attachment avoidance. The insecure attachment styles that 
include preoccupied is described as an experience of high attachment anxiety and low 
attachment avoidance; dismissive attachment is described as high attachment avoidance and 
low attachment anxiety; and fearful attachment is defined as a combination of high insecurity 
on both dimensions of attachment anxiety and attachment avoidance (Ravitz, Maunder, 
Hunter, Sthankiva & Lancee, 2010).                                                                             
 Early attachment stress may result in an individual becoming over-stimulated, creating 
hyper-arousal in relatively minor situations in adulthood (Van der Kolk & Greenberg, 1987). 
Fearful attached individuals long for their partner’s love and support, however, they fear the 
possible negative consequences of intimacy and reliance on significant others. This style of 
adult attachment resembles the disorganized attachment style of simultaneous patterns of 
approach and avoidant behaviours found in abused children. Fearful avoidant strategies in 
adulthood result from a failure to achieve any of the major attachment goals of security and 
safety following proximity seeking due to experiencing unpredictable behaviours by the 
primary caregiver (Mikalincer & Shaver, 2007). These individuals have difficulty recalling 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    65  
  
distressing events without becoming overwhelmed by intense feelings or they utilize strategies 
of denial or suppression to manage emotions (Mikulincer & Shaver, 2007).         
 Individuals often attempt to adapt and function within unstable and abusive 
environments and may develop resilient coping strategies in the event they receive secure 
attachment experiences in later relationships. Individuals who lack this exposure often 
experience long term insecure attachment problems and exhibit stimulus seeking behaviours 
that increase arousal (Wilson, Friedman, & Lindy, 2001). Attachment styles were explored in 
the current study to determine the impact these experiences may have on levels of hyper-
arousal, psychological functioning and scleroderma symptom severity.                                                                                                                            
Attachment - Physiological Responses: Adult feelings of security and emotional responses 
reflect attachment behaviours learned in early childhood. The attachment system developed to 
down-regulate levels of arousal generated by the threat/defence system (Gilbert, 2012). 
Heightened chronic experiences of distress in childhood that are not regulated externally by an 
attachment figure may affect the child’s developing right brain, influencing the limbic system 
and ongoing threat related arousal (Schore, 2002). Early right brain development occurs in the 
context of attachment relationships with the primary caregivers. The attachment experience 
reflects regulation or dysregulation of the stress response and how the right hemisphere of the 
brain develops (Schore, 2002). Children who receive inadequate emotion regulation 
experiences are vulnerable to heightened states of arousal, the development of ineffective 
copying strategies for regulating emotions and psychopathology (Schore, 2002). Responsive 
attachment figures in adulthood facilitate secure attachment; however, when adult attachment 
figures are unavailable and do not provide a sense of safety, attachment related fears may 
trigger insecure attachment responses and anxiety disorders (e.g., Gilbert, 2012; Mikulincer & 
Shaver, 2007). Anxiety has been reported in the scleroderma population and was investigated 
in the current study in relation to early life experiences and attachment styles.                                                                                                                                                                                                                                                                        
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Scleroderma: The Immune System and Psychosocial Variables in the Current Study 
Attachment and the Immune System                                                                          
 Attachment distress is regulated by the primary caregiver’s ability to attend to and calm 
the infant. When the infant’s distress is not adequately reduced high levels of the stress 
hormones ACTH and corticosteroids are released along with lower levels of endorphins 
(Schore, 1994). The mother’s ability to act as an external regulator when a child is distressed 
affects the child’s developing immune and neuro-endocrine systems influencing an 
individual’s vulnerability to psycho-physiological illness and affecting their ability to recover 
from psychological disorders and physiological disease over the lifespan (Schore, 1994).  
Social and emotional interactions are processed by the right hemisphere of the brain and 
regulate the secretion of the stress hormone cortisol, affecting cells in the immune system. 
Hypersecretion of cortisol is primarily trigged by attachment insecurity and may continue into 
adulthood (e.g., Arnetz & Ekman, 2006; Schore 1994).          
  An individual’s capacity to regulate arousal early in life influences immune responses 
and future immune functioning. A study investigating immune related disease and attachment 
found that individuals experiencing breast cancer reported significantly higher levels of 
avoidant attachment style than individuals without a diagnosis of breast cancer (Tacon, 
Caldera, & Bell, 2001). Early adverse experiences may influence vulnerability in numerous 
areas of functioning involving the threat systems including regulating emotions and 
accentuating the experience of stress (Schore, 1994). These vulnerabilities may partly explain 
the relationship between stress experiences and the onset of scleroderma reported by a majority 
of individuals in the two stress studies (Chen et al., 2008; Hui et al., 2007); and are aspects 
further investigated in the current study through the exploration of insecure attachment styles 
(fearful and dismissive) to determine the effects these interpersonal stress experiences (threat 
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/fear and the likely defensive responses) have on individual’s illness related and mental health 
functioning.                                                                                                                   
Emotion Regulation - Suppression, Psychological and Physical Health        
 Threat related emotion regulation strategies are associated with early social experiences 
of threat, attachment insecurity, a lack of nurturing and the development of negative 
psychological and physiological health outcomes (e.g., Bowlby, 1997; Gilbert et al., 2006; 
Gross & John, 2003; Mikulincer & Shaver, 2007). Emotion regulation refers to the processes, 
by which an individual influences the nature and conditions, under which any emotion is 
expressed or experienced (Gross, 1998). Gross (1998) defined emotion regulation as a process 
of managing the experience and expression of emotions either consciously or unconsciously; 
that differs from concepts such as coping and mood regulation. Emotion regulation involves 
the evaluation of a situation and the generation and processing of emotions that include 
modifying cognitions and responses.                                                      
 When the expression of an emotion is not processed but inhibited, a physiological 
response occurs that varies considerably in individuals. This strategy enables an individual to 
decrease the expression of the emotional experience, however, this process subsequently 
increases physiological responses such as increased sympathetic activation of the 
cardiovascular system (Gross, 2002) and can influence health (Petrie, 1998). Gross and 
Levenson (1993) described emotion suppression as an emotion regulation strategy that 
involves intentionally inhibiting the expression of emotion while aroused emotionally. This 
behaviour reduces awareness of an emotion creating ambiguity and the capacity to reappraise 
the negative experience (Gross & John, 2003). Hayes and colleagues (1996) suggested that 
excessive suppression of an emotional experience can result in distorted cognitions and is a 
risk for developing psychological conditions. Thought-suppression has been found in a 
number of studies to produce the opposite effect of the intended objective that is to conceal the 
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thought from conscious awareness. Gold & Wegner (1995) found that excessive negative self-
evaluation can lead to unproductive attempts to regulate unpleasant or distressing private 
experiences by increasing the frequency of the thought or feeling. Lynch and colleagues 
(2001) also found in two studies that thought suppression was associated with more intrusive 
thoughts after exposure to emotion provoking stimuli (Lynch, Robins, Morse, & Krause, 
2001). Negatively evaluated recurring internal distressing experiences, such as memories, 
emotions, cognitions and physiological sensations (Hayes et al., 1996) experienced as 
threatening (Gilbert, 2007), tend to result in the utilization of avoidance or suppression as 
strategies to manage these negative experiences (Gilbert, 2007; Hayes et al., 1996). This 
approach; however, may have negative physiological consequences, as these strategies tend to 
directly activate the threat system and initiate the stress response (Gilbert, 2007). Thought 
suppression has been found to influence the immune and cardiovascular systems and 
experiences of pain. Petrie, Booth, and Penebaker (1998) found that the suppression of 
thoughts decreased circulating T lymphocytes and T suppressor cells and total number of 
lymphocytes; whereas expressing thoughts increased the number of T helper cells and total 
lymphocytes. Findings suggest that the long term effects of suppression, particularly thoughts 
with emotional content may cause changes in immune functioning that can impact on health. 
Therefore the current study examined the relationship between the emotion regulation strategy 
suppression and scleroderma symptoms, as it was hypothesised that these intrapersonal aspects 
may influence immune related symptoms of scleroderma.                                                                                    
 Research has also found an association between pain and the regulation of emotions. 
Thomas and colleagues found that individuals with chronic pelvic pain who suppressed 
unwanted thoughts associated with past abuse were likely to experience higher levels of pain 
(Thomas et al., 2006). Investigation of suppression of emotion in a physical illness population 
(Iwamitsu et al., 2005) also found negative outcomes for individuals diagnosed with breast 
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cancer. This research found that breast cancer patients who engaged in emotional suppression 
had elevated levels of anxiety, depression, anger and psychological distress, when compared 
to individuals without breast cancer.          
 Research suggests that excessive suppression of emotional experience can result in 
distorted cognitions and are a risk for developing psychological conditions (Hayes et al., 1996) 
such as anxiety, depression (Gross & John, 2003; Iwamitsu et al., 2005), an insecure 
attachment style, (Mikulincer & Shaver, 2007) and physiological conditions such as immune 
dysfunction (Petrie et al., 1998; Schore, 1994) and pain (Burns et al., 2006; Thomas et al., 
2006). Research has demonstrated that thought suppression is an emotion regulation strategy 
associated with negative outcomes for the individual through a process that influences 
psychological and physical health including experiences of depression, anxiety and pain, and 
functioning of the immune and cardiovascular systems.                                                  
 Depression, anxiety, immune conditions and pain are associated with scleroderma and 
have not previously been investigated in relation to suppression. Therefore the current study 
examined the relationship between suppression and scleroderma symptoms including pain and 
psychological factors such as depression and anxiety, to determine the influence suppression 
may have on immune related symptoms of this disease (and breast cancer).                                         
Self-Compassion: Biopsychosocial Implications        
 Self-compassion is also an emotion regulation strategy, however it does not involve 
avoiding or suppressing negative experiences that are likely to (Neff, 2003a) engage chemicals 
such as cortisol, implicated in the threat system (Gilbert, 2002). This strategy involves 
kindness and understanding toward the self (Neff, 2003a; Neff et al., 2007), through an 
awareness of distressing feelings and treating oneself with kindness and understanding. Self-
compassion involves recognising that suffering and disappointment are part of being human 
and that people are worthy of kindness and compassionate care (Neff, 2003a). Self- 
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compassion is similar in definition to the concept of compassion.       
 Compassion is defined as an openness and connection to the suffering of others that 
results in feelings associated with sympathetic caring. Compassion felt toward another 
generally involves a non-judgmental view of an individual’s mistakes and a shared human 
understanding with the person’s experience. When compassion is applied to the self, it 
requires a kind openness to one’s own suffering and pain, allowing an accepting kindness 
toward less favourable attributes and inadequacies, when not managing a situation as well as 
expected. Experiencing failure as part of a shared human condition helps reduce feelings of 
isolation and the likelihood of becoming immersed in the emotional experience associated 
with the situation. Self-compassion requires a kindness and understanding towards the self in 
situations where one experiences disappointment, emotional or physical pain; rather than 
engaging in strategies that involve over identifying with the situation, or disconnecting from 
the collective human experience of suffering, associated with feeling isolated and alone. Self-
compassion allows an individual to view the experience from an outside perspective, 
disengaging from the exaggerated experience of over identifying with the subjective content 
and providing kindness to the self from the self; that is from another perspective, a mindful 
and more balanced view (Neff 2003a).          
 Self-compassion involves developing the ability to become mindfully aware of these 
experiences, rather than over-identifying with them, lessening the impact of the negative 
experience and enabling opportunities to develop a more holistic view of one’s situation (Neff, 
2003a). Mindfulness in this situation involves compassionate awareness and acceptance of 
experiences occurring in the present moment. Mindfulness allows one to remain connected to 
and evaluate a situation from an emotional distance, reducing immersion in the experience and 
providing the opportunity to observe thoughts and feelings as they occur, without judgment. 
Mindful self-kindness unlike self-criticism lessens the impact of negative affective 
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experiences, by providing opportunities to reduce heightened threat responses resulting from a 
threat processing deficit (Gilbert, 2007) and develop a more balanced view of one’s cognitions 
and emotions (Neff, 2003a).          
 This strategy provides a more positive emotion regulatory approach, as it is not based 
on an evaluative process (Neff, 2003a) involving the threat system (Gilbert, 2007), but on 
kindness and understanding toward the self (Neff, 2003a; Neff et al., 2007). Self-compassion 
has been described as a strategy to regulate negative emotions, through being aware of and not 
avoiding or suppressing distressing feelings and treating oneself with kindness and 
understanding, as a fellow sufferer of humanity. Self-compassion changes one’s negative view 
of self, to a more positive view of self, because it is not based on an evaluative process, but on 
kindness and understanding and embracing one’s common humanity (Neff, 2003a). Self-
compassion therefore is concerned with being open to one’s suffering and not avoiding it. 
Self-compassion has a negative association with depression, anxiety, self-criticism and 
thought suppression (Neff, 2003a). Self-compassion has not been examined in relation to 
scleroderma symptomology and onset. This factor was explored in scleroderma and breast 
cancer as it was hypothesised that self-compassion may act as a protective factor for immune 
functioning and therefore would provide more positive health outcomes for individuals who 
engage in this emotion regulation strategy.         
 Neff developed the self-compassion scale (2003b), that has been widely used to 
measure this construct. This scale utilized in the current study, constitutes the three major 
aspects of self-compassion discussed above; self-kindness, common humanity and 
mindfulness. Self-kindness refers to treating oneself with warmth and care without engaging 
in self-judgment. Common humanity indicates an ability to understand one’s suffering or 
inadequacies as part of shared human experiences, rather than feeling alone or isolated. 
Mindfulness describes a capacity to employ a balanced view rather than over-identifying with 
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the experiences and is a protective behaviour for experiences of anxiety (Neff, 2003b).                                     
 Research has demonstrated a link between the benefits of self-compassion and 
psychosocial aspects; however, only a few studies have investigated self-compassion and 
physiological factors (e.g., Pace et al., 2009; Wren et al., 2011). Compassion researchers also 
investigated psychosocial stress and physiological reactions of the neuro-endocrine and innate 
immune systems. Pace and colleagues found that people who engaged in more compassion 
focused meditation when compared to people with less engagement, scored lower on 
physiological responses such as cortisol levels and psychological measures of distress; 
suggesting that stress induced immune and behavioural responses may be moderated by 
compassion focused meditations (Pace et al., 2009). Therefore strategies high in self-
compassion are likely to produce positive physical and psychological health outcomes (Neff, 
2003a; Pace et al., 2009).           
 Self-compassion provides a solution for threat processing difficulties, and is negatively 
associated with depression, anxiety, self-criticism and thought suppression and positively 
associated with life satisfaction (e.g., Gilbert 2007; Neff, 2003a; Neff et al., 2007), stress 
reduction (Sharpiro, Astin, Bishop & Cordova, 2005) and lower cortisol levels (Pace et al., 
2009). Self-compassion is significantly related to adaptive functioning and positive health 
outcomes (Neff et al., 2007). Self-compassion was found to be a protective factor for 
psychological distress in women experiencing body changes resulting from breast cancer 
treatment (Przezdziceki et al., 2013).         
 No study the author is aware of has explored self-compassion and scleroderma; 
however, based on the literature presented, it is reasonable to hypothesise that, lower self-
compassion is likely to be associated with higher levels of psychopathology (such as anxiety 
and depression) and elevated scleroderma symptoms (autoimmune activation). As self-
compassion is associated with wellbeing (e.g., Neff, 2003a), the development of inner (self) 
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compassion may therefore provide physiological and psychological health benefits (Gilbert, 
2002) to individuals with compromised psychological and immune functioning. Self-
compassion strategies are theorised to act as a protective factor (Neff, 2003a), with a lowered 
experience of self-compassion likely to be associated with elevated scleroderma symptoms.  
 Strategies that involve avoiding or suppressing painful emotions associated with lower 
experiences of self-compassion and a heightened physiological response to stress may also be 
linked to increased scleroderma symptoms. Ineffective emotion regulation strategies, that 
involve avoidance such as suppression, insecure styles of relating (such as dismissive and 
fearful attachment) and levels of self-compassion, have not been investigated in relation to 
scleroderma and may be factors associated with pain and disability, experienced by 
individuals diagnosed with scleroderma.                                                                                          
Hyper-arousal, the Immune System and Scleroderma         
 Hyper-arousal is a physiological response that involves the threat system (e.g., Every & 
Lating, 2002) and is associated with psychological conditions and the development of 
autoimmunity (Schore, 1994). Hyper-arousal is described as physical or emotional tension 
produced by hormones during the fight-or-flight response. The intensity of this response is 
generally dependant on an individual’s response to a stressor (e.g., Every & Lating, 2002; 
Selye, 1976) and an ability to adapt to repeated exposure to stimuli (Hammad, Barsky & 
Regestein, 2001). Exposure to unexpected stimuli may produce excessive arousal reactions 
and increased cortisol (a stress hormone) levels. Individuals with irregular cortisol arousal 
may be unable to distinguish between physically harmless and threatening stimuli, frequently 
engaging the fight and flight response in non-threatening situations. This condition may 
overwhelm an individual’s resources to accurately process information, decreasing selective 
attention abilities, resulting in ambiguous meaning and difficultly discriminating between 
meaningful and insignificant stimuli (Hammad et al., 2001).      
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 Arousal is also influenced by genetic factors and is higher in individuals who are more 
physiologically and emotionally reactive (Pfaff, 2005). Virtually any stressor whether physical 
or psychological will result in a rapid increase in ACTH (Rice, 1999). The adrenals respond to 
stress by secreting a number of hormones including epinephrine (adrenaline), norepinephrine 
(noradrenaline) and glucocoticids that include the hormone cortisol (Rice, 1999). The main 
function of the glucocorticoid system is to keep the stress response in check (Rice, 1999). 
High levels of the stress hormone cortisol can have negative effects on the immune system, 
while epinephrine and norepinephrine affect the sympathetic nervous system (SNS; Rice, 
1999). When an individual experiences heightened levels of stress the body may excrete high 
levels of epinephrine and norepinephrine, ACTH and other hormones. The SNS increases 
heart rate and blood pressure and constricts the arteries to the kidneys that may result in 
hypertension. The release of rennin by the kidneys also occurs, constricting and causing 
damage to the arteries over prolonged periods of stress (Rice, 1999). Hypertension, and 
constricted blood vessels are conditions associated with scleroderma (Varga, 2004).     
 Norepinephrine and dopamine (catecholamines) are involved in regulating the 
amygdala (Every & Lating, 2002). Norepinephrine increases the fight and flight reactions and 
hyper-vigilance to threat (Every & Lating, 2002). The release of dopamine into the amygdale 
creates a conditioned fear response as a result of an over-reactive amygdale intensifying the 
fear response associated with hyper-arousal (Every & Lating, 2002). Hyper-arousal is 
associated with a number of biopsychosocial stress related factors. It forms part of the fight 
and flight response that functions to protect an individual from threat, however over-reactive 
protection defences that create excessive arousal reactions are a risk factor in the development 
of autoimmunity (e.g., Schore, 1994). It has been suggested that individuals diagnosed with 
Raynaud’s phenomenon and scleroderma have a heightened stress response (Freedman & 
Ianni, 1983); as hyper-arousal is involved in the stress response and autoimmunity (eg., Every 
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& Lating, 2002), it may also be a condition associated with individuals diagnosed with 
scleroderma. As arousal is higher in individuals that are more physiologically and emotionally 
reactive (Pfaff, 2005) and individuals diagnosed with Raynaud’s phenomenon and 
scleroderma have a heightened stress response (Freedman & Ianni, 1983). The exploration of 
factors (adverse early life experiences) that may influence the development of inadequate 
emotion strategies, that contribute to heightened levels of physiological arousal; and the 
relationship between hyper-arousal and increased scleroderma symptom severity require 
investigation.              
 Hyper-arousal is associated with the stress response (e.g., Every & Lating, 2002) and 
the development of autoimmunity (Schore, 1994), conditions associated with scleroderma. 
Hyper-arousal has not previously been examined in relation to scleroderma, and will be 
explored (using a self-report measure the hyper-arousal scale) in relation to onset, symptom 
severity, disability and psychosocial factors implicated in the stress response (EMWS, 
attachment style, emotion regulation strategies: suppression and self-compassion).   
 These factors were explored to determine the relationship between early childhood 
experiences, ineffective emotion regulation strategies, levels of arousal, psychological 
functioning and symptom severity; to determine whether the development of a heightened 
stress response is related to early life experiences and whether these experiences have 
contributed to an earlier onset and exacerbation of symptoms, experienced by individuals 
diagnosed with scleroderma. Levels of self-compassion where also explored to determine 
whether more positive (where compassion is greater) and/or more negative (compassion is 
lower) psychological and physical health outcomes were related to hyper-arousal.                                                                                                                                
Depression, Anxiety, the Immune System and Scleroderma           
 Depression and anxiety are common conditions associated with the management of 
many diseases and illnesses (Hill et al,. 2011; Kiecolt-Glaser & Glaser, 2003; Nietert et al., 
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2005) and in scleroderma have been associated with symptom severity (Beretta et al., 2006; 
Thombs et al., 2007). Several studies have demonstrated a link between scleroderma and 
psychological conditions, such as anxiety and depression (e.g., Angelopoulos et al., 2001; 
Hyphantis et al., 2007; Richards et al., 2004; Roca et al., 1996). These studies revealed a high 
prevalence of depression related to aspects of the disease and psychological factors not 
associated with scleroderma symptoms. Research also suggests immune alterations are 
implicated in psychological conditions such as depression and anxiety (e.g., Miller, 2005). As 
depression and some types of anxiety have been reported as impacting on the immune system 
(e.g., Kiecolt-Glaser & Glaser, 2002; Miller, 2005), a diagnosis of depression and/or anxiety 
prior to the development of scleroderma (or breast cancer) may contribute to the onset of 
disease and or exacerbation of diseases symptoms. Anxiety and depression have been 
associated with immune related diseases and are often preceded by stressful events (e.g., 
Kiecolt-Glaser & Glaser, 2002; Miller, 2005). Depression resulting from stress may activate 
biological mechanisms that increase cytokine secretion and hyperactivity of the HPA-axis that 
affect the immune system (e.g., Kiecolt-Glaser & Glaser, 2002). Prevalence rates for 
depression in a number of general population studies range from 4.9% to 17.1 % for lifetime 
prevalence with previous month rates ranging from 3.2% to 5.2% (e.g., Pignone et al., 2002; 
Wilhelm, Slade, Brownhill, & Andrews, 2003). The DSM V reports lifetime prevalence of 
depression in community samples at approximately 7% and varying from 10% to 21% in 
women (American Psychiatric Association, 2013).       
 Studies of depression experienced by participants in scleroderma samples revealed that 
mild to severe depression was reported by 33% to 65% of individuals (Angelopoulos et al., 
2001; Beretta et al., 2006; Roca et al., 1996; Thombs et al., 2007), indicating that scleroderma 
patients experience higher rates of depression than the general population. Breast cancer 
studies have also demonstrated greater experiences of depression and anxiety than the general 
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population with 22% of participants in one study reporting depression and 19% reporting 
anxiety (Khan et al., 2012) and for individuals reporting severe breast cancer greater numbers 
of individuals reported experiences of depression 38% and anxiety 22% (Vardanima et al., 
2010). However these depressive experiences are lower than reported in scleroderma studies.   
 Gilbert (2007) suggested different types of threat contribute to the development of 
depression, and that depressed individuals suffer a threat processing deficit, that may have 
developed as a result of individual differences and stress experiences that have influenced 
cognitions, emotions, motivation, behaviour and energy levels. Depressed individuals describe 
feelings of sadness and hopelessness; symptoms include depressed mood, loss of interest or 
pleasure in activities, fatigue, an increase or decrease in appetite and weight, along with sleep, 
concentration and psychomotor disturbances, feelings of worthlessness, inappropriate guilt 
and suicidal thoughts.          
 Depression often co-occurs with anxiety (APA, 2013), a psychological condition that 
involves the fight and flight response. Anxiety is described as a normal response to a 
threatening situation, however when the level of response to a specific event or stressor 
becomes excessive and the individual experiences difficulty controlling excessive worry in 
relation to these fears, an anxiety disorder may develop (e.g., Hunt & Jarry, 1997). Individuals 
may experience symptoms such as fatigue, sleep and concentration problems, irritability and 
restlessness. Prevalence rates for anxiety disorders range from approximately 1% to 9% in the 
general population (APA, 2013).         
 Negative rearing experiences that relate to feelings of threat, attachment stress, adverse 
life events, genetic predispositions and immune dysfunction have been associated with 
psychological disorders such as depression and anxiety (Arnetz & Ekman, 2006). Stressful 
psychosocial environments that elicit a prolonged chronic stress response, may result in 
inappropriate adaptive responses that interfere with the regulation of the HPA axis (Arnetz & 
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Ekman, 2006). The development of depression and multiple subtypes of anxiety have been 
associated with maladaptive responses to prolonged stress, negatively impacting on neural-
endocrine and immune interactions, and reducing serotonin receptors involved in the 
regulation of the anti-stress system (Arnetz & Ekman, 2006). Prolactin an immune-stimulant is 
also involved in the anti-stress system and was found to be elevated in 80% of scleroderma 
participants (Vera-Lastra, 2006). Prolactin levels may be affected by stressful environmental 
conditions (Sobrinho et al., 1998); its secretion affects the central nervous system and 
influences an individual’s emotions and behaviour (Sobrinho et al., 1998; Sonino et al., 2004) 
and experiences of depression and anxiety (Fava et al., 1981; Sonino et al., 2004).   
 Depression has been investigated from a number of perspectives in relation to 
scleroderma. Research suggests depression is associated with threat processing deficits, stress 
hormones such as cortisol (Gilbert, 2007) and anti-stress hormones such as prolactin in 
scleroderma samples (Vera-Lastra, 2006). Psychosocial factors associated with depression and 
anxiety that involve the threat system and stress response, such as a lack of early experiences 
of warmth and safeness, avoidant and suppressive emotion regulation strategies and self-
relating approaches low in compassion; reported in the literature as associated with 
depression, the most common psychological condition experienced by individuals diagnosed 
with scleroderma (e.g., Angelopoulos et al., 2001; Roca et al., 1996; Thombs et al., 2007) and 
breast cancer were explored in this study.        
 It was anticipated that individuals with more adverse early life experiences and 
inadequate emotion regulation strategies would experience greater depression and anxiety. It 
was also anticipated that higher depression and anxiety would be experienced by scleroderma 
participants, when compared to breast cancer participants; as these results were found in 
previous scleroderma and breast cancer studies. These studies however were not direct 
comparisons as is investigated in the current study.                            
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Summary of the Literature and Rationale for the First Study     
 Scleroderma is a rare and complex autoimmune disease afflicting individuals with a 
range of symptoms. There is no cure or known cause for scleroderma, although there are many 
factors that have been associated with this disease. Much of the research has found negative 
physical, psychological and social implications for those diagnosed with scleroderma 
(Hyphantis et al., 2007; Malcarne & Greenbergs, 2005; Richards et al., 2004).  Psychosocial 
research has mostly focused on psychological and social variables related to disease severity, 
coping with and adjustment to a diagnosis of scleroderma and depression.  Although people 
diagnosed with scleroderma appear to suffer a range of psychological problems these factors 
have not been fully investigated. A few studies have found that stress events were reported 
before the onset of scleroderma, indicating that disease symptoms may be associated with 
earlier stressful life events.         
 Early life stress has been linked to heightened stress in adults, physical illness and pain. 
Research suggests individuals exposed to childhood stress, experience an increase in physical 
symptoms that include gastrointestinal, respiratory and other types of pain (Thakkar & 
McCanne, 1999) and a greater likelihood of developing a serious health problem such as 
cancer, ulcers or autoimmune diseases (Sachs-Ericsson et al., 2005).    
 Elevated experiences of pain has been associated with a range of psychosocial 
problems that include regulating emotions, an insecure attachment style and childhood 
experiences of stress, and are factors that have not been explored in relation to scleroderma 
symptoms, pain and disability. Stressful events may occur at any time during the lifespan. 
Adverse experiences early in life are capable of affecting an individual’s adaptive functioning 
in adulthood, influencing emotional and cognitive responses and capacity to manage stress and 
distress; factors that may be associated with scleroderma symptoms, disability and experiences 
of pain.                                           
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 Gilbert and colleagues (2008) suggest that feeling safe influences, attachment styles, 
self-evaluative processes and whether psychological disorders develop. Insecurely attached 
individuals have limited personal and environmental resources and rely on emotion regulation 
strategies such as avoidance or suppression, that are likely to increase arousal levels and 
reduce an individual’s ability to manage stress (Simpson & Rholes, 1998). Suppression is 
frequently used to regulate emotional thoughts (Petrie et al., 1998) by decreasing the 
expression of the emotional experience, however this strategy can result in distorted 
cognitions and increased physiological responses (Gross, 2002; Hayes et al., 1996). These 
strategies have the potential to influence physical and psychological health (Petrie et al., 
1998), the development of disorders such as depression and anxiety (Iwamitsu et al., 2005) 
and elevated arousal levels that affect immune functioning associated with autoimmune 
diseases (e.g., Schore, 1994).           
 Strategies that provide a more positive emotion regulatory approach, not based on an 
evaluative process (Neff, 2003a) involving threat (e.g., Gilbert, 2002; 2007), but on kindness 
and understanding toward the self (Neff, 2003a; Neff et al., 2007), tend to reduce arousal 
levels and promote well-being. This emotion regulation strategy is associated with lower 
physiological responses such as cortisol levels and lower scores on psychological measures of 
distress (Pace et al., 2009). Self-compassion has a negative association with depression, 
anxiety and thought suppression (Neff et al., 2007).       
 The literature suggests that psychosocial stressors such as early life stress, depression, 
and anxiety disorders are implicated in the stress response (Boscarino, 2004; Miller, 2005).  
Physiological responses associated with the stress response include hyper-arousal (e.g., 
Schore, 1994), inflammatory conditions, hypertension, constricted blood vessels (Varga, 2004) 
and immune activation (Seyle, 1950; 1976; Schore, 1994). Developing emotion regulation 
strategies capable of reducing arousal levels when stressed or distressed are associated with 
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increased psychological and physiological wellbeing.        
 As stress events can occur at any time and adverse early life experiences can affect the 
adaptive functioning of an individual in adulthood and influence physiological functioning, 
including immune reactions, and emotional and cognitive responses to manage stress; the 
biopsychosocial factors of early memories of warmth and safeness, attachment style, emotion 
regulation/copying strategies (self-compassion and suppression), hyper-arousal, depression 
and anxiety were explored in relation to scleroderma and breast cancer.                         
 CHAPTER THREE: STUDY ONE - THE SCLERODERMA STUDY                         
Psychosocial Scleroderma Model         
 The psychosocial scleroderma model (depicted in figure 1 below) developed by the 
researcher for this study, was based on Gilbert’s social mentalities theory, that early 
environments involving a lack of warmth and safety, influence the development of the threat 
mentality (e.g., Gilbert et al., 2006). This theory together with the hypothesis that these 
negative early rearing experiences, generally involve the development of inadequate emotion 
regulation strategies (such as suppression and low self-compassion) and insecure adult 
attachment styles (such as dismissive and fearful attachment) are ways of relating to self and 
others, that fail to reduce arousal. These interpersonal and intrapersonal experiences are 
hypothesised to be risk factors in the development of psychological disorders, hyper-arousal 
and scleroderma.              
 Figure 1 below depicts the model developed for the first study that illustrates the 
influence negative early relational experiences (EMWS) may have on the development of the 
threat mentality, reflected in negative inter/intra-personal (e.g., levels of self-compassion and 
suppression) adult relationships (insecure attachment), psychological conditions 
(depression/anxiety) hyper-arousal and Raynaud’s/scleroderma onset.                            
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 Overview of the Research Study                                                         
  Previous research has found that individuals diagnosed with scleroderma tend to have a 
co-morbid psychological status and may have experienced stress before or during the onset of 
scleroderma (e.g., Angelopoulos et al., 2001; Chen et al., 2008; Hyphantis et al., 2007).  
Although stress is implicated in the first symptom (Raynaud’s) of scleroderma (Freedman & 
Ianni, 1983), limited research has investigated stress in relation to onset and exacerbation of 
scleroderma symptoms. Previous research has mainly focused on psychological conditions 
associated with the disease course (e.g., Angelopoulos et al., 2001; Richards et al., 2004; Roca 
et al., 1996) with a few studies reporting stress events before the onset of this disease (Chen et 
al., 2008; Hui et al., 2007), without reference to scleroderma symptoms.    
  
                         
                                                               
                                                             
                                                                    
     
  
  
  
                                                                                                                         
    
  
  
                                                     
  
            
  
                                            
   
Figure 1 :  Scleroderma  Stress - Arousal  M odel                                                                           
Scleroderma  
Raynaud’s  
Hyper - arousal   
Psychological            
Includes Mental Health   
  Insecure Adult Attachment          
Inter - personal Relationships   
Emotion Regulation  Strategies         
Intra - personal: Includes Low Self - Compassion   
Development of the Threat Mentality   
Early Life Stress: Inadequate  Nurturing          
Early Inter - personal Experiences: Low  in  Warmth & Safety   
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 Early life stress and the potential long term risk factors associated with hyper-arousal 
and the development of autoimmunity (e.g., Schore, 1994) have not been examined in relation 
to scleroderma and may be associated with psychological and physiological conditions, 
experienced by individuals diagnosed with this disease. As thirty per cent of individuals 
diagnosed with scleroderma die within the first five years of diagnosis (Varga, 2004), the 
examination of symptom severity and the relationship with emotion regulation, attachment 
style and hyper-arousal is of particular interest, as these aspects are associated with immune 
activation and may increase severity.              
  To date no study the researcher is aware of has examined stressors associated with 
affective states of warmth and safety, ineffective emotion regulation strategies and 
physiological stress aspects of hyper-arousal associated with immune alterations and 
scleroderma. The study is primarily interested in the relationship between stressful 
psychosocial issues associated with early life experiences, (affective states of warmth and 
safety), adult attachment styles (e.g., dismissive and fearful) and emotional regulation 
(suppression and self-compassion) associated with physiological stress and hyper-arousal, 
scleroderma disability and specific symptoms (pain, skin, Raynaud’s, ulcers, breathing and 
intestinal conditions) and onset and psychological symptoms (anxiety, depression and stress).   
 The present study examined the experience of scleroderma within the perspective of the 
biopsychosocial model of health incorporating the area of psychoneuroimmunology and  
Gilbert’s biopsychosocial theory of social mentalities and affect regulation systems. As 
differences in both psychosocial and disease symptoms are reported across the scleroderma 
population, analysis measuring (16 variables) difference between groups such as diffuse and 
limited sclerosis, specific symptoms such as Raynaud’s, No Raynaud’s and Pain, no Pain 
groups etc., involved recording (self-report) responses on a number of psychological (EMWS 
scale; Self-Compassion Scale; Relationship Scales Questionnaire; Emotion Regulation Scale; 
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and the DASS) and physiological (e.g., SHAQ; Hyper-arousal Scale) scales. Subscales (e.g., 
self-kindness; over-identification; fearful and dismissive attachment; suppression; reactive 
hyper-arousal) were also utilized to measure a broader range of psychosocial and physical 
variables that could be relevant to difference between groups. To examine the research question 
of the effects of biopsychosocial variables involving interpersonal and intrapersonal 
relationships and levels of hyper-arousal on scleroderma symptoms and onset, a set of nine 
hypotheses involving 16 variables were developed. However it should be noted that the sample 
size obtained for this study was rather small for the number of variables measured.                                                                                                                                  
Study One: Nine Hypotheses                                                                       
  Hypothesis One: Scleroderma Symptoms - Pain                                                                 
Hypothesis One: Higher levels of Pain will be associated with higher levels of Raynaud’s 
phenomenon, Scleroderma disability, Intestinal and Breathing problems.                                   
Hypotheses Two: Scleroderma Symptoms - Early Life Experiences                           
 Hypothesis 2(a): Lower levels of EMWS and an insecure attachment style                        
(Dismissive and Fearful) will be associated (in individuals diagnosed with scleroderma) with 
higher levels of Pain. Hypotheses 2(b): Greater Raynaud’s phenomenon, 2(c): Greater 
scleroderma disability, 2(d): Greater intestinal problems, 2(e): Greater breathing problems and 
2(f): More severe finger ulcers.                                                                                       
Hypotheses Three: Scleroderma Symptoms - Emotion Regulation and Hyper-arousal  
 Hypothesis 3(a): Lower levels of Self-compassion and higher levels of Suppression and 
Hyper-arousal will be associated (in individuals diagnosed with scleroderma) with higher levels 
of Pain. Hypotheses 3(b-f): As for hypothesis 3(a) including other specific symptoms other than 
pain 3(b): Raynaud’s phenomenon, 3(c): Scleroderma disability, 3(d): Intestinal, 3(e): 
Breathing and 3(f): Finger ulcers.                                                                                                        
Table 1 below provides a summary overview of the research project.                                                              
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Table 1                     Summary: Overview of Research Project  
         Study 1: Scleroderma Study                                 Study 2: Comparison Study 
  
DV’s: Disease Symptoms   
• Scleroderma  
• Types of Scleroderma  
• Specific Scleroderma Symptom   
• Age of Disease Onset   
• Mental Health   
  
  
DV’s: Type of immune Disease/No Disease                               
Group Comparisons   
     Study 2     Scleroderma - Community   
     Study 3(a) Scleroderma - Breast Cancer  
• Disease symptoms  
• Age of Disease Onset   
     Study 3(b)  Scleroderma - Breast Cancer        
                         -  Community Groups  
IV’s Psychosocial Variables   
• Early Nurturing Experiences  
• Attachment Style  
• Emotion Regulation Strategies  
• Levels Self-Compassion  
• Hyper-arousal  
• Scleroderma Symptoms  
 IV’s Psychosocial Variables   
• Early Nurturing Experiences  
• Attachment Style  
• Emotion Regulation Strategies  
• Levels Self-Compassion  
• Hyper-arousal  
• Mental Health   
 Theory: All Studies  
• Gilbert’s Social Mentalities Theory  
• Bowlby’s Attachment Theory  
  Models: All Studies  
• Gilbert’s Model of Affect Regulation  
• Biopsychosocial Model of Health  
  
Stress and Physiological Processes: Rational for Studies  
• The literature suggests stressful experiences can cause dysregulation of neurological 
processes, immunological responses and excessive inflammatory reactions involved 
in autoimmunity and the development of scleroderma.   
• Investigating factors that involve the threat/stress response and the relationship with 
disease, may provide a greater understanding of the influence early relational 
experiences may have on adult ways of relating to self and others and physiological 
processes that may impact on disease onset and exacerbation of symptoms.  
• The studies purpose was to provide further evidence for holistic disease treatment.   
• Recognising that thinking processes may be an important factor in understanding an 
individual’s physiological responding and resulting influence on disease symptoms, 
may encourage professionals to engage in a more holistic approach to treatment.  
Aim   
To investigate the link between early 
relational, interpersonal and intrapersonal 
relationships and levels of hyper-arousal 
and self-compassion on scleroderma 
symptoms and onset.   
Aim   
To investigate whether differences occur 
between groups for relational variables, levels 
of self-compassion and hyper-arousal to 
identify whether specific experiences are 
linked to disease symptoms and onset.  
Hypotheses  
      Greater negative relational experiences         
will predict greater hyper-arousal,        
disease severity and earlier onset.   
Hypotheses  
 The scleroderma group will report more           
negative experiences than the breast        
cancer and community groups.  
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 Hypothesis Four: Age Diagnosed with Scleroderma/Raynaud’s - Psychosocial Variables                               
 Hypothesis 4(a): Lower levels of EMWS and Self-compassion, an insecure attachment 
style (Dismissive and Fearful) and higher levels of Suppression and Hyper-arousal will be 
associated with an earlier diagnosis of Scleroderma and hypothesis 4(b): an earlier diagnosis of 
Raynaud’s phenomenon.                                                                  
Hypothesis Five: Diffuse and Limited – Difference in Biopsychosocial Variables  
  Hypothesis 5(a-h): Individuals diagnosed with diffuse and limited sclerosis who have 
experienced more negative psychosocial experiences will also report more negative disease 
outcomes (that will differ across the two groups). The psychosocial variables EMWS, 
Dismissive and/or Fearful attachment, Suppression, Self-compassion (subscales mindfulness, 
self-kindness, common humanity, self-judgment, over-identification and isolation) and Hyper 
arousal (subscales, introspect and reactive) were hypothesised to be associated with the 
following disease symptoms, each described as an independent hypothesis. Hypotheses 5(a): 
Psychosocial variables and Pain; 5(b): Raynaud’s phenomenon; 5(c): Scleroderma disability; 
5(d): Intestinal; 5(e): Breathing; 5(f): Finger ulcers; 5(g): Age Diagnosed with Scleroderma; 
and 5(h): Age Diagnosed with Raynaud’s phenomenon.                                                                               
Hypothesis Six: Specific Scleroderma Symptoms – Difference in Psychosocial Variables  
 Hypothesis 6(a): Lower levels of EMWS, Self-compassion, emotion regulation and 
insecure attachment will also be reported by those individuals diagnosed with Pain when 
compared with individuals without Pain and (hypotheses) 6(b): Raynaud’s phenomenon, 6(c): 
Intestinal, 6(d): Breathing and 6(e): Finger ulcers (experienced by individuals diagnosed with 
scleroderma) when compared with individuals diagnosed with Scleroderma without these 
conditions.                                                                                                    
Hypothesis Seven: Scleroderma Skin Involvement –Psychosocial Variables       
  Hypothesis Seven: Lower levels of EMWS, Self-compassion, an insecure attachment 
style (Dismissive and Fearful) and higher levels of the negative emotion regulation strategy  
Suppression will be associated with greater Skin symptoms associated with progression of  
Scleroderma.                                                                                                                                                        
Hypothesis Eight: Depression, Anxiety and Stress – Biopsychosocial Variables    
 Hypotheses 8(a): Scleroderma - Depression, 8(b): Anxiety and 8(c): Stress will be 
associated with lower levels of EMWS, Self-compassion, an insecure attachment style 
(Dismissive and Fearful), higher Suppression, Scleroderma disability and Specific symptoms. 
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    Hypotheses 8(d): Diffuse and Limited sclerosis - Depression, 8(e): Anxiety and 8(f): 
Stress will be associated with lower levels of EMWS, Self-compassion, an insecure attachment 
style, higher Suppression, Scleroderma disability and Specific symptoms   Hypotheses 8(g): 
Higher levels of Depression, 8(h): Anxiety and 8(i): Stress will be reported by individuals 
diagnosed with Raynaud’s phenomenon, Pain, Finger ulcers,  Intestinal and Breathing 
conditions experienced by individuals diagnosed with scleroderma, when compared to 
individuals diagnosed with scleroderma without these conditions.                                   
Hypothesis Nine: Hyper-arousal – Biopsychosocial Variables        
  Hypothesis Nine: Higher levels of Hyper-arousal will be associated with more severe 
scleroderma symptoms (Pain, Raynaud’s phenomenon, Breathing and Intestinal conditions and 
Finger ulcers), onset of  scleroderma at a younger age and psychosocial experiences of low 
EMWS and Self-Compassion and greater experiences of Suppression and an insecure 
attachment style (Dismissive and Fearful).                                              
               Method                                                                                       
Procedure                         
  A number of scleroderma organisations reaching an international population were 
involved in promoting this study to members diagnosed with scleroderma. These organisations 
included the Queensland and Australian Scleroderma Associations and the United Kingdom 
Scleroderma Society. These non-profit organisations work to provide education and support for 
members. Approval was received from the various associations’ committees responsible for 
scleroderma research once the survey and explanatory letter had been sighted and discussed.    
 Participants in Australia were recruited through newsletters published by the Australian, 
and Australian State Scleroderma Associations, such as Queensland and Victoria and by the 
research student within South East Queensland (Sunshine Coast, Brisbane and Gold Coast) at 
scleroderma meetings to complete an online or hardcopy version of the survey. Australian 
participants who had no online access, received a hardcopy version of the questionnaire. These 
participants were recruited from phone enquires and emails as a result of advertisements in 
scleroderma newsletters and magazines or at scleroderma meetings. A questionnaire with a 
stamped addressed envelope, to the supervisor of this project at Bond University was 
forwarded to interested participants by mail or handed to participants at meetings.   
 A written explanatory letter containing information about the purpose, procedure, where 
questions/complaints could be directed, risks and benefits of the research project and 
anonymity of participants was attached as a cover page to the online and hardcopy versions, for 
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participants to view prior to completing the survey. Completion of the survey required 
approximately 50-60 minutes of the participants time. Information about the study and the 
survey including a written explanatory letter from both the researcher and the United Kingdom 
Scleroderma Society was forwarded by the trustee of the Scleroderma Society to 231 of their 
members that had been diagnosed with Scleroderma. The project was approved by the Bond 
University Human Research Ethics Committee and received approval from the  
Scleroderma Society Ethics Committee in the United Kingdom and the Queensland and  
Australian Scleroderma Associations.                                                                                                          
Participants                                                                                                                         
  Male and female adults aged 18 years and over diagnosed with scleroderma were 
invited to participate in this research project. Participants were asked a number of demographic 
and health questions, ranging from general questions such as the country they resided in, 
gender, current age and age diagnosed with scleroderma to questions relating to participants 
physical symptoms, such as degree of skin involvement and psychological health  
(e.g., diagnosed with a mental health disorder before and/or after diagnosis of scleroderma). 
 Males were recruited with regard to the scleroderma prevalence rates for females and 
males. Similar to other connective tissue diseases, scleroderma has a greater incidence in 
females with predominance of 3-5:1, and up to 14:1 in some female populations (Chifflot et al., 
2008). Therefore a much smaller percentage of males were recruited for this project.  
Significant differences between physiology for males and females are also noted for example 
estrogen tends to feature as a predisposing factor in both autoimmune diseases and breast 
cancer (Cutolo et al., 2006; Eeles et al., 2004; Mavaddat et al., 2010) and may partially explain 
the high prevalence in women when compared to men.                                       
Measures                                                                                                                                  
Psychosocial Stress: Warmth and Safeness    
   Early Memories of Warmth and Safeness Scale. The EMWS scale is a 21 item self-
report, 5 point Likert scale (e.g., 0 = no, never, 2 = yes sometimes and 4 = yes most of the 
time). Items include, “I felt safe and secure”. “I felt a sense of belonging,” “I felt cared for.” 
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This scale assesses emotional memories of an individual’s childhood as a measure of preverbal 
or nonverbal experiences of stress. The EMWS scale focuses on recall of one’s own emotional 
experiences while most other measures focus on recall of others behaviours; recall of positive 
emotions (or deficits) was found to be a better predictor of psychopathology and styles of self-
criticism than recall of parental behaviour. The EMWSS has good psychometric properties 
(high Cronbach’s alpha, retest reliability, divergent and predictive validity). “Recall of parental 
behaviour and recall of positive emotional memories were highly related, but recall of positive 
emotional memories was a better predictor of psychopathology, styles of self-criticism/self-
reassurance and disposition to experience positive affect, than recall of parental behaviour” 
(Richter, Gilbert & McEwan, 2009).                                                                                                  
Attachment: Relationship Scale Questionnaire (RSQ)         
 The Relationship Scale Questionnaire (Griffin & Bartholomew, 1994) comprises 30 
items each rated on a 5 point Likert scale, (e.g., 1 = not at all like me, 3 = somewhat like me, 
and 5 = very much like me). This self-report measure was developed to assess a number of 
insecure anxious-avoidant attachment styles such as anxious-pre-occupied, dismissive-
avoidant, fearful-avoidant and a secure attachment style.  Examples of items include, “I find it 
difficult to depend on other people” (fearful attachment). “It is important for me to feel 
independent” (Dismissive). “I find it easy to get emotionally close to others.” (secure). “I want 
to merge completely with another person” (preoccupied). The questionnaire has good internal 
consistency ranging from .85 to .90 (Griffin & Bartholomew, 1994). This scale has good 
psychometric properties (test-retest reliability and internal consistency, convergent, 
discriminant and predicitive validity (Ravitz, Maunder, Hunter, Sthankiva & Lancee, 2010). 
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Emotional Regulation:  Suppression and Re-appraisal                                           
 Emotional Regulation Questionnaire (ERQ; Gross & John, 2003). ERQ is a 10 item 7 point 
Likert type scale (1 = strongly disagree; 4 = neutral; 7 = strongly agree), self-report measure of 
thought suppression, a regulatory strategy that prevents the expression of the true felt emotion; 
and reappraisal the ability to re-evaluate a situation in a more positive way.  Examples of items 
include, “When I am feeling positive emotions, I am careful not to express them” and “When I 
am faced with a stressful situation, I make myself think about it in a way that helps me stay 
calm”. The ERQ has satisfactory alpha reliability and test-retest reliability and is a valid 
measure of suppression and reappraisal (Gross & John, 2003).                                                                                 
Self-Compassion: Self Compassion Scale              
   The Self Compassion Scale (Neff, 2003) is a 26 item, self-report, emotion regulation 
measure that employs a 5 point Likert scale (e.g., 1 = almost never to 5 = almost always) that 
contains three components. Self-kindness/Self-judgment (being kind and understanding toward 
oneself rather than judgmental or critical); Common humanity/Isolation (viewing one’s 
negative experiences as a normal part of the human condition rather than experiencing 
suffering in isolation); and Mindful acceptance/Over-identifying (being open to and accepting 
of one’s situation rather than over-identifying with painful thoughts and feelings). Examples of 
items include, “When things are going badly for me, I see the difficulties as part of life that 
everyone goes through.”  “When I think about my inadequacies, it tends to make me feel more 
separate and cut off from the rest of the world.”  “I try to be loving towards myself, when I’m 
feeling emotional pain.”  “When I fail at something important to me, I become consumed by 
feelings of inadequacy.” “When I feel inadequate in some way, I try to remind myself that 
feelings of inadequacy are shared by most people.” This scale has good psychometric 
properties (construct, content, convergent and discriminant validity; test-retest reliability) and 
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is a valid theoretical measure of self- compassion (Neff, 2003). Self-compassion may be an 
adaptive process that increases psychological resilience and well-being (Neff, 2003).                          
Psychological: Depression, Anxiety and Stress Scale          
  The Depression, Anxiety and Stress Scale (DASS21; Lovibond & Lovibond, 1995). The  
DASS21 is a 21 item 4 point likert scale, self-report measure of Depression, Anxiety and 
Stress. The DASS21 provides useful clinical information of depression and related problems of 
anxiety and stress that allows for discrimination amongst the variables. In research the 
DASS21 provides a dimensional assessment of three forms of negative affect with minimal 
levels of overlap among these variables (Nezu, Ronan, Meadows, & McClure, 2002). 
Participants indicate either, 0, 1, 2 or 3 which specifies how much the statement applied to 
them over the past week. Examples of items include “I found it hard to wind down” and “I 
couldn’t seem to experience any positive feelings at all.” The DASS21 is a quantitative 
measure of distress along the axes of depression, anxiety (symptoms of psychological arousal) 
and stress (the more cognitive, subjective symptoms of anxiety). It has good reliability and 
adequate convergent and discriminant validity (Crawford & Henry, 2003).                                                           
Physiological: Scleroderma Questionnaire        
 Scleroderma Health Assessment Questionnaire (SHAQ). Scleroderma disability was 
measured using the Scleroderma Health Assessment Questionnaire (SHAQ; Fries, Spitz, & 
Young, 1978; Steen & Medsger, 1997). The SHAQ provides a disability index measuring eight 
areas of functioning including arising, dressing, grooming, hygiene, eating, walking, reach, 
grip and activity and is used to measure severity of disability. Item responses range from 0, 
which indicates without any difficulty to 3 indicating unable to do. The index contains 
questions such as, “are you able to open jars previously opened?” Specific scleroderma related 
symptoms of pain, Raynaud’s, finger ulcers, breathing and intestinal problems were measured 
using an analogue visual scale ranging from 0, indicating no limitation to 100, indicating very 
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severe limitation. The SHAQ has good psychometric properties (incremental, face and content 
validity and satisfactory reliability construct, concurrent, and predictive validity: Johnson, 
Hawker, & Davis, 2005).        
Arousal: Hyper-arousal Scale                                                                 
       The Hyper-arousal Scale (Hammond, Barsky, & Regestein, 2001) is a 26 item self-report 
that measures tendencies to introspect think about feelings; responding intensely to unexpected 
stimuli and other behaviours that involve cortisol arousal. Responses to each item on the 
Hyper-arousal Scale are graded from 0 to 3 respectively where 0 = not at all, 1 = a little, 2 = 
quite a bit and 3 = extremely. Hyper-arousal scale scores correlate with several EEG measures 
of arousal including frequency spectral and evoked potential measures.  Hyper-arousal scores 
signify increased general cerebral responsiveness but decreased selective attention, indicating 
openness to stimuli and difficulty distinguishing between physiologically harmless and 
threatening sensations. This situation may create an information overload and result in 
difficulty adapting to recurring stimuli. A decrease in selective attention may create ambiguity 
as to the meaning attributed to the perceived experience resulting in the development of an 
adversity management system. The scale contains questions involving “Bright lights & crowds 
and thinking a lot about feelings.” This scale has good psychometric properties (predictive and 
construct: Hammond, Barsky, & Regestein, 2001). Participants recorded responses to 26 
questions related to how they would respond in certain situations.                                                                                             
                                                              Results                                                                                
Study One: Overview of Analysis              
  Analysis was performed using SPSS version 18 and descriptive statistics for each of the 
continuous variables was obtained. Frequencies were investigated for demographic and health 
information. Multiple regression assumptions were explored as these analyses were considered 
appropriate to meet the initial hypotheses. Bivariate correlation analyses using Pearson’s 
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product-moment correlation coefficient were conducted between reliable and normally 
distributed or transformed scales and subscales, to establish the relationship between the 
dependent variables, scleroderma disability, pain, intestinal, breathing and Raynaud’s and the 
independent variables, early memories of warmth and safeness (EMWS), attachment style 
(RS), emotion regulation (ER), hyper-arousal and self-compassion (SC). T-Tests were also 
conducted to determine significant mean differences between the major types of Scleroderma, 
Diffuse and Limited Sclerosis and psychological variables. Demographic and health variables 
such as gender, age, education, marital status, age diagnosed with scleroderma and age 
diagnosed with Raynaud’s were also investigated in relation to psychological variables, pain, 
disability and severity of specific scleroderma symptoms.                                   
Preliminary Statistical Analysis                               
             Age: Frequencies for current age revealed the age range for participants at between 26 
and 80 years, with a mean age of 56 years.              
         Demographic: Frequencies for demographic information revealed a total of 129 
participants, 96 (93%) females and nine (7%) males with 24 participants failing to complete 
this information. Thirty four (26%) participants were from Australia, 69 (54%) from the UK 
and two (2%) from European Countries, 24 (18%) participants did not supply this information.  
  Education: Three participants reported gaining a primary school education, 46 (44%), 
reported a secondary school education, with 34 (33%) and 21 (20%) participants respectively 
reporting tertiary and post graduate education, (25 participants did not supply this 
information).           
 Health: for health information revealed 35 (45%) participants were diagnosed with 
diffuse sclerosis and 43 (55%) reported a diagnosis of limited sclerosis, (51 individuals did 
not complete this information). The age range for individuals when first diagnosed with 
scleroderma was 20 to 72 years, with a mean age of 47 (SD, 11.34). Seventy two (96%) 
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participants reported a diagnosis of Raynaud’s while five (4%) participants were not affected 
by Raynaud’s, (41 participants did not complete this information). The age range for 
individuals when they were first diagnosed with Raynaud’s was 20 to 72; the mean age was 
47 years (SD 11.52). Missing data was evident throughout the data. The pattern appeared 
random for all completed scales. A large number of participants had completed demographic, 
health and Scleroderma scales but had failed to complete psychological scales. Some 
participants completed only the Depression Anxiety and Stress Scale (DASS) while 
completion of the remainder of the psychological scales varied with each participant. A 
number of participants failed to specify type of Scleroderma or did not indicate a diagnosis of 
Scleroderma, these participants were excluded from the study. One hundred and twenty nine 
individuals participated in the study; with the exclusion of cases to meet assumptions and 
hypotheses criteria, a total of 92 participants remained. The EMWS scale (childhood warmth 
and safety) was positioned after the first psychological scale in the questionnaire (the DASS); 
revisiting these experiences may have led to a number of withdrawals from the survey.  
 It can be difficult for people to complete questionnaires containing this type of 
material and therefore three sources of psychological support as mentioned on page eight 
were provided on the first page of the survey. Equally participants may have had no interest in 
completing the psychological scales as they have felt they had no psychological issues and 
therefore these scales were not relevant to them. If participants positive or negative reasons 
for non-responding were relatively even then the issue of missing data may not be an issue.                                 
Reliability – Internal Consistency                                                                 
    Analysis revealed Cronbach’s alpha coefficients for the variables Depression, EMWS, Self-
Kindness and the SHAQ were above .90. Stress, Reappraisal, Hyper-arousal, Self-Judgment, 
Common Humanity and Mindfulness were above .80. Self-Compassion, Fearful attachment, 
Suppression, Isolation, Over-identification and Anxiety were .70, or above. Two subscales with 
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a small number of items had alpha coefficients below .70. Dismissive attachment had 5 items 
and an alpha coefficient of .65; the mean inter-item correlation was calculated (and found to be 
within the acceptable range of .20 and .40; Briggs and Cheek, 1986) at .28. Reactive Hyper-
arousal had 3 items and an alpha coefficient of .52 with an acceptable inter-item correlation 
mean of .26. The variables preoccupied and secure attachment were below .30 demonstrating 
low internal consistency and were removed from further analysis.                                                                                                                       
Multiple Regression Analysis for Scleroderma Symptoms                                                                              
 Data was screened for suitability for multiple regression analysis. The assumptions for 
normality were met for EMWS, Suppression and Reappraisal subscales of the ERQ, the Self- 
compassion Scale, and subscales Self-kindness, Mindfulness, Common Humanity, Self-
judgment, Over-identification and Isolation and the Stress subscale of the DASS. The SHAQ 
disability scale, Pain, Intestinal, Breathing and Raynaud’s  subscales, Hyper-arousal, Introspect 
and Reactive Hyper-arousal subscales, Fear subscale of the RQ, the Anxiety and Depression 
subscale of the DASS were positively skewed. Examination of plots revealed univariate and 
multivariate outliers for two cases, which were removed as recommended by Tabachnick and 
Fidell (2007). Square-root, logarithm and inverse (reflect for negatively skewed) 
transformations were conducted according to the shape of the distribution for each of the 
variables: transformation, however, did not reduce the skew.         
         Data was then organised into the two major types of Scleroderma (Diffuse sclerosis and 
Limited sclerosis) and skin related Scleroderma, Morphea (four participants), Localised (two 
participants) Sclerosis and overlap conditions (eight participants). In an attempt to normalise 
the data the skin related and other groups (14 participants) were excluded from the data leaving 
the two major types of Scleroderma: Diffuse and Limited. The skew for these variables was 
reduced and closer to zero meeting the assumptions for normality. A total of 78 participants 
remained for analysis. The data was checked for multicolinarity among the predictor variables 
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and it was found that the correlations among the predictor values were below r < .9 therefore 
meeting this assumption. The assumptions for independence, singularity, linearity and 
homoscedasticity were generally met (unless otherwise discussed).  Pearson’s bivariate 
correlations, t-tests, multiple regression and MANOVA analyses were conducted to investigate 
the nine hypotheses: that lower levels of EMWS, inadequate emotion regulation strategies 
(lower self-compassion and higher suppression) and an insecure attachment style (dismissive 
and fearful) would be associated with higher levels of disability pain, and specific scleroderma 
symptoms (Raynaud’s phenomenon, finger ulcers, skin, intestinal and breathing conditions) in 
individuals diagnosed with scleroderma. Pain was also explored in relation to scleroderma 
symptoms and was hypothesised to be associated with higher levels of specific scleroderma 
symptoms. Comparisons between the two major forms of scleroderma (diffuse and limited 
sclerosis), specific scleroderma symptoms (Raynaud’s phenomenon, finger ulcers, skin, 
intestinal and breathing conditions), age of diagnosis (with scleroderma) and psychosocial 
variables were examined to determine the relationship between biological (severity of 
scleroderma symptoms) and psychosocial factors (insecure attachment, emotion regulation and 
early life experiences). Mental health aspects (depression, anxiety and stress) were explored in 
relation to these biopsychosocial aspects to determine the level of contribution these factors 
made to scleroderma symptom severity.                                                                                     
  The hypotheses were divided into four headings. Hypotheses 1-3: Scleroderma 
symptoms and psychosocial variables. Hypothesis 4: Age diagnosed with scleroderma and  
Raynaud’s phenomenon and psychosocial variables. Hypothesis 5-7: Specific scleroderma 
symptoms (e.g., diffuse/limited, pain, Raynaud’s and skin involvement) and psychosocial 
variables. Hypothesis 8-9: Mental health (e.g., depression and anxiety), psychosocial and 
scleroderma variables. Hyper-arousal, psychosocial and scleroderma.                                                                 
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Hypotheses 1-3: Scleroderma Symptoms and Psychosocial Variables                       
Hypothesis One: Scleroderma Symptoms and Pain            
 Pearson’s bivariate correlations were conducted after the assumptions for multiple 
regression were met for the scleroderma sample (consisting of individual’s with diffuse and 
limited sclerosis). Results partially supporting the first hypothesis revealed meaningful 
relationships between Pain and Raynaud’s (r = -.31, p = .007), Intestinal (r = .58, p = .000), 
Breathing (r = .35, p = .002), and Scleroderma Disability (r = .49, p = .000); these variables 
were entered into a multiple regression analysis to determine the first hypothesis. The results 
for the scleroderma sample (diffuse/limited) demonstrated the variables significantly accounted 
for 68.8% (Adjusted R ² = 44.2%) of the variance, F(4, 69) = 15.48, p = .000, in  
Pain associated with Scleroderma. The regression coefficients demonstrated that Intestinal (β = 
.45, p = .000, sr ² = 16.9%) and Scleroderma Disability (β = .33, p = .001, sr ² = 9.2%; power 
was calculated at .99; Soper, 2011) were significant predictors of Pain.                                                                                       
Hypotheses Two: Scleroderma Specific Symptoms and Early Life Experiences             
Hypothesis 2(a): Pain and Psychosocial Variables, EMWS and Attachment    
  Pearson’s bivariate correlations were conducted to determine hypothesis 2(a), that 
EMWS and an insecure attachment style would predict greater pain in the scleroderma sample 
(consisting of individual’s with diffuse and limited sclerosis). Results supporting the 
hypothesis revealed meaningful relationships between Pain and EMWS (r = -.37, p = .002), 
and Dismissive attachment style (r = .28, p = .017). Variables were entered into multiple 
regression analysis to determine the first hypothesis: Higher levels of Pain would be associated 
with lower levels of EMWS, and an Insecure Attachment Style, in individuals with 
scleroderma (diffuse/limited). The results demonstrated the variables significantly accounted 
for 43.7% (Adjusted R ² = 16.7%) of the variance, F (2, 68) = 8.04, p = .001 in Pain related to 
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Scleroderma Symptoms. The regression coefficients demonstrated that EMWS (β = -.34, p = 
.003, sr ² = 11.2%) and Dismissive attachment (β = .24, p = .032, sr ² = 5.7%; power was 
calculated at .93, Soper, 2010), were significant unique predictors of Pain experienced by 
individuals diagnosed with Scleroderma. Results for predictor variables for Pain are presented 
in Table 2.                                                                                                                        
Table 2                                                                                                             
Summary of the Multiple Regression Analysis for Scleroderma Pain N = 70   
 
Variable                                                                       B                       SEB                     β      
 
    Pain  
           EMWS                                                           - .36                       .12                   -.34**                             
           Dismissive Attachment                                  1.45                       .66                     .24*    
           Total R2                                    .19**       
__________________________________________________________________________        
*p < .05 **p < .01 ***p < .001                 
  The remaining specific scleroderma symptoms Hypotheses 2 (b, c, d, e & f) were not  
significantly related to EMWS or attachment style and detailed tables are not presented here.                            
Hypothesis Three: Specific Symptoms, Emotion Regulation and Hyper-arousal  
Hypothesis 3(a): Pain, Emotion Regulation and Hyper-arousal      
  Pearson’s bivariate correlations were conducted, to determine the relationship between 
Pain and psychosocial variables, Self-compassion, Suppression and Hyper-arousal.  
Results revealed no meaningful relationships between the dependent variable Scleroderma  
Pain and psychosocial variables therefore the hypothesis 3(a) was not supported.                  
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Hypothesis 3(b): Raynaud’s phenomenon, Emotion Regulation and Hyper-arousal  
 Pearson’s bivariate correlations demonstrated meaningful relationships between the 
dependant variable Raynaud’s phenomenon and the independent variables, Self-compassion, (r 
= -30, p = .021) and Hyper-arousal (r = .25, p = .041). Multiple regression analysis revealed the 
Scleroderma sample (consisting of individual’s with diffuse and limited sclerosis) 
demonstrated the variables significantly accounted for 45.5% (Adjusted R ² = 18.3%) of the 
variance, F(2, 65) = 8.49, p = .001 in Raynaud’s associated with a diagnosis of Scleroderma. 
The regression coefficients demonstrated that neither variables were significant predictors of 
Raynaud’s phenomenon.         
 Pearson’s bivariate correlations for the subscales of Self-Compassion and Hyper-arousal 
were explored to determine whether these variables predicted Raynaud’s. Correlation 
coefficients revealed that Reactive Hyper-arousal (r = .36, p = .003), and Self-Kindness (r = -
.35, p = .003) were the highest significant subscales for the variables. Significant variables 
were entered into multiple regression analysis. The results demonstrated the variables 
significantly accounted for 45.5% (Adjusted R ² = 18.3%) of the variance, F (2, 65) = 8.49, p = 
.001, in Raynaud’s associated with Scleroderma Symptoms.     
 The multiple regression coefficients demonstrated that (the subscales of self-
compassion and hyper-arousal) Self-Kindness (β = -.29, p = .014, sr ² = 7.7%) and Reactive 
Hyper-arousal (β = .30, p = .012, sr ² = 8.2%; (power was calculated at .97) were significant 
unique predictors of Raynaud’s phenomenon, experienced by individuals diagnosed with 
Scleroderma; partially supporting hypothesis 3(b).      
 Results are presented in Table 3.                                             
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Table 3                                                                                                                                   
Multiple Regression Analysis Summary for Scleroderma/Raynaud’s and Psychosocial N = 67
 
Variable                                                                   B                       SEB                     β      
 
 Raynaud’s Phenomenon  
            Self-Kindness                                          - 42.82                  17.04                 -.29*                                    
            Hyper-arousal Reactive                               2.85                    1.01                   .30*    
            Total R2                                  .21**     
___________________________________________________________________________       
*p < .05 **p < .01 ***p < .001                                                                                        
Hypothesis 3(c): Scleroderma Disability, Emotion Regulation and Hyper-arousal   
  Pearson’s bivariate correlations revealed a meaningful relationship between the 
dependent variable Scleroderma disability and Reactive hyper-arousal (r = .27, p = .025); 
indicating that individuals with higher levels of Reactive hyper-arousal may experience  
greater Scleroderma disability, partially supporting hypothesis 3(c).                                                                    
Hypothesis 3(d & e): Remaining Specific Symptoms, Emotion Regulation & Hyper-arousal  
  Hypotheses 3(d & e) were not met as Pearson’s bivariate correlation coefficients 
revealed no meaningful relationships for the specific Scleroderma symptoms; Breathing and 
Intestinal and psychosocial variables for the total Scleroderma sample. Pearson’s bivariate 
correlations for hypothesis 3(f): Finger ulcers, were not conducted due to skewed distribution.                          
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Hypothesis Four: Age Diagnosed - Scleroderma/Raynaud’s & Psychosocial Variables                               
Hypothesis 4(a): Age Diagnosed-Scleroderma (diffuse/limited) & Psychosocial Variables 
  Pearson’s bivariate correlations and multiple regression analysis were conducted to 
address hypothesis 4(a); the earlier an individual is diagnosed with Scleroderma the greater the 
likelihood they would report lower levels of Self-compassion, early memories of warmth and 
safeness, an Insecure Attachment Style and higher levels of Suppression and Hyper-arousal. 
Correlation coefficients revealed meaningful relationships between the dependant variable Age 
diagnosed with Scleroderma and the independent variables, Hyper-arousal (r = -.37, p = .003), 
and the negative Self-compassion subscales, over-identification (r = -.39, p  
= .001) and isolation (r = -.25, p = .044) in the scleroderma sample (consisting of individual’s  
with diffuse and limited sclerosis).                
  Results for multiple regression analysis demonstrated the variables significantly 
accounted for 42.4% (Adjusted R ² = 13.8%) of the variance, F (3, 59) = 4.31, p = .008, in Age 
diagnosed with Scleroderma. Although the model was significant and accounted for 14% of the 
variance, the regression coefficients demonstrated that no variable was a significant unique 
predictor of Age diagnosed with Scleroderma. Therefore hypothesis 4(a) was only partially 
supported.                                                                                              
Hypothesis 4(b): Age Diagnosed with Raynaud’s Phenomenon and Psychosocial Variables  
 Pearson’s bivariate correlations and multiple regression analysis were conducted to 
address hypothesis 7(b); the earlier an individual is diagnosed with Raynaud’s phenomenon the 
more likely they will experience lower levels of Self-compassion, EMWS, an Insecure 
Attachment Style and higher levels of Suppression and Hyper-arousal. Correlations revealed 
meaningful relationships between the dependant variable Age diagnosed with Raynaud’s 
phenomenon and the dependent variables (Self-compassion subscales) over-identification               
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(r = -.48, p = .003) and isolation (r = -.41, p = .014). Multiple regression analysis results 
demonstrated the variables significantly accounted for 42.1% (Adjusted R ² = 12.7%) of the 
variance, F (2, 59) = 4.36, p = .010, in Age diagnosed with Raynaud’s. The regression 
coefficients demonstrated that neither variable was a significant unique predictor of Age 
diagnosed with Raynaud’s phenomenon. Therefore hypothesis 4(b) was partially supported.   
Hypothesis 5-7: Specific Scleroderma Symptoms & Psychosocial Variables                   
Hypothesis 5(a): Diffuse & Limited - Pain & Psychosocial Variables                 
 A split file for Diffuse and Limited sclerosis was used to address hypothesis 5(a): 
individuals diagnosed with Diffuse and Limited sclerosis would report different psychosocial 
variables (EMWS, Insecure Attachment, Self-Compassion, Emotion Regulation, Hyper-
arousal and Age diagnosed) that predict Pain. Pearson’s bivariate correlations were obtained 
after the assumptions for multiple regression analysis were met. Results significant at .01 
revealed meaningful relationships for Pain and EMWS, (r = -.48, p = .002), Dismissive 
attachment style, (r = .43, p = .006), and Age diagnosed with scleroderma (r = .43, p = .006), 
for the Limited group and Suppression (r = -.59, p = .001), for the Diffuse group.    
  Significant variables were entered into multiple regression analysis separately for the 
Limited sclerosis group as a split file produced warnings that not all statistics could be 
computed. The only significant correlation coefficient for the Diffuse group was emotional  
Suppression; therefore, multiple regression analysis was not conducted. The results for the 
Limited sclerosis group demonstrated the variables significantly accounted for 77.5%  
(Adjusted R ² = 56.6%) of the variance, F(3, 35) = 17.49, p = .000, in Pain associated with 
Scleroderma symptoms. The regression coefficients for the Limited sclerosis group 
demonstrated that Age diagnosed with scleroderma (β = .51, p = .000, sr ² = 22.8%),  
Dismissive attachment (β = .48, p = .000, sr ² = 20.6%) and EMWS; (β = -.35, p = .003, sr ² =  
11.7%; power .99) were significantly predictive of Pain, experienced by individuals  
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diagnosed with Limited sclerosis.                 
  Results indicated that individuals diagnosed with Limited sclerosis who reported fewer 
early life experiences of warmth and safety, an insecure dismissive attachment style and a later 
diagnosis of scleroderma, were likely to experience greater levels of Pain.  
Suppression was associated with greater Pain for the Diffuse group. Therefore differences were 
found between groups for the variables related to Pain. Results for the Limited group are 
presented in Table 4.                                                                                                                  
Table 4                                                                                                                              
Summary of Multiple Regression Analysis for Split File Limited Sclerosis and Pain N =38 
 
Variable                                                                  B                       SEB                     β      
 
Pain - Limited Sclerosis      
            Age Diagnosed Scleroderma                  71.66                  16.40                 .51***  
            Dismissive Attachment                            2.64                      .62                  .48**    
            EMWS                                                      -.43                      .14                 -.35**                                     
            R2                                           .60***     
___________________________________________________________________________   
*p < .05 **p < .01 ***p < .001                     
  Results partially supported hypothesis 5(a) and demonstrated that differences occurred 
(between the two major types of scleroderma: Diffuse and Limited sclerosis) in variables 
related to pain; with higher emotional Suppression associated with elevated Pain, for 
individuals diagnosed with Diffuse sclerosis and lower EMWS, an insecure Dismissive 
attachment style and a later diagnosis of scleroderma, predicting elevated pain in the Limited  
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sclerosis group.                                                                                                                                            
Hypothesis 5(b): Diffuse & Limited - Raynaud’s Phenomenon & Psychosocial Variables  
 A split file for Diffuse and Limited Sclerosis groups was also utilized to determine 
hypothesis 5(b): individuals diagnosed with diffuse and limited sclerosis will report a 
difference in psychosocial variables EMWS, Dismissive and Fearful attachment, Self-
compassion, Suppression and Hyper-arousal associated with Raynaud’s phenomenon 
(subscales of the self-compassion scale: mindfulness, self-kindness, common humanity, self-
judgment, over-identification and isolation and hyper-arousal subscales: introspect and 
reactive, were also investigated as the full scales of these variables were not significantly  
related to Raynaud’s).                  
  Pearson’s bivariate correlations were performed to determine difference between groups 
(Diffuse and Limited sclerosis) for the dependant variable Raynaud’s phenomenon and 
psychosocial variables. Correlation coefficients significant at .01 (small sample) revealed 
Hyper-arousal Reactive (r = .52, p = .003) and Self-kindness (r = -.55, p = .002), were 
significantly related to Raynaud’s for the Diffuse group; the only significant variable 
associated with Raynaud’s phenomenon for the Limited group was Self-judgement (r = .38, p  
= .021), therefore results demonstrated differences between groups.       
 Significant variables for the Diffuse sclerosis group were entered into multiple 
regression analysis. Results demonstrated that the variables significantly accounted for 65.3% 
(Adjusted R ² = 38.5%) of the variance, F(2, 28) = 10.38, p = .000, in scleroderma disability 
resulting from Raynaud’s phenomenon, experienced by individuals diagnosed with Diffuse 
sclerosis. The regression coefficients demonstrated that low Self-kindness (β = .42, p = .010), 
sr² = 15.8%, and Reactive hyper-arousal (β = .38, p = .018), sr² = 14.4% (power was calculated 
at .98), were significant unique predictors of Raynaud’s disability experienced by  
individuals diagnosed with Diffuse sclerosis.           
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  Results demonstrated differences between scleroderma groups, in that individuals 
diagnosed with Diffuse sclerosis experienced low Self-kindness and Reactive hyper-arousal; 
whereas those diagnosed with Limited sclerosis experienced greater Self-judgment in relation 
to the severity of Raynaud’s phenomenon experienced. Therefore hypothesis 5(b) was  
partially supported. Results are presented in Table 5.                                    
Table 5                                                                                                                                          
Summary of Multiple Regression Analysis for Split File Diffuse N = 30, and Raynaud’s  
 
Variable                                                                  B                       SEB                   β      
 
   Raynaud’s Phenomenon  
        Diffuse Sclerosis                                                                                                                             
        Self-Kindness                                                 66.82                  24.01             -.42*       
        Hyper-arousal Reactive                                     4.20                   1.68             -.38*       
           R2                                               0.43***     
___________________________________________________________________________         
*p < .05 **p < .01 ***p < .001                                        
Hypothesis 5(c): Diffuse & Limited - Scleroderma Disability & Psychosocial Variables                   
  A split file and correlations were also conducted for the Diffuse and Limited groups to 
determine hypothesis 4(c). Results for the Limited group revealed no significant relationship 
between psychosocial variables and Scleroderma disability. Results for the Diffuse group 
revealed that lower Self-kindness (r = -.44, p = .015), was the only significant variable 
associated with higher levels of Scleroderma Disability. These results demonstrated differences 
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between groups, in that individuals diagnosed with Diffuse sclerosis who were less likely to 
engage in Self-kindness were more likely to experience greater Scleroderma disability. While 
this emotion regulation strategy was not significantly related to Scleroderma disability in the 
Limited group; supporting hypothesis 5(c).                                              
Hypothesis 5(d): Diffuse & Limited - Breathing & Psychosocial Variables         
  Pearson’s bivariate correlations for the total scleroderma sample revealed no meaningful 
relationships between psychosocial variables and Breathing. A split file and Pearson’s bivariate 
correlations were utilized to determine differences between the Diffuse and Limited groups to 
address hypothesis 5(d). Correlation coefficients revealed that Suppression (r = -.36, p = .045) 
for the Diffuse group and Common Humanity (r = .35, p = .042, a subscale of Self-
compassion) for the Limited group were significantly related to Breathing problems. Results 
demonstrated differences between groups in that individuals diagnosed with Diffuse sclerosis 
who experience greater levels of Suppression were more likely to suffer elevated Breathing 
problems. Whereas individuals with Limited sclerosis reporting greater Breathing problems 
were likely to experience higher levels of Common Humanity. Results partially supported 
hypothesis 5(d).                                                                                   
Hypothesis 5(e): Diffuse & Limited - Intestinal Conditions & Psychosocial Variables     
 A split file and correlation analysis was conducted to determine hypothesis 5(e) for the 
Diffuse and Limited sclerosis groups for the dependent variable Intestinal. Pearson’s bivariate 
correlations revealed no meaningful relationships for the Limited group between the 
dependent variable Intestinal and psychosocial variables. Correlation coefficients however, 
revealed a meaningful relationship for the Diffuse group between Intestinal and Suppression 
(r = - .42, p = .020); indicating that individuals diagnosed with Diffuse sclerosis who reported 
experiencing higher levels of Suppression, were more likely to experience greater Intestinal 
problems. The Limited group did not report this association therefore hypothesis 5(e) was 
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partially supported; differences between groups do occur in relation to Intestinal conditions. 
Correlations for hypothesis 5(f): Finger ulcers, were not conducted due to skewed  
distribution.                                                                                                                            
Hypothesis 5(g): Diffuse & Limited - Age Diagnosed & Psychosocial Aspects      
 A split file and Pearson’s bivariate correlation coefficients revealed a significant 
relationship (Diffuse sclerosis group) between Age diagnosed with scleroderma and (low 
self-compassion) Over-identification (r = .49, p = .006). Hyper-arousal (r = .38, p =.045), was 
also significantly related to Age diagnosed with scleroderma for the Limited sclerosis group. 
Results for multiple regression analysis demonstrated the variables significantly accounted 
for 49.6% (Adjusted R ² = 18.8%) of the variance, F(2, 26) = 4.25, p = .025, in Age 
diagnosed with Scleroderma. The regression coefficients demonstrated that neither variable 
was a significant unique predictor of Age diagnosed with scleroderma. Therefore hypothesis 
5(g) was partially supported.                                                                                           
Hypothesis 5(h): Diffuse & Limited - Age Diagnosed (Raynaud’s) & Psychosocial Aspects   
 A split file and correlation coefficients revealed a significant relationship for Age 
diagnosed with Raynaud’s for the Diffuse group and Over-identification (r = -.55, p = .015). 
Results indicated that the younger an individual with Diffuse sclerosis is diagnosed with  
Raynaud’s phenomenon the more likely they would over-identify with their experiences; 
whereas for the Limited group, Dismissive attachment (r = -.63, p = .005) and Suppression (r  
= -.50, p = .041) were both significantly related.             
  Significant variables for the Limited group were placed into a multiple regression 
analysis; results demonstrated the variables significantly accounted for 96.4% (Adjusted R ² =  
92.0%) of the variance, F(2,14) = 93.05, p = .000, in Age diagnosed with Raynaud’s 
phenomenon. The regression coefficients demonstrated that Dismissive attachment (β = -.77, 
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p = .000, sr ² = 5.0%) and Suppression (β = -.87, p = .000, sr ² = 5.8%) were both significant 
unique predictors of Age diagnosed with Raynaud’s for the Limited sclerosis group, (power  
was calculated at .99).                 
  Multicolinarity violated assumptions with both variables indicating scores above .9; 
therefore results should be viewed with caution, however, a strong correlational relationship 
was found. These result demonstrate that the younger a Limited sclerosis participant was 
diagnosed with Raynaud’s, the more likely they would utilize the emotion regulation strategy 
suppression and engage in a dismissive style of relating to attachment figures. Both these 
variables involve avoidant emotion regulation strategies and provide partial support for 
hypothesis 5(h).                                                                                                                       
Hypothesis Six: Difference in Scleroderma Specific Symptoms & Psychosocial Variables 
Hypothesis 6(a): Specific Symptoms – Pain/No Pain & Psychosocial Variables     
 T-Tests and a MANOVA were utilized to address hypothesis 6(a): individuals 
experiencing Pain and individuals without Pain would report a difference in levels of EMWS, 
attachment style and emotion regulation strategies (Self-compassion and Suppression). T-tests 
revealed significant mean differences for the independent variables EMWS for the Pain group 
(M = 62.76, SD = 26.32) and the No Pain group, M =78.28, SD = -18.49; t (67) = -2.91, p = 
.005, the magnitude of the mean difference = .85, 95% CI: 4.89 to 26.17 (eta Squared = .12), 
Dismissive attachment for the Pain group (M = 16.58, SD = 3.91) and the No Pain group, M 
=14.32, SD = -4.40; t (70) = -2.31, p = .024, the magnitude of the mean difference = .85, 95% 
CI: -4.21 to -.30 (eta Squared = .07), demonstrating that individuals, in the Pain group reported 
lower levels of EMWS, and a tendency toward a Dismissive Attachment Style when compared 
with the No Pain group.               
 Significant variables were placed into a multivariate analysis of variance to investigate 
differences in the independent variables EMWS, and Dismissive Attachment for the Pain and 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    109  
  
No Pain groups. Preliminary assumption testing was conducted to check for normality, 
linearity, univariate and multivariate outliers, homogeneity of variance, covariance matrices 
and multicollinarity; Levene’s was significant at .017 for EMWS, indicating a violation in the 
assumption of equality of variance. Therefore a more conservative alpha level of .025 (as 
suggested by Tabachinick & Fidell, 2007) was set to determine the significance level for the 
univariate F-test. There was a statistically significant difference between individuals with and 
without Pain on the combined dependant variables, Wilks Lambda F (2, 67) = 6.18, p = .003. 
When the results for the dependent variables were considered separately both EMWS F (1, 68) 
= 7.46, p = .008, partial eta = .10 and Dismissive Attachment F (1, 68) = 5.84, p = .018, partial 
eta = .08 were significant. Inspection of mean scores indicated that individuals in the Pain 
group (M = 63.04, SD = 26.61) reported lower levels of EMWS than individuals in the No Pain 
group (M = 78.28, SD = 18.49) and higher levels of Dismissive Attachment (M = 14.16, SD = 
4.48), than the No Pain group (M = 16.58, SD = 3.91). Therefore results partially supported 
hypothesis 6(a).                                                                                                                            
Hypothesis 6(b): Specific Symptoms – Raynaud’s/No Raynaud’s & Psychosocial Variables  
 T-Tests and a MANOVA were performed to address hypothesis 6(b): individuals 
diagnosed with Raynaud’s phenomenon compared to individuals without a diagnosis of 
Raynaud’s phenomenon will report lower levels of EMWS, an insecure Attachment Style, 
Emotion Regulation (Self- Compassion and Suppression) and higher levels of Hyper-arousal. 
T-tests revealed significant mean differences for the independent variables EMWS for the 
Raynaud’s group (M = 66.66, SD = 25.59) and the No Raynaud’s group, M =85.21, SD = 
11.83; t (46) = 4.00, p = .000, the magnitude of the mean difference = .85, 95% CI: 9.22 to 
27.90 (eta Squared = .27), Common Humanity for the Raynaud’s group (M = 12.73, SD = 3.59) 
and the No Raynaud’s group, M =15.00, SD = 3.74; t (66) = 2.10, p = .040 the magnitude of 
the mean difference = .85, 95% CI: -0.16 to -0.01 (eta Squared = .03). Results demonstrated 
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that individuals diagnosed with Raynaud’s phenomenon reported experiencing lower levels of 
EMWS and Common Humanity when compared with those without a diagnosis of Raynaud’s 
phenomenon.             
 Significant variables were placed into a multivariate analysis of variance to investigate 
differences in the Raynaud’s and No Raynaud’s groups and the independent variables EMWS 
and Common Humanity. Preliminary assumption testing was conducted to check for normality, 
linearity, univariate and multivariate outliers, homogeneity of variance, multicollinarity, Box’s 
tests of equality of covariance matrices was significant at .035; Levene’s test of equality of 
variance was significant at .001 for EMWS, therefore a more conservative alpha of .025 was 
set for the univariate F-test (as suggested by Tabachnick & Fidell, 2007). As unequal group 
sizes were evident in the study, N=52 for the Raynaud’s group and N=15 for No Raynaud’s 
group and as the percentage of Raynaud’s phenomenon in the scleroderma population is 
generally 90-95%, the results may be indicative of this population; and as Tabachnick and 
Fidell (2007) suggest that Box’s M can tend to be too strict, results were reported.    
 There was a statistically significant difference between individuals with and without 
Raynaud’s on the combined dependant variables, Wilk’s Lambda, F (2, 62) = 4.62, p = .014. 
When the results for the dependent variables were considered separately EMWS was the only 
variable to reached statistical significance, EMWS F(1, 63) = 6.36, p = .014, partial eta = .09. 
Inspection of mean scores indicated that individuals in the Raynaud’s group reported lower 
levels of EMWS (M = 66.53, SD = 26.02) than the No Raynaud’s group (M = 85.31, SD = 
12.31), indicating that individuals diagnosed with Raynaud’s reported lower levels of early 
experiences of warmth and safety, when compared with individuals diagnosed with 
scleroderma with Raynaud’s phenomenon, partially supporting hypothesis 6(b).                 
Hypothesis 6(c, d, & e): Remaining Specific Symptoms  & Psychosocial Variables            
 T-Tests were performed to address hypothesis 6(c & d): individuals with Intestinal and 
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Breathing problems will report lower levels of EMWS, Self- Compassion, Emotion Regulation 
and an Insecure Attachment Style and higher levels of Hyper-arousal, than individuals without 
Intestinal and Breathing problem. T-Tests revealed no significant mean difference between 
these groups. A Mann-Whitney U Test was performed due to skewed distribution to address 
hypothesis 5(e): individuals diagnosed with Finger Ulcers will report difference in levels of 
psychosocial variables when compared to individuals without this diagnosis. Results revealed 
no significant difference between groups. Therefore hypotheses 6(c, d & e) were not supported.   
Hypothesis Seven: Skin Severity and Psychosocial Variables     
 T- Tests and a MANOVA were performed to determine the seventh hypothesis: 
individuals reporting higher levels of Skin (thickening) Severity resulting from Scleroderma 
will also report lower levels of EMWS, an Insecure Attachment Style; higher levels of 
Suppression and lower levels of Self-compassion. T-Tests revealed significant mean 
differences for the independent variables Suppression for the Mild skin group (M = 3.07, SD = 
.91) and the Moderate skin group, M =3.94, SD = .60; t (35) = -3.49, p = .001, the magnitude of 
the mean difference = .85, 95% CI: -1.38 to -.365 (eta Squared = .09).      
 Significant differences for EMWS for the Moderate skin group (M = 77.22, SD = 18.94) 
and the Severe skin group, M = 63.45, SD = 27.57; t (52) = 2.17, p = .034, the magnitude of the 
mean difference = .85, 95% CI: 1.06 to 26.48 (eta Squared = .04). Significant differences for 
Dismissive attachment for the Moderate skin group (M = 14.29, SD = 4.19) and the Severe skin 
group, M =17.32, SD = 3.78; t (53) = -2.81, p =  .007, the magnitude of the mean difference = 
.85, 95%  CI: -5.19 to -.871 (eta Squared = .05), and Dismissive attachment for the Mild skin 
group (M = 13.83, SD = 5.01) and the Severe skin group, M =17.32, SD = 3.78; t (53) = -2.19, 
p = .044, the magnitude of the mean difference = .85, 95%  CI: -6.87 to -.106 (eta Squared = 
.05).  Significant differences for Fearful attachment for the Mild group (M = .82, SD = .15) and 
the Severe skin group, M =1.00, SD = .16; t (41) = -3.49, p = .001, the magnitude of the mean 
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difference = .85, 95%  CI: .290 to .078 (eta Squared = .08) and Suppression for the Mild group 
(M = 3.07, SD = .91) and Severe skin group, M =3.78, SD = .87; t (36) = -2.25, p = .030, 
magnitude of the mean difference = .85, 95%  CI:.-1.31 to -.069 (eta Squared = .06). 
 Results revealed significant differences between the Mild and Moderate skin thickening 
groups and the independent variable Suppression, the Moderate and Severe skin thickening 
groups and the independent variables EMWS and Dismissive attachment, Fearful attachment 
and Suppression for the Mild and Severe skin thickening groups.         
 A one way between groups multivariate analysis of variance was performed to 
investigate differences in the independent variables Early Memories of Warmth and Safeness, 
and Dismissive Attachment style, Fearful Attachment and Suppression for the Mild, Moderate 
and Severe Skin thickening groups. There was a statistically significant difference between 
individuals diagnosed with varying levels of skin involvement and the combined dependant 
variables, Wilk’s Lambda F(8,57) = 3.24, p = .002.       
 When the results for the dependent variables were considered separately all variables 
except early memories of warmth and safeness reached statistical significance, insecure 
Dismissive attachment F(2, 58) = 5.03, p = .010, partial eta = .15, insecure Fearful attachment 
F(2, 57) = 4.90, p = .011, partial eta = .15, emotional Suppression F(2, 57) = 4.61, p = .014, 
partial eta = .14, and EMWS,  F(2, 57) = 2.42, p = .098, partial eta = .08.    
 Inspection of mean scores indicated individuals with Severe Skin involvement had less 
experience of early memories of warmth and safeness than the Moderate and Mild Skin 
thickening groups. Mean scores for insecure Dismissive Attachment also indicated that the 
Severe Skin group reported higher levels of this style of attachment than the Mild and 
Moderate Skin groups, and the Moderate group had higher levels of insecure Dismissive 
Attachment than the mild group. The Severe Skin group also had higher levels of insecure 
Fearful Attachment than the Mild and Moderate groups and the Moderate group had higher 
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levels of insecure Fearful Attachment than the Mild group. Results are presented below in 
Table 6.                                                                                                                                               
Table 6                                                                                                                                        
Summary of Results (MANOVA) for Scleroderma Skin Severity  
 
  
Variables                                                                      N                           M                      SD  
 
EMWS (not significant)  
        Mild                                                                      12                       70.83                  23.83   
      Moderate                                                                 23                      77.22                  18.94   
       Severe                                                                    25                       61.72                  28.93  
Dismissive Attachment Style  
       Mild                                                                       12                       13.83                   5.00   
       Moderate                                                                23                      14.17                  13.24   
       Severe                                                                    25                       17.60                   3.94  
Fearful Attachment Style  
       Mild                                                                       12                         0.82                   0.15   
       Moderate                                                                23                        0.92                   0.16   
       Severe                                                                    25                         0.99                   0.17  
Suppression  
       Mild                                                                       12                         3.07                   0.91   
       Moderate                                                                23                        3.88                   0.58  
       Severe                                                                    25                         3.78                   0.87    
___________________________________________________________________________  
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          The Severe Skin group and the Moderate Skin group also reported higher Suppression 
than the Mild group. Therefore individuals with Severe and Moderate Skin involvement 
reported higher levels of the Suppression and a greater tendency to engage in the insecure 
attachment styles, Dismissive and Fearful attachment than the Mild less severe skin group. 
The Severe Skin group also reported higher levels of Dismissive and Fearful attachment than 
the Moderate and Mild Skin groups; partially supporting the seventh hypothesis.                                       
Hypothesis 8-9: Mental Health; Hyper-arousal and Psychosocial and Scleroderma.                                   
Hypothesis Eight: Depression, Anxiety, Stress and Biopsychosocial Variables  
 Bivariate correlations and regression analysis were used to investigate the eighth 
hypothesis: Depression, Anxiety and Stress will be associated with lower EMWS, and Self-
compassion, insecure attachment and higher Suppression, Scleroderma disability, Pain and 
Specific symptoms. Furthermore predictor variables for Depression, Anxiety and Stress will 
differ between individuals with Diffuse and Limited sclerosis. In addition differences will 
occur between individuals reporting specific scleroderma symptoms when compared with 
individuals without these conditions in relation to Depression, Anxiety and Stress.                                            
Hypothesis 8(a): Scleroderma - Depression and Biopsychosocial Variables                                              
  Frequencies (DASS21) were used to determine the percentage of individuals reporting 
Depression, Anxiety and Stress. Results revealed a total of 57.3% of individuals diagnosed 
with scleroderma experienced Depression, 36% experienced mild depression, 10.6% 
experienced moderate depression and 10.7% experienced severe levels of depression. Notably 
the remaining 42.7% all reported the highest score (9) within the normal range (0-9) for 
depression indicating that all participants in this sample experience depressive symptoms. 
Pearson’s bivariate correlations were conducted after the assumptions for multiple regression 
were met; results revealed meaningful relationships between the dependent variable 
Depression and EMWS (r = -.39, p = .001), Dismissive attachment style (r = .29, p = .015), 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    115  
  
Fearful attachment style (r = .36, p = .002), Self-compassion (r = .28, p = .027), Raynaud’s 
phenomenon (r = .29, p = .012). Multiple regression analysis was conducted to determine the 
contribution of the predictor variables EMWS, Fearful attachment and Raynaud’s (variables 
significant at .01 were selected due to large number of variable-participant ratio) with the 
dependent variable and are presented in table 6. Results demonstrated the variables 
significantly accounted for 48.8% (Adjusted R ² = 20.4%) of the variance, F (3, 67) = 6.97, p 
= .000, (power was calculated at .99) in Depression. The regression coefficients presented in 
Table 7, demonstrated that EMWS (β = -.30, p = .009, sr ² = 8.1%) and Fearful Attachment (β 
= .29, p = .012, sr ² = 7.5%) were significant unique predictors of Depression.  
Table 7                                                                                                                                         
Summary of the Multiple Regression Analysis for Scleroderma Depression N = 75             
 
Variable                                                                 B                       SEB                  β      
 
  Depression                                                           
           EMWS                                                       .000                      .000             -.30*                                         
           Fearful attachment                                   - .052                      .021             -.29*           
           Raynaud’s phenomenon                             .016                      .013             -.13                                          
       Total R2                                .24***     
__________________________________________________________________________          
*p < .05 **p < .01 ***p < .001                                                                                         
Hypothesis 8(b): Scleroderma - Anxiety and Biopsychosocial Variables     
  Frequencies were utilised to determine the percentage of individuals reporting  
Anxiety. A total of 80.0% of Scleroderma individuals in this study experienced Anxiety with  
22.7% experiencing mild Anxiety, 44.0% reporting moderate Anxiety and 13.3%  
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experiencing severe levels of Anxiety. Notably the remaining 20.0% reported the highest 
score within the normal range (0-7) for Anxiety, indicating that all participants in this sample 
experience some symptoms of Anxiety. Pearson’s bivariate correlation coefficients revealed a 
number of significant variables for Anxiety. EMWS (r = .47, p = .000), Breathing (r = .42,               
p = .000) and Suppression (r = .33, p = .006), Self-judgment (r = .30, p = .013), Isolation                
(r = .30, p = .013), Intestinal (r = .25, p = .033), Pain (r = .28, p = .014), Disability (r = .26,            
p = .023), were entered into a multiple regression analysis. Results are presented in Table 8.                             
Table 8                                                                                                                        
Summary of the Multiple Regression Analysis for Anxiety & Biopsychosocial Variables N=65 
 
Variable                                                                      B                       SEB                     β      
 
    Anxiety    
            EMWS                                                       - .003                       .000              -.47***          
            Breathing                                                      .019                       .004               .42***                      
            Suppression                                                  .064                       .014               .39***    
            Total R2                             .52***     
___________________________________________________________________________         
*p < .05  **p < .01 ***p < .001                 
  The results for the Scleroderma Sample demonstrated the variables significantly 
accounted for 72.1% (Adjusted R ² = 49.6%) of the variance, F(3, 62) = 22.35, p = .000 in 
Anxiety (power .99). The regression coefficients demonstrated that EMWS (β = -.47, p = 
.000, sr ² = 31.0%), Breathing (β = .42, p = .000, sr ² = 26.4%), and Suppression, (β = .39,  p  
.000, sr ² = 23.8%), were significant unique predictors of Anxiety experienced by individuals 
with Scleroderma. Therefore results partially supported hypothesis 8(d).  
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Hypothesis 8(c): Scleroderma - Stress and Biopsychosocial Variables                                                          
 A total of 22.7% of individuals diagnosed with scleroderma experienced stress; 14.7% 
experienced mild levels of stress, and 8.0% experienced moderate stress. Pearson’s bivariate  
correlations revealed meaningful relationships between, Stress and EMWS (r = -.36,                
p = .002), Self-Compassion (r = -.38, p = .002), Age diagnosed with Raynaud’s (r = -.37,              
p = .026), and Raynaud’s (r = .25, p = .030); the lower correlation of the two Raynaud’s 
variable’s was excluded to prevent multicollinarity; the remaining variables and Age 
diagnosed with Raynaud’s were entered into multiple regression analysis. Results 
demonstrated the variables EMWS, Self-compassion and Age diagnosed with Raynaud’s,  
significantly accounted for 57.3% (Adjusted R ² = 25.0%) of the variance, F(3,26) = 4.23,           
p = .004 (power was calculated at .89), in Stress. The regression coefficients presented in  
Table 9, demonstrated that Age diagnosed with Raynaud’s (β = -.36, p = .042, sr ² = 20.6%)  
significantly predicted Stress in individuals diagnosed with Scleroderma.                                                           
Table 9                                                                                                                                             
Summary of the Multiple Regression Analysis for Stress entering Predictor Variables N= 29             
 
Variable                                                                    B                        SEB                  β      
 
 Stress  
           Age Diagnosed Raynaud’s                          -.004                      -.002            -.36*                                     
           Self- Compassion                                         -.002                     -.001             -.21         
           EMWS                                                         - .002                      .001             -.34                                      
          Total R2                              .33*     
___________________________________________________________________________  
 *p < .05 **p < .01 ***p < .001  
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Results indicated that the earlier an individual with Scleroderma is diagnosed with Raynaud’s  
phenomenon, the greater their reported experience of Stress.                                                       
Hypothesis 8(d): Limited & Diffuse Sclerosis - Depression and Biopsychosocial Variables  
 Limited Sclerosis: A split file for Diffuse and Limited sclerosis was conducted to 
further address the sixth hypothesis; that individuals diagnosed with Diffuse and Limited 
sclerosis would report difference in Scleroderma symptoms, EMWS, insecure attachment and 
emotion regulation strategies associated with Depression. The assumptions for multiple 
regression analysis were met. Pearson’s bivariate correlations for Limited sclerosis revealed 
meaningful relationships between the dependent variable Inverse Depression and EMWS, (r  
= -.50, p = .001), Dismissive attachment (r = -.37, p = .018), Suppression, (r = -.48, p = .002),  
Fearful attachment (r = -.33, p = .036), Self-judgment (r = -.35, p = .030) and Intestinal, (r = -
.32, p = .036). Variables significant at .01 were entered into multiple regression analysis; 
coefficients revealed that both EMWS and Suppression were significant predictors of 
Depression for the Limited sclerosis group. The results for the Limited group demonstrated 
the variables significantly accounted for 65.58 (Adjusted R ² = 40.0%) of the variance, F (2, 
34) = 12.97, p = .000 (power .99), in Depression. The regression coefficients demonstrated 
that EMWS (β = -.45, p = .001, sr ² = 25.5%) and Suppression (β = .43, p = .002, sr ² =  
26.1%) were significant unique predictors of (Inverse) Depression experienced by individuals 
diagnosed with Limited sclerosis.                        
  Diffuse Sclerosis: Pearson’s bivariate correlations for Diffuse sclerosis revealed 
meaningful relationships between the dependent variable (Inverse) Depression and Isolation,  
(r = -.37, p = .045), Raynaud’s (r = -.51, p = .002), Fearful attachment (r = -.41, p =.021), and 
Over-identification (r = -.55, p = .002), variables significant at .01 (due to a small participant 
sample), were entered into a multiple regression analysis. Results for the Diffuse group 
demonstrated the variables significantly accounted for 65.4% (Adjusted R ² = 38.6%) of the 
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variance, F (2, 27) = 10.11, p = .001 (power .98), in Depression. Regression coefficients 
demonstrated that Over-identification (β = -.43, p = .009, sr ² = 16.5%) and Raynaud’s                 
(β = -.38, p = .021, sr ² = 12.6%), significantly predicted Depression for Diffuse sclerosis.  
 Results partially supporting hypothesis 8(d) indicated differences between groups for 
variables that predicted depression; with EMWS and Suppression predicting Depression for 
the Limited group and Over-identification (low self-compassion) and Raynaud’s phenomenon 
predicting Depression for the Diffuse sclerosis group.                               
Hypothesis 8(e): Limited & Diffuse Sclerosis - Anxiety and Biopsychosocial Variables  
 Limited Sclerosis: Pearson’s bivariate correlation coefficients for the Limited sclerosis 
group revealed meaningful relationships between the dependent variable Anxiety and EMWS, 
(r = -.51, p = .001), Suppression, (r = .45, p = .005), Pain (r = .31, p = .049), Scleroderma 
disability (r = .31, p = .044), Breathing, (r = .46, p = .002), and Age diagnosed with Raynaud’s 
(r = .56, p = .013). Variables significant at .01 for the Limited sclerosis group were placed into 
a multiple regression analysis, results demonstrated the variables significantly accounted for 
79.0% (Adjusted R ² = 58.9%) of the variance, F(3,33) = 18.22, p = .000, (power .99) in 
Anxiety. Regression coefficients demonstrated that EMWS (β = -.54, p = .000, sr ² = 28.4%) 
Breathing (β = .47, p = .000, sr ² = 20.4%) and Suppression (β = .29, p = .013, sr ² = 7.8%) 
were significant unique predictors of Anxiety for Limited sclerosis. Results indicated that 
EMWS, Suppression and Breathing problems predicted higher experiences of Anxiety in 
individuals diagnosed with Limited sclerosis.                                         
  Diffuse Sclerosis: Pearson’s bivariate correlations revealed meaningful relationships 
between the dependent variable Anxiety and EMWS, (r = -.42, p = .018), Isolation (r = .38,          
p = .033), Reappraisal (r = .36, p = .044), Breathing (r = .36, p = .039), for the Diffuse 
sclerosis group. Due to small sample size the two most significant variables for the diffuse 
group were placed into a multiple regression analysis, results demonstrated the variables 
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significantly accounted for 59.4% (Adjusted R ² = 30.3%) of the variance, F(2,26) = 7.07,         
p = .004, in Anxiety, power was calculated at .92. Regression coefficients demonstrated  
EMWS (β = -.46, p = .008, sr ² = 20.6%), Isolation (β = .43, p = .012, sr ² = 18.1%) were 
significant unique predictors of Anxiety in individuals with Diffuse sclerosis.     
  Results indicated similarities and differences between groups for variables that predict 
Anxiety; with EMWS, predicting Anxiety in both groups and differences occurring in predictor 
variables Suppression and Breathing problems for Anxiety in individuals diagnosed with 
Limited sclerosis and  Isolation (low Self-compassion) predicting Anxiety in individuals  
diagnosed with Diffuse sclerosis, partially supporting hypothesis 8(e).                                                                
Hypothesis 8(f): Limited & Diffuse Sclerosis - Stress and Biopsychosocial Variables  
  Limited Sclerosis: A split file for Pearson’s bivariate correlations revealed meaningful 
relationships for Limited sclerosis between the dependent variable Stress and EMWS, (r =    -
.45, p = .003), Common humanity (r = -.41, p = .013), Over-identification (r = .35, p = .035), 
variables significant at .01, were entered into a multiple regression analysis. Multiple 
regression analysis was conducted to determine the relationship and unique contribution of the 
predictor variables with the dependent variables. Results demonstrated the variables 
significantly accounted for 52.7% (Adjusted R ² = 23.5%) of the variance, F (2, 34) = 6.54,      
p = .004 (power was calculated at .91), in Stress. Regression coefficients demonstrated that 
EMWS (β = -.36, p = .027, sr ² = 11.4%) was a significant predictor of Stress for Limited 
sclerosis. Results demonstrated that individuals diagnosed with Limited Sclerosis who have 
experienced lower levels of EMWS, were likely to experience greater levels of Stress.   
  Diffuse Sclerosis: Pearson’s bivariate correlations also revealed meaningful 
relationships for Diffuse sclerosis group for the dependent variable Stress and Self- 
Compassion (r = -.51), p = .010, Over-identification (r = .65, p = .000), Isolation (r = .50,             
p = .005), Self-judgment (r = .37, p = .039), Raynaud’s (r = .45, p = .008), Age diagnosed 
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with Scleroderma (r = -.40, p =.021), and Age diagnosed with Raynaud’s phenomenon (r = -
.59, p = .008). Variables significant at .01 for the Diffuse group were placed into multiple 
regression analysis; Raynaud’s was selected due to a greater n over Age diagnosed with 
Raynaud’s to prevent multicolinarity. Results demonstrated the variables significantly 
accounted for 70.2% (Adjusted R ² = 43.6%) of the variance, F (3, 27) = 8.73, p = .000, 
(power was calculated at .99) in Stress. Regression coefficients demonstrated that Over-
identification (β = .56, p = .007, sr ² = 31.7%) was a significant predictor of Stress in Diffuse 
participants.             
 Results indicated that individuals with Diffuse sclerosis, who engaged in higher levels 
of Over-identification, were likely to have greater Stress, while those with Limited sclerosis 
reporting lower EMWS, were likely to experience greater levels of Stress, demonstrating 
differences between groups for predictors of Stress, for the Diffuse (lower Self-compassion) 
and limited (lower EMWS) groups; therefore hypothesis 8(f) was partially supported.  
Hypotheses 8(g, h & i): Specific Symptoms (Raynaud’s) – Depression, Anxiety and Stress  
 Raynaud’s: T-Tests and a MANOVA were utilized to determine hypotheses 8(g): 
higher levels of Depression, 8(h): Anxiety and 8(i): Stress will be reported by individuals 
diagnosed with Raynaud’s phenomenon when compared to individuals without Raynaud’s. T-
tests revealed significant mean differences for the independent variables (transformed 
inverse) Depression for the Raynaud’s group (M = .09, SD = .03) and the No Raynaud’s 
group, M =.12, SD = .02; t (72) = 2.75, p = .008, the magnitude of the mean difference = .85, 
95% CI: -.01 to .40 (eta Squared = .10), Stress for the Raynaud’s group (M = 1.08, SD = .12) 
and the No Raynaud’s group, M =.97, SD = .12; t (72) = -3.27, p = .002, the magnitude of the 
mean difference = .85, 95% CI: -0.18 to - 0.04 (eta Squared = .13), Anxiety for the Raynaud’s 
group (M = 1.03, SD = .13) and the No Raynaud’s group, M =.95, SD = .13; t (73) = -2.16, p 
=  .034, the magnitude of the mean difference = .85, 95% CI: -0.16 to - 0.01 (eta Squared = 
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.06). Significant T-tests are presented in Table 10.                                                                          
Table 10                                                                                                                                          
T-Tests for Raynaud’s/No Raynaud’s for Variables Depression, Anxiety and Stress N=73 
 
Variable                                                                  M                          SD                     t      
 
Depression (inverse)  
           Scleroderma/Raynaud’s                              .09                       .03                     
           Scleroderma/No Raynaud’s                        .12                       .02           
         T-test                                                                                                               2.75**                                  
  Anxiety  
           Scleroderma/Raynaud’s                            1.03                       .13                                                               
           Scleroderma/No Raynaud’s                        .95                       .13                          
           T-test                                                                                                              - 2.16*                                  
  Stress  
           Scleroderma/Raynaud’s                            1.08                       .12                                                               
           Scleroderma/No Raynaud’s                        .97                       .12                       
           T-test                                                                                                              - 3.27**  
__________________________________________________________________________                            
*p < .05 **p < .01 ***p < .001                  
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          Preliminary assumption testing was conducted with no violations noted. There was a 
statistically significant difference between individuals with Scleroderma and Raynaud’s and 
individuals with Scleroderma without Raynaud’s phenomenon on the combined dependant 
variables, Wilk’s Lambda, F (3, 69) = 4.37, p = .007. When the results for the dependent 
variables were considered separately all variables reached statistical significance, Depression, 
F (1, 71) = 7.39, p = .008, partial eta = .09. Stress F (1, 71) = 11.61, p = .001, partial eta = .14 
and Anxiety, F (1, 63) = 7.62, p = .007, partial eta = .10. Inspection of mean scores indicated 
that individuals in the Raynaud’s group reported higher levels of Depression, (transformed 
inverse) (M = .09, SD = .03) than the No Raynaud’s group (M = .12, SD =.02), Stress, (M = 
1.08, SD =.12) than the No Raynaud’s group (M = .96, SD = .12) and Anxiety, (M = 1.03, SD  
=.13) than the No Raynaud’s group (M = .93, SD = .10). Results indicated that differences 
occurred between groups with individuals diagnosed with Raynaud’s experiencing higher levels 
of Depression, Anxiety and Stress than those individual’s without a diagnosis of Raynaud’s, 
partially supporting hypotheses 8(g, h & i). T-tests revealed no significant mean difference 
between any other specific symptom group and Depression, Anxiety and Stress.                                                                                                                     
Hypothesis 8(g): Specific Symptoms - Depression and Biopsychosocial Variables           
           Finger Ulcers: A Mann-Whitney U-Tests was performed due to skewed data to address 
hypothesis 8(j), higher levels of Depression, will be experienced by individuals diagnosed with 
specific scleroderma symptoms (Finger ulcers) when compared to individuals without this 
condition. Results for Finger ulcers revealed significant mean differences for Depression 
(transformed inverse) for the ulcer group (Md = .09, n = 45) and individuals without a diagnosis 
of Finger ulcers (Md = .13, n = 30), U = 451.50, z = -2.44, p = .015.   The Finger ulcer group 
recorded a higher median score for Depression (inverse) than the No Finger ulcer group, 
indicating differences occurred between groups in that individuals with Finger ulcers have more 
severe depression than those without Finger ulcers, partially supporting hypothesis 8(j). No 
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other variable reached significance for Depression.                                                                  
Scleroderma Specific Symptoms - Anxiety and Biopsychosocial Variables                                       
 Pain: T-test were utilized to determine the eighth hypothesis; higher levels of Anxiety will be 
reported by individuals who experience pain when compared to those individuals without pain. 
Results demonstrated a significant mean difference for Anxiety for the Pain group (M = 1.05, 
SD = .14) and the No Pain group, M =.98, SD = .12; t (73) = -2.40, p = .019, the magnitude of 
the mean difference = .85, 95% CI: -.13 to .01 (eta Squared = .06).  Results indicated 
differences between groups as individuals with Scleroderma Pain experienced more severe 
Anxiety than individuals with Scleroderma without Pain, partially supporting hypothesis 8(h). 
No other significant relationships were identified for Pain.                                                                   
8(i): Scleroderma Specific Symptoms - Stress and Biopsychosocial Variables  
 Intestinal: T-Tests for individuals diagnosed with an intestinal condition when compared to 
individuals without this condition, demonstrated a significant mean difference between the 
groups for the independent variable Stress for the Intestinal group (M = 1.08, SD = .12) and the 
No Intestinal group, M =1.01, SD = .13; t (73) = -2.15, p = .035, the magnitude of the mean 
difference = .85, 95% CI: -0.13 to - 0.001 (eta Squared = .06), indicating that individual’s 
diagnosed with an Intestinal condition were likely to experience higher levels of Stress than 
those without this diagnosis. Results indicated differences between groups and therefore 
partially support hypothesis 8(i). No other variable reached significance for Stress.            
Hypothesis Nine: Hyper-arousal and Biopsychosocial Variables      
 Pearson’s bivariate correlations for Hyper-arousal revealed meaningful relationships between 
EMWS, (r = -.30, p = .017), Self-compassion (r = -.38, p = .003), Raynaud’s (r = .26, p = .041), 
and Age diagnosed with scleroderma (r = -.37, p = .003). Variables significant at .01 were 
placed into a multiple regression analysis; results presented in Table 11, demonstrated the 
variables significantly accounted for 49.8% (Adjusted R ² = 22.1%) of the variance, F(2,56) = 
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9.22,  p =.000, (power was calculated at .98) in Hyper-arousal. The regression coefficients 
demonstrated that Self-compassion (β = -.34, p = .005, sr ² = 10.1%) and Age diagnosed with 
scleroderma (β = -.32, p = .008, sr ² = 11.3%) were significant unique predictors of Hyper-
arousal in individuals diagnosed with Scleroderma.                                                                   
Table 11                                                                                                                                             
Summary of the Multiple Regression Analysis for Hyper-arousal entering predictor variables 
 
Variable                                                                      B                       SEB                    β      
 
 Hyper-arousal  
            Self-Compassion                                       - 5.34                       1.84                 - .34**    
            Age Diagnosed Scleroderma                    -24.83                       9.05                 - .32**    
      Total R2                                       .25***           
___________________________________________________________________________                  
*p < .05 **p < .01 ***p < .001  
      Results indicated that individuals with lower levels of Self-compassion and who were 
diagnosed with Scleroderma at a younger age, were more likely to experience greater levels 
of Hyper-arousal; partially supporting the ninth hypothesis. Pearson’s bivariate correlation 
revealed the Hyper-arousal subscale Reactive hyper-arousal demonstrated a stronger 
relationship with a number of scleroderma symptoms and psychosocial variables than the 
total Hyper-arousal scale. Although not part of the original hypothesis this variable was also 
explored. Coefficients revealed meaning relationships between Reactive hyper-arousal and 
EMWS, (r = -.35, p = .003), Dismissive attachment style (r = -.41, p = .001), Fearful 
attachment style (r = .29, p = .045), Self-compassion (r = -.30, p = .018), Over-identification 
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(r = .41), p = .000, Isolation (r = .24, p = .044), Self-judgment (r = .35, p = .003), Raynaud’s 
(r = .36, p = .003), Pain, (r = .28, p = .020) and Scleroderma disability (r = .27, p = .025). 
Due to small sample size and to prevent type 1 error the alpha level was increased to .01 and 
the three most significant variables at .01, were entered into multiple regression analysis. 
Results demonstrated the variables significantly accounted for 60.5% (Adjusted R ² = 33.6%) 
of the variance, F(3,64) = 12.30, p = .000, (power was calculated at .99) in Reactive hyper-
arousal. Regression coefficients demonstrated that Dismissive attachment (β = -.34, p = .001, 
sr ² = 15.1%), Over-identification (β = -.33, p = .002, sr ² = 10.8%) and Raynaud’s 
phenomenon (β = .25, p = .017, sr ² = 6.0%) significantly predicted Reactive hyper-arousal in 
individuals diagnosed with Scleroderma. Results indicated that individuals diagnosed with 
Scleroderma, who experienced more severe Raynaud’s phenomenon symptoms, a Dismissive 
attachment style and engaged in higher levels of Over-identifying (low self-compassion) with 
experiences, reported greater levels of Reactive hyper-arousal. Results presented in Table 12.                                         
Table 12                                                                                                                                         
Multiple Regression Analysis for Reactive Hyper-arousal N = 67 
 
Variable                                                          B               SEB               β                     
 
 Reactive Hyper-arousal  
           Raynaud’s Phenomenon                      .04            .011             .25*         
           Dismissive Attachment                        .22            .064             .34**         
           Over-identification                               .27            .081             .33**    
      Total R2                                      .37***           
___________________________________________________________________________     
p < .05 **p < .01 ***p < .001                                                                                                                    
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Results Supporting the Hypotheses             
  Results partially supported the overall research question: that biopsychosocial  
variables involving interpersonal and intrapersonal relationships and levels of hyper-arousal 
would influence the onset and severity of scleroderma symptoms. Table 13 provides a 
summary of the significant variables for scleroderma, specific types and symptom groups.  
Table 13                                                                                                                                   
Summary of Significant Variables: Scleroderma - Disease Types – Specific Symptoms                            
  Scleroderma   Types of Scleroderma  Specific Scleroderma Symptoms             
Study 1  Scleroderma  Age Onset  
S    R   D    L  
Diffuse 
Sclerosis  
Limited 
Sclerosis  
   Pain        
S  D  L   P  
Raynaud’s  
S   D    L   R  
Disability 
S  D L  I B  
Skin  
EMWS  
  
X    X  X  X      X  X                 X     T  
Fearful  
Attachment  
               X  
Dismissive 
Attachment  
X                  X     X  X      X  X       X  
Low Self- 
Compassion  
X          C      
Low Self- 
Kindness  
X          X   X     C    
Over- 
Identify  
X  C  C   C       X            
Self- 
Judgement  
  
X                         C      
Isolation  
  
X  C  C                          
Suppression  
  
X                 X         C               C    X  
Hyperarousal  X  C             C        C      
R-
Hyperarousal  
      X      X      X  C    
Depression  
  
X          C   X        X  C    
Anxiety  
  
X      C      C           T  C             X  C  CC CX    
Stress  X      X  C                C  C             X      
   S = Scleroderma, D = Diffuse, L = Limited; Between Groups: R = Raynaud’s/No Raynaud’s  
P = Pain/No Pain, I = Intestinal/No Intestinal, B = Breathing/No Breathing                                   
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X = Significant Predictor Variables, C = Significant Correlation Coefficients                                                    
X = Significant between Groups, T = Significant T-Tests   
Table 13 is divided into Scleroderma, Diffuse and limited Sclerosis and Specific Symptoms. 
Psychosocial variables in the Scleroderma and Diffuse/Limited Sclerosis columns predict (X) 
these disease variables. Disease variables in the Specific Symptoms columns: X represents 
psychosocial predictor variables and X represents significant differences between groups with 
more negative experiences reported by those with specific disease symptoms when compared 
to those without these symptoms; for example P = pain/no pain groups - X represents 
significantly higher EMWS in the pain group when compared to the no Pain group.  
Hypothesis One: Scleroderma Symptoms - Pain                                                             
  Results partially supported the first hypothesis: that higher levels of Pain would be 
associated with elevated levels of Raynaud’s phenomenon, Scleroderma disability, Intestinal 
problems and Breathing conditions in individuals diagnosed with Scleroderma. Pearson’s 
bivariate correlation coefficients revealed meaningful relationships between the dependent 
variable Pain and the independent variables Raynaud’s phenomenon, Intestinal and Breathing 
conditions and Scleroderma disability. Multiple regression coefficients demonstrated that 
Intestinal conditions and Scleroderma disability predicted Pain, in individuals diagnosed with  
Scleroderma.                                                                    
Hypotheses Two: Scleroderma Symptoms - Early Life Experiences                 
 Results partially supported the second hypothesis: 2(a): Lower levels of EMWS and an 
insecure attachment style (Dismissive and Fearful) would be associated (in individuals 
diagnosed with Scleroderma) with higher levels of Pain. 2(b): Raynaud’s phenomenon, 2(c):  
Scleroderma disability, 2(d): Intestinal, 2(e): Breathing and 2(f): Finger ulcers.   
  Lower levels of EMWS, and a Dismissive attachment style (fearful attachment was 
not significant) were related to higher levels of Pain, in individuals diagnosed with 
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scleroderma, partially supporting hypothesis 2(a). Findings for hypotheses 2(b, c, d, e, & f) 
were not significant, therefore these findings did not support the second hypotheses.                                         
Hypotheses Three: Scleroderma Symptoms - Emotion Regulation and Hyper-arousal  
 Results partially supported the third hypothesis 3(a): Lower levels of Self-compassion 
and higher levels of Suppression and Hyper-arousal would be associated (in individuals 
diagnosed with Scleroderma) with higher levels of Pain. 3(b): Raynaud’s phenomenon, 3(c): 
Scleroderma disability, 3(d): Intestinal, 3(e): Breathing and 3(f): Finger ulcers.    
  The subscales of Hyper-arousal (Reactive hyper-arousal) and Self-compassion (Self- 
kindness) were significant unique predictors of Raynaud’s experienced by individuals 
diagnosed with Scleroderma, partially supporting hypothesis 3(b). Reactive hyper-arousal 
was also significantly related to scleroderma disability, partially supporting hypothesis 3(c).  
Findings for hypotheses 3(a, d, e, & f) were not significant, and did not provide further  
support for the third hypotheses                                                                                                                       
Hypothesis Four: Age Diagnosed with Scleroderma/Raynaud’s - Psychosocial Variables                               
 Results provided partial support for hypothesis 4(a): Lower levels of EMWS and Self-
compassion, an insecure attachment style (Dismissive and Fearful) and higher levels of 
Suppression and Hyper-arousal would be associated with an earlier diagnosis of Scleroderma 
and hypothesis 4(b): an earlier diagnosis of Raynaud’s phenomenon. Pearson’s bivariate 
correlation coefficients revealed meaningful relationships between Age diagnosed with  
Scleroderma and Hyper-arousal, Over-identification and Isolation; and Age diagnosed with 
Raynaud’s phenomenon and Over-identification and Isolation. Multiple regression analysis 
revealed the models to be significant; however, no variable predicted Age diagnosed with 
Scleroderma or Raynaud’s phenomenon. Therefore low Self-compassion (Over-identification 
and Isolation) was associated with an earlier diagnosis of Raynaud’s and Scleroderma, with 
Hyper-arousal also significantly related to an earlier onset of Scleroderma, partially supporting 
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hypotheses 4(a & b).                                                                                                                  
Hypothesis Five: Diffuse and Limited – Difference in Biopsychosocial Variables  
 Results partially supported hypothesis 5(a): Individuals diagnosed with Diffuse and 
Limited sclerosis would report difference in psychosocial variables (EMWS, Dismissive and/or 
Fearful attachment, Suppression, Self-compassion subscales Mindfulness, Self-kindness, 
Common humanity, Self-judgment, Over-identification and Isolation, Hyper- arousal 
subscales, Introspect, Reactive) associated with Pain. 5(b): Raynaud’s phenomenon, 5(c): 
Scleroderma disability, 5(d): Intestinal, 5(e): Breathing, 5(f): Finger ulcers, 5(g): Age 
diagnosed with Scleroderma and 5(h): Age diagnosed with Raynaud’s phenomenon.         
 Pain: EMWS and a Dismissive attachment style and Age diagnosed with Scleroderma 
were significant unique predictors of Pain for the Limited sclerosis group, while Suppression 
was significantly related to Pain in the Diffuse group, demonstrating differences between 
groups for predictor variables for Pain, supporting hypothesis 5(a).       
 Raynaud’s Phenomenon: Reactive hyper-arousal and low Self-kindness significantly 
predicted Raynaud’s phenomenon for the Diffuse sclerosis group; whereas, higher levels of 
Self-judgment were significantly related to more severe experiences of Raynaud’s in the 
Limited group, partially supporting hypothesis 5(b).          
 Scleroderma Disability: Pearson’s bivariate correlations revealed that individuals 
diagnosed with Diffuse sclerosis reporting higher levels of disability resulting from 
scleroderma symptoms, experienced lower levels of Self-kindness; no significant relationship 
was found for the Limited sclerosis group, therefore differences occurred between groups on 
variables related to Scleroderma disability; results partially supported hypothesis 5(c).   
 Intestinal: Pearson’s bivariate correlation coefficients revealed that Suppression was 
significant for the Diffuse sclerosis group for Intestinal problems; no significant association 
was found for the Limited sclerosis group, therefore a difference occurred between groups for 
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Intestinal conditions; partially supporting hypothesis 5(d).                                                  
 Breathing: Different variables were significant for breathing problems; Suppression 
was significant for the Diffuse group and Common humanity was significant for the Limited 
group; partially supporting hypothesis 5(e).                                                                                  
  Age Diagnosed with Scleroderma – Diffuse Sclerosis: Pearson’s bivariate correlation 
coefficients for Diffuse sclerosis indicated a significant relationship between being diagnosed 
at a younger age with Scleroderma and experiencing elevated Hyper-arousal and low Self- 
compassion (subscale: over-identification).                                 
 Age Diagnosed with Scleroderma – Limited Sclerosis: An association between Hyper-
arousal and an earlier diagnosis of Scleroderma was also found for Limited sclerosis, indicating 
similarities for the variables Hyper-arousal and a difference for the Self-compassion (subscale: 
over-identification) between the sclerosis groups; partially supporting hypothesis 5(g). 
Regression analysis revealed the model to be significant, however, the variables did not 
uniquely predict an earlier diagnosis of scleroderma for the Limited group.                               
 Age Diagnosed with Raynaud’s Phenomenon – Diffuse Sclerosis: Pearson’s bivariate 
correlations revealed a significant relationship for the Diffuse group for Age diagnosed with 
Raynaud’s phenomenon and low Self-compassion (over-identification).                                         
 Age Diagnosed with Raynaud’s Phenomenon – Limited Sclerosis: Regression 
coefficients (multiple regression analysis) demonstrated that Dismissive attachment and 
Suppression were both significant unique predictors of Age diagnosed with Raynaud’s 
phenomenon for the Limited sclerosis group. Results indicated differences between groups 
with low Self-compassion (over-identification) significantly related to Age diagnosed with 
Raynaud’s for Diffuse and Dismissive attachment and Suppression predictors of age diagnosed 
with Raynaud’s for Limited sclerosis, partially supporting hypothesis 5(h).                                 
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Hypothesis Six: Specific Scleroderma Symptoms – Difference in Psychosocial Variables  
 Results partially supported hypothesis 6(a): Lower levels of EMWS, emotion regulation 
(Self-compassion and Suppression) and insecure attachment (Fearful and Dismissive) would be 
reported by individuals experiencing Pain when compared with individuals without Pain. 6(b): 
Raynaud’s phenomenon, 6(c): Intestinal, 6(d): Breathing and 6(e): Finger ulcers (experienced 
by individuals diagnosed with scleroderma) when compared with individuals diagnosed with 
Scleroderma without these conditions.                                                                  
 Pain: Differences between the Pain and no Pain groups were reported; with the Pain 
group reporting lower levels of EMWS and higher levels of Dismissive attachment than the no 
Pain group, partially supporting hypothesis 6(a).                                              
 Raynaud’s: Individuals diagnosed with Raynaud’s also reported lower levels of EMWS 
when compared with individuals without a diagnosis of Raynaud’s phenomenon, partially 
supporting hypothesis 6(b). Results indicated that significant differences were apparent 
between those who experience different Scleroderma symptoms and their psychosocial 
experiences.                                                                                                                                   
Hypothesis Seven: Scleroderma Skin Involvement – Psychosocial Variables           
 Results partially supported hypothesis seven: Lower levels of EMWS, Self-compassion, 
an insecure attachment style (Fearful and Dismissive) and higher levels of Suppression would 
be associated with greater Skin involvement associated with Scleroderma. Inspection of mean 
scores (not significant) indicated that individuals with Severe Skin involvement had less 
experience of EMWS than the Moderate and Mild Skin involvement groups. Mean scores for 
Dismissive attachment indicated that the Severe Skin involvement group reported higher levels 
of this style of attachment than the Mild and Moderate Skin groups, and the Moderate group 
had higher levels of Dismissive attachment than the Mild group. The Severe Skin group 
reported higher levels of Fearful attachment than the Mild and Moderate groups and the 
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Moderate group had higher levels of Fearful attachment than the Mild group; the Severe Skin 
group and the Moderate Skin group reported higher levels of Suppression than the Mild group.  
 Results revealed differences in EMWS and significant differences in attachment style 
and emotion regulation, for the Mild, Moderate and Severe Skin thickening groups. Results 
demonstrated that the more severe an individual’s Skin involvement the more likely they will 
have lower early life experiences of warmth and safety, a significantly greater tendency toward 
a Dismissive and Fearful attachment style and higher levels of Suppression. Results partially 
support hypothesis seven.                                                                                             
Hypothesis Eight: Depression, Anxiety and Stress – Biopsychosocial Variables  
 Hypotheses 8(a): Scleroderma - Depression, 8(b): Anxiety and 8(c): Stress would be 
associated with lower levels of EMWS, Self-compassion, an insecure attachment style (Fearful 
and Dismissive), higher Suppression, Scleroderma disability, Specific symptoms and Age 
diagnosed with Scleroderma/Raynaud’s phenomenon.                     
Scleroderma - Depression: Results partially supported hypothesis 8(a); EMWS and Fearful 
attachment were significant unique predictors of Depression experienced by individuals 
diagnosed with Scleroderma.                            
Scleroderma - Anxiety: Results partially supported hypothesis 8(b); Breathing, EMWS and 
Suppression significantly predicted Anxiety experienced by individuals diagnosed with 
Scleroderma.             
 Scleroderma - Stress: Results partially support hypothesis 8(c); Age diagnosed with 
Raynaud’s phenomenon, significantly predicted Stress in individuals diagnosed with 
Scleroderma, indicating that the earlier an individual diagnosed with scleroderma is diagnosed 
with Raynaud’s the greater their experiences of Stress.                                       
 Hypotheses 8(d): Diffuse and Limited Sclerosis – Differences will occur in predictor 
variables (EMWS, Self-compassion, an insecure attachment style, Suppression, Scleroderma 
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disability and Specific symptoms) for the Diffuse and Limited sclerosis groups for the 
dependant variables, Depression, 8(e): Anxiety and 8(f): Stress.      
 Diffuse and Limited Sclerosis - Depression:  Results partially supported hypothesis 8(d); 
low Self-compassion (over-identification) and Raynaud’s phenomenon predicted higher levels 
of Depression in Diffuse sclerosis; whereas EMWS and Fearful attachment predicted greater 
Depression in Limited sclerosis. Results demonstrated differences between predictor variables 
for Depression in the two illness groups (Diffuse and Limited sclerosis).                                             
 Diffuse and Limited Sclerosis - Anxiety: Results partially support hypothesis 8(e); lower 
EMWS and lower Self-compassion (greater feelings of isolation), predicted more severe 
Anxiety in Diffuse sclerosis; whereas more severe Breathing problems, low EMWS and greater 
Suppression predicted elevated levels of Anxiety in Limited sclerosis.     
 Results indicated that EMWS predicted Anxiety in both groups; however, difference 
occurred between groups for the remaining predictor variables: lower Self-compassion (Diffuse 
sclerosis), greater Suppression and Breathing problems (Limited sclerosis).  
 Diffuse and Limited Sclerosis - Stress: Results partially support hypothesis 8(f); Low 
Self-compassion (Over-identification) predicted Stress in Diffuse sclerosis, while EMWS 
predicted Stress in Limited sclerosis. Results demonstrated that differences occurred between 
groups for predictors of Stress.                                                                    
Hypotheses 8(g): Higher levels of Depression, 8(h): Anxiety and 8(i): Stress would be reported 
by individuals with Scleroderma related Pain, Raynaud’s phenomenon, Intestinal and 
Breathing conditions and Finger ulcers, when compared to individuals diagnosed with 
Scleroderma without these conditions.            
 Raynaud’s Phenomenon - Depression, Anxiety and Stress: Results supported 
hypotheses 8(g, h & i). Results demonstrated that individuals diagnosed with Raynaud’s 
reported higher levels of Depression, Anxiety and Stress when compared with those 
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individual’s without a diagnosis of Raynaud’s phenomenon. Indicating more severe 
psychological symptoms are likely to occur in individuals diagnosed with Scleroderma and 
Raynaud’s when compared to those with a diagnosis of Scleroderma without Raynaud’s 
phenomenon.           
 Finger Ulcers - Depression: Results for Finger ulcers also partially supported 
hypotheses 8(g); Individuals diagnosed with Finger ulcers reported higher levels of Depression 
than those individual’s without this diagnosis. Therefore individuals diagnosed with Finger 
ulcers reported higher levels of Depression when compared with individuals without these 
experiences.              
 Breathing - Anxiety: Results also partially supported hypotheses 8(h): individual’s 
diagnosed with Breathing conditions reported greater experiences of Anxiety when compared 
to those without this diagnosis; indicating differences between groups for Anxiety for those 
with and without Breathing problems.        
 Intestinal - Stress: Results partially supported hypotheses 8(i): Difference were reported 
for the Intestinal group and the no Intestinal group for Stress, indicating that individuals 
diagnosed with an Intestinal condition have higher levels of Stress than those without this 
diagnosis.             
 The results demonstrated that different psychological experiences occurred between 
Scleroderma participants who experienced different disease symptoms; with higher levels of 
Depression, Anxiety and Stress experienced by individuals diagnosed with Scleroderma and 
Raynaud’s. Higher levels of Stress were also reported by individuals with Intestinal conditions; 
higher levels of Anxiety were experienced by those experiencing Breathing problems and 
higher levels of Depression were reported by individuals with Finger ulcers. Results indicated 
differences in psychological functioning between those individual’s diagnosed with various 
Scleroderma symptoms when compared with individuals without those symptoms, partially 
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supporting the eighth hypothesis.                                                                                                   
Hypothesis Nine: Hyper-arousal – Biopsychosocial Variables                                    
 Hypothesis nine: Higher levels of Hyper-arousal would be associated with lower levels 
of EMWS and Self-compassion, an insecure attachment style, greater levels of suppression and 
a diagnosis of scleroderma at a younger Age.          
 Hyper-arousal - Self-Compassion & Age Diagnosed with Scleroderma: Results 
indicated that the variables Self-compassion and Age diagnosed with scleroderma significantly 
predicted Hyper-arousal in individuals diagnosed with Scleroderma; demonstrating that 
individuals diagnosed with Scleroderma who have experienced lower levels of Self-
compassion and were diagnosed with scleroderma at a younger Age, were more likely to 
experience greater levels of Hyper-arousal. Results therefore partially supported the ninth 
hypothesis.            
 Reactive Hyper-arousal: Although not part of the original hypotheses results 
demonstrated that Raynaud’s, phenomenon, a Dismissive attachment style and low self-
compassion (Over-identification) predicted Reactive hyper-arousal in individuals diagnosed 
with Scleroderma. Results indicated that individuals diagnosed with Scleroderma who 
experienced more severe Raynaud’s symptoms, a Dismissive attachment style and a tendency 
to Over-identify with their situation, were likely to experience greater levels of Reactive hyper-
arousal.                                                                                                                                                    
Summary of Significant Results                                                                                                 
Pain                                                                                                                               
Hypotheses 1, 2(a), 5(a) & 6(a): Pearson’s bivariate correlation coefficients and multiple 
regression analysis were conducted to determine the relationship between scleroderma 
symptoms and pain; psychosocial variables and pain, in individuals with scleroderma; and 
diffuse and limited sclerosis. T-test and MANOVA were also conducted to compare 
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differences in psychosocial variables between groups with pain and no pain symptoms.     
 Scleroderma Symptoms – Pain: Bivariate correlations revealed meaningful relationships 
between Raynaud’s, phenomenon, intestinal conditions, breathing problems and scleroderma 
disability. Multiple regression analysis revealed that intestinal conditions and scleroderma 
disability were significant predictors of Pain. Results partially supported hypothesis one and 
demonstrated that individuals reporting greater scleroderma disability and intestinal problems 
were likely to experience more severe pain.                     
 Scleroderma, Psychosocial – Pain: Results from multiple regression analysis for 
psychosocial variables demonstrated that individuals diagnosed with scleroderma who 
experienced low warmth and safety as a child and engaged in a dismissive style of relating 
reported more severe pain; partially supporting hypothesis 2(a).                               
 Diffuse & Limited, Psychosocial - Pain: When the data was separated into the diffuse 
and limited sclerosis groups, low EMWS, a dismissive attachment style and a later diagnosis of 
scleroderma significantly predicted pain for the limited sclerosis group. However, suppression 
(and not EMWS, dismissive attachment or age diagnosed with scleroderma) was significantly 
related to pain in the diffuse group, indicating that different variables were related to pain in 
the two major subsets of scleroderma, supporting hypothesis 5(a).     
 Pain/No Pain – Psychosocial: A difference was also reported for individuals 
experiencing pain resulting from scleroderma symptoms and those diagnosed with scleroderma 
without associated pain; with the pain group reporting lower EMWS and higher levels of 
dismissive attachment than the no pain group, supporting hypothesis 6(a).     
 The hypotheses for pain were partially supported, with results generally indicating 
significant relationships between negative early life experiences, a dismissive attachment style, 
emotional suppression and scleroderma related pain/elevated pain.                                               
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Raynaud’s Phenomenon                         
 Hypotheses 3(b), 5(b) & 6(b): Pearson’s bivariate correlations and multiple regression 
analysis were conducted to determine the relationship between Raynaud’s phenomenon and 
psychosocial variables in individuals diagnosed with scleroderma; and diffuse and limited 
sclerosis. T-test and MANOVA were also conducted to compare differences between groups 
on psychosocial variables for Raynaud’s and no Raynaud’s symptoms.      
 Total Scleroderma Group: Reactive hyper-arousal and low self-kindness significantly 
predicted Raynaud’s (multiple regression analysis) in individuals diagnosed with scleroderma; 
supporting hypothesis 3(b).           
 Diffuse & Limited: Reactive hyper-arousal and low self-kindness were significant 
unique predictors of Raynaud’s for the diffuse sclerosis group; however, greater self-judgment 
(and not hyper-arousal and self-kindness) was the only significant correlation coefficient for 
Raynaud’s in the limited group. Therefore different variables were related to and predicted 
Raynaud’s phenomenon in the two major subsets of scleroderma; supporting hypothesis 5(b).   
 Raynaud’s/No Raynaud’s: A difference was also reported in individuals with Raynaud’s 
when compared to those without a diagnosis of Raynaud’s. EMWS predicted Raynaud’s 
phenomenon when compared to those without this condition (MANOVA); partially supporting 
hypothesis 6(b). The hypotheses for Raynaud’s phenomenon were partially supported, with 
results generally indicating differences between groups with significant relationships found 
between psychosocial variables, low self-compassion (low self-kindness and high self-
judgment), elevated reactive hyper-arousal, negative early life experiences and Raynaud’s 
symptoms.                                                                                                                               
Scleroderma Disability, Intestinal, Breathing and Finger Ulcers                              
 Hypotheses 3(c), 5(c) & 6(c): Pearson’s bivariate correlations and multiple regression 
analysis were conducted to determine the relationship between scleroderma specific symptoms 
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(disability, intestinal, breathing and finger ulcers) and psychosocial variables in individuals 
with scleroderma and diffuse and limited sclerosis. T-test and MANOVA were also conducted 
to compare differences between groups for psychosocial and specific scleroderma variables.                                                                     
  Scleroderma Disability: Results demonstrated that individuals reporting greater 
scleroderma disability experienced significantly higher reactive hyper-arousal; partially 
supporting hypothesis 3(c).                                                                                 
 Diffuse/Limited: Results demonstrated that individuals with diffuse sclerosis who 
reported greater scleroderma disability experienced significantly lower levels of self-kindness, 
providing partial support for hypothesis 5(c); no variable was significant for the limited group.  
  Intestinal-Diffuse/Limited:  Difference was found between groups; greater suppression 
was significantly related to more severe intestinal problems in the diffuse sclerosis group; 
however, no variable was significant for the limited group providing partial support for 
hypothesis 5(d).                    
 There was no difference between the intestinal group and the no intestinal group 
therefore hypothesis 6(d) was not supported. No meaningful relationships were found between 
intestinal and psychosocial variables; therefore hypothesis 3(d) was not supported.                              
 Breathing-Diffuse/Limited: Different variables were significant for groups for 
breathing; suppression was significant for the diffuse group and common humanity was 
significant for the limited group, partially supporting hypothesis 5(e).        
 No meaningful relationships were found between breathing and psychosocial variables, 
therefore hypothesis 3(e) was not supported. No difference was found between those with 
breathing conditions and those without this diagnosis, therefore hypothesis 6(e) was not 
supported.                
 Finger ulcers: Non-parametric analysis revealed no difference between individuals 
diagnosed with finger ulcers and those without a diagnosis of finger ulcers therefore hypothesis 
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6(f) was not supported.               
 The hypotheses for specific scleroderma symptoms was partially supported. Results 
demonstrated that elevated reactive hyper-arousal was significantly related to greater 
scleroderma disability. Some results indicated significant differences between the diffuse and 
limited groups for specific symptoms. Low self-compassion (subscale: low self-kindness) was 
significantly related to scleroderma disability; whereas greater suppression was significantly 
related to more severe intestinal and breathing experiences for individuals diagnosed with 
diffuse sclerosis. These variables were not significant for limited sclerosis.                                       
Skin Severity                                                                                                                            
Hypothesis Seven                                                                                       
 Results (t-tests) revealed significant differences between the mild, moderate and severe 
skin thickening groups and early memories of warmth and safeness, dismissive attachment 
style, fearful attachment and suppression, partially supporting the hypothesis. Multivariate 
analysis demonstrated that a greater tendency toward a dismissive and fearful attachment style 
and higher levels of suppression predicted more severe skin involvement (than those with mild 
and moderate skin thickening); partially supporting hypothesis seven. Mean differences 
although not significant also indicated that individuals with more severe skin thickening 
symptoms also experienced lower levels of EMWS when compared with individuals reporting 
mild and moderate skin involvement.       .                                                                                          
Age diagnosed with Scleroderma and Raynaud’s Phenomenon          
 Hypotheses 4(a) & 5(g) - Scleroderma: Results demonstrated that hyper-arousal, and 
low self-compassion (over-identification and isolation) were significantly related to age 
diagnosed with scleroderma. However, the variables did not predict age diagnosed with 
scleroderma, therefore hypothesis 4(a) was partially supported.                                                                           
 Diffuse/Limited: Correlation coefficients revealed similarities and differences for age 
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diagnosed with scleroderma for the diffuse/limited groups. Hyper-arousal was significant for 
both groups, with over-identification also significant for the diffuse sclerosis group.   
Regression coefficients for the diffuse sclerosis group did not reach significance, indicating 
partial support for hypothesis 5(g). Therefore the greater the levels of hyper-arousal the 
younger an individual would be diagnosed with diffuse/limited sclerosis, and for diffuse 
sclerosis, lower self- compassion (over-identification) was also associated with being 
diagnosed at a younger age with scleroderma.                                
 Hypotheses 4(b) & 5(h) - Raynaud’s: Correlation coefficients revealed meaningful 
relationships between age diagnosed with Raynaud’s phenomenon and low self-compassion 
(subscales: over-identification and isolation), partially supporting hypothesis 4(b). Regression 
coefficients however, demonstrated that no variable predicted age diagnosed with Raynaud’s.                          
 Diffuse/Limited: Correlation coefficients demonstrated a significant relationship 
between age diagnosed with Raynaud’s phenomenon and low self-compassion (over-
identification) for the diffuse group; indicating that the younger the diagnosis with Raynaud’s 
the greater the over-identification with one’s experiences. Regression coefficients 
demonstrated that dismissive attachment and suppression were both significant predictors of 
age diagnosed with Raynaud’s for limited sclerosis; indicating that the more an individual 
engages in suppression of emotions and a dismissive style of relating, the earlier the diagnosis 
with Raynaud’s. Results demonstrated differences between groups and partially supported 
hypothesis 5(h).                                                                                                                
Depression                                                                                                   
 Hypotheses 8(a, d & g) - Scleroderma: Results revealed that 57% of individuals 
diagnosed with scleroderma experienced depression, 36% experienced mild depression, 11% 
experienced moderate depression and 11% experienced severe levels of depression. The 
remaining participants reported symptoms of depression within the normal range, although all 
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of these scores were at the highest end of this range, indicating that all participants in this 
sample experience depressive symptoms. Multiple regression coefficients demonstrated that 
EMWS and fearful attachment were significant unique predictors of depression experienced by 
individuals diagnosed with scleroderma, partially supporting hypothesis 8(a).                           
 Diffuse/Limited: Differences between limited and diffuse sclerosis were also found to 
support hypothesis 8(d). The regression coefficients for diffuse sclerosis demonstrated that low 
self-compassion (subscale: over-identification) and Raynaud’s phenomenon were significant 
unique predictors of depression. The regression coefficients for limited sclerosis demonstrated 
that both EMWS and fearful attachment significantly predicted depression.    
 Overall results demonstrated that individuals diagnosed with scleroderma particularly 
those with limited sclerosis who have lower experiences of early memories of warmth and 
safety and a fearful style of relating, experienced higher levels of depression. Results also 
demonstrated that individuals diagnosed with diffuse sclerosis, who experienced more severe 
Raynaud’s symptoms and (less self-compassion) a tendency to over-identify with their 
situation, experienced higher levels of depression.        
 Finger Ulcers/No Finger Ulcers: Individuals with finger ulcers also reported higher 
levels of depression than individuals without this condition supporting hypothesis 8(g).    
Anxiety               
Hypotheses 8(b, e & h) - Scleroderma: Eighty percent of individuals experienced anxiety; with 
23% experiencing mild anxiety, 44% reporting moderate anxiety and 13% experiencing severe 
levels of anxiety. The remaining 20% reported the highest score for the normal range for 
anxiety indicating that all participants in this sample experience some anxiety symptoms. 
Results supporting hypothesis 8(b) demonstrated that elevated breathing problems, low EMWS 
and greater emotional suppression were significant unique predictors of anxiety experienced by 
individuals diagnosed with scleroderma.                                                                     
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 Diffuse/Limited: These variables also predicted higher levels of anxiety in individuals 
diagnosed with limited sclerosis. While EMWS and low self-compassion (subscale: isolation) 
predicted more severe anxiety in individuals diagnosed with diffuse sclerosis; demonstrating 
that different variables predicted anxiety for the diffuse and limited sclerosis group (although 
EMWS was significant in both groups), partially supporting hypothesis 8(e). Results indicated 
that individual’s diagnosed with scleroderma, with fewer experiences of EMWS, greater 
breathing problems and use suppression as an emotion regulation strategy were more likely to 
experience greater levels of anxiety, particularly those diagnosed with limited sclerosis. 
EMWS appears to be a variable that is constant for both groups in predicting anxiety, while 
different variables for diffuse (greater experiences of isolation) and limited (greater 
suppression and breathing problems) also predicted anxiety in the respective groups.   
 Pain/No Pain: Results also demonstrated that individuals reporting pain resulting from 
scleroderma symptoms, experienced higher levels of anxiety than those individuals diagnosed 
with scleroderma without associated pain. These results provide partial support for hypothesis 
8(h).                                                                                                                                             
Stress                                                                                                                                   
Hypotheses 8(c, f & i) - Scleroderma: Twenty three percent of individuals diagnosed with 
scleroderma experienced stress, 15% experienced mild levels of stress and 8% experienced 
moderate levels of stress, with the remaining participants reporting low levels of stress. Results 
demonstrated that age diagnosed with Raynaud’s phenomenon significantly predicted stress in 
individuals diagnosed with scleroderma; indicating that the earlier an individual (diagnosed 
with scleroderma) is diagnosed with Raynaud’s phenomenon the greater their experiences of 
stress; partially supporting hypothesis 8(c).                       
 Diffuse/Limited: Results revealed different predictor variables for each of the major 
subsets of scleroderma, partially supporting hypothesis 8(f). Low self-compassion (subscale: 
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over-identification) predicted stress in individuals diagnosed with diffuse sclerosis, while 
EMWS significantly predicted stress in individuals diagnosed with limited sclerosis.  
 Intestinal/No Intestinal: A difference was also reported for those reporting intestinal 
problems when compared to those without intestinal problems. Results indicated that 
individuals diagnosed with an intestinal condition experienced higher levels of stress than those 
without this diagnosis, partially supporting hypothesis 8(i).                  
 Raynaud’s/No Raynaud’s: Results also revealed that individuals diagnosed with 
Raynaud’s also reported higher levels of stress than those individual’s without a diagnosis of 
Raynaud’s phenomenon, partially supporting hypothesis 8(i).     
 Overall results revealed different predictor variables for each of the major subsets of 
scleroderma, EMWS for limited sclerosis and low self-compassion (over-identification) for 
diffuse sclerosis; while for the total sample an earlier diagnosis of Raynaud’s phenomenon 
indicated greater levels of stress. Individuals reporting intestinal problems and Raynaud’s 
phenomenon also reported elevated stress when compared to individuals without these 
conditions.                                                                                                                                  
Hyper-arousal                                                                                                                          
Hypothesis Nine: Correlation coefficients revealed meaningful relationships between EMWS, 
self-compassion, Raynaud’s phenomenon and age diagnosed with scleroderma. Regression 
coefficients indicated that individuals diagnosed with scleroderma who experienced lower 
levels of self-compassion and were diagnosed with scleroderma at a younger age, were more 
likely to experience greater levels of hyper-arousal, partially supporting the ninth hypothesis. 
Correlation coefficients also revealed that reactive hyper-arousal (subscale of hyper-arousal) 
demonstrated a stronger relationship with a number of scleroderma symptoms (Raynaud’s 
phenomenon, pain and scleroderma disability) and psychosocial variables (EMWS, dismissive 
attachment, fearful attachment, self-compassion, over-identification, isolation and self-
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judgment), than the total hyper-arousal scale and was therefore further investigated. Results 
indicated that individuals diagnosed with scleroderma who experienced more severe Raynaud’s 
symptoms, a dismissive attachment style and tended to over-identify (low self-compassion) 
with their experiences were likely to report greater levels of reactive hyper-arousal.           
                                Discussion                                                  
 Results indicated that a number of relational factors and elevated arousal were linked to 
mental health and scleroderma symptoms and onset. Similarities and differences were also 
found between scleroderma groups for variables related to psychophysiological symptoms.  
 Pain: Results demonstrated that individuals diagnosed with scleroderma who 
experienced low warmth and safety as a child and engaged in a dismissive style of relating 
reported more severe pain, these results were also significant for individuals reporting pain 
when compared and those without pain. Low EMWS, a dismissive attachment style and a later 
diagnosis of scleroderma significantly predicted pain for the limited sclerosis group; whereas, 
suppression was significantly related to pain in the diffuse group, indicating differences 
between groups for variables that related to pain. The hypotheses for pain were partially 
supported, with results generally indicating significant relationships between negative early 
rearing experiences, a dismissive attachment style, emotional suppression and scleroderma 
related pain/elevated pain.            
 Specific Scleroderma Symptoms- Raynaud’s: Reactive hyper-arousal and low self-
kindness significantly predicted Raynaud’s in the scleroderma group and also for the diffuse 
sclerosis group; whereas greater self-judgment was significantly related to Raynaud’s for the 
limited group. Difference between groups were also reported by those with Raynaud’s 
(EMWS) when compared to those without Raynaud’s (no variable significant).   Scleroderma 
Disability: Higher reactive hyper-arousal was related to greater scleroderma disability in the 
total group, whereas low self-kindness was significantly related to greater scleroderma 
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disability for diffuse sclerosis; no variable was significant for the limited group.      
 Intestinal & Breathing: Greater suppression was significantly related to more severe 
intestinal problems in the diffuse sclerosis group; whereas, no variable was significant for the 
limited group. Greater suppression was also significantly related to greater intestinal problems 
for the diffuse group and common humanity was significant for the limited group.   Skin 
Involvement: A greater tendency toward a dismissive and fearful attachment style and higher 
levels of suppression predicted more severe skin involvement (than those with mild and 
moderate skin thickening).                                                                           
 Age Diagnosed Scleroderma/Raynaud’s: Hyper-arousal, and low self-compassion 
(over-identification and isolation) were significantly related to age diagnosed with scleroderma 
in the total sample. Hyper-arousal was also significant for both the diffuse and limited groups, 
as well as over-identification (low self-compassion) for the diffuse group. Therefore greater 
hyper-arousal was significantly related to being diagnosed with diffuse/limited sclerosis, at a 
younger age, and for diffuse sclerosis, lower self-compassion (over-identification) was also 
significantly related. Low self-compassion (subscales: over-identification and isolation) was 
significantly related to a diagnosis of Raynaud’s at a younger age for scleroderma. Low self-
compassion (over-identification) was also significantly related to a diagnosis of Raynaud’s at a 
younger age for the diffuse group; whereas dismissive attachment and suppression were 
significant predictors of being diagnosed with Raynaud’s at a younger age for limited sclerosis.   
 Mental Health-Depression: Lower experiences of early memories of warmth and safety 
and a fearful style of relating, predicted greater depression in the scleroderma group and the 
limited sclerosis group. More severe Raynaud’s symptoms and less self-compassion (over-
identification) predicted higher levels of depression in the diffuse sclerosis group. Individuals 
with finger ulcers also reported significantly higher levels of depression than individuals 
without this condition.                  
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  Anxiety: Fewer experiences of EMWS, greater breathing problems and suppression 
predicted elevated anxiety in the scleroderma and limited groups. EMWS and low self-
compassion (greater isolation) predicted anxiety in the diffuse group. Individuals reporting 
scleroderma pain experienced significantly higher levels of anxiety than those without pain.  
 Stress: Low EMWS predicted stress in the limited sclerosis group, whereas low self-
compassion (over-identification) predicted stress for the diffuse sclerosis group. An earlier 
diagnosis of Raynaud’s phenomenon was significantly related to greater levels of stress for 
the total sample. Individuals with intestinal problems and Raynaud’s phenomenon reported 
significantly greater levels of stress when compared to individuals without these conditions.  
 Hyper-arousal: Lower self-compassion and diagnosed with scleroderma at a younger 
age, predicted greater hyper-arousal. Whereas more severe Raynaud’s symptoms, a 
dismissive attachment style and low self-compassion (over-identification) predicted greater  
reactive hyper-arousal.                    
  The results suggest that individuals diagnosed with scleroderma generally experience 
a combination of symptoms that differ between the major subsets of scleroderma and specific 
symptom groups; although, some similarities were evident. Greater hyper-arousal was 
significantly related to being diagnosed at a younger age for both diffuse and limited sclerosis 
and fewer experiences of EMWS predicted anxiety for both the diffuse and limited groups. A 
range of different psychosocial variables in the current study were found to predict different 
scleroderma symptoms for the total sample and for the major subsets, diffuse and limited 
sclerosis; findings that provided partial support for the hypotheses.   
  Differences were found between individuals with specific scleroderma symptoms 
when compared to individuals with scleroderma without specific symptoms (e.g., Pain, No 
Pain; Raynaud’s, No Raynaud’s) and psychosocial variables. Differences may occur due to a 
number of reasons, such as exposure to early life stress, individual differences in how a 
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person may relate to themselves and others in times of stress; and the different effects that 
stress may have on an individual’s immune functioning and levels of pain, or a combination 
of these experiences. Scleroderma participants exposed to stressful situations may also 
experience different responses to stress. Stressors generally evoke different physical and 
emotional responses depending on an individual’s experiences and resources, such as 
previous exposure to stress and trauma, coping styles, age, gender and/or genetic 
predispositions (e.g., Every & Lating, 2002; Lazurus & Folkman, 1984).    
  Different responses to stress may therefore explain the different predictor variables 
associated with a range of different scleroderma symptoms. Stressors, such as emotional, 
immunological and inflammatory responses may elicit excessive arousal reactions dependant 
on the intensity of the individual’s response (Selye, 1976), as a result of the internal (e.g., 
adequacy of emotion regulation strategies) and external resources (e.g., capacity to engage 
others in times of need) that are available to the individual (Lazurus & Folkman 1984).   
 These factors may account for differences in the predictor variables, early memories of 
warmth and safety, dismissive and fearful attachment styles, hyper-arousal, stress, the 
emotion regulation strategy suppression, self-compassion and mental health disorders of 
depression and anxiety for the total scleroderma sample; and the diffuse and limited subsets 
of scleroderma; in relation to multiple aspects of this complex disease such as Raynaud’s 
phenomenon, intestinal conditions, breathing problems, disability and pain.                                                       
Early Life Stress, Attachment and Suppression Predict Elevated Pain                     
 Scleroderma: Severity of scleroderma pain was predicted in the total scleroderma 
sample by early stress experiences, specifically recall of few experiences associated with 
warmth and safety and insecure (dismissive) attachment (and a later diagnosis of scleroderma 
in the limited sample). These variables with the exception of a later diagnosis of scleroderma 
were also significant for scleroderma participants experiencing pain, when compared to 
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scleroderma participants without pain. These findings supported the hypothesis and are 
consistent with the biopsychosocial perspective of pain that includes physical, emotional, 
cognitive, anticipatory and previous experiences, psychological factors and aspects that 
involve sensations, attention and interpretation (Lee-Chiong et al., 2010). The 
biopsychosocial model emphases that pain is a multifaceted experience explained by 
biological factors such as tissue damage while acknowledging the influence of social and 
psychological aspects (Keefe et al., 2006); the results in the current study provide further  
support for this model.                   
  The implication is that early stress experiences are likely to compromise an 
individual’s ability to manage the emotional and cognitive aspects associated with pain, 
resulting in elevated experiences of pain. Pain is recognized as a subjective experience that 
differs between individuals (Lee-Chiong et al., 2010) and in the current study was due to a 
number of factors including personal experiences. The intensity of the pain experienced in the 
current study was linked to early childhood experiences associated with feelings of insecurity 
and limited resources to manage emotions in relationships, which may reflect negative early 
relational experiences. Early experiences associated with affective states of safety and 
nurturing are important factors in relation to emotion regulation strategies and coping (Gilbert 
and colleagues, 2008). Early experiences of threat and affective states associated with feeling 
unsafe or uncared for appear to promote the development of neural networks in the threat 
system and a diminished ability to generate self-soothing behaviours.       
  Findings in the current study are consistent with research by Gilbert (2008), Sachs-
Ericsson et al. (2005), and Thakkar and McCanne (1999), which suggests early life stress 
involving a lack of warmth and safety (including experiences of child abuse) is linked to 
elevated levels of stress in adulthood and to physical illness (scleroderma, in the current 
study) and pain (scleroderma related pain). These negative childhood experiences are also 
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associated with an insecure attachment style (e.g., Gilbert, 2008) and emotion regulation 
strategies that involve avoidance, such as suppression (Gross, 1998; Hayes et al., 1996;  
Iwamitsu, et al., 2005), also found in the current study to be associated with scleroderma.  
 Recall of affect in relation to childhood memories explain feelings of threat not 
accounted for by the recall of any particular stressful event (Richter et al., 2009). Individual 
perceptions of experiences and the development of adequate resources to manage adversity 
may impact on the experience of pain for individuals with scleroderma. As exposure to early 
life stress can influence the developing brain and the individuals’ capacity to regulate 
emotions and reduce arousal levels in stressful situations throughout life, affecting pain 
thresholds and impacting on the regulation of the immune system (Depue et al., 2005; Heit et 
al., 1999; Schore, 1994); findings in the current study suggest that individuals with 
scleroderma reporting negative early life experiences, may suffer elevated levels of pain 
resulting from the emotional contribution involved in a dismissive style of relating to  
attachment figures.                   
  Engaging in a dismissive way of relating to significant others reduces the opportunity 
for the individual diagnosed with scleroderma to engage others as external emotion regulators 
in times of stress/distress to reduce arousal levels. This way of relating limits the individual’s 
calming resources to that of self-reliance and the capacity to self-sooth. The ability to self-
sooth and reduce arousal may be inadequate, due to limited early learning experiences that 
provide feelings of warmth and safety and enable the development of effective emotion 
regulation strategies that decrease arousal. Adverse early life experiences and the inability to 
rely on others to reduce arousal in the current study, are experiences that contributed to  
elevated pain in individuals diagnosed with scleroderma.           
  Individuals who have an under-developed ability to self-sooth may respond 
defensively and have difficulty feeling safe or content; which may explain the findings by 
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Angelopoulos et al. (2001), and Hyphantis et al. (2007), that suggested individuals with 
scleroderma tend to be defensive. The current findings provide a possible explanation as to 
the process involved in the development of defensiveness in individuals diagnosed with 
scleroderma. The findings in the current study suggest that low early life experience of 
warmth and safety and a dismissive style of relating may result in individuals diagnosed with 
scleroderma expressing behavioural responses that appear defensive. Early life experiences 
that do not provide opportunities to experience nurturing and safety may increase the 
development of the threat system and reduce the capacity to self-sooth and therefore the  
ability to reduce arousal.                   
  Early life and adult attachment experiences involving the threat system (a reduced 
capacity to effectively down regulate emotions and the subsequent physiological response), 
significantly predicted elevated pain in individuals diagnosed with scleroderma; when 
engaged in higher levels of threat related (attachment) protective strategies. Pain is a common 
experience associated with scleroderma and in the current study is associated with a number 
of scleroderma symptoms including gastrointestinal, Raynaud’s phenomenon, scleroderma 
disability and breathing problems; with intestinal and disability resulting from scleroderma 
symptoms significant predictors of pain. The current findings are consistent with previous 
biological findings related to pain and disability in scleroderma research by Miller and  
colleagues (2012).                     
  As pain involves emotional and sensory experiences associated with tissue damage 
(Lee-Chiong et al., 2010), the findings in the current scleroderma study (not previously 
studied) suggest that the level of pain intensity experienced in the current scleroderma findings 
is related to more negative early relational and adult relational experiences. Individual 
differences in attachment styles may be a determining factor in relation to the coping strategies 
utilized to manage internal and external stress and the level of pain experienced by individuals 
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diagnosed with scleroderma. Individuals with scleroderma who have developed a dismissive 
style of relating may lack the capacity to trust others; and as a result exhibit independent 
defensive behaviours, due to underlying insecurity around gaining assistance from others that 
results in avoidance and distancing. This way of relating may result in individuals diagnosed 
with scleroderma becoming over-stimulated, creating hyper-arousal in relatively minor 
situations and increasing experiences of pain.                
  The intensity of the pain experienced by the person diagnosed with scleroderma may 
also be compounded when attempting to manage adverse situations due to limited abilities to 
use flexible coping strategies that facilitate the reorganisation of thoughts (attachment 
characteristics identified by Simpson & Rholes, 1998). The incapacity to adapt to situations 
due to an inflexible thinking style may also explain the increase in pain experienced by 
individuals diagnosed with scleroderma; as the function of pain involves a number of  
processes including cognitive appraisal.            
  Physiologically elevated or excessive experiences of pain in individuals diagnosed 
with scleroderma may also result from nociceptors that are sensitive to tissue damage and that 
react to changes such as inflammation, a condition experienced by people with scleroderma 
(Lee-Chiong et al., 2010; Smith & Kahaleh, 2008; Sumpio, Riley, & Dardik, 2002). The 
effect of this condition may create an over sensitivity to pain, due to over stimulation or 
irritation resulting in a lowering of the nociceptors firing thresholds, increasing the 
responsiveness to painful stimuli; and in some cases individuals may become hypersensitive 
to non-dangerous/harmless stimuli (Lee-Chiong et al., 2010). These experiences activate 
reflexes in a number of structures including the spinal cord, brainstem, cortex and limbic (or 
emotional) system and tend to distort the relationship between the degree of tissue damage 
and the extent to which pain intensity is perceived by the individual (Lee-Chiong et al., 
2010).     
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  Therefore emotional stimuli perceived as threatening in relational experiences by 
individuals diagnosed with scleroderma may also be explained by physiological responses 
that create an overstimulation of the nociceptors firing thresholds, increasing scleroderma  
individual’s experience of pain.              
  Scleroderma – Pain: The results in the current study (that limited early life experiences 
of warmth and safety and a greater tendency to engage in a dismissive attachment style 
predicted elevated levels of pain) are consistent with previous research that has explored 
emotions in relation to how people experience pain in other illness populations  
(e.g., Davies et al., 2009; Dragkioti et al., 2011; Jones et al., 2009; McWilliams et al., 2000).  
Research suggests that increased pain is associated with a number of psychosocial problems 
including regulating and expressing emotions, an insecure attachment style and childhood 
experiences of stress; this research is consistent with the current findings not previously  
studied in the total scleroderma sample.            
  Diffuse & Limited Sclerosis- Pain: When the sample in the present study was divided 
into the two major subsets of scleroderma (limited sclerosis and diffuse sclerosis), results 
provided partial support for the hypothesis and demonstrated differences in predictor 
variables. Early memories of warmth and safety, dismissive attachment and age diagnosed 
with scleroderma were significant predictors of pain in the limited sclerosis sample, 
indicating that individuals with limited sclerosis reporting lower levels of EMWS, a greater 
tendency to engage in a dismissive style of relating and a diagnosis of scleroderma at an older 
age, were more likely to experience elevated levels of pain; while the emotion regulation 
strategy suppression was significant for the diffuse sclerosis sample; demonstrating that 
diffuse sclerosis participants reporting higher suppression strategies, experienced elevated  
pain. Differences in the variables between the two groups demonstrated that negative social 
relational experiences (interpersonal and intrapersonal) involving attachment and early 
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experiences of nurturing are implicated in the levels of pain experienced by those diagnosed 
with limited sclerosis. Individuals with an insecure attachment style may interpret their 
relational experiences as threatening and may physiologically respond to this perception, 
producing elevated levels of arousal that may increase the experience of pain; due to a limited 
capacity to self-sooth. These experiences may have resulted from very few experiences of 
warmth and safety as a child and therefore ineffective emotion regulation strategies to self-
sooth and reduce arousal. Whereas intrapersonal experiences involving suppression of negative 
thoughts, emotions or memories which may increase arousal due to the physiological 
expression of distress when emotions are not processed, impacted on those individuals 
diagnosed with diffuse sclerosis experience of pain. Recognising that differences may occur 
between sclerosis groups for emotional responding to pain may be beneficial to inform 
treatment for this condition in the scleroderma population.       
 It is noteworthy that employing a dismissive style of attachment or utilizing a suppressive 
emotion regulation approach are avoidant strategies used by the two major subsets of 
scleroderma in this study, to manage painful emotions and thoughts. Although early 
experiences deficit in warmth and safety were not reported in the diffuse sclerosis group as a 
predictor of elevated levels of pain, the strategies to manage painful private experiences were 
similar in that both the limited and diffuse groups utilize avoidance as a coping strategy. These 
findings are consistent with research exploring the effects of thought suppression on the 
immune system and pain (Thomas et al., 2006). Diffuse sclerosis participants who utilized the 
avoidant strategy of suppression to evade distressing thoughts, feelings or memories; enable the 
inhibition of emotional expression associated with these experiences (Gross, 2009). It is 
possible therefore that the diffuse sample have experienced distressing memories that may have 
been experienced early in life that are the target for suppression. These individuals may 
therefore be avoiding expressing the emotional experiences associated with these memories 
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(Gross, 2002) and may not have accurately reported scores on the EMWS scale experiences, 
that are associated with immune dysfunction and elevated pain. Alternatively individuals with 
diffuse sclerosis may focus emotional avoidance strategies on negatively evaluated inner 
experiences as targets for avoidance or suppression (Hayes et al., 1996) and thoughts and 
behaviours that directly activate the threat system and initiate the stress response (Gilbert, 
2007). Further research is required to investigate these suggestions.     
 As suppression of inner experiences may be an ineffective emotion regulation strategy 
that increases the occurrence of the distressing experience, this strategy may create recurring 
elevated physiological responses that increase exposure to physiological reactions and the 
perception of the severity of the pain experience. As many experiences of pain associated with 
scleroderma involve chronic pain, exposure to ongoing distressing inner experiences that could 
also be described as chronic experiences of stress or distress, may explain the elevated levels of 
pain experienced by those using avoidant strategies such as suppression and dismissive 
attachment in the current sample. Longer exposure to these inadequate cognitive and emotional 
appraisal strategies, may also explain why those individuals diagnosed with limited sclerosis at 
a later stage in life reporting early experiences deficit in warmth and safety and the utilization 
of strategies to avoid painful emotions through a dismissive style of relating, suffer more severe 
levels of pain.                                                                                                       
Self-Kindness and Reactive Hyper-arousal Predict Elevated Raynaud’s Symptoms    
 Low levels of self-kindness and reactive hyper-arousal in the total scleroderma sample 
significantly predicted more severe Raynaud’s phenomenon (providing partial support for the 
hypothesis), generally the first symptom of scleroderma. Raynaud’s phenomenon is a vascular 
disorder that involves the constriction of blood vessels generally in the extremities, such as the 
fingers and toes and can involve the internal organs (Baker & Denton, 2008). Raynaud’s 
phenomenon may occur decades before the onset of the inflammatory stage of scleroderma 
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(Bolster & Silver, 2008) and is associated with physiological and emotional stress and a 
heightened stress response (Freedman & Ianni, 1983). Emotional stress is implicated in the 
physiological mechanisms that are involved in the constriction of blood vessels. Endothelial 
cells in the inner lining of the blood vessels interact with the circulation system to regulate 
immunological and inflammatory responses (Sumpio et al., 2002). Therefore individual’s with 
scleroderma who use emotion regulation strategies that increase physiological responses, such 
as the release of chemicals involved in the stress response, that increase the constriction of 
blood vessels, may experience greater Raynaud’s symptomology.       
 These experiences may explain why individuals with more severe Raynaud’s symptoms 
were less likely to use emotion regulation strategies related to self-kindness and experience 
greater levels of reactive hyper-arousal. Low levels of self-kindness may create greater levels of 
reactive hyper-arousal, that increases the stress response and the constriction of blood vessels 
associated with Raynaud’s. Hyper-arousal is associated with psychosocial stress and excessive 
arousal reactions that may create physiological responses, such as the constriction of blood 
vessels associated with Raynaud’s phenomenon. Individuals diagnosed with scleroderma 
reporting elevated Raynaud’s symptoms, were less likely to employ self-kindness to regulate 
their emotions and manage negative emotions, and more likely to employ strategies such as 
avoidance to manage distressing feelings and thoughts, rather than treating oneself with 
kindness and understanding. The incapacity to use self-kindness to regulate emotions may 
impede an individual’s (with scleroderma) ability to change a negative self-view related to 
inner thoughts and emotions to a more positive one as they are less likely to engender kindness 
and understanding toward themselves (Neff, 2003a).         
 Individuals with a limited capacity to engage in self-kindness are less likely to be 
accepting toward their less favourable attributes and inadequacies when unable to manage a 
situation as well as expected. They may also have difficulty recognising that these aspects are 
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part of being human and that no one is perfect (Neff, 2003a). Engaging in kindness and 
understanding towards the self in situations where an individual experiences disappointment, 
emotional or physical pain and the capacity to be open to ones experiences without over 
identifying, may enable individuals with scleroderma to view adverse subjective experiences 
with kindness, to manage negative emotions (Neff, 2003a) and reduce the physiological 
response associated with reactive hyper-arousal. Scleroderma participants reporting low self- 
kindness may not only lack the resources to reduce arousal in stressful situations but may by 
their reactions to the event, increase their bodily response, increasing arousal levels as a result 
of not engaging self-soothing strategies, that may increase Raynaud’s symptomology.    
 The findings in the current study are consistent with the research on psychosocial stress 
and physiological reactions of the neuroendocrine and innate immune systems by Pace and 
colleagues (2009). These findings suggest that stress induced immune and behavioural 
responses may be moderated by compassion focused meditations (Pace et al., 2009), while in 
other studies, self-compassion was associated with stress reduction (Sharpiro et al., 2005), 
lower cortisol levels (Pace et al., 2009), adaptive functioning and positive health outcomes 
(Neff et al., 2007). As self-kindness is concerned with being open to one’s suffering with 
kindness and not utilizing strategies such as self-criticism or avoiding one’s painful 
experiences; engaging in self-kindness as an emotion regulation strategy may reduce arousal 
levels when distressed and provide the majority of individuals with scleroderma who suffer 
elevated Raynaud’s phenomenon with an ability to reduce physiological reactions to stress by 
not avoiding painful thoughts and emotions or engaging in negative self-evaluation.     
 It has been suggested that individuals diagnosed with Raynaud’s phenomenon and 
scleroderma have a heightened stress response (Freedman & Ianni, 1983); as reactive hyper-
arousal involves an intense response to unexpected stimuli and behaviours that involve cortisol 
and the stress response, engaging in emotion regulation strategies devoid or low in self-
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kindness may increase a normally elevated stress response; further increasing arousal levels and 
impacting on the severity of Raynaud’s symptoms, experienced by scleroderma participants. 
When the sample in the current study was divided into the two major subset of scleroderma 
(limited and diffuse sclerosis), results demonstrated that different variables were associated 
with Raynaud’s phenomenon. Low self-kindness and reactive hyper-arousal predicted more 
severe Raynaud’s symptoms for individuals diagnosed with diffuse sclerosis, whereas higher 
levels of self-judgment were associated with greater experiences of Raynaud’s symptoms for 
individuals diagnosed with limited sclerosis.       
 These findings suggest that individuals with scleroderma, diagnosed with diffuse or 
limited sclerosis, utilize different negative emotion regulation strategies that impact on their 
experience of Raynaud’s phenomenon. These differences may be due to different physiological 
and emotional responses to stress.  Higher levels of self-judgment were found for the limited 
group when compared to the diffuse group who reported lower levels of self-kindness 
associated with elevated Raynaud’s symptoms. Although hyper-arousal did not contribute to 
Raynaud’s symptom severity in the limited sclerosis group, engaging in this negative emotion 
regulation strategy, low in self-compassion (self-judgment) may increase arousal levels, 
impacting on Raynaud’s symptoms. It is also possible that individuals diagnosed with diffuse 
sclerosis may generally have a more heightened response to stress than the limited group. This 
reaction combined with emotion regulation strategies low in self-kindness, may increase 
physiological reactions and elevate hyper-arousal levels, responses that may partly explain the 
more severe general disease symptoms individuals diagnosed with diffuse sclerosis experience.  
 Findings also demonstrated that individuals with Raynaud’s phenomenon had limited 
experiences of warmth and safety when compared to those individual’s without a diagnosis of 
Raynaud’s. As exposure to early life stress can influence a person’s developing brain and the 
capacity to regulate emotions and reduce arousal levels in stressful situations throughout the 
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lifespan. It is possible these events may be a risk factor in the development of Raynaud’s the 
first symptom of scleroderma (diagnosed as early as decades before the onset of the 
inflammatory stage of scleroderma, the stage when scleroderma is generally diagnosed).   
 It is likely that individuals diagnosed with scleroderma who have been exposed to adverse 
early life experiences may suffer Raynaud’s phenomenon as a result of the cognitive and 
emotional experiences associated with feeling uncared for and unsafe and the contribution this 
stress exposure, along with a heightened stress response (Freedman & Ianni, 1983), may have 
on an individual’s physiology. These early life experiences and the subsequent emotional and 
cognitive responses that are likely to increase arousal; may partially explain the Freedman and 
Ianni findings (1983), that individuals with both scleroderma and Raynaud’s experience a 
heightened stress response. Chronic emotional and cognitive stress, may result in an individual 
remaining in a constant state of stress, that may constrict blood vessels and influence the 
development of Raynaud’s phenomenon associated with scleroderma. This conclusion is 
supported by the findings that individuals diagnosed with Raynaud’s reported fewer 
experiences of nurturing and feelings of safety in early life, than those individuals diagnosed 
with scleroderma without Raynaud’s phenomenon.                                                                    
Greater Reactive Hyper-arousal – Low Self-Kindness: Greater Scleroderma Disability                    
 Findings partially supporting the hypothesis indicated that individuals reporting greater 
scleroderma disability also experienced significantly higher levels of reactive hyper-arousal. 
Reactive hyper-arousal involves an intense response to unexpected stimuli and behaviours that 
involve cortisol and the stress response that may increase scleroderma symptoms and level of 
disability experienced. When the diffuse and limited sclerosis groups were investigated 
separately low self-kindness was the only significant variable related to scleroderma disability 
experienced by individuals diagnosed with diffuse sclerosis.       
 Results indicated that individuals with diffuse sclerosis who experienced higher levels of 
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disability resulting from scleroderma symptoms, also experienced significantly lower levels of 
self-kindness. Self-kindness is concerned with being open to one’s suffering with kindness and 
not using critical, judgmental or avoidant strategies to manage one’s painful experiences. A 
lack of self-kindness may increase arousal levels when distressed, (Neff, 2003a/b) resulting in 
more severe levels of disability, due to a limited capacity to manage emotions and reduce 
physiological reactions to stress, in individuals diagnosed with diffuse sclerosis. Therefore 
strategies that reduce arousal such as self-kindness, may decrease the level of disability 
experienced by individuals diagnosed with diffuse sclerosis, who generally use emotion 
regulation strategies low in self-kindness.                                                                                  
Higher Suppression Predicts Elevated Breathing & Intestinal Issues in Diffuse Sclerosis     
 Findings suggested there were no meaningful relationships between intestinal or 
breathing problems and psychosocial variables for the scleroderma sample, and no difference in 
psychosocial variables for those individuals with and without intestinal or breathing conditions. 
When the diffuse and limited sclerosis groups were explored, correlation coefficients revealed 
that suppression was the only significant variable for intestinal and breathing problems in the 
diffuse sclerosis group. Results indicated that individuals with diffuse sclerosis who engaged in 
higher levels of suppression, experienced greater intestinal and breathing problems. 
 Suppression is an emotion regulation strategy that reduces awareness and expression of 
an emotion. The suppressed emotion; however, is expressed physiologically, increasing bodily 
responses that in the current scleroderma study were related to exacerbated gastrointestinal and 
breathing conditions, in individuals with diffuse sclerosis. As suppression is utilized to regulate 
excessive negative inner experiences (that over time are likely to increase in frequency and 
directly activate the threat system; Hayes et al., 1996); it is likely that that over time these 
avoidant strategies may influence functioning of the gastrointestinal and breathing systems or 
exacerbate the conditions due to the physiological process involved in elevated negative 
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arousal. Therefore individuals diagnosed with diffuse sclerosis who engaged in higher 
suppression, may experience poorer health outcomes for these conditions when compared to 
individuals with limited sclerosis who did not report elevated breathing and gastrointestinal 
conditions associated with psychological strategies for managing emotions.     
  Individuals diagnosed with scleroderma who use suppression, either consciously or 
unconsciously, as an emotion regulation strategy to manage negative emotions and memories, 
may experience physiological responses that vary considerably across the current sample. As 
suppression decreases the expression of the emotional experience and subsequently increases 
physiological responses (Gross, 2002); this strategy may produce heightened gastrointestinal 
and breathing responses that increase symptomology, in individuals diagnosed with diffuse 
sclerosis in the current study. These findings are consistent with research exploring suppression 
and physiological conditions such as immune dysfunction (Schore, 1994) and partially support 
the hypothesis.                                                                                                                                
Insecure Attachment and Suppression - Skin Severity      
 Findings supporting the hypothesis in the current study revealed significant differences 
between individuals (diagnosed with scleroderma) with mild, moderate and severe levels of 
skin thickening and psychosocial variables (EMWS, fearful and dismissive attachment and 
suppression). Lower EMWS and greater utilisation of suppression and insecure attachment 
styles (dismissive and fearful) were found for individuals with more severe skin thickening, 
when compared with the mild and moderate skin thickening groups. Findings indicated more 
negative outcomes for individuals who engaged in these avoidant emotion regulation strategies, 
in that these psychosocial experiences may impact on immune functioning and exacerbate 
scleroderma skin symptoms.         
 Findings that have not previously been found in this population, may be explained by the 
engagement of intrapersonal (suppression) and interpersonal and intrapersonal (fearful and 
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dismissive attachment) avoidant behaviours and the physiological responses resulting from 
these experiences that is likely to increase arousal. These avoidant and fear related strategies, 
do not effectively regulate emotions or down regulate arousal and appear to impact on 
scleroderma skin symptoms.           
 Differences in attachment experiences in individuals diagnosed with differing levels of 
skin severity and differences between groups for early life experiences low in warmth and 
safety, demonstrated that avoidance and insecurity may be experiences learnt in early life and 
factors that continue to impact on individuals in later life (diagnosed with scleroderma) with 
more severe skin conditions. As insecurely attached individuals tend to lack the resources 
necessary to cope successfully with and adapt to, adverse situations and generally appraise 
stressful situations as more demanding and difficult to manage, than securely attached 
individuals (e.g., Bowlby, 1998); protective strategies (such as suppression and insecure 
attachment styles) may have developed (as a result of adverse early life experiences) that have 
negatively influenced physiological responses, immune system functioning and the level of skin 
involvement found in the current study, in individuals diagnosed with scleroderma.   
 As the immune system is highly sensitive to psychosocial stressors (particularly when 
arousal levels are not reduced and homeostasis does not occur), the individual with scleroderma 
who utilizes avoidant strategies, may increase the risk of stimulating an autoimmune response 
and experiencing more severe levels of skin thickening. As insecure attachment involves the 
secretion of cortisol (a stress hormone that impacts on cells in the immune system) and as high 
levels of cortisol can be trigged by attachment insecurity, that may continue into adulthood (e.g. 
Arnetz & Ekman, 2006; Schore, 1994); the level of psychophysiological experiences an 
individual has endured, may influence the severity of skin thickening an individual diagnosed 
with scleroderma may experience.            
 Individuals diagnosed with scleroderma who reported a dismissive and/or fearful 
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attachment style and engaged emotion regulation strategies to suppress negative thoughts, 
emotions and memories, experienced more severe skin involvement than individuals diagnosed 
with scleroderma reporting less severe skin symptoms. As skin symptoms are a general gauge 
of overall severity of scleroderma symptoms (Steen & Medsgar, 2001); significant differences 
between groups in the current study suggests a link between protective avoidant threat 
strategies when relating to self and others, greater skin involvement and perhaps overall disease 
severity in individuals diagnosed with scleroderma. Therefore therapies that provide education 
around threat related arousal and the immune system in relation to interpersonal and 
intrapersonal communications; and strategies to manage avoidant emotion regulation, require 
investigation in this population to determine the effectiveness of reducing arousal on the 
exacerbation of scleroderma symptoms.                                                                                       
Hyper-arousal, and Self-Compassion were Linked to Early Onset of Scleroderma.   
 Results partially supported the hypothesis and demonstrated that hyper-arousal, over-
identification and isolation (domains of low self-compassion) were significant for age 
diagnosed with scleroderma. Together these variables predicted age diagnosed with 
scleroderma, indicating that the younger an individual is diagnosed with scleroderma the more 
likely they have experienced greater levels of hyper-arousal and lower self-compassion. When 
diffuse and limited sclerosis were explored separately lower self-compassion (subscale, over-
identification) and higher levels of hyper-arousal together predicted an earlier diagnosis of 
scleroderma for individuals diagnosed with diffuse sclerosis (however independently these 
variables were not significant).               
 Findings indicated that the younger an individual is diagnosed with diffuse sclerosis the 
more likely they will engage in the over-identifying strategy, low in self-compassion and 
experience increased levels of hyper-arousal. Therefore scleroderma participants diagnosed 
with diffuse sclerosis who utilize strategies low in self-compassion and experience heighted 
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levels of arousal (possibly due to inadequate emotion regulation strategies low in self-
compassion that increase arousal), may influence bodily processes involved in the earlier 
development of scleroderma symptoms.              
 Hyper-arousal and strategies that increase arousal such as low self-compassion have the 
potential to influence immune functioning. Findings suggest that individuals who may be 
predisposed to developing scleroderma and utilize inadequate emotion regulation strategies 
(low in self-compassion) that increase arousal levels to the stage where autoimmunity occurs, 
may be prone to an earlier diagnosis of scleroderma. Therefore education that informs 
counsellors about the negative potential of engaging in low self-compassion on the immune 
system (autoimmunity), may provide preventative opportunities (reducing the incidence of 
autoimmunity), through treatment methods based on developing self-compassion.           
Insecure Attachment, Self-Compassion & Suppression - Predict Early Onset Raynaud’s  
 Scleroderma: Results revealed meaningful relationships between the dependant variable 
age diagnosed with Raynaud’s phenomenon and the independent variables over-identification 
and isolation (low self-compassion). Although neither variable was a significant unique 
predictor of age diagnosed with Raynaud’s, together this model was significant. As over-
identification and isolation indicated lower levels of self-compassion and are strategies that 
may increase physiological arousal; these factors may have some influence on an earlier 
development of Raynaud’s phenomenon.             
 Individuals with Scleroderma and those also diagnosed with scleroderma and Raynaud’s 
phenomenon who reported low self-compassion may have limited experiences of compassion 
as a result of not receiving warm nurturing experiences at an earlier time in their life. These 
individuals therefore, may not have developed strategies involving self-kindness in situations 
where they experienced stress, distress or disappointment. These individuals may over-identify 
with the subjective experience and/or emotions related to feeling isolated, reducing the 
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opportunity to decrease the impact of the negative experience and the ability to manage an 
elevated threat response (Gilbert, 2007; Neff, 2003a). These experiences may have influenced 
immune functioning and an earlier diagnosis of Raynaud’s phenomenon in individuals 
diagnosed with scleroderma.                                                 
 Diffuse & Limited Sclerosis: When the two major subsets of scleroderma (diffuse and 
limited sclerosis) were explored independently, over-identification for the diffuse group and 
dismissive attachment and suppression for the limited group demonstrated meaningful 
relationships for age diagnosed with Raynaud’s phenomenon. Therefore individuals with 
diffuse sclerosis were more likely to over-identify with their experiences, a strategy that may 
increase physiological arousal impacting on immune system responses and an earlier diagnosis 
of Raynaud’s for the diffuse sclerosis group.            
 Findings for the limited sclerosis group indicated that the younger an individual was 
diagnosed with Raynaud’s phenomenon, the more likely they would utilize the emotion 
regulation strategy suppression and engage in a dismissive style of relating to attachment 
figures, both of which are avoidant emotion regulation strategies. Insecurely attached 
individuals generally do not feel safe and secure when exposed to stressful or threatening 
situations, thereby increasing the likelihood of experiencing long term effects of the stress 
evoking event that may elevate physiological responses, and possibly immune functioning 
associated with an earlier diagnosis of Raynaud’s phenomenon, in individuals diagnosed with 
scleroderma. Whereas individuals who engaged in suppression as an emotion regulation 
strategy, tend to experience an increase in the occurrence of the distressing experience, a 
strategy that may create recurring elevated physiological responses, that can impact on immune 
responses and in this study, a greater likelihood of experiencing an earlier diagnosis of 
Raynaud’s phenomenon in those with limited sclerosis.          
 Individual differences in emotion regulation strategies of suppression and over-
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identification and avoidant styles of relating (dismissive attachment) to significant others may 
be a determining factor in relation to coping strategies used by individuals diagnosed with the 
major subsets of scleroderma when managing stress. These strategies that are likely to increase 
arousal may influence processes that initiate physiological responses involved in the 
development of Raynaud’s phenomenon, generally the first symptom of scleroderma. As the 
onset of Raynaud’s can occur up to decades before a diagnosis of scleroderma for those with 
limited sclerosis, these strategies may in part contribute to an earlier onset of Raynaud’s 
phenomenon and the process involved in initiating the development of scleroderma.                     
Self-Compassion and Age Diagnosed with Scleroderma Predict Hyper-arousal  
 Results demonstrated that self-compassion and age diagnosed with scleroderma predicted 
hyper-arousal in individuals diagnosed with scleroderma, indicating that individuals diagnosed 
with scleroderma, who utilized strategies low in self-compassion and were diagnosed with 
scleroderma at a younger age, were more likely to experience greater levels of hyper-arousal. 
Therefore engaging in emotion regulation strategies low in self-compassion and experiencing 
elevated hyper-arousal may influence immune functioning, by initiating an autoimmune 
reaction that may result in an earlier diagnosis of scleroderma. An inability to treat oneself with 
compassion and reduce the emotional and physiological response associated with arousal linked 
to immune functioning; may generate an earlier onset in those individuals diagnosed with 
scleroderma, who utilize emotion regulation strategies that reduce the capacity to self-sooth and 
manage the threat response.               
 Reactive hyper-arousal a subscale of hyper-arousal demonstrated different predictor 
variables to hyper-arousal that included Raynaud’s phenomenon, a dismissive attachment style 
and low self-compassion (over-identification) for individuals diagnosed with scleroderma. 
Results indicated that individuals diagnosed with scleroderma who experienced more severe 
Raynaud’s symptoms, a dismissive attachment style and a tendency to over-identify with their 
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situation, were likely to experience greater levels of reactive hyper-arousal.  Results indicated 
that these more reactive individuals (with scleroderma) may be more likely to react intensely to 
unexpected stimuli and have difficulty discriminating between physiological sensations that are 
harmless, and threatening sensations that involve cortisol arousal. These experiences may result 
in a difficulty adapting to recurring stimuli that may increase arousal levels.      
 Individuals diagnosed with scleroderma who generally experience heightened arousal 
may use inadequate emotion regulation strategies likely to engage the threat response, possibly 
due to exposure to early life stress, low in compassion and limited opportunities to develop self-
soothing strategies. This situation may have created long term exposure to heightened levels of 
arousal early in life; or alternately scleroderma participants reporting hyper-arousal may have a 
genetic predisposition to hyper-arousal such as a heightened stress response, findings consistent 
with Ianni and Freedman’s research (1983). Chronic states of hyper-arousal whether generated 
biologically, or physiologically induced through personal experience, may have impacted on 
the immune system and increased the likelihood of developing Raynaud’s phenomenon.                                                                                                                               
Summary of Predictor Variables for Scleroderma Symptoms                                                  
 Severity of scleroderma symptoms were associated with and predicted by a number of 
variables that have supported a pattern of experiences and strategies reported in the literature as 
associated with elevated physical reactions and immune related responses.     
 These early life experiences and avoidant (threat related) emotion regulation strategies 
that generally increase arousal, as hypothesised either predicted or were associated with 
scleroderma symptoms, disability and pain. Severity of symptoms in individuals diagnosed 
with diffuse and limited sclerosis, were generally related to different psychosocial variables and 
may be the result of different physiological and emotional responses to stress. These results 
partially supported the hypotheses.               
 Diffuse Sclerosis: Individuals diagnosed with Diffuse sclerosis who engaged in strategies 
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high in suppression or reported using emotion regulation strategies low in self-compassion 
(such as over-identifying with their situation), a strategy likely to elevate the fight and flight 
response tended to report more negative health outcomes.        
 Limited Sclerosis: Whereas limited early life experiences around nurturing and safety and 
the development of fear related protective strategies involving insecurity (insecure attachment 
styles dismissive and fearful) and avoidance (suppression of negative inner experiences) were 
significantly related to scleroderma symptoms and pain.         
 Similarities/Differences between Groups: Avoidance was utilized by both diffuse and 
limited groups as a strategy to regulate emotions; however, this approach appears to exacerbate 
scleroderma symptoms, perhaps due to increased levels of arousal. Different avoidant strategies 
generally predicted scleroderma symptoms in the two groups. The diffuse groups’ greater 
utilization of emotion regulation strategies low in self-compassion and high in suppression were 
likely to increase arousal levels and initiate the fight and flight response impacting on immune 
system functioning, thereby exacerbating scleroderma symptoms. Individuals diagnosed with 
limited sclerosis who may have experienced adverse early life experiences, tended to engage 
avoidant emotion regulation strategies and attachment styles that may also initiate the threat 
response, impacting on the immune system and elevating scleroderma symptoms.   
 Although variables tended to differ between individuals, the severity of symptoms 
appears to relate to experiences and strategies that increase the threat response, immune 
functioning, and an earlier onset of Raynaud’s phenomenon and scleroderma. Raynaud’s 
phenomenon the first symptom of scleroderma can occur decades before the onset of 
scleroderma, particularly in individuals diagnosed with limited sclerosis.        
 This suggests that early adverse experiences and the resulting emotional and cognitive 
strategies may create a chronic state of hyper-arousal that engages the threat system, an 
autoimmune response and an earlier diagnosis of Raynaud’s, for individuals with limited  
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sclerosis.                                                                                                                                              
What Predicts Depression, Anxiety and Stress in Individuals with Scleroderma                                         
Depression                       
  A majority of individuals (58%; diagnosed with scleroderma) in the current study 
reported experiencing elevated levels of depression. Thirty six percent experienced mild 
depression, 11% reported moderate depression while 11% experienced severe levels of 
depression. The remaining participants experience some depressive symptoms (although not 
clinical levels), indicating that all participants in this study experienced some depressive 
symptoms. The current findings are considerably higher than prevalence rates in community 
samples (APA, 2013); however, they are consistent with previous studies on depression and 
scleroderma by Thombs et al., (2007); Beretta et al., (2006); Daniele et al., (2005); 
Angelopoulos et al., (2001) and Roca et al., (1996) that identified high levels of mild to 
severe depression in 33% to 65% of individuals diagnosed with scleroderma.   
  Findings in the current study revealed that EMWS and fearful attachment predicted 
elevated levels of depression in individuals diagnosed with scleroderma. Levels of depression 
in the total scleroderma sample were likely to be more severe, in individuals who have been 
exposed to stressful early childhood experiences low in warmth, emotions associated with 
feeling safe and secure and a fearful style of relating to attachment figures. Depression 
resulting from early life stress may activate physiological systems involving an increase in 
cytokine secretion and hyperactivity of the HPA-axis affecting immune system functioning.  
 Fearfully attached individuals with scleroderma in the current study were likely to 
have a negative view of themselves and others and engage in avoidant emotion regulation 
strategies, likely to impact on the ability to reduce arousal and disengage the fight and flight 
response in stressful situations. Engaging in a fearful attachment style that may have 
developed as a result of exposure to experiences low in warmth and safety and possibly high 
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in fear and threat, are therefore likely to increase symptoms of depression associated with 
threat processing deficits and stress hormones in individuals diagnosed with scleroderma.      
 More severe depression was also experienced by individuals diagnosed with limited 
sclerosis (in the current study), who engaged in a greater utilization of suppression as an 
emotion regulation strategy and reported limited experiences of EMWS. These individuals 
were likely to engage the threat system through the use of avoidant strategies such as 
suppression or emotions associated with threat such as feeling unsafe and uncared for. These 
strategies may negatively impact on communications between the neural, endocrine and 
immune systems, reducing serotonin receptors and increasing the experience of depression 
and symptoms such as worthlessness, hopelessness and sadness associated with these early  
life experiences.   
                   
  In the diffuse sclerosis group those diagnosed with Raynaud’s phenomenon and who 
have a tendency to use over-identification strategies were likely to experience elevated levels 
of depression. These individuals were likely to experience higher levels of depression, 
possibly due to chronic focusing on their experience, which may have been interpreted as 
threatening, impacting on their experiences of helplessness and hopelessness, symptoms 
associated with depression. When comparing specific scleroderma symptoms, findings 
revealed that individuals reporting scleroderma symptoms of pain, Raynaud’s phenomenon 
and finger ulcers, experienced greater levels of depression, when compared to individuals 
(with scleroderma) without these specific scleroderma symptoms.        
  These findings are consistent with those found for individuals diagnosed with  
Raynaud’s in the diffuse sclerosis group, who experienced more severe levels of depression. 
Raynaud’s phenomenon and finger ulcers were associated with considerable pain and 
disability and these experiences may possibly increase the individual’s feelings (diagnosed 
with scleroderma) associated with a lack of control over their disease, elevating depressive  
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symptoms such as feelings of sadness and hopelessness.            
  Overall the results demonstrated that depression was not only related to some specific 
scleroderma symptoms and greater Raynaud’s severity but also to psychosocial aspects 
including early life stress, strategies that involve the threat and immune systems and limited 
internal (e.g., suppression, low self-compassion and insecure attachment) and external 
resources (fear related to relying on others in times of need) to manage stress. These findings 
add to the literature on disease symptoms (Raynaud’s phenomenon) and psychosocial aspects 
involving early childhood stress and cognitive and emotional strategies; that suggest that the 
threat and immune systems are likely to underlie the experience of depression in some 
individuals diagnosed with scleroderma. The results suggest significant relationships between 
depression and early life experiences, insecure attachment and inadequate emotion regulation 
strategies; and the need to assess these experiences in individuals diagnosed with scleroderma 
to inform treatment of depressive symptoms.                                                                          
Anxiety                       
 Eighty per cent of individuals in this study reported experiencing anxiety with 23% 
experiencing mild levels of anxiety, 44% reporting moderate anxiety and 13% experiencing 
severe levels of anxiety. The remaining participants also reported some anxiety symptoms 
indicating all participants reported experiencing some level of anxiety. These figures are 
consistent with prevalence rates of anxiety of 83% in individuals diagnosed with scleroderma 
reported by Legendre and colleagues (2005). Variables that predicted the high prevalence of 
anxiety in the total scleroderma sample included scleroderma specific symptoms and 
psychosocial factors. Scleroderma related breathing problems, low experiences of early 
memories of warmth and safety and the ineffective emotion regulation strategy suppression, 
predicted elevated levels of anxiety in individuals with scleroderma. These variables also 
predicted higher levels of anxiety for individuals diagnosed with limited sclerosis.   
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 Scleroderma disease symptoms in the diffuse sclerosis group did not predict anxiety; 
however, similar findings for the psychosocial variable, early experiences of warmth and 
safety (found in the limited and scleroderma groups) were also found in the diffuse group. 
Greater feelings of isolation (and not suppression), however, predicted greater levels of 
anxiety in the diffuse group. Findings indicated that for the total sample, higher levels of 
anxiety were likely to be experienced by scleroderma participants who have experienced 
lower levels of warmth and safety in their childhood and for the limited sample this variable 
together with higher levels of suppression and more severe scleroderma related breathing 
problems, predicted greater anxiety. For the diffuse group, EMWS and increased experiences 
of feeling isolated (low self-compassion) predicted elevated levels of anxiety.     
 These results suggest that while EMWS predicted anxiety in both groups; different    
scleroderma symptoms and psychosocial variables (other than EMWS) predicted elevated 
anxiety in individuals diagnosed with diffuse and limited sclerosis. Findings are consistent 
with research on negative early experiences low in warmth, nurturing and safety and the 
development of anxiety (Gilbert, 2008) and emotion regulation strategies such as suppression 
and avoidance (Gross, 1998; Hayes et al., 1996; Iwamitsu et al., 2005).           
 Heightened levels of anxiety in the current study for some individuals, were likely to 
result from early experiences associated with stressful psychosocial environments, involving 
chronic exposure to stress and the development of ineffective emotion regulation strategies 
that may create a physiological stress response. Exposure to prolonged stressful psychosocial 
experiences early in life has the potential to negatively impact on neural-endocrine and 
immune interactions (Arnetz & Ekman, 2006). Individuals diagnosed with scleroderma 
exposed to early prolonged levels of stress, may have developed a hyper-vigilance to threat 
that engages the fight and flight response and the development of suppression as an avoidant 
strategy, to manage the stressor and heightened levels of anxiety.         
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  Early experiences of chronic stress may therefore impact on the ability of individual’s 
with scleroderma to develop adaptive psychological strategies and may affect functioning of 
physiological systems such as those involved in breathing. Scleroderma participants reporting 
elevated levels of anxiety who have suffered frequent negative childhood events may 
experience difficulty regulating the emotional response to stressors, due to a lack of 
opportunity to develop the self-soothing social mentality and the capacity to reassure (Gilbert  
et al., 2004) when distressed.                  
  These individuals may also lack the experience and capacity to believe they are 
worthy of care or that others will be there for them in time of need; experiences that may 
result in elevated feelings of isolation. Consequently these experiences may result in the use 
of maladaptive cognitive and emotional strategies that may generate a physiological stress 
response (Neff, 2003a; Mills, 2005) and impact on scleroderma participant’s levels of 
anxiety. Scleroderma participants who have experienced early stress environments and 
developed a limited capacity to use calming strategies, may lack the resources to regulate 
negative emotions and therefore utilize suppression as an avoidance strategy; to manage 
unpleasant feelings or to disengage from the threatening situation (Langens & Morth, 2003).  
 Early memories associated with feeling unsafe and uncared for and adult experiences 
of isolation (low self-compassion) were also likely to elevate the experience of anxiety in 
those diagnosed with diffuse sclerosis. These early childhood experiences may not only have 
impacted on the individuals capacity to connect with others and understand that other people 
suffer similar human conditions, but also their expectations that others are willing to be 
supportive. This way of thinking is likely to increase individuals with diffuse sclerosis 
feelings of isolation and impact on the level of anxiety experienced.       
 Results also demonstrated that individuals reporting pain resulting from scleroderma 
symptoms, experienced higher levels of anxiety than those diagnosed with scleroderma 
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without associated pain. This may be explained by findings that suggest pain is a subjective 
experience associated with tissue damage. Pain is therefore perceived as physiological as well 
as psychological, with the psychological aspects of pain playing a greater part in the 
experience of pain when it becomes chronic; as it involves sensory, emotional and cognitive 
experiences that require attention and interpretation (Lee-Chiong et al., 2010). Individuals 
who experience anxiety may therefore engage in emotions that increase the experience and 
perception of pain (physiologically and/or emotionally) due to an inability to self-sooth and  
reduce arousal in fearful or threatening situations.            
  The findings in the current study are consistent with research conducted by Tan and 
colleagues (2008) in that, individuals experiencing anxiety reported elevated levels of chronic 
pain. The reporting of experiences of pain may therefore reflect not only a physical  
expression of pain but also a subjective component involving the interpretation of sensory  
experiences that are likely to elevate levels of anxiety.           
  Individuals diagnosed with Raynaud’s reported higher levels of anxiety than those 
individual’s without a diagnosis of Raynaud’s. As research demonstrates that individual’s 
diagnosed with both Raynaud’s and scleroderma have a heightened stress response 
(Freedman & Ianni, 1983); this response may impact on the emotional and/or subjective 
experience of the individual and subsequently increase the experience of anxiety. Although 
results suggest that early social experiences of nurturing and feeling safe were similar for the 
limited and diffuse groups for some variables, different psychological and biological 
predictor variables were found for these groups and also for those with different scleroderma 
symptoms. These findings suggest that early childhood experiences and the subjective 
interpretation of individual’s experiences, may impact on scleroderma symptoms and  
elevated levels of anxiety.                                                                                                                                      
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Stress                                                
  Age diagnosed with Raynaud’s phenomenon predicted stress in the scleroderma 
sample, indicating that the earlier an individual with scleroderma was diagnosed with 
Raynaud’s phenomenon the greater their current experiences of stress. Individuals diagnosed 
with Raynaud’s also reported higher levels of stress than those individual’s without a 
diagnosis of Raynaud’s. Therefore the earlier an individual is diagnosed with Raynaud’s 
phenomenon the greater the experience of stress; these findings may reflect the suggestion 
that individuals diagnosed with scleroderma and Raynaud’s phenomenon have a heightened 
stress response and therefore these findings have implications for treatment. Education that 
informs counsellors about this heightened stress response in those with Raynaud’s and 
scleroderma may improve outcomes, in that strategies that effectively manage stress may be  
provided for these individuals.   
               
  Drawing on the findings in the current study: Results could reflect individual’s 
(diagnosed with scleroderma) exposure to biopsychosocial stress and the limited resources to 
manage cognitive and emotional experiences of stress, that may result in chronic states of 
fight and flight, an elevated level of stress and an earlier diagnosis of Raynaud’s; generally  
the first symptom of scleroderma.                 
  Therefore an inability to manage stress over long periods of time may affect the bodily 
processes involved in the fight and flight response such as the constriction of blood vessels 
and an earlier onset of Raynaud’s phenomenon. Conversely these results may reflect longer 
exposure to the symptoms associated with Raynaud’s that have increased the current 
experience of elevated levels of stress; or an innately heightened stress response that may 
have initiated an earlier diagnosis of Raynaud’s. These results do however reflect that 
heighted levels of stress are linked to an earlier diagnosis of Raynaud’s.       
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  Findings also demonstrated that over-identification (low self-compassion), a cognitive 
and emotional experience involving the threat response, was likely to be reported by 
individual’s diagnosed with diffuse sclerosis experiencing more severe levels of stress. These 
individuals were likely to focus attention on their negative experience, engaging the fight and 
flight response and increasing the experience of stress. Elevated stress was also experienced 
by individuals diagnosed with limited sclerosis reporting lower childhood exposure to feeling 
cared for and safe; experiences also associated with the threat response and inadequate 
emotion regulation strategies. An inability to manage negative emotions associated with a 
lack of nurturing and feelings of safety and security over long periods of time may heighten 
physiological responses to stressors (experienced as chronic stress) that may underlie the 
current reporting of elevated stress by individuals diagnosed with limited sclerosis.     
 A difference was also reported for individuals experiencing different scleroderma 
symptoms. Individuals with intestinal complaints reported greater levels of stress than those 
without this condition. These results are consistent with (Tache et al., 2001) findings that 
stress has the potential to generate alterations in gastro-oesophageal functioning as part of 
physiological changes that occur during a response to stressors. Individuals reporting pain 
resulting from scleroderma symptoms, also reported more severe levels of stress than those 
diagnosed with scleroderma without associated pain. As the literature describes pain as a 
subjective experience associated with personal experience (Lee-Chiong et al., 2010) and as 
early stress experiences may result in ineffective emotion regulation strategies associated 
with the threat system and immune activation (e.g., Gilbert et al., 2008), these stressful 
psychosocial aspects may partially explain the elevated levels of pain.     
  Physiological pain and disability associated with scleroderma symptoms may also 
partially explain greater reporting of stress when compared to individuals without these pain 
experiences. Stressors generally do not elicit the same response, thereby effecting each 
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individual differently as a result of a number of factors, such as genetic predispositions, 
gender, exposure to stressful social environments, age of exposure and coping strategies. 
These aspects may reflect in part the difference in stress experienced by those individuals 
diagnosed with scleroderma. As psychological stress involves an evaluation of any particular 
circumstance as exceeding the capacity of an individual to manage any situation or 
experience that may potentially endanger their well-being (Lazarus & Folkman, 1984). The 
type of strategies used by individuals diagnosed with scleroderma to manage negative stress 
arousal may explain the difference in variables in the current study related to psychological 
and physiological symptom severity in individuals diagnosed with scleroderma.        
  The ability to manage the negative cognitive and emotional responses that may occur as 
a result of early life stress and the capacity to effectively manage emotions associated with 
living with a chronic and life threatening disease were factors that were likely to impact on 
elevated levels of stress and an earlier diagnosis of Raynaud’s phenomenon for some 
individuals diagnosed with scleroderma. It should be noted that the sample size obtained for 
this study was rather small for the number of variables used to measure the relationship 
between disease symptoms and onset and is a limitation in this study.   
 Recommendations                   
  Living with a complex chronic and potentially life threatening disease (that has no 
known cure) and experiencing negative cognitive and emotional strategies that reduce the 
likelihood of effectively managing emotions and thoughts, reflects greater scleroderma 
symptomology. Developing strategies that involve awareness and understanding of 
experience (rather than avoiding, suppressing or over-identifying) may assist individuals 
diagnosed with scleroderma to reduce the physiological response to stress and immune 
reaction associated with elevated scleroderma symptoms.   
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            Education around individual thinking patterns and levels of negative arousal and the 
likely impact on an individual’s specific set of scleroderma symptoms, may provide some 
insight into each individual with scleroderma’s current copying style. The intention of this 
education would be to motivate this population to engage in therapeutic techniques that 
reduce negative arousal to improve current psychological and physiological health.   
 Further research (involving individuals with scleroderma) that focuses on psycho-
education around immune activation; engaging in compassion focused and cognitive 
behavioural therapies that involve mindfulness; to develop skills that effectively manage 
emotions, reduce arousal and exacerbation of scleroderma symptoms requires investigation.                          
Limitations                      
  As scleroderma is a rare disease it was difficult to gain a large sample in a country with 
a small population such as Australia compared with countries with a greater population pool to 
draw from such as the UK and USA. Although an international population was sought from 
which to collect data to gain the necessary participant numbers, to complete a research project 
of this type (that is with a large number of variables). Participant numbers were lower than 
expected and as a result impacted on what analysis were conducted. The low participant 
numbers in relation to number of variables and analysis in this study is therefore also a 
limitation. Post-hoc power calculations were therefore conducted to measure adequate power. 
Power was found to be adequate for all significant findings. The pattern resulting from all 
findings indicated a link between experiences and strategies that are likely to engage the fight 
and flight response and possibly impact on immune functioning. Therefore although the 
number of participants was smaller than anticipated the sample indicated a relationship 
between scleroderma symptom severity, strategies and experiences that the literature suggests 
are linked to immune dysregulation and the possible development of autoimmunity (in this 
study a link to scleroderma). The type of measures used to determine scleroderma symptom 
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severity is also a limitation as self-report rating scales provide a subjective view of an 
individual’s symptomology rather than an objective assessment of an individual’s health as 
determined by a medical measure.                                                                                        
Conclusion                      
  The findings in the current study are consistent with Gilbert’s biopsychosocial theory 
of social mentalities that postulates experiencing early environments deficient in compassion, 
tend to impact on an individual’s capacity to develop the self-soothing social mentality and 
use self-soothing strategies. These individuals are likely to function in the threat mentality 
due to internalising early life experiences of external threat and engaging ineffective avoidant 
emotional regulation strategies to manage stress or distress (e.g., Gilbert, 2000; Gilbert, 2002; 
Gilbert, 2012). Findings suggest that individuals diagnosed with scleroderma may have 
different copying styles when managing stress as a result of varying positive and negative 
inter-personal experiences in early life that involve attachment. These experiences may have 
created ways of relating to self and others (e.g., levels of self-compassion and emotional 
suppression and adult attachment strategies) that to varying degrees, either elevate or reduce 
arousal levels (hyper-arousal) dependant on whether the type of strategies used, engage the 
threat mentality or self-soothing social mentality (Gilbert, 2000). These strategies may impact 
of how the individual responds to stress events (such as receiving a diagnosis of a rare disease 
that has a high mortality rate, no cure and symptoms that affect the sufferer’s level of 
functioning). The way individuals cope and adapt to situations and their capacity to reduce 
arousal in a short time-frame may explain the difference in variables related to psychological 
and physiological symptom severity, in individuals diagnosed with scleroderma.   
 Effective or ineffective management of negative intra-personal and inter-personal 
experiences may also result in a vulnerability to psychological conditions such as anxiety and 
depression (e.g., Gilbert, 2007; Gilbert, 2012) and immune dysregulation (Schore, 1994) that 
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may impact on scleroderma symptomology.  Threatening early life experiences, deprived of 
warmth and safety tend to limit the activation of the self-soothing mentality and would be 
generally more likely to stimulate the threat system and subsequently the development of 
defensive strategies (e.g., Gilbert et al., 2008; Irons, Gilbert et al., 2006) such as avoidance 
behaviours and emotional suppression (Gross, 2002), to prevent engagement in the fearful or 
threatening situation (Langens & Morth, 2003). The current study has expanded on Gilbert’s 
research through the exploration of early life stress and strategies associated with activation 
of the threat system and the relationship to disease symptomology.         
 Elevated biologically related scleroderma symptoms and psychosocial experiences in 
the current study reflect emotional and physiological responses likely to engage the fight and 
flight response involved in the threat system and immune related functioning associated with 
an earlier onset of disease symptoms and elevated symptomology. Early life stress associated 
with low experiences of warmth, and feeling safe and secure can affect an individual’s ability 
to regulate their emotions and calm the threat response.     
  Insecure attachment styles such as dismissive and fearful attachment also engage the 
threat system, through the use of avoidant strategies or emotions associated with fear and 
feeling unsafe. Emotion regulation strategies such as suppression, and low self-compassion 
(over-identification, self-judgment, feelings of isolation, and a limited ability to provide 
oneself with kindness) and self-soothing reflect inadequate emotion regulation strategies, and 
a limited capacity to rely on significant others; and for some people stressful early life 
experiences and attempts to manage adversity with limited internal and external resources. 
 While both groups reported early life experiences as impacting on their physical or 
psychological functioning, the diffuse group tended to use emotion regulation strategies that 
were likely to increase arousal levels, the fight and flight response, immune system 
functioning and increase scleroderma symptomology. While individuals with limited sclerosis 
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tended to report negative early life experiences, avoidant emotion regulation and attachment 
styles also associated with the threat system, as impacting on severity of scleroderma 
symptoms. Although variables differed between individuals, the severity of symptoms 
appeared to relate to interpersonal and intrapersonal experiences and strategies that increase 
the threat response, immune functioning, and an earlier onset of Raynaud’s and  
scleroderma disease symptoms.                 
  Mental health variables depression, anxiety and stress were also related to scleroderma 
symptoms, early life stress and cognitive and emotional strategies such as low self-compassion 
that involve the threat response, immune system functioning and the capacity to manage stress.                                                                                                                                                             
CHAPTER FOUR - STUDY TWO: SCLERODERMA AND COMMUNITY STUDY                           
Introduction - Comparison Study between Community and Scleroderma Groups       
 Findings from the first study indicated that lower early life experiences related to 
warmth and safety, emotion regulation and physiological responses such as hyper-arousal 
(experiences likely to involve the threat mentality and the fight and flight response) predicted 
a variety of scleroderma related conditions and psychological symptoms such as depression 
and anxiety. The literature suggests that early social experiences involving low warmth and 
safety and inadequate strategies for managing stress and emotions, may increase 
physiological arousal over extended periods of time and impact on immune system 
functioning and physiological and psychological health (Arnetz & Ekman, 2006; Lekander,  
2002; Maier & Watkins, 1998; Schore, 1994).             
  Investigating whether these experiences were as likely to occur in the general 
population, was the focus of the second study. This study investigated whether negative 
rearing experiences and significant psychosocial variables explored in the scleroderma study 
were also common in community individuals without this illness. The aim was to demonstrate 
the likelihood that these variables may contribute to the psychopathology experienced by 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    182  
  
individual’s diagnosed with scleroderma and the development or earlier onset of scleroderma; 
and therefore not found to the same degree in the community sample. It was anticipated that 
individuals from the community sample would have more positive early life and attachment 
experiences, a greater capacity to engage in self-compassion and lower experiences of arousal 
than scleroderma participants. Participants for the community study where recruited from 
Bond University first year psychology students and individuals from local sporting clubs.  
Study Two: Hypotheses                                                                   
  Hypothesis one: Lower levels of EMWS, inadequate Emotion Regulation, (low Self-
Compassion and higher Suppression) an Insecure Attachment Style (Dismissive and Fearful) 
and higher levels of Hyper-arousal would be reported by individuals diagnosed with 
Scleroderma when compared with Community participants without a diagnosis of 
Scleroderma.            
 Hypothesis two: Individuals diagnosed with Scleroderma would report higher levels of 
Anxiety, Depression and Stress when compared would individuals from the Community 
sample without a diagnosis of Scleroderma.       
 Hypothesis three: Higher levels of Anxiety, Depression and Stress would be found 
between the Diffuse sclerosis group when compared with the Community group and Limited 
sclerosis group when compared with the Community group.      
 Hypothesis four: Lower levels of EMWS, inadequate Emotion Regulation, (limited 
experiences of Self-Compassion and higher Suppression) an Insecure Attachment Style 
(Dismissive and Fearful) and higher levels of Hyper-arousal would be reported between the 
Diffuse sclerosis group when compared with the Community group and between the Limited 
sclerosis group when compared with the Community group without a diagnosis of 
scleroderma.                                
            
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    183  
  
                                                                       Method                                    
Participants                                                                 
  Male and female adults aged 18 years and over who had not been diagnosed with  
Scleroderma were invited to participate in this research project. One hundred and six Bond 
University psychology students and individuals from the general community completed either 
the online or hardcopy questionnaire.                                                                                  
Measures                                                 
  The measures were the same as those included in study one with the exclusion of the 
Scleroderma Health Assessment Questionnaire SHAQ: Steen & Medsger, 1997). These 
questionnaires were the Early Memories of Warmth and Safeness Scale (EMWS: Richter, 
Gilbert & McEwan, 2009), the Relationship Scale Questionnaire (RSQ: Griffin & 
Bartholomew, 1994), the Emotional Regulation Questionnaire (ERQ: Gross & John, 2003), 
the Self-Compassion Scale (SCS: Neff, 2003), the Depression, Anxiety and Stress Scale  
(DASS21: Lovibond & Lovibond, 1995) and the Hyper-arousal Scale (HS: Hammond, 
Barsky, & Regestein, 2001). Additional questions such as diagnosis of scleroderma or other 
autoimmune disease were included.                                                                                  
Procedure                                                                                                                              
  Non Scleroderma participants were recruited through Bond University and in the 
general community. Participants included Bond University psychology students who were 
recruited through notices posted on the Research Participation Notice board of the HSS 
Faculty, within the Psychology Department, informing potential participants of the research. 
Participants were also recruited from non-biological relatives and friends of people diagnosed 
with scleroderma by scleroderma associations. The general community sample also included 
people from a wide range of ethnic, socioeconomic and educational backgrounds that were 
involved in local sporting competitions (tennis, golf and bowls). This population was 
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included in the study as being active is generally perceived as healthy.        
 As scleroderma is generally diagnosed later in life and mostly in women, all 
participants were assessed for suitability to be included in the study, in that individuals were 
matched for gender and age (between 26 and 80 years, mean age 56) with those in the 
scleroderma study.                                   
                    Results                                                                                             
Study Two: Overview of Analyses               
 Analysis was performed using SPSS version 18. Frequencies revealed an age range 
between 18 and 76 years in the community sample. Individuals are generally diagnosed with 
scleroderma after the age of thirty years and are predominately female, therefore it was 
necessary to match participants in the community sample for age and gender. The youngest 
age for scleroderma participants in the current study was 26 years; eight participants in the 
community sample aged below the age of 26 were therefore removed from the analysis.  The 
age range for participants in the community sample (individuals without a diagnosis of 
scleroderma), entered into analysis was between 28 and 76 years with a mean age of 48.   
 Frequencies for the demographic and health information revealed a total of 75 
community participants (54 females, 19 males, two participants failed to complete this 
information); 64 participants were from Australia, two were from the UK, one from the USA, 
and five from European Countries; three participants did not supply this information. Three 
participants reported gaining a primary school education, 34, reported a secondary school 
education with 26 and seven participants reporting tertiary and post graduate education 
respectively, five participants did not supply this information. Scleroderma and community 
data files were merged to conduct comparison analysis to address the hypotheses.   
 T-Tests and MANOVA were conducted as well as non-parametric analyses (Mann 
Whitney U and Kruskal-Wallis tests) due to skewed data. Cronbach’s alpha revealed the 
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variables Depression, EMWS, Dismissive and Fearful Attachment were above .90, the 
variables Stress, Hyper-arousal, Self-Compassion and the subscales Self-kindness, over-
identification and mindfulness were (when rounded up) .80 or above; the variables Anxiety 
and Suppression were .70 or above, Reactive Hyper-arousal was .62 with an acceptable inter-
item mean of .35; demonstrating that these scales had good internal consistency.                     
Statistical Analysis: Comparison Study - Scleroderma and Community                                                       
 Missing data was evident throughout the data. The pattern appeared random for all 
completed scales. T-Tests and a MANOVA were performed to address the first hypothesis; 
that individuals diagnosed with Scleroderma would report lower levels of Self-Compassion, 
Emotion Regulation, EMWS, and an Insecure Attachment Style and higher levels of Hyper-
arousal when compared with Community participants without a diagnosis of Scleroderma.  
Preliminary assumption testing was conducted. The variables that met the assumptions were 
analysed utilizing parametric tests. T-Tests revealed significant mean differences between 
groups (Scleroderma and Community).         
 EMWS: Individuals with Scleroderma reported lower levels of EMWS (M = 70.03, SD 
= 23.94) than the no scleroderma group; M = 78.65, SD = 20.22, t (148) = 2.31, p = .022, the 
magnitude of the mean difference = .85, 95% CI: .1.25 to 15.98 (eta Squared =. 038).   
 Self-Compassion: Lower levels of Self-Kindness (SCS), (M = 13.61, SD = 4.80) than 
the No Scleroderma group; M = 15.81, SD = 4.46; t (137) = 2.75, p = .007, the magnitude of 
the mean difference = .85, 95% CI: 0.62 to 3.79 (eta Squared =. 05) and lower Mindfulness 
(SC), (M = 12.80, SD = 3.36, than the No Scleroderma group; M = 13.95, SD = 2.95; t (137) 
= 2.08, p = .039 the magnitude of the mean difference = .85, 95% CI: .058 to 2.23 (eta 
squared = .03). One way between groups multivariant analysis of variance was performed 
entering significant variables; preliminary assumption testing was conducted with no 
violations noted. Means, Standard Deviations and T-Tests for EMWS, Self-kindness and 
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Mindfulness are presented below in Table 13.                                                                                                   
Table 13                                                                                                                                          
T-Tests for Scleroderma/No Scleroderma groups for Depression, Anxiety and Stress  
 
Variable                                                                  M                          SD                 t      
 
  EMWS                                                                  
           Scleroderma                                             70.03                       23.94                     
           Community                                              78.65                       20.22           
T-test                                                                                                                        2.31*  
__________________________________________________________________________                              
Self-Kindness  
           Scleroderma                                            13.61                         4.80                                                            
           Community                                             15.81                         4.46                                                
T-test                                                                                                                          2.75** 
__________________________________________________________________________                             
Mindfulness  
        Scleroderma                                               12.80                          3.36                      
        Community                                                13.95                          2.95                                                           
T-test                                                                                                                         2.08*           
________________________________________________________________________                            
*p < .05 **p < .01 ***p < .001  
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There was a significant difference between individuals diagnosed with Scleroderma and those 
without a diagnosis of Scleroderma on the combined dependant variables, Wilks’ Lambda F 
(3,131) = 2.80, p = .042. When the results for the dependent variables were considered 
separately all variables reached statistical significance, early memories of warmth and safety 
(EMWS), F (1, 133) = 4.26,  p = .041, partial eta = .03 (3.1% of the variance), Self-Kindness,  
F (1, 133) = 6.26, p = .014, partial eta = .045 (4.5% of the variance) and Mindfulness F (1, 133) 
= 4.00, p = .048, partial eta = .03 (2.9% of the variance). Inspection of mean scores indicated 
that individuals with Scleroderma reported lower EMWS (M = 69.67, SD = 23.90), than 
individuals without a diagnosis of scleroderma, M = 77.74, SD = 20.24, lower levels of Self-
Kindness (M = 13.64, SD = 4.80) than those without a diagnosis of scleroderma, M = 15.65, SD 
= 4.32, and lower Mindfulness, (M = 13.84, SD = 2.86) than individuals without a diagnosis of 
Scleroderma, M = 12.74, SD = 3.35.       
 A Mann Whitney U Test was also conducted to address the first hypothesis as the variable 
Over-identification (SCS) was negatively skewed in the Community group and normally 
distributed in the Scleroderma sample; the variable Reactive Hyper-arousal was positively 
skewed in the Scleroderma sample and normally distributed in the Community sample. 
Attempts to use the same transformations to achieve normality for each of these variables was 
unsuccessful. Analysis revealed significant differences in levels of Over-identification for 
individuals without a diagnosis of Scleroderma (Md = 13.0, n = 58) and individuals diagnosed 
with Scleroderma (Md = 16.0, n = 80), U=1542.50, z = -3.37, p = .001, r = -0.29. The 
Scleroderma group recorded a higher median score on Over-identification than the Community 
group. Reactive Hyper-arousal however failed to reach significance.            
    The results indicated that individuals with Scleroderma have fewer experiences of 
EMWS, less self-compassion (lower mindfulness and self-kindness and greater over-
identification) than those not diagnosed with Scleroderma.                            
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Scleroderma – Community: Depression, Anxiety and Stress        
  Preliminary assumption testing was also conducted to check for normality, linearity, 
univariant and multivariant outliers, homogeneity of variance, covariance matrices and 
multicollinarity for the Anxiety, Depression and Stress subscales of the DASS. Analysis 
revealed the Anxiety and Depression subscales were negatively skewed. Examination of plots 
revealed univariate and multivariate outliers for the DASS subscales; two cases were 
removed as recommended by Tabachnick and Fidell (2007). The skewness was reduced with 
removal of outliers; however not sufficiently as data remained skewed. Inverse 
transformations were conducted for these variables resulting in more acceptable skews closer 
to zero, meeting the assumptions for normality. Attempts to use the same transformations to 
achieve normality for Stress, Depression and Anxiety (logarithm transformations for the 
Scleroderma Sample and normally distributed variable Stress, and Inverse transformed 
variables Depression and Anxiety for the Community sample) were unsuccessful.    
 Therefore a Mann Whitney U Test was conducted to compare Depression, Anxiety 
and Stress in the Community and Scleroderma samples to investigate the second hypothesis; 
that individuals diagnosed with Scleroderma would report higher levels of Anxiety, 
Depression and Stress than participants without a diagnosis of Scleroderma.     
 Depression: Results revealed significant differences in levels of depression in 
individuals without a diagnosis of Scleroderma (Md = 8.0, n = 63), when compared with 
individuals with Scleroderma (Md = 10.0, n = 92), U = 2105.0, z = - 2.92, p = .003, r = - 0.24.  
 Anxiety: Results revealed significant medium differences in Anxiety levels for 
individuals without a diagnosis of Scleroderma (Md = 8.0, n = 63), when compared with 
individuals diagnosed with Scleroderma (Md = 10.0, n = 93), U = 1671.5, z = - 4.60, p = .000,  
r = - 0.37.                     
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    189  
  
  Results demonstrated that the Scleroderma group recorded a higher median score for 
Depression and Anxiety than the Community group; however the scores for Stress failed to 
reach significance. These results indicated that individuals diagnosed with Scleroderma 
experienced higher levels of Anxiety and Depression than those without a diagnosis of 
Scleroderma. Results for Stress levels were not significantly different. Therefore the results 
support two of the three comparisons for the second hypothesis.                                                                          
Comparison Study: Community and Scleroderma Groups (Diffuse, Limited) 
Depression, Anxiety and Stress: DASS scores revealed higher levels of Depression  
and Anxiety in the Diffuse (more rapid symptom onset than limited sclerosis) and Limited 
sclerosis groups when compared with the Community sample. The Community group 
reported a greater percentage of scores within the normal range for all three variables 
(Depression, Anxiety and Stress) when compared to the Scleroderma groups. Some 
individuals diagnosed with Diffuse and Limited sclerosis reported severe levels of Depression 
and Anxiety; scores not indicated by the Community sample. Results for clinical scores 
(measured by the DASS) suggested individuals diagnosed with Diffuse and Limited Sclerosis 
experienced more severe levels of Depression and Anxiety than individuals from the 
Community without this diagnosis. The Community group reported a greater percentage of 
scores within the normal range for all three variables (Depression, Anxiety and Stress) when 
compared to the Scleroderma groups. Some individuals diagnosed with Diffuse and Limited 
sclerosis reported severe levels of Depression and Anxiety; scores not indicated by the 
Community sample. Results for clinical scores (measured by the DASS21) suggested 
individuals diagnosed with Diffuse and Limited Sclerosis experienced more severe levels of 
Depression and Anxiety than individuals from the Community without this diagnosis. Results 
for clinical scores are presented in Table 14.                                                                                                                             
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Table 14                                                                                                                                
Depression Anxiety & Stress for the Community, Diffuse and Limited sclerosis groups   
Variable  No Sclero  Limited 
Sclerosis  
Diffuse   
Sclerosis 
Depression  
0-9        Normal  
  
   61.9%  
  
40.0%  
  
45.5%  
10-13    Mild  28.6%  42.0%  27.2%  
14-20    Moderate  9.5%  10.0%  15.2%  
21-27    Severe    8.0%  12.1%  
Anxiety  
0-7         Normal  
  
36.5%  
  
22.0%  
  
11.8%  
8-9         Mild  34.9%  22.0%  23.5%  
10-14     Moderate  28.6%  38.0%  50.0%  
15-19     Severe    16.0%  14.7%  
20+        Ex  Severe       
Stress  
    2.0%    
0-14       Normal  90.5%  75.5%  79.4%  
15-18     Mild   7.9%  12.3%  14.7%  
19-25     Moderate  
26-11     Severe  
 1.6%  
  
12.2%  
  
   5.9%  
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As clinical scores do not provide significance levels further statistical analysis was conducted 
(Kruskal Wallis Test: non-parametric due to skewed variables) to support the hypothesis that 
individual’s diagnosed with Scleroderma would report greater experiences of Depression, 
Anxiety and Stress when compared with Community participants.                                                    
 A Kruskal-Wallis Test was conducted to investigate the third hypothesis: higher levels 
of Anxiety, Depression and Stress would be found between the Diffuse sclerosis group when 
compared with the Community group and the Limited sclerosis group when compared with 
the Community group. Mean Rank for Anxiety in the Community group was reported at 
55.56 (63), diffuse 92.82, (34) and the limited group, 84.44 (50), χ², 22.06, 2df, p=.000.  
Depression in the Community group, 61.89 (63), diffuse 78.95 (33), and limited group, 84.53 
(50), χ², 8.89, 2df, p =.012.                                                                                             
 Results indicated that significant differences occurred between groups, in that 
significantly higher levels of Depression and Anxiety were reported by Diffuse and Limited 
Sclerosis participants when compared to Community participants.          
 Anxiety: The Diffuse group recorded a higher median score (Md = 10.5) on Anxiety 
than the Limited group (Md = 10.0) with both Scleroderma groups reporting significantly 
higher levels of Anxiety than the Community group (Md = 8.0).     
 Depression: The Limited group reported higher levels of Depression (Md = 10.5) than 
the Diffused group (Md =10.0), with both Scleroderma groups recording significantly higher 
levels of Depression than the Community group (Md = 8).      
 Results indicated that both the Limited and Diffuse groups had higher levels of 
Anxiety and Depression than the Community groups. However the Limited group reported 
higher levels of Depression than the Diffuse group with the Diffuse group reporting higher 
levels of Anxiety than the Limited group. Therefore both scleroderma groups differed 
significantly from the Community group, partially supporting the third hypothesis.  
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 Hyper-arousal and Low Self-Compassion (Over-identification): A Kruskal-Wallis 
Test was conducted to investigate part of the fourth hypothesis as Hyper-arousal and Over-
identification were skewed. The hypothesis was that individuals diagnosed with Diffuse and 
Limited Sclerosis would report lower levels of Self-Compassion, Emotion Regulation, 
EMWS, an Insecure Attachment Style and higher levels of Hyper-arousal when compared 
with Community participants without a diagnosis of Scleroderma. Mean Rank for Reactive 
Hyper-arousal for the Community group was 60.59 (58), Diffuse 81.48 (31), Limited 63.66 
(43), χ², 6.46, 2df, p=.039. Mean Rank for Over-identification for the Community group was 
53.31 (58), Diffuse 79.39 (31), Limited 73.64 (42), χ², 12.14, 2df, p=.002.     
  Hyper-arousal: The Diffuse group recorded a higher median score (Md = 8.0) on 
Hyper-arousal (Reactive) than the Community group, (Md = 6.0) with the Limited group 
reporting the same median score as the Community group (Md = 6.0).       
 Low Self-compassion: The Diffuse group recorded a higher median score (Md = 16.0) 
on Over-identification than the Community group (Md = 13.0) while the Limited group also 
reported a higher median score than the Community group for over-identification and similar 
scores to the Diffuse sclerosis group (Md = 15.5).       
 The results demonstrated that the Diffuse group reported significantly higher levels of 
Hyper-arousal and Over-identification than the Community and Limited groups with the 
Limited group reporting similar levels of Hyper-arousal when compared to the Community 
group and slightly lower levels of Over-identification than the Diffuse group. Comparison 
results for groups (mean rank) are presented below in Table 15.                                                                                                              
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Table 15                                                                                                                            
Scleroderma Diffuse/Limited Sclerosis and Community Samples Non-Parametric Statistics    
 
Significant Variables                                                                    N                     Mean Rank                   
 
Anxiety   
       Community Group                                                                63                            55.56                   
       Limited Sclerosis                                                                  50                            84.44                 
       Diffuse Sclerosis                                                                   34                            92.82                     
Depression  
       Community Group                                                                63                            61.89                    
       Limited Sclerosis                                                                  50                            84.53  
      Diffuse Sclerosis                                                                    33                            78.94  
Reactive Hyper-arousal  
       Community Group                                                                58                             60.59                    
       Limited Sclerosis                                                                  43                             63.66  
       Diffuse Sclerosis                                                                   31                             81.48                    
Over-identification  
       Community Group                                                                58                             53.31                     
       Limited Sclerosis                                                                  42                             73.64                   
       Diffuse Sclerosis                                                                   31                             79.39                    
 __________________________________________________________________________  
T-tests and MANOVA were conducted to investigate the remainder of the fourth 
hypothesis: that lower Self-compassion, EMWS, insecure Attachment and higher Suppression 
would be reported by the Diffuse group when compared to the Community group and the 
Limited sclerosis group when compared with the Community group. T-Tests revealed 
significant mean differences between the Diffuse/Limited and Community groups.  
EMWS: Individuals with Diffuse reported experiencing lower EMWS (M = 66.77, SD  
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= 27.24) than the no scleroderma group; M = 78.65, SD = 20.22, t (92) = 2.18, p = .034, the 
magnitude of the mean difference = .85, 95% CI: 2.01 to 21.75 (eta Squared =.05).   
 Self-Compassion: Lower Self-Kindness (SCS), (M = 12.42, SD = 3.97) was found for 
the Limited group when compared to the No Scleroderma group; M = 15.81, SD = 4.46; t  
(99) = 3.96, p = .000, the magnitude of the mean difference = .85, 95% CI: 1.69 to 5.09 (eta 
Squared = .16). Lower Mindfulness (SC), (M = 12.00, SD = 3.09, was found for the Limited 
group when compared to the No Scleroderma group; M = 13.95, SD = 2.95; t (99) = 3.22, p = 
.002, mean difference = .85, 95% CI: 0.75 to 3.15 (eta squared = .10).        
 Re-appraisal: A greater ability for Re-appraisal was found for the No Scleroderma 
group; M = 30.31, SD = 6.08 when compared to the Limited group M = 27.56, SD = 7.25; t  
(99) = 3.22, p = .002, mean difference = .85, 95% CI: 0.75 to 3.15 (eta squared = .01).  
  A one way between groups MANOVA was performed. Violations were evident for 
Box's Test of Equality of Covariance Matrices, significant at .004. EMWS was significant at 
.010 on Levene’s test of equality of error variance and removed from analysis. Once removed 
Box's Test of Equality of Covariance Matrices was no longer significant, however Self-
Kindness was significant at .030 on Levene's test of equality of error variance. Therefore an 
alpha level of .025 was set (as suggested by Tabachinick & Fidell, 2007). Results revealed a 
significant difference between individuals diagnosed with Diffuse and Limited sclerosis and 
those from the Community sample without this diagnosis on the combined dependent 
variables (Wilks’ Lambda F(2,130) = 3.03,  p = .007). When the results for the dependent 
variables were considered separately, Self-Kindness, F(1, 131) = 7.25, p = .001, partial eta = 
.10 (10.1% of the variance) and Mindfulness, F(1, 131) = 6.44,  p = .002, partial eta = .09  
(9.1% of the variance) were statistically significant. Re-appraisal failed to reach significance. 
Inspection of mean scores indicated that individuals diagnosed with Limited sclerosis 
reported significantly lower levels of Self-Kindness (M = 12.42, SD = 3.97), when compared 
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with community individuals without this diagnosis M = 15.81, SD = 4.46, while the Diffuse 
sclerosis group reported lower levels of Self-Kindness (M = 15.35, SD = 5.59) than 
individuals without scleroderma and higher levels of Self- Kindness than the Limited group.  
Means and standard deviations are presented in Table 16.                                                                     
Table 16                                                                                                                                               
Scleroderma - Diffuse & Limited Sclerosis - Community - Means and Standard Deviations                               
 
              
Variables                                                                       N                           M                      SD  
 
EMWS   
       Non-Scleroderma Group                                        62                      78.64                  20.22   
       Scleroderma Group                                                88                      70.03                  23.94   
       Limited Sclerosis                                                   47                      72.72                  21.74  
       Diffuse Sclerosis                                                    32                      66.76                  27.23  
Self-Kindness  
       No Scleroderma Group                                          57                      15.65                    4.32   
       Scleroderma Group                                                78                      13.65                    4.80   
       Limited Sclerosis                                                   43                      12.42                    3.97  
       Diffuse Sclerosis                                                    31                      15.35                    5.59  
Mindfulness  
       No Scleroderma Group                                          57                      13.95                    2.95   
       Scleroderma Group                                                78                      12.80                    3.39   
       Limited Sclerosis                                                   43                      12.00                    3.12         
       Diffuse Sclerosis                                                    31                      14.29                    3.50  
___________________________________________________________________________  
Mean scores also revealed that individuals diagnosed with Limited sclerosis reported  
significantly lower levels of Mindfulness (M = 12.00, SD = 3.09), than those without this 
diagnosis (M = 13.95, SD = 2.95) while the Diffuse sclerosis group reported slightly higher 
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levels of Mindfulness (M = 14.29, SD = 3.50) than individuals without this diagnosis; and 
higher levels of Mindfulness than the Limited group. Results also presented in Table 16 
demonstrate that individuals diagnosed with Limited sclerosis reported significantly lower 
levels of Self-Kindness and Mindfulness when compared with the Community group. The 
Diffuse group reported significantly higher levels of Over-identification than the Community 
group and similar (non-significant) levels of Self-Kindness and Mindfulness when compared 
with this group. Means and standard deviations for EMWS are also shown in Table 16.                                
Results for Hypotheses: First Hypothesis; Psychosocial – Scleroderma/Community                       
  Results partially supported the first hypothesis: that lower levels of Self-Compassion, 
Emotion Regulation EMWS, and an Insecure Attachment Style and higher levels of Hyper-
arousal would be reported by the Scleroderma group when compared with the non-
Scleroderma group. Results indicated that individuals diagnosed with Scleroderma have 
fewer early experiences of warmth and safety (EMWS) and treat themselves with less Self- 
Kindness than individuals who have not been diagnosed with Scleroderma. Results also 
indicated that individuals with Scleroderma reported lower levels of Mindfulness and greater 
levels of Over-identification than those without Scleroderma, partially supporting the first  
hypothesis. 
Results for the Second and Third Hypotheses: Mental Health                    
  Results partially supported the second hypothesis: that individuals diagnosed with 
Scleroderma would report higher levels of Anxiety, Depression and Stress when compared 
with individuals from the Community sample without a diagnosis of Scleroderma. Results 
indicated that individuals diagnosed with Scleroderma reported higher levels of Anxiety and 
Depression (DASS) than individuals without a diagnosis of Scleroderma; furthermore results 
to address hypothesis three; higher levels of Anxiety, Depression and Stress would be found 
between the Diffuse sclerosis group when compared with the Community group and the 
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Limited sclerosis group when compared with the Community group were partially supported. 
Findings demonstrated that both the Limited and Diffuse groups had significantly higher 
levels of Anxiety and Depression than the Community groups, however the Limited group 
reported higher levels of Depression than the Diffuse group and the Diffuse group reported  
higher levels of Anxiety than the Limited group.                                                                               
Results for the Fourth Hypothesis: Psychosocial – Diffuse/Limited/Community                       
 The fourth hypothesis compared the Scleroderma groups (Diffuse and Limited 
sclerosis) independently with the Community group; Lower levels of Self-compassion, 
EMWS, an insecure Attachment style and higher levels of Suppression and Hyper-arousal 
would be reported by the Diffuse sclerosis group when compared with the Community group 
and the Limited sclerosis group when compared with the Community group. Results 
indicated that individuals diagnosed with Limited sclerosis reported significantly lower levels 
of Self-Kindness and Mindfulness when compared with the Community group. The Limited 
group reported similar levels of Hyper-arousal to the Community group. While the Diffuse 
group reported significantly higher levels of Hyper-arousal (Reactive) and Lower Self-
Compassion (Over-identification) than the Community group and similar levels of Self- 
Kindness and Mindfulness to the Community group.                                                                    
Summary of Results                    
  Results indicated that individuals diagnosed with Scleroderma had fewer early 
experiences of warmth and safety (EMWS) and utilized emotion regulation strategies that 
reflect lower Self-Compassion (Self-Kindness, Mindfulness and Over-Identification) and 
higher levels of Anxiety and Depression than individuals without Scleroderma. Significant 
differences were identified between the Limited and Diffuse groups and the Community 
group. Individuals with Limited sclerosis reported lower levels of Self-Kindness,  
Mindfulness, Anxiety and Depression when compared with the Community group and similar  
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levels of Hyper-arousal when compared to the Community group. The Diffuse group 
reported similar levels of Self-Kindness and Mindfulness and significantly higher levels of 
Hyper-arousal, Over-identification, Anxiety and Depression than the Community group.      
  Figure 2 provides a visual representation of the differences between individual’s 
diagnosed with scleroderma (more negative experiences) and those without this illness (more 
positive experiences) for early life experiences, levels of  self-compassion and mental health.  
 
                                                                                                                 
 
 
                                     
                                                          
 
Figure 2: Scleroderma – Community Model: Differences between Groups                                                      
                                                               Discussion                                               
Differences between Groups for EMWS, Self-Compassion, Anxiety and Depression  
 Findings partially supported hypothesis one and two and indicated that individuals 
diagnosed with scleroderma had fewer experiences of warmth and safety than individuals 
from the general community. Individuals diagnosed with scleroderma were also less likely to 
use self-compassion strategies of self-kindness and mindfulness, more likely to over-identify 
with their experiences and report higher levels of anxiety and depression than individuals 
without scleroderma. The findings suggest that early life stress and the limited use of self-
compassion strategies may impact on an individual’s autoimmune response and development 
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of scleroderma. Findings relating to depression and anxiety further support and add to the 
literature that suggests that a large percentage of individuals with scleroderma experience 
elevated levels of depression (e.g., Thombs et al., 2007; Beretta et al., 2006; Angelopoulos et 
al., 2001; Roca et al., 1996). When compared with depression in community populations 
(e.g., Pignone et al., 2002), individuals with scleroderma experienced more depression and 
also more anxiety (Legendre et al., 2005) than community individuals (APA, 2013).  
 Although these studies investigated prevalence rates separately and did not make 
comparisons between illness groups and the general population, percentages were 
considerably higher in scleroderma samples than community samples. The second study’s 
findings, that individuals with scleroderma experience more depression and anxiety than 
community participants without a diagnosis of scleroderma, therefore contributes to the 
literature by directly comparing these two groups. Depression and anxiety are conditions 
associated with immune alterations (e.g., Miller, 2005) and in the first study were predicted 
by low self-compassion. Depression resulting from stress may trigger hyperactivity of the 
HPA-axis that impacts on immune system functioning (e.g., Kiecolt-Glaser & Glaser, 2002) 
and scleroderma symptomology. Engaging in self-compassion strategies may reduce arousal 
levels involved in the flight and fight response thereby decreasing the risk of an autoimmune 
response. Elevated levels of depression and anxiety may also reflect more negative, less 
compassionate cognitions and emotions when attempting to manage stressful situations.   
 The findings support the earlier study in this series that suggests psychosocial 
experiences linked to scleroderma symptoms and earlier onset are likely to involve the fight 
and flight response and immune activation and may partly explain why individuals reporting 
a limited ability to provide self-compassion strategies, experienced elevated scleroderma  
symptoms.                                                                                                                                          
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Differences between Limited and Diffuse Sclerosis and Community Groups      
  Differences were identified between the limited and diffuse sclerosis and community 
groups. Limited systemic sclerosis affects 60% of individuals diagnosed with scleroderma. 
This form is the most common type of scleroderma and is also known as limited cutaneous 
disease or CREST syndrome (calcinosas, Raynaud’s phenomenon, esophagal dysmolity, 
scleradactal and telangiectasias) and also involves skin thickening of the extremities. Diffuse 
systemic sclerosis is present in 35% of individuals diagnosed with scleroderma and involves a 
more rapid onset, symptoms include swelling of the hands and legs, carpal tunnel arthritis, 
Raynaud’s phenomenon and fatigue and generally more severe skin thickening than limited 
sclerosis. The extent of skin thickening and pace of disease progression differentiates diffuse 
scleroderma from limited scleroderma. Both diffuse and limited scleroderma subsets have 
similar gastrointestinal disease and interstitial lung fibrosis symptoms (Bolster & Silver, 
2008).           
 Differences between the group’s psychosocial experiences were investigated in 
relation to a sample from a normal population (without scleroderma) to determine whether 
different psychosocial experiences such as levels of warmth and safety in early life and 
emotion regulation strategies such as self-compassion were lower for those with an illness 
(scleroderma) than those without scleroderma. The findings that lower self-kindness and 
mindfulness and elevated anxiety and depression were experienced by individuals diagnosed 
with limited sclerosis when compared with the community group, partially supported 
hypothesis three and four. The diffuse sclerosis group reported similar levels of self-
compassion (self-kindness and mindfulness) to the community group and significantly higher 
levels of hyper-arousal (reactive), lower self-compassion (over-identification), anxiety and 
depression than the community group; findings that also partially supported hypothesis three 
and four. These findings suggest that the diffuse group were more likely to engage in self-
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compassion strategies that involve self-kindness and mindful awareness. However, these 
individuals tended to over-identify with their situation, a strategy that may increase their 
experiences of anxiety and depression and levels of reactive hyper-arousal and subsequently 
their immune reactions.           
  Lower levels of self-kindness and mindfulness (for the limited group when compared 
with community participants) may develop from early life experiences low in warmth and 
safety (reported by the limited group with greater scleroderma severity in the first study). The 
inability to engage in self-compassion strategies of mindfulness and self-kindness may result 
from limited experiential exposure to compassionate others (that provide nurturing and feelings 
of safeness) and limited early learning experiences that may assist in the development of self-
compassionate behaviours (such as self-kindness). These early life experiences may influence 
cognitive and emotional processes involved in an individual’s (with limited sclerosis) ability to 
self-sooth and physiological processes involved in the development of scleroderma symptoms. 
These results support the findings in the first study that demonstrated limited early life 
experiences of warmth and safety and insecure attachment styles predicted severity of some 
scleroderma symptoms (such as pain) and depression, anxiety and stress in the limited sclerosis 
group. The reporting of elevated depression at the time of the study by scleroderma participants 
in relation to community participants may influence these participants recall of early rearing 
experiences as more negative than those reporting less depression and may partly be a reason 
for the more negative reporting on the EMWS scale from scleroderma participants; although 
these depressive symptoms may also be bidirectional in that the EMWS experiences may also 
have generated negative or depressive views of early life.     
  Differences between reported experiences of self-compassion and hyper-arousal for 
the diffuse and limited groups, when compared with the community group, suggests that 
different cognitive, emotional and physiological process may be involved in how these 
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individuals respond to situations and how these responses may affect immune functioning. It 
may be possible that individuals with diffuse sclerosis may have a greater predisposition to 
heightened levels of arousal and elevated levels of anxiety (may also be a result of the disease 
process) that may influence the functioning of the immune system. These participants also 
tended to over-identify with their experiences (low self-compassion a strategy that may also 
increase arousal) that may include their experiences of scleroderma due to the severity of 
their condition. These experiences (anxiety and over-identification) may elevate already 
heightened physiological responses (reactive hyper-arousal) that could result in a heightened  
immune response associated with autoimmunity.            
  Individuals diagnosed with limited sclerosis were more likely to experience more 
severe depression than the diffuse and community groups. This may reflect early life stress 
and the development of limited internal resources to cope with managing emotional and 
physical stress (such as low self-compassion), when compared with individuals diagnosed 
with diffuse sclerosis who generally suffer more severe symptom and engage in greater self-
compassion strategies (mindfulness and self-kindness) than the limited sclerosis participants.  
 These findings may reflect the different experiences and strategies for managing stress 
and possible predispositions to an augmented autoimmune response. It may be possible to 
suggest that individuals diagnosed with diffuse sclerosis (the more severe type of 
scleroderma) are more likely to have a predisposition to hyper-arousal and anxiety and 
although appear to employ positive self-compassion strategies (at similar levels to community 
participants) they tend to engage in strategies that involve over-identifying with their 
experiences, that may also increase levels of arousal and impact on the immune system and 
scleroderma symptoms. Whereas limited sclerosis participant’s scleroderma symptoms may 
be influenced by social and emotional experiences found in the first study. Early life stress 
and avoidant relational styles involving fearful and dismissive attachment that may have 
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resulted in the development of inadequate emotion regulation strategies lacking in self-
compassion and limited in self-soothing may be linked to the threat response. These 
experiences (perhaps learnt in early childhood) may have become the normal way of 
responding to stress and as a consequence engaged the fight and flight system over long 
periods (chronic) of time, eventually initiating an autoimmune reaction.         
 This suggestion is further supported by the findings supporting the hypothesis that 
scleroderma participants reporting lower levels of early life experiences of warmth and safety 
were also likely to report a diagnosis of Raynaud’s when compared to individuals with 
scleroderma without a diagnosis of Raynaud’s; the first symptom of scleroderma that can be 
diagnosed up to decades before the onset of limited sclerosis (Smith & Kahaleh, 2008). 
Raynaud’s phenomenon; however, is generally diagnosed immediately before or at the time 
of receiving a diagnosis of diffuse sclerosis (Smith & Kahaleh, 2008). Early life stress and the 
resulting ineffective emotional and cognitive strategies for managing stress may therefore 
influence the onset of Raynaud’s and the development of scleroderma in individuals with 
limited sclerosis. Stress may also effect the development of Raynaud’s in the diffuse sclerosis 
group. However, as different antibodies are involved in the two major subsets of this disease 
and the onset and severity is significantly more rapid in the diffuse group, it is suggested that 
a greater predisposition to diffuse sclerosis and greater experiences of stress in individuals 
diagnosed with limited sclerosis may explain the differences in predictor variables for each of  
the groups.                                                                                                                     
Limitations                                                                                                                                
   Reporting of early memories of warmth and safeness required the recall of past 
experiences. Recounting these events may be impeded (under-reported or over-reported) by 
individual’s ability to accurately report experiences that may have occurred at a much earlier 
time in the participant’s lifespan. The reporting of these early life experiences may also have 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    204  
  
been influenced by memory bias as elevated levels of depression were reported by the 
scleroderma sample when compared to the community sample, which may have resulted in 
more negative reporting on the EMWS scale. However in support of using this information, the 
reporting of low self-compassion and an insecure attachment styles by scleroderma participants 
was related to a number of negative psychological and physiological variables in the first study, 
which suggests this reporting may be reliable. The small sample size for the limited and diffuse 
groups is also a limitation although fewer analysis were conducted in this study compared with 
study one. Assumptions for a few analyses were violated therefore these results should be 
viewed with caution (although correlations showed significant relationships between variables), 
however overall the results from the second study supported the findings in the first study.     
Conclusion                                                                                                 
  These findings provide further support for research findings in the first study, which  
suggested a limited capacity to reduce arousal may contribute to the development of 
scleroderma; in that early life stress and limited opportunities to develop the self-soothing 
social mentality and related emotion regulation strategies such as self-compassion, may 
contribute to the development of scleroderma. Community participants showed a greater 
capacity to utilize self-soothing strategies (such as self-compassion) to reduce emotional and 
physical arousal, strategies that may have developed as a result of greater experiences of 
warmth and safety as a child, when compared to scleroderma participants. Self-compassion 
strategies may calm arousal levels when the threat response is engaged, reducing immune 
reactions that may impact on an individual’s health.              
 Community participants also reported lower experiences of depression and anxiety, 
which are conditions associated with immune alterations (e.g., Miller, 2005) and low self-
compassion (Neff et al., 2007). Scleroderma participant’s limited capacity to use self-
compassionate cognitions (that were higher in the community sample) that may have developed 
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from a deficit in early life experiences of warmth and safety, when experiencing distress or 
stressful events, may impact on their psychological and physiological health and contribute to 
the earlier development and/or exacerbation of scleroderma symptoms.                                         
Implications       
 Findings suggest, a limited capacity to engage self-compassionate emotion regulation 
strategies when managing stress or distress, may reduce the capacity of an individual to return 
the body to a pre-stress state within a short time-frame, increasing vascular, inflammatory and 
immune related responses, and the risk of immune dysfunction. In terms of clinical applications 
it may be beneficial for therapists to evaluate individuals levels of self-compassion (e.g., using 
the Self-Compassion Scale: Neff, 2003b) and the levels of warmth and safety experienced as a 
child (e.g., EMWS Scale: Gilbert and colleagues, 2009) and provide education around how 
these experiences may be impacting on scleroderma symptomology. These measures used in 
this study may assist in the understanding of the client’s capacity to provide self-compassion 
and inform psychological treatment and preventative treatments for physiological health, 
particularly individuals with family histories involving immune conditions such as autoimmune 
diseases like scleroderma. Further research in the form of comparison studies on other 
autoimmune diseases may also provide similar outcomes for these populations and require 
investigation. Outcomes from this type of research may also inform therapeutic treatments to 
aid in the reduction of negative arousal inflammatory responses and symptomology of other 
autoimmune diseases.                                                                                                                     
CHAPTER FIVE: STUDY THREE – SCLERODERMA & BREAST CANCER    
 Comparison Study between Scleroderma and Breast Cancer Groups     
 The findings from the first study on scleroderma suggest that early negative rearing 
experiences and emotional and cognitive approaches such as low self-compassion and 
suppression, coping strategies likely to create a chronic state of hyper-arousal and the 
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engagement of the threat system, were likely to predict a range of scleroderma symptoms and 
psychopathology such as depression and anxiety. The second study supported the findings from 
the first study, in that significant results suggested, individuals diagnosed with scleroderma 
experienced fewer positive early life experiences and greater psychosocial stress than 
community individuals. These results supported the focus of the third study 3(a): that explored 
whether similar biopsychosocial experiences were also likely to occur in individuals diagnosed 
with another severe illness (breast cancer). That is, whether negative early childhood 
experiences were as likely to occur in breast cancer participants (when compared with those 
diagnosed with scleroderma) and if so, whether the resulting emotional and cognitive outcomes 
were also experienced. Study 3(b) involved comparative analysis to determine differences 
between all groups involved in the three studies; Scleroderma, Breast Cancer and Community 
groups.                                                                                                    
   Review of the Literature: Cancer and Psychosocial Stress                                               
 Researchers suggest stress is associated with dysregulation of the immune system and is 
linked to other immune related diseases (that do not involve autoimmunity). Cancer related 
diseases unlike autoimmune diseases (that involves a hyper-responsive immune system) that 
attack healthy tissue (Smith & Kalhaleh, 2008) are associated with immune suppression 
(Whiteside, 2006). Biopsychosocial cancer studies have found associations between stress and 
individuals diagnosed with cancer. Research suggests an association with neuroendocrine-
immune changes, psychosocial stress and an increased risk of cancer (Sephton & Spiegel, 
2003). Scleroderma researchers have not previously compared differences in stressors in 
individuals with different immune responsive diseases such as cancer. The current study 
therefore investigated differences in the type of stressors experienced and/or strategies used to 
regulate emotions; in diseases that involve different immune responses (scleroderma: hyper-
responsive and breast cancer: suppressed) and whether these experiences were linked to onset 
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and increased symptomology of the respective diseases.          
 Different processes are involved in the development of autoimmunity and cancer, 
although managing exposure to stressors appears to play a part in both diseases. Individuals 
diagnosed with cancer demonstrated a disruption in a number of responses including rhythms 
of cortisol, melatonin (Blask et al., 2005), prolactin, temperature, circulating proteins and cell 
cycles. Cancer patients with advanced disease symptoms demonstrate higher levels of circadian 
disruption (Mormont & Levi, 1997), a condition associated with stress (Sephton & Spiegel, 
2003). Stress experiences are also linked to cancer. The adverse childhood experiences (ACE) 
study a large scale research project was conducted in the USA to assess the relationship 
between adverse early life experiences and health conditions in adulthood. This study found 
that there was a higher risk of developing cancer with exposure to four or more stress/trauma 
events (Dube et al., 2009).         
  Cancer is the main cause of illness in Australia and in 2012 it was anticipated that 
approximately120,000 Australians would receive a cancer diagnosis, with over 50% of this 
disease expected to be diagnosed in males with prostrate and bowel cancers. Breast cancer was 
expected to be the most commonly occurring cancer in females in 2012. The number of new 
cancer cases has risen significantly from 1991 (approximately 66,000) to 2009 (approximately 
114,000) and is reported as partly due to an increase in population and an aging population. In 
2010 approximately 43,000 Australians died from cancer; this statistic is exceeded only by 
cardiovascular disease. Five year survival rates for all cancers has increase by 19% from 1982-
1987 (47%) to 2006-2010 (66%), although this increase is not consistent across all cancers. 
Higher incidence and mortality rates of all cancers are experienced by Indigenous Australians 
and those with lower socioeconomic status; therefore higher incidence and mortality was 
associated with decreased levels of socioeconomic status (Australian Institute of Health and 
Welfare, 2013).                                                                                                                         
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Breast Cancer       
 Breast cancer is a complex heterogeneous disease and includes pathological features 
such as hormone-receptor profile and tumours that are categorised into distinct groups 
(Mavaddat, Antoniou, Easton, & Garcia-Closas, 2010). The breast is primarily an excretory 
gland that functions to produce milk as nourishment for a baby. The female breast consists of 
terminal duct lobular units that are grouped into larger units called lobes. These units consist of 
specialised interlobular connective tissue, interlobular collecting ducts and terminal ductules. 
The lobules are surrounded by dense connective tissue and fat. The female breasts may vary 
considerably in size during the life span; older postmenopausal women’s breast progressively 
become atrophic, and by age 80, the majority (80%) of the breast tissue consists of fat cells 
surrounded by thickened connective tissue. Breasts contain lymphatics that drain into the 
parasternal; and the majority (75%) into the axilla; the axillary location of metastases (cancer 
cells) in women who develop breast cancer. Some breast cancers express hormone receptors; 
blocking the oestrogen receptors on cancer cells may reduce tumour growth (Australian 
Government, Cancer Australia, 2012). Breast cancer is one of the most common forms of 
cancer that develops in women; it also occurs in men, however it is much rarer (1: 100 
carcinomas are diagnosed in men when compared with women). Breast cancer was selected as 
a comparison study as both scleroderma and breast cancer are disease that are more prevalent in 
women than men.        
 The age a woman is affected by breast cancer influences the type of breast disease 
experienced. Generally post pubertal girls and young women experience fibroadenomas, which 
are benign tumours of the breast. Fibrocystic breast disease occurs in middle aged women and 
breast cancer is more prevalent in older women. Approximately 50% of all breast masses are 
not cancerous; benign lesions, such as fibrocystic disease and fibroadenoma, account for half of 
breast masses that undergo biopsy, with the remaining 50% found to be malignant. Fibrocystic 
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change involves three features; fibrosis, cysts and epithelial proliferation. This disease involves 
ductual budding, crowding of ductals, and capillary projections called papillomatosis. Larger 
papillomas may appear and extend into the lumen of the larger ducts. Papillomatosis and 
atypical intraductal are premalignant changes that may occur in the breasts of some women. 
These atypical intraductal or lobular lesions may develop into invasive carcinoma over a 
number of years in some women; however, approximately 80% of women will not develop 
breast cancer (Australian Government, Cancer Australia, 2012).      
 Some breast cancers are non-invasive and are therefore confined to a specific area. This 
type of cancer includes ductal carcinoma in situ and is confined to the ducts of the breast. 
Lobular carcinoma in situ is also a non-invasive breast cancer that is confined to the lobules of 
the breast. Invasive breast cancers are another form that may spread to other areas. Early breast 
cancer is an invasive cancer that is contained in the breast and may or may not spread to lymph 
nodes in the breast or armpit. Some cancer cells may extend outside the breast and into the 
armpit area but cannot be detected. Locally advanced breast cancer is an invasive breast cancer 
that has spread to areas near the breast, such as the chest wall. Secondary breast cancer (also 
called metastatic or advanced breast cancer) is an invasive breast cancer that has spread from 
the breast to other parts of the body.      
 There are also rarer types of invasive breast cancer; Paget’s disease of the nipple is a 
rare form of invasive breast cancer that affects the nipple and the area around the nipple. 
Inflammatory breast cancer is also a rare form of invasive breast cancer that affects the blood 
vessels in the skin of the breast, causing the breast to become red and inflamed (Australian 
Government, Cancer Australia, 2012). As age is a factor in breast cancer diagnosis, age of 
breast cancer onset was also explored in this study to determine whether psychosocial stress 
was linked to an earlier onset of breast cancer. Differences between variables and age of onset 
of disease symptoms for breast cancer and scleroderma were also explored.                                
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Stages and Categories of Breast Cancer       
 There are a number of stages of breast cancer. Stage 0 is regarded as pre-invasive’ 
breast cancer that includes ductal carcinoma in situ and lobular carcinoma in situ; Stage I and 
Stage II, describe early breast cancer; Stage IIB and III are used to classify advanced breast 
cancer and Stage IV describes advanced breast cancer (locally advanced breast cancer or 
secondary breast cancer). Breast cancer is also divided into three categories. Breast cancer cells 
that are found in one to three lymph nodes in the armpit are classed as category one. Category 
two describes breast cancer cells in four to nine lymph nodes in the armpit, and lymph nodes  
that are enlarged, and/or attached to each other or to nearby tissue; or one or more lymph nodes 
under the breastbone. Breast cancer cells that are found in 10 or more lymph nodes in the 
armpit or one or more lymph nodes above or below the collarbone or breast cancer cells that are 
found in one or more lymph nodes under the breastbone and in one or more lymph nodes in the 
armpit describe the features of category three (Australian Government, Cancer Australia, 2012).     
 Incidence of Breast Cancer: Breast cancer accounted for approximately 27% of new 
cancers in women and except for non-melanoma skin cancer was the most common cancer in 
Australian women in 2009, with over 13,000 new cases reported in women and 110 in men 
during this period. The risk of developing breast cancer increases with age with the average age 
recorded in 2009 at approximately 61 years; with around 77% of women diagnosed with breast 
cancer in 2009 aged over 50 years, with a risk (for women) of developing breast cancer before 
the age of 85 years, at one in eight in Australia (Australian Institute of Health and Welfare, 
2013). In 2010, breast cancer accounted for 15% of cancer deaths in women and was the second 
highest cause of cancer-related deaths in women (2,840 women and 24 men).    
 The incidence of breast cancer is rising and it is predicted that by 2020 over 17,000 new 
cases will be diagnosed in Australian women; however five-year relative survival rates are also 
increasing from 72% (1982–1987) to 89.4% (2006–2010). Five-year relative survival rates for 
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breast cancer were higher relative to tumour size with greater survival rates for smaller tumours 
(98% 0–10 mm, 95% 11–15 mm, 93%16–19 mm, 88% 20–29 mm and 73% for women with 
tumours 30 mm or greater (AIHW, 2013). There are a number of genetic and non-genetic risk 
factors associated with the development of breast cancer, such as the role of oestrogens, and 
high family prevalence of breast cancer that tends to reflect a clustering in families. Non 
genetic factors include alcohol intake, body mass index, and physical activity; these aspects 
may be shared within families but are likely to contribute moderately to genetic familial risk 
(Mavaddat et al., 2010). Genetic factors were also identified in a study that involved 
genotyping of over 10,000 breast cancer participants and more than 9,000 controls from five 
countries; findings demonstrated a higher prevalence of the CHEK2 gene 1100delC amongst 
first-degree relatives diagnosed with breast cancer and a higher odds ratio of breast cancer 
occurring at younger ages (Eeles, Peto, & Stratton, 2004).      
 Therefore it is possible genetic factors may play a greater part in the development of 
breast cancer (than scleroderma) with stress perhaps impacting on genetic predispositions. 
Whereas for scleroderma a low prevalence rate of developing scleroderma within families was 
reported (with the absolute risk at less than 1%; Arnett et al., 2001). This Indicates genetic 
factors combined with other factors including those linked to psychosocial stress may have a 
greater influence on the development of scleroderma. The involvement of stress may be greater 
in scleroderma than breast cancer. Therefore the current study explored these two diseases and 
psychosocial variables to determine differences between internal and external stressors and 
onset and exacerbation of disease symptoms.                                                                                  
Breast Cancer and Psychosocial Stressors     
 A number of studies have identified a relationship between breast cancer and insecure 
attachment styles. A study by Tacon and colleagues (2001) demonstrated that individual’s with 
breast cancer reported significantly higher incidences of insecure histories and early loss and 
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significantly higher scores on avoidant attachment when compared to those without breast 
cancer (Tacon et al, 2001). Research also found that breast cancer patients who reported a 
fearful avoidant attachment style, attended fewer mammograms screenings than those breast 
cancer participants with other styles of attachment (Tuck & Consedine, 2015).    
  A number of studies have also reported associations between stress and trauma in 
individuals diagnosed with breast cancer. A study conducted into adverse childhood 
experiences (ACEs) found a possible relationship between multiple adverse childhood 
experiences reported by 62% of participants and cancer diagnosis which was reported by 10% 
of participants (Brown, Thacker & Cohen, 2013). While a similar study on childhood adversity 
found that emotional, physical, and sexual abuse were associated with breast cancer-related 
intrusive symptoms (Goldsmith et al., 2010). In a study by Palesh and colleagues (2007) 
approximately 42% of female participants reported experiencing one or more traumatic events. 
A comparison study was conducted between these women and female participants who reported 
no traumatic or stressful life event in relation to disease-free intervals. Results demonstrated 
that significantly longer disease-free intervals occurred amongst participants with no stress or 
trauma events, when compared to those who had experienced one or more stressful events, with 
those reporting one or more traumatic life events experiencing the shortest disease-free interval. 
Results indicated a link between stressful or traumatic experiences and more rapid breast cancer 
progression, and the possibility that stressful or trauma events may reduce the capacity of the 
individual’s immune system to resist tumour growth. However a study by Spiegel and 
colleagues found no relationship between metastatic breast cancer and stress experiences. 
Progression and irregularities in daytime cortisol levels in this study were found in two thirds of 
a sample of 104 female participants with metastatic breast cancer. Flatter daytime cortisol 
slopes in this sample predicted earlier mortality. However no significant relationship was found 
between daytime cortisol slope and social stress, or an elevated HPA response to stimuli 
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(Spiegel, Giese-Davis, Taylor, & Kraemer, 2006).        
 A comparison study by Abercrombie et al., (2004) also found that women with 
metastatic breast cancer had flatter cortisol slopes than women without this disease. Breast 
cancer participants with greater disease severity demonstrated higher cortisol levels, and flatter 
diurnal cortisol rhythms, however no relationship was found between cortisol slope and 
psychological factors. When compared with controls flatter rhythms were related to higher 
perceived stress, suggesting differences between women diagnosed with breast cancer and 
those without this disease with regard to stress related correlates and cortisol diurnal slope. 
Flatter cortisol levels were associated with a number of responses that include hyper-
responsiveness to stimulation resulting from either corticotrophin releasing factor (CRF) or 
acute stress, however in some studies these levels appear to be affected by factors unrelated to 
stress or psychological functioning in breast cancer individuals .        
 Research therefore suggests that stress and trauma can significantly impact on an 
individual’s immune system and may result in the development of disease. However the 
chemicals involved in the stress response in breast cancer may not always be related to 
psychosocial factors. There are a number of known genetic, gender and physiological risk 
factors associated with breast cancer, such as having a family history of breast cancer, being 
female, oestrogens and age of onset (Eeles et al., 2004; Mavaddat et al., 2010), as well as 
personal stress experiences (Palesh et al., 2007). As stress experiences are involved in the 
mechanisms associated with immune responses and autoimmune diseases, it is possible that 
different psychosocial variables as well as physiological factors may be associated with these 
two diseases. Therefore the examination of difference and similarities in variables that are 
related to stress and disease were explored in the current study in relation to scleroderma and 
breast cancer; to determine the degree psychosocial stress influences onset and exacerbation of 
the respective diseases. Also investigated were more positive ways of relating to self through 
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investigation of self-compassion and suppression of emotions; to determine whether difference 
occurred between illness groups for positive and negative interpersonal relating and the 
influence these experiences may have on disease symptoms and age of onset.    
 Suppression and Self Compassion: Previous research has investigated emotional 
suppression and self-compassion techniques in breast cancer patients (Iwamitsu et al., 2005; 
Przezdziceki et al., 2013). Iwamitsu and colleagues (2005) found that breast cancer patients 
who engaged in emotional suppression had elevated levels of anxiety, depression, anger and 
psychological distress, when compared to individuals without breast cancer. Research suggests 
that suppression of emotional experiences may result in distorted cognitions and are a risk for 
developing psychological conditions (Hayes et al., 1996) such as anxiety, depression (Gross & 
John, 2003; Iwamitsu et al., 2005), an insecure attachment style, (Mikulincer & Shaver, 2007) 
and physiological conditions such as immune dysfunction (Petrie et al., 1998; Schore, 1994) 
and pain (Burns et al., 2006; Thomas et al., 2006). Whereas research revealed that self-
compassion was found to be a protective factor for psychological distress in women 
experiencing body changes resulting from breast cancer treatment (Przezdziceki et al., 2013). 
These variables were further investigated in relation to breast cancer symptoms to determine 
whether differences occur between the two illness groups (breast cancer and scleroderma) in 
the management of their intra-personal relationship and the connection between these variables 
and disease onset and symptomology.                                                                         
Scleroderma and Breast Cancer Precipitatory Factors        
 Although genetic factors appear to be involved in the development of both scleroderma 
and breast cancer, external factors that invoke a stress response and impact on immune 
functioning may differ between individuals diagnosed with these two diseases. There appears to 
be a link between genetic factors (that influence inflammation, collagen, vascular and immune 
functioning) involved in the development of scleroderma and stress chemicals (that also involve 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    215  
  
similar physiological responses; e.g. Crittenden & Claussen, 2000; Every & Lating, 2002; 
Miller, 2005; Schore, 1994; Van der Kolk & Greenberg, 1987). Whereas for breast cancer the 
link between genetic factors and psychosocial stress appears to be less apparent, with the stress 
chemical cortisol (a major contributor to the development of breast cancer) found in a number 
of studies not to be related to psychological factors (e.g., Abercrombie et al., 2004). Research 
also suggests that differences occur in the stress response for individuals with scleroderma and 
breast cancer (in separate studies) when compared to individuals without these diseases 
(Abercrombie et al., 2004; Freedman & Ianni, 1983). To investigate the hypotheses differences 
between the scleroderma and breast cancer groups were explored in relation to psychosocial 
aspects and levels of pain experienced by both groups. Differences between groups were also 
explored in relation to psychosocial aspects with the postulation that the breast cancer group 
would have lower negative psychosocial experiences than the scleroderma group (greater 
predisposition to the disease, rather than stress related). That is whether the reported childhood 
experiences and the subsequent negative ways of relating to self and others were more likely to 
have influenced the experience of scleroderma when compared with the experience of 
individuals diagnosed with breast cancer. The literature suggests individuals with breast cancer 
experience depression and anxiety at lower rates than individuals with scleroderma (Thombs et 
al., 2007; Beretta et al., 2006; Angelopoulos et al., 2001; Roca et al., 1996; Legendre et al, 
2005); although, these studies did not involve direct comparisons. For example Khan and 
colleagues found that 22% of participants experienced depression and 19% reported anxiety 
and stress associated with breast cancer (Khan, Amatya,  Pallant, & Rajapaksa, 2012). Research 
by Vardanima, Omidvari and Montazer (2010), found that 82% of participants who had 
undergone a mastectomy experienced a decrease in anxiety and depression symptoms over 
time, however, 38% of participants continued to experience severe anxiety and 22% reported 
severe levels of depression, at 18 month follow-up. Hill and colleagues found that 40% of 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    216  
  
breast cancer participants reporting anxiety, had a previous episode of anxiety prior to a 
diagnosis of breast cancer and 66% of those reporting depression had experienced a 
reoccurrence of depression after receiving a diagnosis of breast cancer. This research suggests 
that a significant number of individuals diagnosed with breast cancer have experienced 
depression and/or anxiety (Hill et al., 2011); however at lower rates than individuals with 
scleroderma where studies reported between 33% and 65% of individuals with depression (e.g., 
Beretta et al., 2006).       
 The third study therefore investigated whether individuals with scleroderma have 
greater clinical scores for depression and anxiety than breast cancer and community participants 
and whether these experiences can be predicted by negative rearing experiences and emotion 
regulation strategies associated with the threat mentality. In addition this study explored 
whether individuals who engaged in emotion regulation strategies high in self-compassion 
experienced more favourable psychological and physiological health outcomes. These aspects 
are outlined in the following hypotheses.                                                                                
Hypotheses: Study 3(a)        
 The hypotheses were divided into three headings. Hypothesis 1: Comparison study 
between scleroderma and breast cancer groups for psychosocial variables that predict mental 
health. Hypotheses 2-3: Comparison study between scleroderma symptoms and breast cancer 
symptoms of pain and psychosocial and mental health variables. Breast cancer symptoms and 
psychosocial and mental health variables. Hypothesis 4: Age diagnosed with scleroderma and 
age diagnosed with breast cancer and psychosocial variables.                                                      
Hypothesis One: Comparison Study: Scleroderma/Breast Cancer-Mental Health    
 1(a): Individuals diagnosed with Scleroderma and Breast Cancer reporting elevated 
levels of Depression, Anxiety, Stress and Disease Symptoms would experience lower Early 
Memories of Warmth and Safety, Self-Compassion, an Insecure Attachment Style 
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(Dismissive/Fearful), greater Suppression, Hyper-arousal and Disease symptoms.    
 1(b): Furthermore these experiences would differ between illness groups.            
Hypotheses 2-3: Scleroderma and Breast Cancer – Psychosocial/Mental Health/Physical  
Hypothesis Two: Scleroderma & Breast Cancer - Pain    
 2(a): Lower levels of Self-Compassion, Emotion Regulation, EMWS, and Insecure 
Attachment and higher levels of Hyper-arousal would predict greater levels of pain in both 
illness (Scleroderma/Breast Cancer) groups.     
 2(b): Furthermore individuals with Scleroderma and Breast Cancer would experience 
differences in psychosocial variables that predict Pain.                                                                  
Hypothesis Three: Breast Cancer - Biopsychosocial & Mental Health      
 3(a): Lower levels of Self-Compassion, Emotion Regulation, EMWS, and an Insecure 
Attachment Style and higher levels of Hyper-arousal would predict higher levels of Fatigue and 
Nausea in the Breast Cancer group.         
 3(b): Furthermore higher levels of Depression, Anxiety and Stress would predict greater 
levels of Nausea and Fatigue in individuals diagnosed with Breast Cancer.             
Hypothesis Four: Age Diagnosed with Illness – Psychosocial Variables        
 4(a): Differences would occur between the predictor variables for Age diagnosed with 
Breast Cancer and Age diagnosed with Scleroderma.        
 4(b): Furthermore lower EMWS and Self-compassion and higher levels of insecure 
attachment, Hyper-arousal and Suppression would predict being diagnosed with an illness 
(Scleroderma or Breast Cancer) at a younger age; conversely lower Hyper-arousal, insecure 
attachment and Suppression and higher EMWS and Self-compassion would predict illness 
diagnosis at an older age.               
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                                                       Method                                                                                       
Procedure                                                                                               
  Several breast cancer organisations and support groups reaching an international 
population were contacted to determine interest in promoting this study to members 
diagnosed with breast cancer. A number of organisations reported some concern about 
exploring early rearing experiences of members diagnosed with breast cancer, due to the fear 
members would blame themselves or their family for their disease. This concern was raised 
by a number of breast cancer organisations, as the gate keepers of these organisations felt it 
was in the best interest of their members to restrict information about the study. This situation 
reduced the opportunity to collect a larger sample for the study. Organisations that agreed to 
participate in this study were the Breast Cancer Care Organisation from Western Australia 
and the West End Advanced Breast Cancer Group in Queensland. These non-profit 
organisations provide support and education for their members. Approval was received from 
these organisation’s committees once the survey and explanatory letter had been sighted and 
discussed.                     
  Information explaining the purpose of the study was placed on the Western Australian  
Breast Cancer Care’s websites notice board and included a link to the online 
survey posted on the Bond University research website.          
  Information about the study was also displayed on a poster on the notice board at the 
Advanced Breast Cancer Support Group in Brisbane informing potential participants about 
the study along with information about the web address to access the survey. A notice was 
also posted on the Research Participation Notice board of the Psychology Department within 
the Humanities and Social Science Faculty, informing potential participants about the  
research.                       
  A written explanatory letter containing information about the purpose, procedure, 
where questions/complaints could be directed, risks and benefits of the research project and 
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anonymity of participants was attached as a cover page to the questionnaire for participants to 
view prior to completing the survey. Completion of the survey required approximately 30-40 
minutes of the participant’s time. This project was approved by the Bond University Human  
Research Ethics Committee.                                                                                                                   
Participants                     
  Males and female adults aged 18 years and over who have been diagnosed with breast 
cancer, were invited to participate in this research project. Thirty-one individuals diagnosed 
with breast cancer from breast cancer organisations and staff and students from Bond  
University completed the online survey.                                                                                
Measures                                                                                      
  The measures were the same as those included in studies one and two with the 
exclusion of the Scleroderma Health Assessment Questionnaire (except for the pain scale: 
adapted for breast cancer) and the inclusion of questions related to nausea, fatigue and breast 
cancer related information such as category, stage and type of breast cancer (examples 
include, ductal carcinoma in situ, early breast cancer, and inflammatory breast cancer).       
                                               Results                                                                                    
Study Three: Overview of Analyses               
 Analysis was performed using SPSS version 20, Cronbach’s alpha revealed the 
coefficients for the variables, Depression, EMWS, Dismissive and Fearful Attachment were 
above .90, the variables, Stress, Self- Kindness and Hyper-arousal, were above .80; Self-
Compassion Mindfulness, and Over-identification, were above .79, Suppression was above 
.75 and Anxiety was above .70. Results demonstrated the variables to be reliable, with good 
to satisfactory internal consistency.           
 Descriptive statistics for each of the continuous variables was conducted to determine 
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means, standard deviations and sample size. Frequencies for demographic information such 
as age and education and health information, such as age diagnosed with breast cancer and  
type of breast cancer were also investigated.           
  Age: Frequencies for current age were reported at between 37 and 76 years with a 
mean age of 54; for age diagnosed with breast cancer, the age range for participants was  
between 36 and 69 years, mean age was 50.              
  Participants: Frequencies for participants revealed a total of 31 subjects, 28 females  
and one male with two participants failing to complete this information.       
 Education: One participant reported gaining a primary school education, seven 
participants, reported achieving a secondary education, 16 participants reported attaining a 
tertiary education and five participants indicated post graduate qualifications, two participants  
did not supply this information.                
  Health: Frequencies for breast cancer related health information, revealed four 
participants were diagnosed with Ductal carcinoma in situ (DCIS); 17 reported a diagnosis of 
early breast cancer (EBC), one participant reported inflammatory breast cancer (IBC), nine 
individuals did not complete this information. A Comparison study between the different 
types of breast cancer and psychosocial variables was part of the initial study; however, due 
to insufficient participant responding to health questions, analysis was not conducted.  
 Missing data was evident, the pattern appeared random for all completed scales. A 
large number of participants had completed demographic, health and breast cancer 
information. However approximately 30% did not complete the psychological scales. Thirty 
one individuals participated in the study; with the exclusion of cases to meet assumptions and 
hypothesis criteria a total of 22 participants remained. Low participation rates are evident in 
cancer studies. Research suggests that the number of breast cancer participants prepared to 
engage in research studies is between 1.2% and 11% of available participants (Habersack & 
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Luschin, 2013). As similar studies (e.g., Habersack & Luschin, 2013; that compared 12 breast 
cancer participants with 10 non-breast cancer participants on psychosocial variables) have 
had similar difficulties with gaining numbers we proceeded with the study.                       
              Results: Hypotheses                                                                                        
Hypothesis One: Scleroderma and Breast Cancer - Mental Health                                     
Scleroderma/Breast Cancer – Depression, Anxiety and Stress         
  The Scleroderma (total sample) and Breast Cancer data files were merged. Data was 
  
screened for suitability to enter into multiple regression analysis. The assumptions for 
normality were met for Early Memories of Warmth and Safeness (EMWS) Suppression and  
Reappraisal subscales of the ERQ, Hyper-arousal, the Self-compassion scale and subscales 
(Self-kindness, Mindfulness, Common humanity, Self- judgment and Isolation) were 
normally distributed. The Self-compassion subscale Over-identification, Fear subscale of the 
RQ, Pain scale of the SHAQ, Anxiety, Depression and Stress, subscales of the DASS21 were 
positively skewed, examination of plots revealed no univariate or multivariate outliers. 
Square-root, logarithm and inverse transformations were conducted according to the shape of 
the distribution for each of the variables reducing the skew to within acceptable range.    
 Scleroderma/Breast Cancer – Depression: A split file conducted to address 
hypothesis 1(a/b) for the Breast Cancer and Scleroderma groups produced warnings (that not 
all data could be computed) when multiple regression analysis was conducted, (possibly due 
to the number of variables that were not significant for both groups and the small sample size  
in relation to the number of variables) therefore the data was divided into the two respective 
groups (using only those variables significant to each of the groups) and analysis conducted 
independently.           
 Scleroderma: Results for the Scleroderma group revealed meaningful relationships 
between the dependent variable Depression and psychosocial variables, EMWS (r = -.37),         
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p = .000 Fearful attachment (r = .36), p = .001, Dismissive attachment (r = .28), p = .000, 
Suppression (r = .26), p = .019, and Self-compassion (r = -.37), p = .001. These variables 
were entered into multiple regression analysis. Results for the Scleroderma group 
demonstrated the variables significantly accounted for 54.0% (Adjusted R ² = 24.2%) of the 
variance, F (5, 72) = 5.92, p = .000, in Depression. The regression coefficients demonstrated 
that EMWS (β = - .24, p = .035, sr ² = .05%) and Self-compassion (β = - .24, p = .030, sr ²  
= .05%; power was calculated at 1.0) were significant unique predictors of Depression  
experienced by individuals diagnosed with Scleroderma.           
  Breast Cancer: Pearson’s bivariate correlations revealed meaningful relationships for 
the Breast Cancer group between the dependent variable Depression and psychosocial 
variables, Dismissive attachment (r = .56), p = .007 and Self-compassion (r = -.51), p = .014. 
These significant variables were entered into a multiple regression analysis. Results for the  
Breast cancer group demonstrated the variables significantly accounted for 66.7% (Adjusted 
R ² = 38.6%) of the variance, F(2, 19) = 7.04, p = .004, in Depression. The regression 
coefficients demonstrated that Self-compassion (β = -.39, p = .040, sr ² = .14%) and an 
insecure Dismissive attachment style (β = .47, p = .015, sr ² = .21%; power was calculated at 
.99) significantly predicted Depression experienced by individuals diagnosed with Breast  
Cancer.                    
 Conclusion - Results Hypotheses 1(a/b) - Depression: Results for hypothesis 1(a) indicated 
that lower levels of Self-compassion and a greater tendency to engage in a Dismissive style of 
relating predicted Depression in individuals diagnosed with Breast Cancer; whereas, lower 
early life experiences of warmth and safety and lower Self-compassion predicted Depression 
in individuals diagnosed with Scleroderma. Results demonstrated similarities in the predictor 
variable Self-compassion for both illness groups; however, differences in predictor variables 
were also found for the Scleroderma and Breast Cancer groups. EMWS predicted Depression 
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in the Scleroderma group; whereas Dismissive attachment predicted Depression in the Breast 
Cancer group. Results indicated some differences between illness groups for predictor 
variables for Depression and therefore provided partial support for hypothesis 1(b).       
 Scleroderma/Breast Cancer – Hypothesis 1(a/b) for Anxiety: A split file was conducted to 
address hypotheses 1(a/b): with regard to psychosocial variables that predict anxiety; and 
difference between predictor variables for psychosocial and physiological symptoms for 
Breast Cancer and Scleroderma groups for Anxiety.                                                                      
  Scleroderma: The results for the Scleroderma sample demonstrated the variables 
significantly accounted for 66.6% (Adjusted R ² = 41.3%) of the variance, F(4, 71) = 14.18,  
p = .000, in Anxiety in individuals diagnosed with Scleroderma. The regression coefficients 
demonstrated that Pain (β = -.26, p = .007, sr ² = .06%), EMWS (β = .27, p = .008, sr ²  
= .06% Suppression (β = .34, p = .000, sr ² = .11% and Hyper-arousal (β = .28, p = .004, sr ² 
= .07%; power was calculated at 1.0) were significant unique predictors of Anxiety in 
individuals diagnosed with Scleroderma. Indicating that early life experiences (limited 
EMWS) and high utilization of Suppression (an inadequate emotion regulation strategy) and 
physiological symptoms of Hyper-arousal and Pain were involved in heightened levels of  
Anxiety in individuals diagnosed with Scleroderma; partially supporting hypothesis 1(a).   
  Breast Cancer: When comparing the results (split file) for predictor variables for  
Anxiety in the Breast Cancer group; the variables accounted for 61.5% (Adjusted R ² =  
23.2%) of the variance, F(4, 17) = 2.59, p = .074, in Anxiety in individuals diagnosed with 
Breast cancer. Although the model was not significant, the regression coefficients 
demonstrated that Suppression (β = .53, p = .028, sr ² = .21%; power was calculated at .95) 
was a significant unique predictor of Anxiety experienced by individuals diagnosed with  
Breast Cancer. To determine whether the model for Anxiety was significant, the Breast 
Cancer sample was analysed independently of the Scleroderma sample. Significant 
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correlation coefficients for the Breast Cancer sample revealed meaningful relationships 
between Anxiety and Pain (r = .43), p = .046 and Suppression (r = .52), p = .012. These 
variables were entered into a multiple regression analysis to determine whether the model 
with the significant variables unique to the Breast Cancer group, made a greater significant 
contribution than the split file (for the total illness sample; Scleroderma and Breast Cancer) 
analysis for the Breast Cancer group. The results for the Breast Cancer sample demonstrated 
the variables significantly accounted for 55.7% (Adjusted R ² = 23.8%) of the variance, F(2, 
19) = 4.28, p = .029, in Anxiety in individuals diagnosed with Breast cancer. The regression 
coefficients demonstrated that Suppression (β = .47, p = .037, sr ² = .18%; power was 
calculated at .99) was the only significant variable in the Breast Cancer group; partially 
supporting hypothesis 1(a).         
Conclusion - Results Hypotheses 1(a/b): Anxiety       
 Results demonstrated that both the Scleroderma and Breast Cancer models were 
significant and that Suppression was the only predictor variable for Anxiety for both groups; 
and the only variable that predicted Anxiety for the Breast Cancer group. Whereas early life 
experiences low in warmth and safety, greater use of Suppression and elevated levels of 
Hyper-arousal and Pain were all involved in heightened levels of Anxiety in individuals 
diagnosed with Scleroderma, partially supporting hypothesis 1(a). Therefore differences and 
similarities exist between the two groups (Scleroderma and Breast Cancer) as to what predicts 
Anxiety, providing partial support for hypotheses 1(b).                                 
 Scleroderma/Breast Cancer – Hypothesis 1(a/b) for Stress: A split file for the illness 
groups (Breast Cancer/Scleroderma) produced warnings when multiple regression analysis 
was conducted, therefore the data was divided into the two respective groups and analysis 
conducted independently.                 
 Scleroderma: Results for the Scleroderma group revealed meaningful relationships 
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between the dependent variable Stress and psychosocial variables, EMWS (r = - .35), p = 
.001, Hyper-arousal (r = .50), p = .000, Fearful attachment (r = .23), p = .033, and Self-
Compassion (r = -.44), p = .000. Significant variables were entered into multiple regression 
analysis. Results for the Scleroderma group demonstrated the variables significantly 
accounted for 57.7% (Adjusted R ² = 29.6%) of the variance, F (4, 71) = 8.87, p = .000, in 
Stress. The regression coefficients demonstrated that Hyper-arousal (β = .35, p = .002, sr ² = 
.09%) and Self-compassion (β = -.24, p = .036, sr ² = -.04%; power was calculated at .99) 
significantly predicted Stress experienced by individuals diagnosed with Scleroderma. 
 Results demonstrate that elevated levels of Hyper-arousal and low experiences of Self-
compassion predicted higher levels of Stress in individuals diagnosed with Scleroderma 
partially supporting hypothesis 1(a).         
 Breast Cancer: Pearson’s bivariate correlations revealed meaningful relationships for 
the Breast Cancer group between the dependent variable Stress and psychosocial variables. 
Correlation coefficients demonstrated associations between the dependant variable, Stress and 
Dismissive attachment (r = .45), p = .034, Self-compassion (r = - .56), p = .007 and Hyper-
arousal (r = .61), p = .003. These variables were entered into a multiple regression analysis to 
determine the hypothesis 1(a). The results for the Breast Cancer sample demonstrated the 
variables significantly accounted for 71.7% (Adjusted R ² = 43.4%) of the variance, F(3, 18) 
= 6.36, p = .004, (power was calculated at .99) in Stress in individuals with Breast Cancer. 
However the regression coefficients demonstrated that no variable was a significant unique 
predictor of Stress experienced by individuals diagnosed with Breast Cancer. Therefore this 
part of hypothesis 1(a) was not supported.                                                                            
Conclusion - Results Hypotheses 1(a/b): Stress        
 Results indicated that a number of variables were significantly associated with Stress 
in both illness groups, however only Hyper-arousal and Self-compassion predicted Stress in 
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the Scleroderma group providing partial support for hypothesis 1(a). No variable predicted 
Stress in the Breast Cancer group. Results demonstrated that differences occurred between the 
two groups for variables that predicted Stress; partially supporting hypothesis 1(b).                
Results for Different Predictor Variables: Depression, Anxiety and Stress    
 Results for predictor variables for mental health partially supported hypothesis 1(b) by 
demonstrating that differences occurred between the groups (although some variables were 
similar predictors of Depression and Anxiety). Lower Self-compassion and a greater 
Dismissive attachment style predicted Depression in Breast Cancer participants, whereas 
lower Self-compassion and limited EMWS predicted Depression in individuals diagnosed 
with Scleroderma. Results for Anxiety also demonstrated similarities and difference between 
groups for predictor variables with Suppression significant for both groups and the only 
variable that predicted Anxiety for the Breast Cancer group. Whereas scleroderma 
participants experienced a number of other psychosocial variables including suppression that 
were related to anxiety (Lower EMWS, higher levels of emotional suppression and elevated 
pain and hyper-arousal), Differences occurred between groups for Stress; with Hyper-arousal 
and Self-compassion predicting Stress in the Scleroderma group and no variable predicting 
Stress in the Breast Cancer group. Results demonstrated that some similarities were evident 
for Depression (lower Self-compassion) and Anxiety (higher Suppression); however, 
differences did occur between the two groups (Scleroderma/Breast Cancer) for variables that 
predicted Mental Health (Depression, Anxiety and Stress); thereby findings provide partial 
support for hypothesis 1(b).                                                                                                                           
Conclusion of Results: Hypotheses One              
 Some similarities were evident for predictor variables for Depression (lower Self-
compassion) and Anxiety (higher Suppression) for Scleroderma/Breast Cancer groups; 
however, differences also occurred between the two groups for variables that predicted 
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Mental Health (Depression, Anxiety). Difference between variables that predicted Depression 
were EMWS (Scleroderma) and Dismissive attachment (Breast Cancer) and for Anxiety, 
EMWS, Hyper-arousal and Pain (Scleroderma), no variable was significant for Breast 
Cancer. For Stress, Hyper-arousal and Self-Compassion were significant for Scleroderma; 
however, no variable was significant for Stress and Breast Cancer. Results demonstrated 
differences between groups for variables that predict Depression and Anxiety; partially 
supporting hypothesis one.                                                                                                                          
Results for Hypothesis Two: Difference in Predictor Variables for Pain                                           
Pain and Psychosocial Variables: Hypotheses: 2(a) Lower levels of Self-Compassion, 
Emotion Regulation, EMWS, and an Insecure Attachment Style and higher levels of Hyper-
arousal would predict higher levels of Pain in both illness groups. 2(b): Furthermore 
individuals with Scleroderma and Breast Cancer (split file) would experience differences in 
psychosocial variables that predict Pain.              
 Pearson’s bivariate correlations were conducted after the assumptions for multiple 
regression were met; correlation coefficients demonstrated meaningful relationships between 
the dependent variable, Pain and psychosocial variables, EMWS, (r = -.24), p = .009, and 
Dismissive attachment (r = .23), p = .018. Multiple regression analysis was conducted to 
determine the relationship and unique contribution of the predictor variables with the 
dependent variable Pain. The results for the total sample demonstrated the variables 
significantly accounted for 3.2% (Adjusted R ² = 0.8%) of the variance, F(2, 104) = 5.72, = 
.004, in Pain associated with disease symptoms.       
 The regression coefficients demonstrated that Dismissive attachment (β = .20,                  
p = .041, sr ² = .04%, and EMWS (β = -.22, p = .021, sr ² = -.02%; power was calculated at 
.44; Soper, 2013) were significant unique predictors of Pain experienced by individuals 
diagnosed with both Breast Cancer and Scleroderma (illness group). Therefore early life 
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experiences and insecure attachment predicted elevated pain in the total illness group; 
partially supporting the second hypothesis.         
 Scleroderma: A split file was conducted for Pain and the total illness groups, to 
explore the Scleroderma and Breast Cancer groups and psychosocial variables EMWS and 
Dismissive attachment to determine hypothesis 2(b). Multiple regression analysis 
demonstrated the variables significantly accounted for 41.0% (Adjusted R ² = 14.8%) of the 
variance, F (2, 82) = 8.30, p = .001, in Pain associated with disease symptoms. The regression 
coefficients demonstrated that EMWS (β = -.29, p = .006, sr ² = -.08%) and a Dismissive 
attachment style (β = .24, p = .021, sr ² = .06%; (power was calculated at .99) significantly 
predicted Pain experienced by individuals diagnosed with Scleroderma.      
 Breast Cancer: Multiple regression analysis for Breast Cancer participants 
demonstrated the variables significantly accounted for 3.2% (Adjusted R ² = -10.4%) of the 
variance, F(2, 19) = 0.10, p = .990, in Pain associated with disease symptoms. The regression 
coefficients demonstrated that neither EMWS (β = -.004, p = .985, sr ² = -.00%) nor 
Dismissive attachment (β = .03, p = .891, sr ² = .00%; (power was calculated at .09) were 
significant for Pain for Breast Cancer participants.                                                                
Conclusion - Hypothesis Two                 
 Results demonstrated that the total illness model was weaker than the Scleroderma 
model. The independent variables (EMWS and Dismissive attachment) for the illness model 
demonstrated a lower contribution to Pain than the Scleroderma model, indicating a 
difference between groups for predictor variables for Pain. Results therefore partially 
supported the second hypothesis in that early life experiences low in Warmth and Safety and 
an insecure Dismissive attachment style predicted greater experiences of Pain related to 
disease symptoms in Scleroderma participants. These factors (EMWS and Dismissive 
attachment); however, did not predict Pain for individuals diagnosed with Breast Cancer. 
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Therefore differences occurred between groups for what predicted pain in the Scleroderma 
and Breast Cancer groups and provide partial support for hypothesis two.                            
Hypothesis Three: Breast Cancer Symptoms and Psychosocial/Mental Health   
Hypothesis 3(a) - Psychosocial: Pearson’s bivariate correlations were conducted after the 
assumptions for multiple regression were met to address hypothesis three: Lower levels of 
Self-compassion, Emotion Regulation, EMWS, and an Insecure Attachment style and higher 
levels of Hyper-arousal would predict higher levels of Nausea and Fatigue in Breast Cancer 
participants.                      
  Nausea: Correlation coefficients revealed meaningful relationships between the 
dependent variable Nausea and psychosocial variables Dismissive attachment (r = .46),               
p = .030, and Fearful attachment (r = .46), p = .031; these variables were entered into multiple 
regression analysis. Results for the Breast Cancer  group demonstrated the variables 
significantly accounted for 53.5% (Adjusted R ² = 21.1%) of the variance, F(2, 19) = 3.81,            
p = .041, (power was calculated at .97) in Nausea related to Breast Cancer. Although the 
model was significant, the regression coefficients demonstrated that neither variable was a 
significant unique predictor of Nausea experienced by individuals diagnosed with Breast 
Cancer.                      
 Fatigue: Pearson’s bivariate correlations also revealed meaningful relationships 
between the dependent variable Fatigue and psychosocial variables, Hyper arousal (r = .53),  
p = .013, and Fearful attachment (r = .48), p = .029; these variables were entered into a 
multiple regression analysis. Results for the Breast Cancer group demonstrated the variables 
significantly accounted for 62.6% (Adjusted R ² = 32.4%) of the variance, F(2, 18) = 5.80,        
p = .011, in Fatigue associated with Breast cancer. The regression coefficients demonstrated 
that Hyper-arousal (β = .14, p = .040, sr ² = .17%; power was calculated at .99) was a 
significant unique predictor of Fatigue experienced by individuals diagnosed with Breast 
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cancer.                                                                                                                   
Conclusion: Hypothesis 3(a): Psychosocial             
 Results demonstrated that the disease variables (Nausea/Fatigue) were significantly 
related to an insecure attachment style (Fearful or Dismissive); however the only variable that 
significantly predicted disease related symptoms (Fatigue) was hyper-arousal. Findings 
demonstrated partial support for hypothesis 3(a) in that individuals reporting elevated levels 
of Fatigue experience higher levels of hyper-arousal. A comparison for differences between 
groups for psychosocial variables that predicted disease variables demonstrated that a number 
of disease variables were related to scleroderma symptoms; however this was not so for  
breast cancer. The results may be due to the small sample size and the inability to complete 
analysis on a number of disease related variables such as specific types of breast cancer 
experienced. Future research that involves a greater sample size may provide further insight 
into whether there is a relationship between types of breast cancer and the psychosocial 
variables investigated in the current study. This research would then demonstrate whether 
differences occur between disease symptoms and the relationship with psychosocial variables 
and may inform biopsychosocial treatment for each individual disease.                               
Results - Hypothesis 3(b): Breast Cancer Symptoms and Mental Health   
 Results for hypothesis 3(b): that higher levels of Depression, Anxiety and Stress 
would predict higher levels of Nausea and Fatigue in Breast Cancer participants demonstrated 
significant results for Depression.               
 Depression: Bivariate correlations revealed meaningful relationships between the 
dependent variable Depression and disease symptoms Nausea, (r = .44), p = .043, and 
Fatigue, (r =.62), p = .003. These variables were entered into a multiple regression analysis to 
determine hypothesis 5(b). Results for the Breast Cancer sample demonstrated the variables 
significantly accounted for 61.6% (Adjusted R ² = 31.0%) of the variance, F(2, 18) = 5.50,        
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p = .014, in Depression in individuals diagnosed with Breast Cancer. The regression 
coefficients demonstrated that Fatigue (β = .61, p = .033, sr ² = .18%; power was calculated at 
.99) was the only disease symptom that was a significant unique predictor of Depression 
experienced by individuals diagnosed with Breast Cancer; indicating that elevated levels of 
Fatigue predicted higher levels of Depression in individuals with Breast Cancer. No variables 
were significantly related to Anxiety.                
 Stress: Correlation coefficients also revealed meaningful relationships between the 
dependent variable Stress and disease symptoms Nausea, (r = .60), p = .003, and Fatigue,            
(r =.58), p = .006, for the Breast Cancer sample. These variables were entered into multiple 
regression analysis to determine the hypothesis. Results for the Breast Cancer sample 
demonstrated the variables significantly accounted for 63.7% (Adjusted R ² = 34.0%) of the 
variance, F(2, 18) = 6.14, p = .009, in Stress for individuals diagnosed with Breast Cancer. 
The regression coefficients demonstrated that neither Fatigue nor Nausea significantly 
predicted Stress in individuals diagnosed with Breast Cancer. Results demonstrated that 
fatigue was the only variable to predict mental health symptoms of depression in Breast 
Cancer participants.                                                                                                               
Conclusion- Hypothesis Three                
  Results demonstrated that fatigue was the only significant variable for Breast Cancer 
participants. Psychosocial variable Hyper-arousal and the Mental Health variable Depression 
significantly predicted Fatigue in individuals diagnosed with Breast Cancer. Therefore 
elevated levels of Hyper-arousal and greater experiences of Depression created heightened 
Fatigue experiences for Breast Cancer participants. Findings that partially supported the third 
hypotheses.                                                                                                                         
Conclusion Summary - Hypotheses 2-3: Comparison: Scleroderma/Breast Cancer   
 Results partially supported the second and third hypotheses in that differences 
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occurred between illness groups for psychosocial variables that predicted Pain; for 
Scleroderma, EMWS and Dismissive attachment predicted pain and for Breast Cancer, no 
variable predicted Pain related to disease symptoms. Results for Breast Cancer related 
symptoms other than Pain, demonstrated that psychosocial and mental health variables 
predicted fatigue (Hyper-arousal and Depression). Findings demonstrated that psychosocial 
and mental health variables predicted breast cancer related symptom of fatigue and that 
differences occurred between groups for psychosocial variables that predicted pain.      
Results – Hypothesis Four: Age Diagnosed with Illness (Scleroderma/Breast Cancer) 
 Illness group: Pearson bivariate correlations were conducted to determine hypothesis 
4(a): that more negative psychosocial experiences would predict an earlier onset of illness. 
Results revealed meaningful relationships between the dependent variable, Age diagnosed 
with illness (Breast Cancer or Scleroderma) and Self-compassion (r = .22), p = .029, Stress  (r 
= -.25), p = .029,  and Hyper-arousal (r = .30), p = .003. These variables were entered into a 
multiple regression analysis to determine the fourth hypothesis. The results for the total 
illness group demonstrated the variables significantly accounted for 32.7% (Adjusted R ² = 
8.0%) of the variance, F(3, 91) = 3.62, p = .016, (power was calculated at .98) in Age 
diagnosed with an illness. The regression coefficients demonstrated that that no variable 
significantly predicted Age diagnosed with an illness (scleroderma or breast cancer).    
 A split file was conducted to determine hypothesis 4(b) differences between the illness 
groups for Age diagnosed with either Scleroderma or Breast Cancer and psychosocial 
variables. Multiple regression analysis was conducted to determine the relationship and 
unique contribution of predictor variables with dependent variables.       
 Scleroderma: The results for the total Scleroderma group (diffuse/limited/other forms) 
demonstrated the variables significantly accounted for 35.2 (Adjusted R ² = 8.6%) of the 
variance, F (3, 70) = 3.29, p = .025, in Age diagnosed with scleroderma. The regression 
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coefficients demonstrated that Hyper-arousal (β = - .31, p = .023, sr ² = .10%; power was 
calculated at .99) was a significant unique predictor of Age diagnosed with scleroderma.   
 Breast Cancer: The results for the Breast Cancer sample demonstrated the variables 
significantly accounted for 67.4 (Adjusted R ² = 35.8%) of the variance, F (3, 17) = 4.71,          
p = .014, in Age diagnosed with Breast Cancer. The regression coefficients demonstrated that 
Self-compassion (β = .61, p = .013, sr ² = .25%; power was calculated at .99) accounted for a 
large percentage of the variance (25%) and was a significant unique predictor of Age 
diagnosed with breast cancer.                                                                                 
Conclusion- Hypothesis Four                
 Results supported hypothesis four by demonstrating differences in predictor variables 
for Age diagnosed with scleroderma and Age diagnosed with breast cancer; with higher levels 
of Self-compassion predicting a diagnosis of Breast Cancer at an older Age (conversely lower 
Self-compassion predicted a diagnosis of Breast Cancer at a younger Age). Whereas higher 
levels of Hyper-arousal predicted a diagnosis of scleroderma at a younger Age (conversely 
lower Hyper-arousal predicted a diagnosis of Scleroderma at an older Age). Demonstrating 
that levels of hyper-arousal for Scleroderma participants and levels of Self-compassion for 
Breast Cancer participants are involved in the earlier or later development of the respective 
diseases. These results partially supported the fourth hypothesis.                                   
Predictor Variables - Self-Compassion & Hyper-arousal         
 Predictor variables for Age diagnosed with Scleroderma (Hyper-arousal) and Age 
diagnosed with Breast Cancer (Self-compassion), although not part of the original hypotheses 
were explored to determine whether early life experiences low in warmth and safety also 
contributed to levels of arousal (as well as levels of self-compassion and age diagnosed with 
the respective diseases) and whether these experiences differed between groups.    
 Scleroderma- Hyper-arousal: Pearson’s bivariate correlations demonstrated  
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significant relationships between Hyper-arousal and Self-compassion (r = - .43, p = .000), 
Age diagnosed (r = .35, p = .002) and EMWS (r = - .31, p = .006). Multiple regression 
analysis for the Scleroderma group demonstrated the variables significantly accounted for  
54.9 (Adjusted R ² = 27.1%) of the variance, F (3, 70) = 10.04, p = .000, in Hyper-arousal.  
The regression coefficients demonstrated that Self-compassion (β = -.30, p = .007, sr²  
= .09%), Age diagnosed with scleroderma (β = -.30, p = .004, sr² = .09%) and EMWS (β =  
-.22, p = .046, sr² = .05%; power was calculated at .99) significantly predicted Hyper-arousal 
in individuals diagnosed with Scleroderma.                                                                             
  Breast Cancer- Self-compassion: Pearson’s bivariate correlations demonstrated 
significant relationships between Self-compassion and Hyper-arousal (r = - .49, p = .020) and 
Age diagnosed (r = .60, p = .004). Results demonstrated that the variables Hyper-arousal and 
Age diagnosed with Breast Cancer significantly accounted for 73.6% (Adjusted R ² = 49.0%) 
of the variance, F(2, 18) = 10.61, p = .001, in Self-compassion for the Breast Cancer group. 
The regression coefficients demonstrated that Hyper-arousal (β = -.43, p = .017, sr ² = .17% 
and Age diagnosed (β = .55, p = .003, sr ² = .22%; power was calculated at .99) were 
significant unique predictors of Self-compassion in individuals diagnosed with Breast Cancer. 
Correlation coefficients demonstrated that no significant relationship was found between 
EMWS and Self-compassion or any of the other psychosocial variables for the Breast Cancer 
group investigated in this study.                                                                                             
Conclusion Predictor Variables for Age Diagnosed - Self-Compassion & Hyper-arousal  
 Scleroderma: Results demonstrated that early life experiences low in warmth and 
safety and low Self-compassion (as well as a diagnosis of scleroderma at a younger age) 
contributed to elevated levels of Hyper-arousal. Indicating that Scleroderma participants 
reporting fewer experiences of warmth and safety, fewer experiences of Self-compassion and 
an earlier onset of Scleroderma, experienced greater levels of Hyper-arousal.                      
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 Breast Cancer: Results for the Breast Cancer group demonstrated that lower Hyper-
arousal (as well as a diagnosis of Breast Cancer at an older age) predicted greater Self-
compassion. Indicating that individuals who engaged in greater Self-compassion were likely 
to experience lower levels of Hyper-arousal (conversely greater Hyper-arousal predicted 
lower Self-compassion) and report, a later onset of Breast Cancer.           
 These experiences demonstrated differences in how Self-compassion and Hyper-
arousal were experienced by the two illness groups. With lower Self-compassion and limited 
EMWS predicting elevated Hyper-arousal for Scleroderma participants and greater Self-
compassion predicting lower Hyper-arousal (conversely lower Self-compassion predicted 
greater Hyper-arousal) for Breast Cancer participants. Elevated levels of Hyper-arousal also 
predicted a diagnosis of Scleroderma at a younger Age; whereas greater Self-compassion was 
predicted by a diagnosis of Breast Cancer at an older Age.           
 The results indicated that greater Self-compassion predicted lower experiences of 
arousal. Results also demonstrated that individuals diagnosed with Scleroderma who 
experienced low EMWS were also likely to experience greater levels of Hyper-arousal. No 
relationship was found between EMWS and any psychosocial variable for the Breast Cancer 
group. Results demonstrated differences in predictor variables for Age diagnosed with 
scleroderma and Age diagnosed with breast cancer; with higher levels of Self-compassion 
(lower Hyper-arousal related to higher Self-compassion) related to a later diagnosis of Breast 
Cancer (conversely lower Self-compassion was related to a diagnosis of Breast Cancer at a 
younger age). Whereas greater Hyper-arousal (low Self-compassion and low experiences of 
EMWS were related to elevated Hyper-arousal) and an earlier onset of Scleroderma (greater 
Self-compassion and greater early life experiences of warmth and safety were related to lower 
arousal). Conversely lower arousal was related to a later diagnosis of Scleroderma, indicating 
differences between groups for what relates to age of disease onset.                               
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Conclusion- Hypothesis Four                     
 Results provided partial support for the fourth hypothesis, demonstrating differences 
in   what relates to Age diagnosed with scleroderma and Age diagnosed with breast cancer. 
Higher levels of Self-compassion was related to a diagnosis of Breast Cancer at an older Age 
(Conversely lower Self-compassion was related to a diagnosis of Breast Cancer at a younger 
Age). Whereas elevated levels of Hyper-arousal was related to a diagnosis of Scleroderma at 
a younger Age (Conversely lower Hyper-arousal was related to a diagnosis of Scleroderma at 
an older Age). Greater Self-compassion was related to lower Hyper-arousal for individuals 
diagnosed with Breast Cancer. However lower Self-compassion and limited experiences of 
warmth and safety was related to Hyper-arousal for individuals diagnosed with Scleroderma.  
 Results demonstrated that differences occurred between groups for what relates to Age 
of diagnosis for the two illness groups and the variables that underlie the significant variables 
for Scleroderma participants diagnosed at a younger Age (elevated Hyper-arousal: low Self-
compassion & low EMWS) and Breast Cancer participants diagnosed at an older Age (greater 
Self-compassion: low Hyper-arousal).   
 
                                                                                                                  
 
 
                                     
                                                          
Figure 3: Scleroderma - Breast Cancer Model: Age of Disease Onset                 
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Figure 3 above provides a visual representation of the results in the current study that suggest, 
EMWS (scleroderma), Self-compassion (S-C) and Hyper-arousal are involved in the  earlier 
(greater hyper-arousal; lower self-compassion) or later (greater self-compassion; lower hyper-
arousal) onset of Scleroderma and Breast Cancer.                                                                       
Conclusion Summary - Hypotheses Four: Age of Onset Scleroderma/Breast Cancer     
 Results demonstrated differences between illness groups for predictor variables for Age 
diagnosed with scleroderma and Age diagnosed with breast cancer. Greater Self-compassion 
was related to Breast Cancer onset at an older age. Whereas elevated Hyper-arousal was related 
to Scleroderma onset at a younger age. Significant variables for greater Self-compassion for 
Breast Cancer was lower Hyper-arousal; and greater Hyper-arousal for Scleroderma were 
related to low Self-compassion and EMWS.         
 Results demonstrated differences between the groups for what predicts Age of diagnosis 
for Scleroderma and Breast Cancer participants and the variables that underlie the predictor 
variables (Hyper-arousal and Self-compassion) for the two illness groups. Scleroderma: 
diagnosed at a younger Age (elevated Hyper-arousal: low Self-compassion & low EMWS) and 
for Breast Cancer: diagnosed at an older Age (greater Self-compassion: low Hyper-arousal).  
                                  Study 3(b)                                                                     
Comparison Study: Scleroderma, Breast Cancer and Community Groups                        
 The third study 3(b) also investigated differences between Scleroderma (total sample 
and diffuse/limited groups), Breast Cancer and Community participants and psychosocial 
variables explored in studies one and two. Differences between groups were explored in 
relation to psychosocial aspects with the postulation that the community group would have 
lower negative psychosocial experiences than both illness groups (breast cancer and 
scleroderma); and the breast cancer group would have lower negative psychosocial experiences 
than the scleroderma group (greater predisposition to the disease, rather than stress related). 
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The literature suggests individuals with breast cancer experience depression and anxiety at 
higher rates (Khan, 2012; Vardanima et al., 2010) than community individuals (e.g., APA, 
2000; Pignone et al. 2002) and lower rates than individuals with scleroderma (Thombs et al., 
2007; Beretta et al., 2006; Angelopoulos et al., 2001; Roca et al., 1996; Legendre et al, 2005); 
although, these studies did not involve direct comparisons.      
 The third study therefore investigated whether scleroderma participants have greater 
experiences of depression and anxiety and fewer positive rearing experiences and less self-
compassion than breast cancer and community participants. This study also investigated 
comparisons between breast cancer and community participants on psychosocial variables. 
These aspects are outlined in the following hypotheses.                                             
 The hypotheses were divided into three headings. Hypotheses 5-7: Comparison studies 
between scleroderma, diffuse and limited sclerosis, breast cancer and community groups and 
psychosocial and mental health variables.                                                                          
Hypotheses 5-7: Scleroderma/Breast Cancer/Community – Psychosocial/Mental Health     
Hypothesis Five: Comparison between Groups – Psychosocial Variables    
 5(a): Lower levels of Self-compassion, Emotion Regulation (Suppression), EMWS, 
Insecure Attachment (Dismissive/Fearful) and higher levels of Hyper-arousal would be 
reported by individuals diagnosed with Scleroderma and Breast Cancer when compared with 
Community participants.                   
 5(b): When comparing (Scleroderma/Breast Cancer, Scleroderma/Community, Breast 
Cancer/Community) groups, more negative levels of psychosocial variables (EMWS, 
Attachment style, Emotion Regulation and Hyper-arousal) would occur between each of the 
illness groups (Scleroderma/Breast Cancer) when compared to the community groups; with 
differences occurring in levels of psychosocial variables between illness groups 
(Scleroderma/Breast Cancer).                                                                                           
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    239  
  
Hypothesis Six: Scleroderma/Breast Cancer/Community-Mental Health    
  6(a): Individuals diagnosed with Scleroderma and Breast Cancer (illness group) would 
report higher levels of Depression, Anxiety and Stress when compared to individuals from the 
Community sample.               
  6(b): Scleroderma participants would report higher levels of Depression, Anxiety and 
Stress, than Breast Cancer participants who would report higher levels than the Community  
group.                                                                                                                                        
Hypothesis Seven: Diffuse/Limit/Breast Cancer/Community–Psychosocial/Mental Health  
   Lower levels of EMWS, Self-compassion, the emotion regulation strategy – 
Suppression, an Insecure Attachment style and higher levels of Hyper-arousal would be 
reported by the Breast Cancer group when compared to the Community group and by the  
Scleroderma groups (diffuse and limited sclerosis) when compared with the Community and  
Breast Cancer groups.                                  
Data Analysis                                         
  The breast cancer, community and scleroderma (diffuse/limited/ other forms of 
scleroderma) data files were merged to address the hypotheses. Several variables were 
skewed including, Dismissive attachment, Fearful attachment, Suppression, Pain, Anxiety, 
Depression and Stress subscales of the DASS (positively skewed) and EMWS, Suppression  
and Self-compassion (negatively skewed).            
  One case of extreme univariate outliers for each of the relationship subscales 
dismissive and fearful attachment were identified and removed (as recommended by  
Tabachnick & Fidell, 2007); however, these variables remained skewed. As a majority of the 
variables were skewed, non-parametric analysis was conducted.                                                
Results for Hypothesis Five – Comparison: Scleroderma/Breast Cancer/Community  
 Hypothesis 5(a): Kruskal-Wallis analysis was utilized to investigate the hypothesis 
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that lower Self-compassion, Emotion Regulation, EMWS, an Insecure Attachment Style and 
higher levels of Hyper-arousal would be reported by individuals diagnosed with Scleroderma 
and Breast Cancer when compared with Community participants. Results demonstrated that 
the Self-compassion subscales Over-identification, and Self-kindness were significantly 
higher for the Scleroderma group when compared with the other groups. Mean Rank and 
median scores for Over-identification were higher for the Scleroderma group (94.18, n = 80), 
Md, 16.0, when compared to the Breast Cancer, (64.39, n = 22), Md, 13.0 and Community 
groups (67.74, n = 58), Md, 13.0 reporting similar scores, χ², 14.15, 2df, p =.001.    
 Mean rank and medium scores for Self-kindness were lower for the Scleroderma 
group (72.30, n = 81), Md, 14.0 when compared to the Breast Cancer (80.86, n = 22), Md, 
15.0 and Community groups, (93.21, n = 58), Md, 15.0, χ², 6.84, 2df, p =.033. Although the 
results for EMWS did not reach significance, the Scleroderma group reported lower levels of 
EMWS (79.17, n = 88), Md., 71.5 than the Breast Cancer (85.32, n = 22), Md., 80.0 and 
Community groups (97.20, n = 62), Md., 82.0, χ², 4.82, 2df, p=.090.   
 Results for hypothesis 5(a) demonstrated that (low Self-compassion) Over-
identification was higher for the Scleroderma group, than for the Breast Cancer and  
Community groups while Self-kindness was lower in the Scleroderma group than for the  
Breast Cancer and Community groups. The Scleroderma group also reported lower levels of 
EMWS than the Breast Cancer and Community groups, although these results did not reach 
statistical significance. The results partially supported hypothesis 5(a) and demonstrated that 
individuals diagnosed with Scleroderma were more likely to Over-identify (low self-
compassion) with their experiences and less likely to engage in Self-kindness (greater self-
compassion) than the Community and Breast Cancer groups who reported similar experiences 
in relation to self-compassion and EMWS (medium scores). Results are presented in Table 
18. Please see appendix H for Means and SD for variables for the three groups.                                                                                                                                 
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Table 18                                                                                                                            
Summary of Results (Kruskal-Wallis) for Scleroderma – Breast Cancer – Community Groups  
Variables                                                                  N                       MR                      Md  
 
Over-Identification  
      Scleroderma                                                      80                      94.18                  16.0                    
      Breast Cancer                                                    22                      64.39                  13.0   
      Community                                                       58                       67.74                  13.0  
Self-Kindness  
       Scleroderma                                                      81                     72.30                   14.0                    
      Breast Cancer                                                    22                      80.86                   15.0   
      Community                                                       51                       93.21                   15.0  
EMWS (non-significant)  
       Scleroderma                                                      88                     79.17                   71.5                    
      Breast Cancer                                                    22                      85.32                   80.0   
      Community                                                       62                      97.20                   82.0  
__________________________________________________________________________  
 Results for hypothesis 5(b): Comparing Scleroderma and Breast Cancer groups, 
Scleroderma and Community groups, and Breast Cancer and Community groups; it was 
postulated that more negative levels of psychosocial variables (EMWS, Attachment style, 
Emotion Regulation and Hyper-arousal) would occur between each of the illness groups 
when compared to the community groups; and that difference would occur between illness 
groups for these variables. That is elevated levels of different psychosocial variables would  
occur between the Scleroderma and Breast Cancer groups.         
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  Scleroderma - Breast Cancer: Mann Whitney U Tests were conducted to compare 
variables of interest (EMWS, Insecure Attachment, Self-compassion, Emotion Regulation 
and Hyper-arousal) in the Scleroderma and Breast Cancer samples. Significant differences 
were found for Over-identification (low Self-compassion) between Scleroderma (55.46, n = 
80), Md, 16.0, and Breast Cancer participants (37.09, n = 22), Md, 13.0, U = 563.0,                 
z = -2.59, p = .010, r = - 0.26; and for Fearful attachment, between Scleroderma (51.08,                
n = 86) Md, 9.0, and Breast Cancer participants (67.86, n = 22), Md, 12.0, U = 652.0,                        
z = -2.25, p = .024, r = - 0.22.                 
  Therefore individuals diagnosed with Scleroderma had significantly higher median 
scores for Over-Identification (low self-compassion) and significantly lower scores for 
insecure Fearful attachment than individuals diagnosed with Breast Cancer; indicating that 
Scleroderma participants were more likely to engage in lower self-compassion by Over-
Identifying with their experiences than Breast Cancer participants; whereas individuals 
diagnosed with Breast Cancer were more likely to engage in a Fearful style of relating when 
compared with Scleroderma participants.       
 Results demonstrated differences between psychosocial variables implicated in the 
respective diseases (scleroderma and breast cancer); partially supporting hypothesis 5(b). 
Results are presented in Table 17.                                                                                             
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Table 17                                                                                                                               
Summary of Results (Mann Witney U Test) Scleroderma and Breast Cancer Groups  
 
 Variables                                                                  N                       MR                      Md   
 
Over-Identification  
     Scleroderma                                                      80                      55.46                   16.0        
     Breast Cancer                                                    22                      37.09                   13.0   
Fearful Attachment  
      Scleroderma                                                      86                      51.08                     9.0        
      Breast Cancer                                                    22                      67.86                   12.0  
__________________________________________________________________________       
  Scleroderma – Community: Mann Whitney U Tests were also conducted to compare 
variables of interest (EMWS, Self-compassion, attachment style, Hyper-arousal and the 
emotion regulation strategy - Suppression) in the Scleroderma and Community samples. 
Significant differences were found for Early Memories of Warmth and Safety and the Self-
compassion subscales (greater self-compassion: Self-kindness and Mindfulness and low self-
compassion: Over-identification).                    
  EMWS: Results demonstrated significantly higher scores on Early Memories of 
Warmth and Safety for the Community group, (85.02, n = 62) Md, 82.0, when compared with 
the individuals diagnosed with Scleroderma (67.09, n = 88), Md, 71.5. U = 2137.5, z = - 2.25, 
p = .024, r = - 0.18.              
 Self-kindness: Results revealed significantly higher scores on Self-kindness (greater 
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self-compassion) for the Community group, (80.43, n = 58), Md, 15.0, when compared with 
the individuals diagnosed with Scleroderma (62.5316 n = 81), Md, 14.0, U = 1744.0, z = -
2.59, p = .010, r = - 0.22.                 
 Mindfulness: Results for Mindfulness revealed significantly higher scores for the 
Community group, (79.16, n = 58), Md, 14.0, when compared with the Scleroderma group 
(63.44, n = 81), Md, 12.5, U = 1818.0, z = -2.28, p = .023, r = - 0.19.       
 Over-identification: Results for Over-identification (low self-compassion) revealed 
significantly lower scores for Community participants (56.09, n = 58) Md, 13.0 when 
compared with Scleroderma participants (79.22, n = 80), Md, 16.0, U = 1542.50, z = -3.37,    
p = .001, r = - 0.29.                    
 Results indicated that Scleroderma participants have significantly lower early life 
experiences of warmth and safety and significantly lower experiences of Self-compassion 
(low Self-kindness and Mindfulness and high engagement in Over-identifying with 
experiences) when compared with Community participants.                                             
Conclusion – Hypothesis Five              
 Scleroderma – Breast Cancer – Community: Results for hypotheses 5(a) demonstrated 
that individual’s diagnosed with Scleroderma reported lower Self-Compassion experiences 
(Over-identification and Self-kindness) when compared to Breast Cancer and Community 
participants; indicating that these emotion regulation strategies were more greatly 
experienced by Scleroderma participants; partially supporting hypothesis 5(a).          
 Scleroderma – Community: Results for hypothesis 5(b) also demonstrated that 
Scleroderma participants were more likely to Over-identify with their experiences (low Self-
compassion) and were less likely to engage in strategies high in Self-compassion, (Self-
kindness and Mindfulness) and have fewer experiences of Warmth and Safety in childhood 
when compared with Community individuals. Indicating that differences in reported early life 
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experiences and the capacity for Self-compassion occurred between Scleroderma and 
Community participants, with Scleroderma participants reporting more negative experiences 
than Community participants; partially supporting the hypothesis. Results for the scleroderma 
community study are presented below in Table 19.                                                                          
Table 19                                                                                                                                    
Summary of Results (Mann Witney U Test) Scleroderma and Community                   
 
 Variables                                                                  N                       MR                      Md   
 
EMWS   
      Scleroderma                                                      88                       67.09                   71.5   
      Community                                                       62                       85.02                    82.0   
Self-Kindness  
      Scleroderma                                                      81                       62.53                    14.0        
      Community                                                       58                       80.43                    15.0  
Mindfulness  
      Scleroderma                                                      81                       63.44                    12.5        
      Community                                                       58                       79.16                    14.0  
Over-Identification  
      Scleroderma                                                      80                       79.22                    16.0        
      Community                                                       58                       56.09                    13.0  
__________________________________________________________________________       
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           Scleroderma - Breast Cancer: Results for hypothesis 5(b) demonstrated that  
Scleroderma participants were more likely to Over-identify with their experiences than Breast  
Cancer participants; whereas Breast Cancer participants were more likely to engage in a 
Fearful attachment style when compared to Scleroderma participants. Results demonstrated 
differences between psychosocial variables implicated in the respective diseases; partially  
supporting hypothesis 5(b).                
  Breast Cancer - Community: Mann Whitney U Tests were also conducted to identify 
differences in psychosocial variables between participants in the Community group and 
individuals diagnosed with Breast Cancer; however, none of the variables reached statistical 
significance. Therefore no significant difference occurred between the Community and Breast 
Cancer groups on these variables; indicating that this part of hypothesis 5(b) was not 
supported.                                             
Conclusion Fifth Hypothesis               
  Individuals diagnosed with Scleroderma demonstrated lower levels of Self-
compassion than both groups and lower early life experiences of warmth and safety than 
Community participants. Whereas Breast Cancer participants reported greater experiences of 
Fearful attachment than Scleroderma participants. No significant difference was found 
between Breast Cancer and Community participants for psychosocial variables. Findings 
suggest that significant differences occurred on some psychosocial variables between 
Scleroderma, Breast Cancer and Community participants. Therefore findings partially 
supported the fifth hypothesis.                                                                                                                                                              
Results for Hypothesis Six – Mental Health           
  Hypothesis 6(a): Higher levels of Depression, Anxiety and Stress would occur 
between illness groups compared to the community group; with the scleroderma group 
reporting greater scores for mental health. The percentage of individuals who experienced 
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differing levels of Depression, Anxiety and Stress (as measured by the DASS) were 
determined using frequencies.          
 Hypothesis 6(b): Mann Witney U tests were utilized to investigate the part of the sixth 
hypothesis: that individuals from the illness groups (Scleroderma/Breast Cancer) would 
report higher scores for Depression, Anxiety and Stress than individuals from the Community 
group.                                                                                                                                                
Illness (Scleroderma & Breast Cancer Groups) – Community Groups: Depression- Anxiety  
 Results revealed higher levels of Depression, Anxiety and Stress in the total illness 
group (Scleroderma/Breast Cancer) when compared to the Community group. The illness 
group reported approximately twice the levels of elevated Anxiety as individuals from the 
Community group; with the Community group reporting approximately twice the percentage 
of individuals within the normal range for Anxiety, when compared with the illness group. 
Results demonstrated that the illness group (Scleroderma/ Breast Cancer) reported more 
severe Anxiety than the Community group; results that partially supported the sixth 
hypothesis.                                                                                                                             
Scleroderma - Breast Cancer: Depression, Anxiety and Stress      
 A higher percentage of individuals diagnosed with Scleroderma reported elevated 
levels of Anxiety, Depression and Stress when compared to individuals diagnosed with 
Breast Cancer. A greater percentage of individuals diagnosed with Breast Cancer also 
reported scores within the normal range for Depression, Anxiety and Stress when compared 
with individuals diagnosed with Scleroderma. Results presented in Table 20 demonstrate the 
percentage of Community, Breast Cancer and Scleroderma participants in terms of their 
responses on the Depression, Anxiety and Stress Scale.                                                                    
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Table 20                                                                                                                              
Percentages - Depression, Anxiety & Stress for Scleroderma - Breast Cancer - Community   
Variable  
Community   Total illness  
(Scleroderma & 
Breast Cancer) 
Breast 
Cancer  
Scleroderma   
Depression  
0-9        Normal  
10-13    Mild  
14-20    Moderate  
21-27    Severe  
28+       Ex Severe   
Anxiety  
0-7         Normal  
8-9         Mild  
10-14     Moderate  
15-19     Severe  
20+        Ex Severe        
Stress   
0-14      Normal  
15-18     Mild  
19-25     Moderate  
26-11     Severe  
34+        Ex Severe  
  
  61.9%  
28.6%  
9.5%  
  
  
  
36.5%  
34.9%  
28.6%  
  
  
  
  90.5%  
  7.9%  
  1.6%  
  
  
  
44.7%  
32.5%  
13.2%  
  9.6%  
  
  
19.1%  
23.5%  
43.5%  
13.0%  
   0.9%  
  
76.3%  
15.8%  
 7.9%  
  
  
  
50.0%  
31.8%  
 5.4%  
 13.7%  
  
  
22.7%  
27.3%  
45.5%  
 4.5%  
  
  
81.8%  
13.7%  
 4.5%  
  
  
  
43.5%  
38.0%  
 9.8%  
 8.7%  
  
  
18.3%  
22.6%  
43.0%  
15.0%  
  1.1%  
  
75.0%  
16.3%  
 8.7%  
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 Mann Whitney U Tests: Results for Mann Whitney U Tests demonstrated significantly lower 
Depression for Community individuals (65.4, n = 63) Md = 8.0, when compared with those 
diagnosed with Scleroderma (86.6, n = 91), Md, 10.0, U = 2105.0, z = -2.92, p = .003, r = - 
0.24.  Significantly lower Anxiety for Community, 39.2, n = 63), Md, 8.0, when compared to 
Breast Cancer participants (53.9, n = 22), Md, 9.5, U = 453.0, z = -2.47, p = .014, r = - 0.27 and 
significantly lower Anxiety for Community (58.5, n = 63), Md, 8.0, when compared with 
Scleroderma participants (92.0, n = 93), Md, 10.0, U = 1671.5, z = - 4.60, p = .000, r = - 0.37. 
Lower Anxiety for Breast Cancer (51.1, n = 22), Md, 9.5, when compared with Scleroderma 
participants (59.6, n = 93), Md, 10.0; however, these results did not reach significance. Stress 
was not significantly related to any variable. Significant results are presented in Table 21.                                                                                                                         
Table 21                                                                                                                             
Summary of Significant Results (Mann Witney U) Breast Cancer/Scleroderma/Community        
 
Variables                                                                  N                       MR                    Md   
 
Depression  
     Scleroderma                                                      91                      86.6                     10.0        
     Community                                                       63                      65.4                       8.0   
Anxiety  
     Scleroderma                                                      93                      92.0                     10.0        
     Community                                                       63                      58.5                       8.0   
 
     Breast Cancer                                                    22                      59.6                       9.5    
     Community                                                        63                     39.2                       8.0  
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            Results demonstrated that significantly higher levels of Depression and Anxiety were 
experienced by individuals diagnosed with Scleroderma when compared with Community 
individuals. No significant difference was found between Breast Cancer and Scleroderma 
participants and Breast Cancer and Community participants for levels of Depression.  
Significantly higher levels of Anxiety were experienced by individuals diagnosed with 
Scleroderma and Breast Cancer when compared with Community individuals. No significant 
difference was found between Breast Cancer and Scleroderma participants for Anxiety. There  
were no significant differences between groups for Stress.                                                   
Conclusion - Hypothesis Six               
  Findings indicated that those with illness (Scleroderma/Breast Cancer) showed higher  
DASS scores for Depression and Anxiety than the Community participants. DASS Scores for 
Depression for Community participants ranged from normal to moderate with over 90% of 
this group reporting normal to mild depression. The illness groups’ DASS scores ranged from 
normal to severe, with a majority of this group experiencing mild to severe levels of 
depression. DASS Scores for Anxiety for community participants ranged from normal to 
moderate with over 70% of this group reporting normal to mild Anxiety. The illness groups’ 
scores ranged from normal to extremely severe with a majority of this group experiencing  
mild to extremely severe levels of depression.          
  Results demonstrated significant findings for Scleroderma participants in relation to 
greater experiences of Depression and Anxiety when compared with Community participants. 
Significantly greater experiences of Anxiety were also reported by Breast Cancer participants 
when compared with Community participants. Therefore individuals diagnosed with 
Scleroderma and Breast Cancer tend to experience greater levels of Anxiety than Community 
participants. While Scleroderma participants experienced greater levels of Anxiety they also 
experienced greater levels of Depression when compared to Community participants.  
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 Table 22 below provides a summary of significant variables from the third study (a/b) 
for Depression, Anxiety and Stress for the Scleroderma and Breast Cancer groups and the 
Scleroderma, Breast Cancer and Community groups.                                                                                           
Table 22                                                                                                                                                                       
Significant Variables: Scleroderma/Breast Cancer/Community – Mental Health    
Differences  
Between  
Groups  
                 
               Depression   
  
                   Anxiety  
  
                   Stress  
     Sig MR/C  
S               BC   
Between Grps  
 S       BC        C  
   Sig MR/C  
S               BC  
Between Grps  
 S      BC        C  
  Sig MR/C  
S               BC  
Between Grps  
 S        BC       C  
Between 
Groups  
  
  
  
H                    L  
  
         
  
H        H         L  
    
EMWS    
X         
    
X  
    
C           
  
Fearful  
Attachment  
 
C      
        
C  
  
Dismissive 
Attachment  
  
C                X  
               
                  C  
  
Low Self- 
Compassion  
                    
X                X  
        
X                C  
  
Self-  
Judgment  
               
C  
      
Isolation             
C  
      
Suppression    
C          
    
X                X  
        
Hyperarousal        
X  
    
X                C  
  
Pain        
X                C  
      
Nausea                     
                  C  
                         
                  C  
  
Fatigue                     
                  X  
                         
                  C  
  
  S= Scleroderma BC = Breast Cancer C = Community Groups  
  MR = Multiple Regression, X = Significant Predictor Variables, C = Sig Correlations   
  Between Groups: H = Significantly Higher, L = Significantly Lower  
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Results demonstrated that individuals diagnosed with Scleroderma experience greater     
psychopathology when compared to the Community and Breast Cancer groups, partially  
supporting hypothesis six.                                                                                                          
Conclusion - Results Hypothesis Six: Depression, Anxiety and Stress       
  Overall results for Depression, Anxiety and Stress provided partial support for the  
hypothesis and demonstrated that similarities and differences occurred between groups for 
scores on the DASS. Findings for hypothesis 6(a) demonstrated higher DASS scores for 
illness participants for Depression and Anxiety than for Community participants. Significant 
difference occurred between Scleroderma participant’s experiences of (elevated) Depression 
and Anxiety when compared to Community participants. Significantly elevated Anxiety was 
also experienced by Breast Cancer participants when compared to Community participants.  
Scleroderma and Breast Cancer participants therefore tended to experience greater levels of  
Anxiety than Community participants. Whereas Scleroderma participants experienced greater 
levels of Anxiety and Depression when compared to Community participants.                                               
Results – Hypothesis Seven: Diffuse - Limited - Breast Cancer - Community Groups  
 A Kruskal-Wallis Test was conducted to investigate significant differences between 
the two major subsets of Scleroderma (diffuse and limited sclerosis groups), the Breast 
Cancer group and the Community group on psychosocial variables. The Self-compassion 
subscales Over-identification, Self-kindness and Mindfulness were significant, demonstrating  
that differences occurred between the groups.             
  Results revealed a similar mean rank and medium scores for Over-identification for 
the Community (64.96, n = 58), Md, 13.0 and Breast Cancer groups, (61.68, n = 22),                  
Md, 13.0, when compared with the Limited sclerosis, (88.36, n = 42), Md, 15.5 and Diffuse 
sclerosis groups, (95.02, n = 31), Md, 16.0, χ², 14.92, 3df, p =.002, who reported higher  
scores, indicating lower self-compassion. Results are presented in Table 22.                                  
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Table 22                                                                                                                                      
Summary of Significant Results for Diffuse –Limited – Breast Cancer - Community                         
 
  
Variables                                                                  N                       MR                      Md   
 
Over-Identification  
     Diffuse                                                                34                     95.02                    16.0        
      Limited                                                              50                      57.41                   15.5         
      Breast Cancer                                                    22                      61.68                   13.0   
      Community                                                        63                      64.96                   13.0  
Self-Kindness  
      Diffuse                                                               34                      85.05                   16.0        
      Limited                                                              50                      88.36                   13.0         
      Breast Cancer                                                    22                      76.89                   15.0   
      Community                                                        63                      88.59                   15.0  
Mindfulness  
      Diffuse                                                               34                      87.48                   13.0        
      Limited                                                              50                      60.35                    12.0         
      Breast Cancer                                                    22                      71.45                    15.0  
      Community                                                        63                      87.17                    14.0          
__________________________________________________________________________  
  Mean rank and medium scores for Self-Kindness were higher for the Community,  
(88.59, n = 63), Md, 15.0, Breast Cancer (76.89, n = 22), Md, 15.0, and Diffuse groups  
(85.05, n = 34), Md, 16.0, compared to the Limited group, (57.41, n = 50), Md, 13.0, χ²,  
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13.28, 3df, p =.004. Mean Rank and medium scores for Mindfulness were higher in the  
Community group, (87.17, n = 63), Md, 14.0, and Breast Cancer group (71.45, 22), Md, 13.5  
when compare with the Diffuse, (87.48, n = 34), Md, 13.0, and Limited sclerosis groups,  
(60.35, n = 50), Md, 12.0, χ², 11.15, 3df, p =.011. Although EMWS did not reach significance  
the Community group, (91.37, n = 63), Md, 82.0, reported higher scores than the Breast Cancer  
group, (80.41, n = 22), Md, 80.0, with both groups reporting higher scores than the Limited,  
(78.50, n = 50), Md, 72.0, and Diffuse groups (70.1, n = 34), Md, 71.5, χ², 4.77, 3df, p =.189.    
  Results indicated similar scores for Over-identification (low self-compassion) for the  
Community and Breast Cancer groups; that were significantly lower than scores for the 
Limited and Diffuse groups. The Diffuse group reported higher median scores than all groups  
for Over-identification.                 
  Self-kindness was higher in the Community, Breast Cancer and Diffuse groups, when 
compared with the Limited group; indicating that the Limited group were less likely to 
engage in acts of Self-kindness than Community, Breast Cancer or Diffuse sclerosis 
participants, with the Diffuse group reporting the highest of all the groups for Self-kindness.  
  Results for Mindfulness indicated higher medium scores for the Breast Cancer group 
when compared to the Community group that reported higher scores than the Diffuse group. 
All groups demonstrated significantly higher median scores than the Limited group. Results 
indicated that the Limited group engaged in less Mindfulness than the remaining three 
groups; with the two Scleroderma groups demonstrating less Mindfulness than the  
Community and Breast Cancer groups.                                                                                                                  
Conclusion - Hypothesis Seven                      
 Table 23 below, provides a summary of results for positive and negative outcomes for the  
Scleroderma groups and the Community and Breast Cancer groups.                                         
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Table 23                                                                                                                                   
Summary of Significant Variables: Positive and Negative Outcomes Between Groups   
                      Negative Outcomes                                                       Positive Outcomes  
  
  Sclero  
  
 Diff   Lim     BC  Com  Sclero    Diff  L    BC  Com  
EMWS  Low 
Lower  
Low  Low                
Higher  
Fearful  
Attachment  
High  High      
Higher  
    
Lower  
        
Dismissive 
Attachment  
High    High  High              
Self- 
Compassion  
Low 
Lower  
    Low             
Higher  
  
Highest  
Self- 
Kindness  
Low 
Lower  
Low    
Lowest  
        
Highest  
  High 
Higher  
  
Higher  
Mindfulness  
  
  
Lower  
  
Lower  
  
Lowest  
        
  
    
Highest  
  
Higher  
Over- 
Identify  
High 
Higher  
High 
Highest  
High 
Higher  
            
Lowest  
  
Lowest  
Self- 
Judgement  
High    High                
Isolation  
  
High  High                  
Suppression  
  
High  High  High  High              
Re-appraise  
  
      
Lower  
              
Higher  
Hyperarousal  High    High  High          Low    
R-
Hyperarousal  
High  High                  
Lower  
Depression  
  
  
Higher  
                
Lower  
  
Lowest  
Anxiety  
  
  
Highest  
      
Higher   
            
Lower   
Age Onset  
  
  
Earlier  
                
Later  
  
Sclero = Scleroderma Symptoms: Pain, Raynaud’s, Disability, Intestinal, Breathing and Skin.                                                   
Diff = Diffuse Sclerosis, Lim = Limited Sclerosis, BC = Breast Cancer, Com = Community Group.                                
Table 23 provides a summary of variables that were significant for each of the groups. The 
table is divided into positive and negative outcomes and provides an overview of the direction 
of results (low or high) for the psychological variables that were related to disease 
symptoms, onset or mental health; demonstrating more negative outcomes for the 
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scleroderma groups. Comparison between groups for significant variables are represented by 
lower, lowest, higher and highest and also generally demonstrate more negative outcomes for 
the scleroderma groups when compared to the other groups. For example, between two 
groups: EMWS was lower in the scleroderma group and higher in the community group.  
 Results partially supported the hypothesis with the Scleroderma groups  
(Diffuse/Limited sclerosis) generally reporting significantly lower Self-compassion than the 
Breast Cancer and Community groups that generally reported similar scores. The Diffuse 
group engaged in significantly greater Over-identification strategies than all groups, while the 
Limited group engaged in less Self-kindness and Mindfulness than the other three groups 
with the Diffuse group reporting less Mindfulness than the Breast Cancer and Community  
groups and greater Self-kindness than all groups.   
 
Conclusion Summary - Hypotheses                                                                                    
Conclusion Summary - Hypotheses 5-7: Comparison between Groups                            
Results partially supported hypotheses 5-7: Scleroderma participants demonstrated 
significantly lower Self-compassion than Community and Breast Cancer groups and 
significantly lower EMWS than Community participants. Breast Cancer participants reported 
significantly greater experiences of Fearful attachment than Scleroderma participants. 
Scleroderma participants reported greater mental health scores (DASS) for depression and 
anxiety. Findings therefore partially supported hypotheses five, six and seven and suggest that 
significant differences were found between groups for psychosocial and mental health 
experiences; with scleroderma participants generally reporting more negative experiences.  
Summary of Results: Hypotheses 1-7                                                                                                                 
Study 3(a/b) - Comparison: More Negative Outcomes for the Scleroderma Groups  
 Scleroderma/Breast Cancer/Community: Results partially supported the hypotheses 
related to differences between groups (scleroderma, breast cancer and community) for 
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psychosocial variables. Scleroderma participants demonstrated significantly less self-
compassion (over-identification and self-kindness) than breast cancer and community 
participants. Results demonstrated that significant differences occurred between groups for 
self-compassion, with scleroderma participants engaging in significantly less compassion 
toward themselves than individuals from the breast cancer and community groups.                                           
 Scleroderma/Breast Cancer: Results also partially supported the hypothesis by 
demonstrating significant differences in experiences of over-identification and fearful 
attachment style in individuals diagnosed with scleroderma (limited, diffuse and rarer forms 
of scleroderma) when compared to individuals diagnosed with breast cancer. Scleroderma 
participants were more likely to over-identify with their experiences (low self-compassion) 
than breast cancer participants. Whereas individuals diagnosed with breast cancer were more 
likely to engage in a fearful style of relating when compared to individuals with scleroderma. 
Findings demonstrated significant differences in how the illness groups relate to themselves 
and their experiences (low self-compassion: over-identifying with experiences) and to 
significant others (insecure attachment style: fearful attachment).                                 
 Differences in Predictor Variables – Scleroderma/Breast Cancer: Results from study 
3(a) demonstrated that early life experiences low in warmth and safety and an insecure 
dismissive attachment style predicted greater experiences of pain related to disease symptoms 
for the scleroderma group; however these factors (EMWS and dismissive attachment) did not 
predict pain for individuals diagnosed with breast cancer. Therefore differences occurred 
between groups for what related to pain in the scleroderma and breast cancer groups. Results 
also demonstrated differences in predictor variables for age diagnosed with disease; for the 
scleroderma group, elevated levels of hyper-arousal predicted a diagnosis of scleroderma at a 
younger age; whereas greater self-compassion predicted a diagnosis of breast cancer at an 
older age. The results also indicated that greater self-compassion predicted lower experiences 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    258  
  
of arousal and lower self-compassion predicted greater hyper-arousal for both groups; 
whereas, low EMWS also predicted greater levels of hyper-arousal in the scleroderma group. 
No relationship was found between EMWS and any psychosocial variable for the breast 
cancer group. Results demonstrated differences between groups for what predicts disease 
related symptoms and onset; partially supporting the hypotheses for comparison between 
groups.                  
 Scleroderma/Community: Results also partially supported the hypothesis, and 
demonstrated that significant differences occurred between the scleroderma and community 
groups. Individuals with scleroderma were likely to have fewer experiences of warmth and 
safety as a child than community individuals and were less likely to engage in self-
compassion strategies of self-kindness and mindfulness and more likely to engage in 
strategies (low self-compassion) high in over-identifying with their experiences, when 
compared with community participants.           
 Breast Cancer/Community: Results conducted to identify differences in psychosocial 
variables between individuals diagnosed with breast cancer and community individuals were 
not significant and therefore did not support this part of the hypothesis. Results indicated that 
no significant difference occurred between the community and breast cancer groups for 
psychosocial variables.                                                                                                       
 Scleroderma - More Negative Outcomes: Overall the results suggested that individuals 
diagnosed with scleroderma have significantly different experiences to those individuals from 
the community in relation to their early life experiences and significantly different 
experiences to breast cancer and community participants in their capacity to provide 
themselves with self-compassion. The results demonstrated that individuals diagnosed with 
scleroderma were more likely to have lower experiences of warmth and safety as a child and 
tended to demonstrate less compassion toward them-selves (by engaging in less self-kindness 
PSYCHOSOCIAL STRESS SELF-COMPASSION & SCLERODERMA                    259  
  
and over-identifying to a greater extent with their experiences) than community and breast 
cancer participants (breast cancer: not significantly higher for EMWS) and by engaging in 
less mindfulness than community participants. Therefore scleroderma participants were more 
likely to engage in less self-compassion than the breast cancer and community groups who 
indicated similar scores on these variables, an experience that may be influenced by fewer 
experiences of warmth and safety as a child. Breast cancer participants however experienced 
greater fearful attachment than scleroderma participants.           
 Differences also occurred between the scleroderma and breast cancer groups for the 
variables EMWS and self-compassion and disease related variables pain and onset. Early life 
experiences low in warmth and safety and an insecure dismissive attachment style predicted 
greater experiences of pain related to disease symptoms for the scleroderma group; however 
these factors did not predict pain for the breast cancer group.         
 Results also demonstrated difference in predictor variables for age diagnosed with 
disease; with elevated hyper-arousal predicting a diagnosis of scleroderma at a younger age; 
and greater self-compassion predicting a diagnosis of breast cancer at an older age. Lower 
self-compassion predicted greater hyper-arousal, conversely greater self-compassion 
predicted lower arousal for both groups; whereas, low EMWS also predicted greater levels of 
`hyper-arousal for the scleroderma group.         
 EMWS was not significant for any variable for the breast cancer group. Results 
demonstrated differences between groups for what predicts disease related symptoms and 
onset. Therefore results for the biopsychosocial hypotheses for comparison between groups 
was partially supported.                                                                   
Hypotheses - Comparison Mental Health: More Negative Outcomes - Scleroderma Group  
 Results investigating depression, anxiety and stress demonstrated that the community 
group reported lower scores on the depression, anxiety and stress scale (DASS) and a greater 
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percentage score within the normal range for depression, anxiety and stress when compared 
to the illness group (scleroderma and breast cancer). Approximately twice the percentage of 
community individuals reported anxiety scores within the normal range, when compared to 
the illness group.            
 As hypothesised these scores indicated that a higher percentage of community 
individuals did not experience elevated levels of depression, anxiety and stress, with twice the 
percentage of community individuals experiencing non-clinical levels of anxiety when 
compared with illness individuals. A higher percentage of scores on the DASS were also 
reported by the total illness group for depression, anxiety and stress, when compared with the 
community group, with the illness group reporting approximately twice the levels of elevated 
anxiety as individuals from the community group; indicating the illness group had twice the 
percentage of individuals experiencing clinical levels of anxiety than individuals from the 
community group.               
 When comparing depression, anxiety and stress (DASS) between the illness groups 
(scleroderma/breast cancer), as hypothesised, a higher percentage of scleroderma participants 
reported clinical levels of anxiety, depression and stress than those individuals diagnosed 
with breast cancer, and a greater percentage of individuals with breast cancer reported 
nonclinical scores for anxiety, depression and stress when compared with individuals 
diagnosed with scleroderma. Results indicated that a higher percentage of scleroderma 
participants reported clinical levels of anxiety, depression and stress than breast cancer and 
community participants. A greater percentage of the total illness group reported clinical levels 
of depression, anxiety and stress, with a higher percentage (twice that of community 
individuals) experiencing elevated anxiety when compared to community participants.      
 Results comparing differences between groups revealed significantly higher levels of 
anxiety and depression for individuals diagnosed with scleroderma when compared with 
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community individuals and significantly higher levels of anxiety for breast cancer 
participants when compared with community individuals. Results demonstrated, that overall 
similar levels of stress and depression were reported by breast cancer and scleroderma 
participants, however higher levels of anxiety were experienced by individuals diagnosed 
with scleroderma when compared to breast cancer participants, although these results did not 
reach significance. Therefore results partially supported the hypotheses comparing 
differences between illness and community groups in that scleroderma and breast cancer 
participants had significantly more psychopathology than community participants. 
Scleroderma participants reported significantly higher levels of anxiety and depression, 
whereas breast cancer participants reported significantly higher levels of anxiety when 
compared to community participants.                                                                            
 Results provide partial support for the hypotheses in that significantly higher levels of 
depression and anxiety where reported by individuals diagnosed with scleroderma when 
compared to community individuals and significantly higher levels of anxiety were 
experienced by breast cancer participants when compared to community participants.  
 Predictor Variables: Scleroderma/Breast Cancer - Depression, Anxiety and Stress 
Predictor variables for depression, anxiety and stress for the scleroderma and breast cancer 
groups revealed that, low self-compassion predicted depression for both groups, while 
EMWS (scleroderma) and a dismissive attachment style (breast cancer) also predicted 
depression in the respective groups. Suppression predicted anxiety for both groups while a 
number of other variables (pain, early memories of warmth and safety, and hyper-arousal) 
predicted anxiety in scleroderma participants. While low self-compassion and elevated hyper-
arousal predicted stress in the scleroderma group.             
 Results indicated that emotion regulation strategies low in self-compassion in both 
illness groups predicted depression, while suppression was a common predictor variable for 
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both groups (scleroderma/breast cancer) for anxiety. However differences supporting the 
hypothesis also occurred between groups for the remaining predictor variables for depression 
(scleroderma: EMWS; breast cancer: dismissive attachment) and anxiety (scleroderma: pain, 
EMWS and hyper-arousal). Low self-compassion and elevated levels of hyper-arousal 
predicted stress in the scleroderma group while no variable was a unique predictor of stress 
for the breast cancer group. Results indicated that although there were common predictor 
variables for depression and anxiety, differences also occurred between groups for the 
remaining variables that contributed to depression, anxiety and stress.     
 These results demonstrated that while some psychosocial predictor variables were 
similar for scleroderma and breast cancer groups for mental health factors, differences also 
occurred. Differences in predictor variables related to mental health, were found for a number 
of psychosocial and physiological factors that included early life experiences, attachment 
styles, hyper-arousal and pain. Findings therefore provided partial support for the hypothesis. 
Comparison: Diffuse/Limited, Breast Cancer & Community Groups     
 Scleroderma Groups - More Negative Outcomes: Results partially supported the 
hypothesis that compared difference between psychosocial experiences in the two major 
subset of scleroderma (diffuse and limited sclerosis groups), the breast cancer group and the 
community group. Results demonstrated significant differences between the three illness 
groups and the community group on the self-compassion domains, over-identification, self-
kindness and mindfulness. Breast cancer and community participants reported similar 
experiences with regard to over-identification. While limited and diffuse sclerosis participants 
reported higher experiences of over-identification, diffuse participants indicated higher levels 
of over-identifying than limited sclerosis participants. Self-kindness was higher in individuals 
diagnosed with diffuse sclerosis when compared to the remaining three groups. Individuals 
with limited sclerosis reported lower experiences of self-kindness than all the other groups, 
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whereas the breast cancer and community groups again reported similar scores. The 
community group reported higher mindfulness than all groups with the lowest scores reported 
by the scleroderma groups. Limited sclerosis participants reported the lowest experiences of 
self-compassion, for the domain mindfulness.                                                                        
 Results suggest that breast cancer and community participants have similar approaches 
of identifying with their experiences and that these experiences were significantly lower than 
for individuals with limited and diffuse sclerosis, who were more likely to over-identify with 
their experiences, and less likely to engage in mindfulness techniques. Self-kindness however 
was higher for diffuse sclerosis participants when compared with community individuals who 
reported lower scores than diffuse and higher scores then breast cancer participants. Breast 
cancer participants reported lower scores for self-kindness than community individuals and 
higher scores than those diagnosed with limited sclerosis. Limited sclerosis participants again 
reported the lowest scores of all the groups.          
 Results suggest that individuals diagnosed with limited sclerosis were less likely to 
engage in acts of self-kindness and mindfulness than the other illness groups (individuals 
with diffuse sclerosis and breast cancer) or those from the community group, however the 
diffuse sclerosis group were more likely to over-identify with their experiences than the other 
illness and community groups. Results also indicated that individuals with breast cancer were 
more likely to report similar experiences of self-compassion, when compared to community 
participants. These groups generally indicated higher levels of self-compassion than the 
scleroderma groups (except for the subscale self-kindness that was higher for the diffuse 
group).                      
 Results suggest differences between the illness groups (more negative outcomes for 
scleroderma when compared to breast cancer) and similarities between the community and 
breast cancer groups for self-compassion; and therefore provide partial support for the 
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hypotheses.                                                                                     
Conclusion – Results: Scleroderma/Diffuse/Limited/Breast Cancer/Community Hypotheses  
 Results for study 3(a/b) indicated greater mental health problems for individuals 
diagnosed with scleroderma when compared to the breast cancer and community groups. 
Some similarities in predictor variables (low self-compassion and greater emotion 
suppression) for mental health between illness groups were found; however, differences also 
occurred between the breast cancer and scleroderma groups in that negative early nurturing 
experiences, low self-compassion and hyper-arousal predicted a number of negative mental 
health outcomes for the scleroderma group; whereas, dismissive attachment was the only 
other variable to predict any mental health factor (depression) for the breast cancer group. 
Findings that partially supported the comparison hypotheses for mental health.    
 Differences also occurred between the community, breast cancer and scleroderma 
groups with more negative early nurturing experiences (scleroderma: lower EMWS) and 
lower self-compassion reported by the scleroderma groups and greater reporting of fearful 
attachment for the breast cancer group when compared to the scleroderma group. These 
scleroderma experiences (EMWS and low self-compassion) along with hyper-arousal and 
dismissive attachment predicted disease related variables. Whereas greater self-compassion 
predicted more favourable disease related outcomes for the breast cancer group. Results 
generally indicated more negative outcomes for the scleroderma group when compared to the 
breast cancer and community groups and therefore provide partial support for the mental 
health and biopsychosocial group comparison hypotheses.           
                        Discussion: Study 3(a/b)                                                     
Comparison: Scleroderma/Breast Cancer                                       
 Scleroderma: Low Self-Compassion - Breast Cancer: Fearful Attachment: When the 
total scleroderma sample (diffuse and limited sclerosis and rarer forms of scleroderma) was 
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compared with the breast cancer sample, significant differences were identified in 
experiences of over-identification and fearful attachment style. Individuals diagnosed with 
scleroderma reported greater experiences of over-identifying with their experiences than 
breast cancer participants and lower experiences of fearful attachment than individuals 
diagnosed with breast cancer. Results suggest that individuals diagnosed with scleroderma 
were more likely to over-identify with their experiences than breast cancer participants, 
suggesting individuals with scleroderma engage in strategies lower in self-compassion than 
individuals with breast cancer.                   
 Lower scores for fearful attachment style were found for individuals diagnosed with 
breast cancer, when compared to scleroderma participants. This suggests that breast cancer 
participants were more likely to experience a fearful style of relating when compared with 
individuals with scleroderma. This attachment behaviour may reflect feelings of insecurity 
and emotional responses developed in early childhood. Heightened chronic experiences of 
distress in childhood that are not regulated externally by an attachment figure may affect the 
child’s developing immune system and increase vulnerability to psychological and 
physiological health conditions across the lifespan (Schore, 1994). Breast cancer participants 
who reported a greater tendency toward a fearful way of relating to significant others may be 
more likely to engage in the use of avoidant behaviours that reflect difficulties in becoming 
close to and relying on others (Mikulincer & Shaver, 2007; Simpson & Rholes, 1998). 
Fearfully attached individuals have negative expectations of both the self and others and are 
extremely self-conscious, self-doubting, experience a sense of social insecurity and exhibit 
high levels of anxiety and arousal (Mikulincer & Shaver, 2007; Simpson & Rholes, 1998). 
These individuals tend to long for their partner’s love and support, however they fear the 
possible negative consequences of intimacy and reliance on significant others. (Mikalincer & 
Shaver, 2007).                   
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 The findings of greater levels of fearful attachment in breast cancer participants may 
be partially explained by the difference in areas of the body affected by each of the diseases. 
The area affected by breast cancer may have a greater impact on these individual’s view of 
attachment and fearful insecurity around how their partner may now view or feel toward 
them. Fearfully attached breast cancer participants may have negative expectations about 
being cared for and although they desire their partners love may use avoidant strategies due to 
experiencing a disease that affects a very female (for women in this study) part of the body 
that is connected to intimacy in a relationship. Feeling fearful and avoiding connecting with 
significant others (when the need for comfort and support to reassure and provide soothing 
experiences is great); suggests copying strategies that are likely to increase arousal levels and 
reduce the capacity to self-sooth or engage in behaviours likely to elicit support and care from 
significant others.               
 The findings suggest that breast cancer participants were more likely to exhibit an 
insecure fearful attachment style than scleroderma participants and although these findings 
demonstrate differences in emotion regulation strategies, both coping styles are likely to 
create elevated levels of arousal and influence immune system functioning; and may partially 
explain the mechanisms that underlie the development of these two diseases. Findings 
indicated differences between illness groups for psychosocial responses that may impact on 
the immune system, and demonstrate the importance of identifying how different stress 
experiences may impact on individuals with different disease symptoms, to inform 
psychological treatment.                                                                                 
Comparison: Scleroderma/Community             
 Scleroderma: Lower Self-Compassion and EMWS: Significant differences were found 
between the scleroderma (diffuse and limited sclerosis and rarer forms of scleroderma) and 
community groups, for scores on early memories of warmth and safety and the domains of 
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self-compassion (over-identification, self-kindness and mindfulness) for the community 
group when compared with individuals diagnosed with scleroderma. Scleroderma participants 
reported lower levels of self-compassion and experiences of warmth and safety as a child than 
individuals from the community sample. Self-compassion domain scores were lower for self-
kindness and mindfulness and higher for over-identification (low self-compassion) for 
scleroderma participants when compared with community individuals.       
 Therefore scleroderma participants were likely to have fewer experiences of warmth 
and safety as a child than community individuals, were less likely to engage in self-
compassion strategies of self-kindness and mindfulness and more likely to engage in 
strategies high in over-identifying with their experiences, when compared to community 
individuals. These negative early childhood experiences may have included few occurrences 
or role modelling of kindness, or experiences that provide opportunities to calm the self and 
down-regulate emotions. These negative experiences reduce the opportunity to disengage 
from practices involving extended over-identification (low self-compassion), that are likely to 
increase levels of arousal, influence immune system functioning and possibly contribute to 
the development of this disease.                 
Comparison: Breast Cancer/Community                                
 No Significant Difference between Groups: Findings indicated that no significant 
difference was found between community and breast cancer participants on any of the 
psychosocial variables under investigation in this study.                                               
Comparison: Scleroderma/Breast Cancer/Community Groups        
 Scleroderma: Less Self-Compassion - Over-identification/Self-Kindness: Results 
comparing individuals diagnosed with scleroderma, breast cancer and community participants 
and psychosocial variables, found that individuals diagnosed with scleroderma demonstrated 
less self-compassion (over-identification, and self-kindness) than the breast cancer and 
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community participants. Scleroderma participants tended to over-identify with their 
experiences when compared with breast cancer and community participants. Individuals with 
scleroderma engaged in less self-kindness than breast cancer and community participants and 
also experienced less early memories of warmth and safety than community individuals and 
lower experiences than breast cancer participants (however not significantly between the 
three groups). The Scleroderma group therefore tended to demonstrate less compassion 
toward them-selves than the other groups, perhaps at a time when being kind to one-self and 
not over-identifying (low self-compassion) with one’s experience (associated with increased 
arousal in the current study) may be beneficial to an individual’s emotional health.  
 When attempting to manage the emotional and physical effects of coping with a 
diagnosis of a chronic or life threatening disease; it is conceivable those individuals who 
engage in emotion regulation strategies low in self-compassion may be likely to over-identify 
with their experiences, and that this strategy may negatively impact on their individual illness 
experience; due to the engagement of over-identification with negative experiences that may 
include illness experiences. This strategy low in self-soothing may increase levels of negative 
arousal (hyper-arousal) and impact on disease symptoms. Lower early life experiences of 
warmth and safety may explain the significant difference between the groups in levels of self-
kindness and over-identification. Scleroderma participants reporting lower self-kindness and 
greater experiences of over-identification were likely to have experienced less warmth and 
safety as a child. Limited exposure to compassionate care (warmth) and safe environments 
(safety) as a child may reduce the development of the self-soothing social mentality and the 
capacity to provide ones-self with compassionate soothing experiences in adulthood. 
 These results suggest that early life experiences deficient in nurturing and security are 
likely to influence an individual’s ability to engage in compassionate soothing emotion 
regulation strategies and may explain the differences in levels of self-compassion experienced 
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between the groups.                      
 Comparison Study: Diffuse/Limited/Breast Cancer/Community Groups    
 Limited: Less Self-Kindness/Mindfulness - Diffuse: Greater Over-identification: 
Results for individuals diagnosed with one of the major subsets of scleroderma (diffuse and 
limited sclerosis), breast cancer and community participants for psychosocial variables; 
demonstrated significant differences between the self-compassion domains of self-kindness, 
mindfulness and over-identification. Individuals diagnosed with limited and diffuse sclerosis 
were more likely to engage in strategies that involved over-identifying with their experiences 
than breast cancer and community participants (reporting similar experiences). Diffuse 
sclerosis participants were more likely to engage in higher levels of over-identification than 
individuals with limited sclerosis. Whereas limited sclerosis participants were more likely to 
engage in strategies lower in self-kindness than the other illness and community participants. 
Individuals with diffuse sclerosis engaged in higher levels of self-kindness than all other 
groups. Limited sclerosis participants engaged in less mindfulness than all other groups, 
whereas diffuse sclerosis participants reported higher scores on mindfulness than the limited 
group and lower scores than the breast cancer and community groups. The community group 
reported the highest score on mindfulness than all of the groups. Diffuse sclerosis participants 
were therefore more likely to over-identify with their experiences than the remaining groups 
and less likely to engage in mindfulness (than community and breast cancer participants).  
 Over-identifying experiences tend to reduce the likelihood of engaging in mindfulness 
as a strategy to manage difficult experiences. Limited sclerosis participants tended to over-
identify with their experiences at a greater level than breast cancer and community 
participants and were also less likely to engage in strategies high in self-kindness and 
mindfulness than the other illness (diffuse sclerosis and breast cancer) or community 
participants. The limited group generally appear to exhibit less self-compassion than all other 
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groups, and may over-identify (low self-compassion) with experiences at a greater level than 
breast cancer and community participants as a result of not engaging in compassionate 
mindfulness when stressed or distressed. These individuals therefore are not mindfully aware 
they are engaging in over-identification and therefore are unable to utilize self-soothing 
compassionate strategies to calm the self. Ways of relating to self may therefore involve over-
identifying with the stress experience rather than self-soothing a strategy that may have 
resulted in negative health consequences. Breast cancer and community participants tended to 
exhibit similar scores on the self-compassion variables.              
 Higher levels of over-identifying with one’s experiences for diffuse sclerosis 
participants may result from the type of disease symptoms these individuals are likely to 
endure; such as skin thickening that involves rapid progression beginning in the extremities 
and advancing to the trunk early in the development of the disease. Other problematic issues 
include gastrointestinal disease and lung fibrosis (e.g., Bolster & Silver, 2008), the 
uncertainty of developing further symptoms, the disease course and likely prognosis. 
Although over-identifying with one’s experiences is a negative domain of self-compassion, 
individuals with diffuse sclerosis were able to engage in self-compassion strategies of self-
kindness at higher levels than other participants in this study, strategies that may help these 
individuals manage the emotional aspects of experiencing such disease symptoms.  
 Individuals with limited sclerosis tended to over-identify with their experiences at a 
greater level than breast cancer and community participants. This may also be explained by a 
difficulty in attempting to manage a range of symptoms that are different for most 
individuals; such as skin thickening in the extremities, Raynaud’s phenomenon, finger ulcers, 
calcinosas, oesophageal and intestinal conditions, pulmonary hypertension, breathing 
problems, pain (e.g., Etkin et al.; Giuggioli et al., 2010) and uncertainty of the disease course.  
 However unlike the diffuse sclerosis participants, individuals with limited sclerosis 
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were less likely to engage in strategies high in self-kindness and demonstrated the lowest 
levels of self-kindness and mindfulness of all participants. Lower reports by limited sclerosis 
participants of over-identifying with their experiences when compared with diffuse sclerosis 
participants, may be due to a slower onset of the disease for limited sclerosis participants, 
providing the individual with more time to adjust to diagnosis and generally less severe 
disease symptoms to manage than diffuse sclerosis participants. Limited sclerosis participants 
may also over-identify with their experiences due to engaging emotion regulation strategies 
low in self-kindness and mindfulness.               
 Mindfulness enables an individual to remain connected to and evaluate their current 
circumstances from an emotional distance, reducing immersion in the experience and 
providing the opportunity to observe thoughts and feelings as they occur with compassionate 
awareness and acceptance. Mindful self-kindness reduces negative emotions and provides a 
more positive emotion regulatory approach, based on kindness and understanding toward the 
self (Neff, 2003a; Neff et al., 2007), rather than an evaluative process (Neff, 2003a) 
(involving the threat mentality, that is likely to increase arousal; e.g., Gilbert, 2000) that is 
likely to increase the practice of over-identifying with one’s experiences and may explain the 
lower levels of self-kindness and mindfulness reported by individuals with limited sclerosis .   
 Individuals with breast cancer were less likely to over-identify with their experiences 
than limited and diffuse sclerosis participants and more likely to engage in self-kindness and 
mindfulness than limited sclerosis participants. Breast cancer participants were also less 
likely to engage in the self-compassion strategy of self-kindness than diffuse sclerosis 
participants. Community individuals generally tended to exhibit higher scores on self-
compassion than scleroderma participants and reported similar scores to breast cancer 
participants, with the exception of self-kindness that was higher for diffuse sclerosis 
participants. How an individual regulates their emotions may be an indicator of whether they 
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operate in the threat mentality or the self-soothing social mentality and may impact on the 
relationship the individual has with the self. Engaging in strategies low in self-kindness and 
mindfulness in times of stress or distress, may reduce an individual’s ability to self-sooth and 
manage difficulties without over-identifying with them, a strategy likely to increase the stress 
experience and level of arousal.         
 Research suggests the first symptom of scleroderma (Raynaud’s phenomenon) is 
associated with stress (Freedman & Ianni 1983), findings that are supported by results from 
the first study (greater experiences of stress were linked to scleroderma participants reporting 
an earlier diagnosis of Raynaud’s phenomenon). Results from the first study also 
demonstrated that elevated levels of stress were experienced by scleroderma participants 
diagnosed with Raynaud’s phenomenon when compared with non-Raynaud’s/scleroderma 
participants. Findings for individuals diagnosed with limited sclerosis indicated the younger 
these individuals were diagnosed with Raynaud’s phenomenon the more likely the utilization 
of emotion regulation strategies suppression and insecure dismissive attachment. These 
strategies suggest a pattern of avoidance when relating to self and others as a method of 
coping. Avoidant coping strategies likely to engage the threat mentality may influence 
physiological responses in times of stress, increasing the likelihood of exposure to the long 
term effects of the stress and possibly immune functioning associated with an earlier 
diagnosis of Raynaud’s phenomenon. Individuals who utilize a dismissive style of relating 
tend to engage avoidance and distancing strategies to manage emotions associated with 
thoughts such as not believing they are worthy of care; strategies likely to increase 
physiological processes involving stress and immune responses (Mikalincer & Shaver, 2007).   
 Raynaud’s phenomenon is a vascular disorder that involves constriction of blood 
vessels generally in the peripheral areas of the body; however, this condition can also affect 
internal organs (e.g., Baker & Denton, 2008). Emotional stress influences physiological 
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systems that are implicated in the constriction of blood vessels. Sympathetic activation of 
blood vessels, constriction of blood vessels and blood circulation are controlled by neural 
pathways that involve chemicals such as norepinephrine and epinephrine released during 
situations such as physical and emotional stress (Sumpio et al., 2002). Individuals with 
scleroderma who engage emotion regulation strategies low in self-soothing are likely to 
increase physiological responses involving the release of chemicals in the stress response.  
 Strategies lower in self-compassion may therefore result in the underutilization of the 
self-soothing social mentality and increase the experience of stress over prolonged periods of 
time, impacting on the immune system and an earlier onset of Raynaud’s phenomenon in 
individual’s diagnosed with limited sclerosis. Raynaud’s phenomenon in individuals 
diagnosed with diffuse sclerosis generally tends to occur immediately preceding or at the time 
of onset of the inflammatory stage of this form of scleroderma (Smith & Kahaleh, 2008).  
Diffuse sclerosis participants tended to engage in greater use of self-compassion (self-
kindness) than other participants, however this group was more likely to over-identify (low 
self-compassion) with their experiences than any of the other illness or community 
participants. Individuals with diffuse sclerosis who utilize the practice of over-identify with 
their experiences may have difficulty adapting to and attempting to manage the more rapid 
onset and greater symptomology (can affect a number of systems in the body) of their 
condition when compared with the other participants.            
 An earlier diagnosis of Raynaud’s phenomenon in the first study was also associated 
with over-identifying (low self-compassion) strategies in individuals diagnosed with diffuse 
sclerosis. Over-identifying with ones experiences is likely to reduce the ability to calm the 
emotional response increasing arousal levels and possibly impacting on the immune system. 
As diffuse sclerosis participants were more likely than any of the other participants to engage 
in this emotion regulation strategy at greater levels, it is possible this strategy may influence 
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immune functioning and an earlier onset of the first symptom (Raynaud’s) of this disease; 
findings that are consistent with the first study.             
 Differences between the disease groups and community participants may indicate that 
stress, in the form of how an individual relates to the self in times of difficulty, may result in 
individuals with limited sclerosis remaining in chronic states of threat, due to a reduced 
capacity to self-sooth when compared with other participants in this study. The 
underutilization of emotion regulation strategies such as self-compassion and the practice of 
over-identifying with experiences in times of stress, may therefore increase the likelihood of 
an individual engaging the threat system on a regular basis for prolonged periods of time, 
heightening arousal levels and impacting on immune processes that may be associated with 
the onset of the first symptom of limited sclerosis. Continuing to use these threat related 
strategies may therefore place an individual in chronic states of fight and flight over a long 
time frame, further impacting on the immune system and perhaps the progression to the next 
stage of the disease that may take up to decades to occur.            
 While diffuse sclerosis participants tended to engage in greater use of self-kindness, 
their practice of over-identifying with their experiences may be partially explained by 
difficulties experienced adapting to and attempting to manage the more rapid onset and 
greater symptomology of their condition when compared with the other groups. This 
experience; however, may also involve over-identifying with other emotional experiences not 
related to the emotional and physical aspects of managing the symptoms of diffuse sclerosis.  
 Findings in the first study demonstrated that over-identifying with emotional 
experiences, were strategies likely to increase physiological arousal and possibly influence 
immune functioning, factors that were related to an earlier onset of Raynaud’s for diffuse 
(and limited) sclerosis participants; suggesting these participants engaged in this style of 
thinking before onset of the disease. This way of thinking may therefore impact on immune 
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functioning, an earlier onset of scleroderma and possibly the disease course. Both diffuse and 
limited sclerosis participants were more likely to engage in strategies lower in self-
compassion than breast cancer and community participants, (with the exception of self-
kindness for diffuse sclerosis) inadequate emotion regulation strategies that may be likely to 
impact on immune system functioning and the development or earlier onset of the two major 
forms of scleroderma.                                                                                                                     
Overall Findings: Scleroderma -Breast Cancer - Community                             
Psychosocial: Scleroderma - Diffuse - Limited - Breast Cancer - Community     
 Scleroderma - Lower EMWS and Self-Compassion: Overall findings demonstrated 
that scleroderma participants and in particular individuals with limited sclerosis have 
significantly different experiences from community and breast cancer participants in relation 
to their early life experiences and their capacity to be kind to themselves. Limited 
opportunities to develop the self-soothing social mentality due to early life experiences low in 
warmth and safety and a limited capacity to engage in self-compassion strategies may (for 
individuals with scleroderma) engage the threat system rather than the soothing system when 
stressed or distressed. This way of relating to the self may impact on the immune system and 
over time, initiate an autoimmune reaction.               
 The findings in this study further support the literature and Gilbert’s social mentalities 
theory (e.g., 2000; 2002; 2012), that proposes early rearing experiences deficient in 
compassion are likely to impede the development of the self-soothing social mentality, a 
system that assists in the regulation of emotions when distressed. Individuals who tend to 
function in the threat mentality as a result of inadequate exposure to compassion experiences 
in early life, may experience situations as more threatening, than others with more positive 
nurturing experiences. These individuals may experience augmented physiological responses 
such as increased sympathetic nervous system activation (Campbell-Sills et al., 2006) and 
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immune dysregulation (Schore, 1994) as a consequence of developing a hyper-responsive 
threat processing system (Gilbert, 2007).                 
 The literature suggests that early stress experiences may impact on an individual’s 
ability to cope in stress situations and reduce arousal levels, impacting on the immune system 
and increasing the likelihood of an autoimmune response (Heit et al., 1999; Schore, 1994) 
that may contribute to the development of scleroderma. Living with a chronic and incurable 
disease and having few compassionate strategies to manage ones thinking, may exacerbate 
one’s identification with experiences, particularly those associated with the negative aspects 
of this disease. These strategies may increase the individual’s distress at a time when a well-
developed soothing mentality (that would assist in the reduction of distress) may be more 
beneficial.                                                                                                                         
Mental Health: Scleroderma/Breast Cancer/Community         
 Scleroderma: Higher Levels of Depression and Anxiety: Findings for the hypothesis: 
that individuals with scleroderma and breast cancer would report higher levels of depression, 
anxiety and stress when compared with community individuals; demonstrated lower scores 
for community participants on depression, anxiety and stress. A higher percentage of scores 
for community participants were recorded within the normal range for these variables, when 
compared to illness participants; with almost double the percentage of community 
participants reporting anxiety scores within the normal range, when compared to illness 
participants. A higher percentage of community participants did not report elevated 
depression, anxiety and stress; indicating non-clinical levels of anxiety at twice the level of 
illness individuals. Illness participants reported greater scores for depression, anxiety and 
stress and twice the percentage of clinical levels of anxiety than community participants.   
 A higher percentage of individuals with scleroderma reported clinical levels of 
anxiety, depression and stress, when compared with breast cancer participants, with a greater 
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percentage of breast cancer participants reporting non-clinical scores for anxiety, depression 
and stress than scleroderma participants. Findings demonstrated that a greater percentage of 
individuals with scleroderma, reported clinical levels of depression, anxiety and stress when 
compared to breast cancer and community participants. When comparing illness and 
community participants, a greater percentage of individuals with illness reported clinical 
levels of depression, anxiety and stress with a higher percentage (twice that of community 
individuals) experiencing elevated anxiety.               
 Clinical findings were supported by statistical results comparing differences between 
illness and community participants. Significantly higher levels of anxiety and depression 
were reported by scleroderma and breast cancer participants when compared with community 
participants and significantly higher levels of depression were reported by scleroderma 
participants compared to community individuals. Higher levels of anxiety were experienced 
by individuals diagnosed with scleroderma when compared to those diagnosed with breast 
cancer, although these results did not reach significance. These findings suggest that 
individuals attempting to manage a chronic and/or potentially life threatening disease may 
experience elevated levels of depression, anxiety and stress, perhaps due to the uncertainty of 
their prognosis and an inability to utilize the self-soothing mentality to manage affect. 
Engaging the threat mentality may increase physiological and psychological symptoms such 
as depression and anxiety in individuals diagnosed with scleroderma and breast cancer.    
 A greater percentage of scleroderma participants reported clinical levels of depression, 
anxiety and stress than breast cancer participants, indicating that individuals with scleroderma 
may be more susceptible to psychopathology than breast cancer and community individuals. 
This may be partially explained by deficits in compassion consequential to lower early life 
experiences of warmth and safety. Individuals with limited early life experiences involving 
feeling safe and nurtured are less likely to be exposed to experiences of compassion and 
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kindness and subsequently are likely to exhibit an underdeveloped self-soothing social 
mentality (e.g., Gilbert, 2000). Therefore individuals with scleroderma may be more likely to 
engage the threat mentality (rather than engage in self-compassion) due to previous negative 
experiences, than breast cancer and community participants.                  
Comparison - Predictor Variables Mental Health: Scleroderma/Breast Cancer 
Scleroderma: EMWS/Self-Compassion/Suppression/Hyper-arousal       
  Findings related to predictor variables for depression, anxiety and stress for breast 
cancer and scleroderma participants revealed a number of differences between groups. 
Experiences low in early memories of warmth and safety and low in self-compassion 
predicted depression for scleroderma participants. While a dismissive attachment style and 
low self-compassion predicted depression for breast cancer participants. Suppression was the 
only variable to predict anxiety for breast cancer participants, whereas early memories of 
warmth and safety, suppression, hyper-arousal and pain predicted anxiety in individuals 
diagnosed with scleroderma. Low self-compassion and elevated levels of hyper-arousal 
predicted stress in the scleroderma group, while there was an association between these 
variables for the breast cancer group, no variable was a unique predictor of stress. Therefore 
there were some similarities between scleroderma and breast cancer individuals for predictor 
variables for depression (low self-compassion) while EMWS (scleroderma) and dismissive 
attachment (breast cancer) also predicted depression.             
 For anxiety, suppression was the only common predictor variable for both groups, 
while early memories of warmth and safety (a predictor variable for self-compassion), hyper-
arousal and pain also predicted anxiety in scleroderma participants. These results indicated 
that emotion regulation strategies low in self-compassion (predictor variables for self-
compassion; elevated hyper-arousal for both groups as well as EMWS for scleroderma 
participants) in both illness groups predicted depression, while suppression was a common 
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predictor variable for both groups for anxiety. Differences occurred between the groups on 
the remaining predictor variables for depression (dismissive attachment style for the breast 
cancer group and early memories low in warmth and safety for the scleroderma group). Low 
self-compassion and elevated levels of hyper-arousal predicted stress in individuals diagnosed 
with scleroderma, while no variable was a unique predictor of stress for breast cancer 
participants.                     
 Results indicated that although there were common predictor variables for depression 
and anxiety, differences also occurred between groups for the remaining variables that 
contributed to depression, anxiety and stress. As a large percentage of scleroderma 
participants experienced clinical levels of depression, anxiety and stress, individuals 
diagnosed with scleroderma may be more vulnerable to psychopathology than breast cancer 
and community participants. This may be partially explained by deficits in compassion 
consequential to lower early life experiences of warmth and safety and elevated levels of 
hyper-arousal. Individuals with limited early life experiences involving feeling safe and 
nurtured are less likely to be exposed to experiences of compassion and kindness and 
subsequently are likely to exhibit an underdeveloped self-soothing social mentality (e.g., 
Gilbert, 2000; 2012), that may elevate threat related arousal levels.       
 Individuals with scleroderma may therefore be more likely to engage the threat 
mentality due to previous negative experiences, than breast cancer participants who may 
experience depression due to their disease diagnosis; rather than perhaps underlying 
developmental factors, or community participants, who reported significantly greater levels of 
non-clinical depression. Depression has been associated with self-criticism; higher levels of 
self-criticism in previous studies were associated with higher levels of depression (Gilbert et 
al., 2006). Therefore the inability to be kind to ones-self when stressed or exposed to threat 
events such as a diagnosis of a disease (where the recipient must manage the constraints 
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imposed on the body as a consequence of the disease and the fear associated with a poor 
prognosis) by engaging in strategies low in self-compassion, may exacerbate experiences of 
depression and therefore the development of a more depressive view of the disease course, 
for both scleroderma and breast cancer participants.            
 How participants develop their emotion regulation strategies appears to vary between 
illness groups. Scleroderma participant’s early life experiences, low in warmth and safeness 
may have impacted on their levels of self-compassion, whereas breast cancer participant’s 
dismissive way of relating to attachment figures may influence how they relate to themselves; 
i.e., with or without compassion and whether they engage the assistance of significant others 
for support as external emotion regulators in times of stress/distress. Dismissively attached 
(breast cancer) individuals are likely to demonstrate avoidant behaviours that reflect 
difficulties in relying on others and developing feelings of closeness to significant others (as 
identified by Mikulincer & Shaver, 2007). These individual’s generally view themselves 
positively and exhibit independent behaviours, however they engage in avoidance and 
distancing due to uncertainty of others willingness to support then in times of need (Simpson 
& Rholes, 1998), a strategy that may create hyper-arousal in relatively minor situations (Van 
der Kolk & Greenberg 1987).                
 Breast cancer participants who engage these strategies may therefore be less likely to 
employ the self-soothing social mentality and engage significant others in a manner that 
engenders support. This strategy reduces the likelihood of accessing external emotion 
regulation resources that may provide soothing experiences when distressed and opportunities 
for the individual to reduce arousal and feel safe and secure. Employing strategies such as a 
dismissive style of relating and engaging in low-self compassion are negative ways of 
relating to the self and others likely to engage the threat mentality, and in this study increased 
breast cancer participant’s experience of depression.       
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  Suppression was a common predictor variable for anxiety for both scleroderma and 
breast cancer participants and may be utilized as an emotion regulation strategy to avoid 
fearful cognitions or emotions involving the adapting to and managing disease symptoms. 
Early life experiences low in warmth and safety as well as hyper-arousal and pain also 
predicted anxiety in individuals with scleroderma. This suggests these individuals were more 
likely to operate in the threat mentality as a result of limited early life experiences of feeling 
safe and nurtured and this may reduce their ability to operate in the self-soothing mentality, 
increasing their experience of anxiety. Therefore individuals with scleroderma who operate in 
the threat mentality as a result of experiencing limited nurturing and opportunities to feel safe 
in their childhood, may experience heightened states of arousal likely to impact on pain levels 
associated with their disease and elevated anxiety levels.       
  Scleroderma participants were also likely to suppress emotions, cognitions, memories 
or experiences that create distress as a strategy to regulate their emotions. This approach 
however is also likely to increase arousal levels and elevate anxiety. Living with a disease 
may elevate an individual’s experience of anxiety and depression. Fear associated with 
disease symptoms and no known cure may engage feelings of helplessness and hopelessness 
associated with depression. These results suggest that thoughts associated with managing a 
disease are likely to impact on an individual, irrespective of the type of disease an individual  
suffers.                      
  Low self-compassion and elevated levels of hyper-arousal predicted stress in 
individuals diagnosed with scleroderma, further demonstrating the likelihood that 
scleroderma participants were more likely to generate elevated levels of arousal when 
stressed, possibly due to engaging the threat mentality as a result of under-developed emotion 
regulation strategies in self-compassion. The utilization of strategies low in self-compassion, 
are likely to reduce the ability to self-sooth and reduce arousal levels, strategies likely to 
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increase the experience of stress in this study. Therefore the underdevelopment of the self-
soothing social mentality as a result of early threatening environments (that fail to provide 
feelings of safeness and warmth) likely to over-activate the threat mentality (e.g., Gilbert, 
2000; Gilbert, 2012), may impact on individuals experiences of depression, anxiety and stress  
in the current study.                     
  The greater an individual’s lack of positive early life experiences and the more an 
individual engages in emotion regulation strategies that involve avoidance or a negative way 
of relating to the self or others (that does not engage the self-soothing social mentality), the 
greater the likelihood an individual with scleroderma or breast cancer may engage negative 
cognitions and emotions associated with the threat mentality. This way of relating may 
elevate arousal levels associated with threat processing, the fight and flight response and 
physiological processes associated with immune dysregulation.        
 These threat experiences are therefore likely to impact on the individual with 
scleroderma and breast cancer’s psychological wellbeing and capacity to manage a disease 
prognosis. The findings in this illness population are consistent with Gilbert and colleagues 
findings (2008; in a non-illness study) and add to the literature that suggest feeling safe and 
content and engaging in self-compassion strategies has a significant negative correlation with 
depression, stress, and an insecure attachment style (Gilbert et al., 2008; Neff et al., 2007) 
and also impacts on pain associated with disease symptoms in individuals diagnosed with  
scleroderma, as found in the current study.                              
Comparison: Pain - Scleroderma/Breast Cancer                                        
 Scleroderma: EMWS/Dismissive Attachment: Findings for pain in the total illness 
group (scleroderma and breast cancer) demonstrated that early life experience low in warmth 
and safety and a dismissive style of relating predicted pain. When the scleroderma and breast 
cancer groups were explored separately, early life experience low in warmth and safety and a 
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dismissive attachment style were significant unique predictors of pain experienced by 
individuals diagnosed with scleroderma. While neither variable predicted pain in breast 
cancer participants. These findings suggest that negative nurturing experiences associated 
with not feeling safe and cared for and an insecure dismissive attachment style, predict 
elevated levels of pain associated with scleroderma and are factors likely to engage the fight 
and flight response as a result of engaging the threat mentality. These variables however did 
not predict pain for breast cancer participants, suggesting that scleroderma participants were 
more likely to engage the threat mentality perhaps due to an in ability to self-sooth that may 
increase the experience of pain, than individuals diagnosed with breast cancer.                   
Breast Cancer Symptoms: Mental Health/Psychosocial           
  Fatigue - Depression: Findings for depression, anxiety and stress and breast cancer 
symptoms nausea and fatigue, demonstrated that fatigue was the only disease variable to 
predict depression, no other variable was significant for anxiety or stress; therefore breast 
cancer participants who reported elevated levels of fatigue were likely to experience higher 
levels of depression. Individuals were therefore more likely to experience greater levels of  
fatigue when depression was more severe.              
  Fatigue - Hyper-arousal: Findings for breast cancer participants for fatigue and 
nausea and psychosocial variables demonstrated that hyper-arousal was the only variable that 
predicted fatigue (no psychosocial variable predicted nausea); therefore breast cancer 
participants who experienced higher levels of hyper-arousal were more likely to experience 
elevated fatigue. Hyper-arousal may result from a number of factors including a heightened 
physiological stress response (Freedman & Ianni, 1983) or psychological stress involving the 
threat mentality, such as fear associated with a diagnosis of breast cancer or a fearful style of 
relating, a variable that was significantly associated with fatigue (but did not reach 
significance as a predictor variable) and significantly higher in breast cancer participants than 
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scleroderma participants. Feeling fearful and avoiding support from significant others in 
times of distress, may engage the threat system and increase levels of physiological arousal 
that may impact on the immune system and individuals with breast cancer experience of  
fatigue and depression.                                                                                                                                 
Age Diagnosed with Scleroderma/Breast Cancer            
  Scleroderma: Hyper-arousal - Breast Cancer: Self-Compassion: Findings for age 
diagnosed with an illness (breast cancer or scleroderma) for the total illness group 
demonstrated that low self-compassion and elevated hyper-arousal were significantly related 
to age diagnosed with an illness; however neither variable significantly predicted age 
diagnosed with an illness. When analysis for the illness groups was conducted independently, 
higher experiences of self-compassion predicted a diagnosis of breast cancer at an older age, 
while elevated levels of hyper-arousal predicted a diagnosis of scleroderma at a younger age. 
These findings demonstrate differences between the illness groups for aspects that are likely 
to contribute to an earlier onset of scleroderma and a later onset of breast cancer.     
 Elevated experiences of hyper-arousal may result from an individual operating in the 
threat mentality due to a limited capacity to engage the self-soothing mentality and return the 
body to a state of homeostasis. Scleroderma participants who experienced elevated and 
perhaps chronic states of hyper-arousal were more likely to report an earlier onset of 
scleroderma; whereas breast cancer participants who employed self-compassion strategies 
were more likely to experience a later onset of breast cancer. The utilization of self-
compassion a strategy likely to engage the self-soothing social mentality to manage emotions 
and reduce the threat experience (this assumption is supported by the significant relationship 
between self-compassion and hyper-arousal; with greater self-compassion predicting lower 
levels of hyper-arousal), may possibly decrease arousal and return the individual with breast  
cancer’s body to a state of equilibrium.              
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  These findings suggest that self-compassion is a powerful strategy for managing an 
individual’s emotions and effectively reducing the experience of threat, arousal levels and the 
effect on the immune system in a manner that appears to delay the onset of breast cancer. 
This suggests that individuals who are likely to experience breast cancer may delay the onset 
of this disease by engaging in strategies high in self-compassion. It is therefore possible that 
negative early life experiences and the development of certain cognitions and emotions that 
are low in self-compassion are likely to increase arousal levels and subsequently impact on 
the immune system; and may partially contribute to the development or earlier onset of 
scleroderma. Breast cancer participants when compared to scleroderma participants did not 
report significant results for negative early life experiences and reported more positive 
outcomes due to engaging in self-compassion (e.g., a later diagnosis of breast cancer).  
Conclusion: Differences between Groups              
  In conclusion findings suggest difference between groups on a number of variables, 
with all variables under investigation significantly related to or predicting dependant 
variables; partially supporting the hypotheses. Results suggest that differences between 
groups may be related to early life experiences of stress/threat and the individual’s capacity to 
engage inter-personal and intra-personal resources to manage stress/distress and reduce the 
impact of negative events. Early life experiences that provide limited experiences of warmth 
and feelings associated with safety may impact on an individual’s subjective evaluation of 
stress/threat experiences, the capacity to self-sooth and to rely on others as emotion 
regulators. These negative rearing experiences may subsequently reflect a reliance on 
inadequate resources such as suppressing emotions and strategies low in self-compassion that 
may impact on the level and duration of arousal or hyper-arousal, an individual experiences 
throughout the lifespan. Hyper-arousal in the current study was related to scleroderma 
symptomology and lower self-compassion and may be a consequence of negative early 
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rearing experiences, lacking adequate opportunities to feel safe and calm.    
 Scleroderma participants were more likely to report less childhood memories of 
warmth and safety and lower self-compassion (over-identification, self-kindness and 
mindfulness) than community participants. Scleroderma participants were also more likely to 
over-identify with their experiences than breast cancer participants and less likely to 
experience an insecure fearful attachment style than breast cancer participants. Breast cancer 
participants demonstrated similar levels of self-kindness and over-identification with their 
experiences when compared with community individuals. Scleroderma participants therefore 
have significantly different experiences than community participants in relation to their early 
life experiences and significantly different experiences than community and breast cancer 
participants in their capacity to be kind to themselves; however, breast cancer participants 
were more likely to experience a fearful attachment style than scleroderma participants.  
  Difference between groups demonstrated that negative rearing experiences that are 
likely to impact on the development of self-compassionate emotion regulation strategies and 
impede the development of the self-soothing social mentality were greater in scleroderma 
participants than community participants. Breast cancer participants were more likely to 
experience a fearful style of relating to significant others than scleroderma participants; a way 
of relating that for some individuals with breast cancer may also have developed in 
childhood. This strategy may as a consequence of developing breast cancer, create further 
insecurity in intimate relationships as a result of negative perceptions around reliance on 
others at a time when seeking support from a significant other may be beneficial; in that it 
provides opportunities to reduce arousal and increase feelings of safety and security.  
  Higher levels of self-compassion were predicted by lower experiences of arousal for 
individuals diagnosed with breast cancer, while lower engagement in self-compassion and 
limited early life experiences of warmth and safety predicted elevated hyper-arousal in 
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individuals diagnosed with scleroderma. These predictor variables may further explain the 
issues that underlie the experiences explored in this study that involve limited experiences of 
feeling safe and secure in childhood and the under-development of self-compassion, an 
emotion regulation strategy likely to increase the engagement of the threat mentality, levels  
of arousal and dysregulation of the immune system.           
  A higher percentage of scleroderma participants reported clinical levels of anxiety, 
depression and stress when compared to breast cancer participants, with a greater percentage 
of breast cancer participants reporting non-clinical scores for anxiety, depression and stress 
than scleroderma participants. Clinical findings were supported by statistical results 
comparing differences between illness and community participants. Similarities were found 
between scleroderma and breast cancer individuals for the predictor variable low self-
compassion for depression, while EMWS (scleroderma) and dismissive attachment (breast 
cancer) also predicted depression for the respective groups. Suppression was the only 
common predictor variable for both groups for anxiety and the only significant variable for 
breast cancer. While early memories low in warmth and safety, hyper-arousal and pain also 
predicted anxiety in scleroderma participants. Low self-compassion and elevated levels of 
hyper-arousal predicted stress in individuals diagnosed with scleroderma, while no variable 
predicting stress for breast cancer participants. Findings indicated that although there were 
common predictor variables for depression (self-compassion) and anxiety (suppression), 
differences also occurred between groups for the remaining variables, with EMWS, self-
compassion, hyper-arousal and pain predicting the dependent variables for scleroderma  
participants. 
                      
  Findings also demonstrated early life experiences low in warmth and safety and a 
dismissive attachment style predicted pain for scleroderma participants; however, no variable 
predicted pain in breast cancer participants; indicating difference between groups for 
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experiences that predict elevated levels of pain. Scleroderma participants negative early life 
experiences appear not only to impact on their levels of depression and anxiety but also effect 
pain related aspects of this disease, whereas these early life experiences and the variables they 
predict were not shared by individuals diagnosed with breast cancer. Breast cancer 
participant’s low experiences of self-compassion however predicted depression, along with 
an insecure dismissive attachment style. This way of relating to others may also be learnt in 
early childhood (Schore, 1994) and involves the utilization of avoidant behaviours low in 
self-compassion. These strategies reflect distancing and difficulty relying on significant 
others for support and soothing in times of need (Mikulincer & Shaver, 2007; Simpson & 
Rholes, 1998). A way of relating that is also likely to engage the threat mentality (e.g., Van 
der Kolk & Greenberg 1987; Gilbert, 2000; 2012) and reduce opportunities to manage  
arousal levels and feel safe and secure.              
  Lower experiences of self-compassion and elevated hyper-arousal also predicted stress 
in scleroderma participants, suggesting that stress experiences were also related to operating 
in the threat mentality, resulting from using strategies that indicate limited opportunities to 
develop and utilize emotion regulation strategies high in self-compassion. Strategies likely to 
reduce arousal levels (this argument is supported by the statistical significant predictor 
variables for low self-compassion for scleroderma participants; elevated hyper-arousal and 
limited experiences of warm and safety as a child) and the experience of stress. Scleroderma 
and breast cancer participants also demonstrated differences in predictor variables for age 
diagnosed with these respective conditions. Higher experiences of self-compassion predicted 
a later diagnosis of breast cancer, while elevated experiences of hyper-arousal predicted an 
earlier onset of scleroderma. Therefore early life experiences that provide opportunities to 
development the self-soothing social mentality through the use of emotion regulation 
strategies that promote self-compassion and a secure attachment style are likely to be 
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associated with lower arousal levels and more beneficial physical and psychological health 
outcomes.               
  Scleroderma - Greater Negative Psychosocial Experiences: Individuals with 
scleroderma appear to suffer greater levels of psychopathology when compared with breast 
cancer and community participants in this study. These findings may be due to greater early 
life experiences deficit in warmth and safety, a situation likely to increase fear and threat 
factors associated with the threat mentality and elevated levels of arousal, associated with 
physical, psychological and social factors in this study. Scleroderma and breast cancer 
participants who engaged in negative ways of relating to self (low self-compassion) and 
others (dismissive attachment style) were more likely to report greater psychological distress 
and therefore more likely to engage the threat mentality. As greater levels of self-compassion 
predicted a later onset of breast cancer and greater levels of hyper-arousal predicted an earlier 
diagnosis of scleroderma, it is likely that engaging in self-compassion strategies that involve a 
well-developed self-soothing social mentality rather than the threat mentality may predict 
better outcomes for individual experiences, of disease related symptoms and psychological  
well-being.                        
  In conclusion, the absence of compassionate soothing experiences and the 
internalisation of early external threat (early life experiences low in warmth and safety) may 
impede the development of the self-soothing social mentality and lead to an inability to use 
effective strategies for regulating the emotional response to stress or distress. The 
development and utilization of strategies that involve self-compassion and reliance on 
attachment figures to promote emotional and subsequently physiological calming responses 
may be beneficial to individuals with scleroderma and breast cancer in relation to emotional 
and physical health.                    
 Engaging defensive strategies such as suppression and a dismissive style of relating to 
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avoid internal and external threat experiences may reduce the ability to engage in self-
kindness and may reduce the capacity to draw on compassionate resources and subsequently 
increase an individual with scleroderma’s susceptibility to conditions such as depression, 
anxiety and stress and physiological responses, that increase sympathetic nervous system 
activation (hyper-arousal) and create immune dysregulation; experiences that may explain an 
earlier onset of scleroderma. While a greater capacity to engage in self-compassion as an 
effective emotion regulation strategy to reduce arousal and return the body to homeostasis 
may contribute to a later diagnosis of breast cancer.         
 Findings suggest that different psychosocial stressors may indicate different symptom 
responding in different illness populations and therefore the need to identify how different 
stressors may impact on a range of different diseases. The implications for stress reduction 
and psychological treatments based on common stressors in each of the illness populations 
may prove helpful in treating patients with physical illness through the utilisation of 
psychological therapies.                                                                                                     
Limitations                       
 The recruitment of a larger sample of breast cancer participants for this research 
project was difficult to gain due to breast cancer organisations concerns about exploring 
members early childhood experiences, due to factors related to blame for the development of 
the disease. Therefore low participant numbers in relation to number of variables and analysis 
in this study is a limitation. Post-hoc power calculations were therefore conducted to ensure 
adequate power. Calculations for significant findings except pain in the total illness sample 
indicated adequate power. The pattern resulting from all findings in both illness groups 
indicated a link between early life experiences (scleroderma) and insecure attachment styles 
(scleroderma and breast cancer) and inadequate emotional strategies that are likely to engage 
the threat mentality, the threat response and possibly impact on immune functioning.     
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 A pilot study was originally planned for the third study for this research project. This 
study was to involve conducting compassion focused therapy for scleroderma participants 
based on the findings of the first two studies. During the confirmation process the committee 
decided that the third study should not involve a pilot study but a comparison of a different 
disease population, to identify whether differences between community individuals and 
individuals with scleroderma were unique to that population, or whether there were 
similarities or differences between illness groups. Breast cancer was selected as the 
comparison disease as it has a high prevalence in women and because it was not an 
autoimmune disease; therefore different biological processes were involved in the disease 
course.                      
 Collection of data for the first two studies was in progress at the time of this change 
therefore a question indicating whether participants in the community sample had 
experienced breast cancer was not included in the original survey as at this time, the breast 
cancer question was not relevant to the study. The omission of this question was not realised 
until all data had been collected. Therefore it is possible that some of the participants from the 
community sample may have been diagnosed with breast cancer at some stage in their life 
and that these participants have been included in the second comparison study (third study) as 
community participants when in fact they should have been included in the breast cancer 
group or excluded from the study. Results for the hypothesis involving the comparison 
between the breast cancer and community participants must therefore be viewed with caution 
as the similarities in some of the results may be due to measuring participants in the 
community group who have experienced breast cancer. However as prevalence rates of breast 
cancer in general community samples are one in eight (AIHW, 2013), it is likely that from a 
sample in this study the number of participants that may have had breast cancer would 
possibly be as low as two and as high as three, a figure that may not impact on the statistical 
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significance of the results. The self-report rating scale used to measure EMWS is also a 
limitation as it is reliant onf recall of early life experiences which may be subject to memory 
bias.                          
           CHAPTER 6 - THE THESIS PROJECT IN REVIEW          
   General Discussion of Research Findings from the Three Studies                 
Regulation Predicts Physiological and Psychological Health Outcomes    
 Purpose of the Studies: This series of studies set out to find whether adverse childhood 
experiences, insecure attachment behaviours (interpersonal) and emotional and cognitive 
strategies (intrapersonal) that increase arousal (hyper-arousal) and physiological responses 
were involved in the exacerbation or earlier onset of scleroderma symptoms. Levels of 
arousal were examined in 1983 (Freedman & Ianni) and have not been examined since that 
time. This research suggested that individuals with scleroderma and Raynaud’s responded 
with greater physiological arousal than individuals diagnosed with Raynaud’s, without 
scleroderma. Research identifying the factors that may contribute to this stress response have 
not been previously investigated. A number of scleroderma studies have investigated mental 
health and disease related psychosocial variables (e.g., Angelopoulos et al., 2001; Roca et al., 
1996; Thombs et al., 2008); however, these studies did not explore these variables from a 
stress-arousal-disease symptoms and onset perspective.         
 The current research project therefore examined factors reported in the literature as 
related to arousal and the threat/stress response, to provide an understanding of psychosocial 
factors that may contribute to an elevated physiological response and the exacerbation and/or 
onset of scleroderma symptoms. The study also explored the benefits of engaging in self-
compassion in relation to levels of arousal, psychosocial experiences and scleroderma 
symptoms and onset.                                                                                                                                         
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                                                               Discussion 
 The findings in the current study provide some insight into the link between  
 
psychosocial factors that involve interpersonal (such as EMWS and attachment style) and 
intrapersonal (such as self-compassion) relationships, physiological responding such as 
hyper-arousal and the onset and exacerbation of scleroderma symptoms. These factors were 
explored through the investigation of variables that predicted symptoms (illness related/ 
psychosocial/mental health) and two studies, comparing psychosocial and mental health 
symptoms in individuals from a general community sample and psychosocial symptoms and 
pain in individuals diagnosed with breast cancer, to determine differences in experiences and 
the influence these different experiences may have on psychological and physical health. 
These aspects were expected to be more severe in those with scleroderma when compared  
with the two groups.                   
  The purpose of the current study was to inform treatment by providing further 
understanding around the implications of utilizing strategies that increase arousal and impact 
on physical and psychological health. That is to emphasise the importance of engaging 
individuals in effective emotion regulation strategies such as self-compassion to reduce 
arousal and improve psychological and physical health outcomes.                     
 Scleroderma: Interpersonal/Intrapersonal Experiences: Results for the three studies 
suggested scleroderma symptoms were associated with and predicted by a number of 
psychosocial variables linked to elevated physical reactions and immune related responses 
that may have developed in early childhood. Childhood experiences for low warmth and 
safety predicted elevated scleroderma related pain, and Raynaud’s phenomenon and were 
associated with skin severity. Mental health factors (depression and anxiety) were 
experienced by more scleroderma participants at greater clinical levels than breast cancer and 
community participants. These factors were also predicted by limited early life experiences of 
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warmth and safety. Having low self-compassion for oneself was also a significant factor in 
predicting problems of depression (for both scleroderma and breast cancer participants) and  
in a diagnosis of breast cancer at a younger age. Elevated stress was associated with limited 
childhood experiences of warmth and safety in individuals with scleroderma. Scleroderma 
participants’ experiences of warmth and safety (EMWS) were significantly lower than those 
experienced by community participants. However EMWS did not predict any variable for  
individuals diagnosed with breast cancer.               
  Insecure attachment variables, dismissive and fearful attachment styles reflect ways of 
relating to significant others that may also have developed in early childhood. These aspects 
were also significant for several physical and psychological factors in both breast cancer and 
scleroderma participants. Individuals diagnosed with limited sclerosis reporting a greater 
tendency to engage in a dismissive attachment style, were more likely to have experienced an 
earlier onset of Raynaud’s phenomenon. The first symptom of scleroderma is Raynaud’s 
phenomenon, which is often diagnosed in individuals with limited sclerosis, up to decades 
before the onset of the inflammatory stage of scleroderma. These findings suggest that the 
way an individual relates to significant others may impact on an earlier (for insecure 
attachment style) onset of disease symptoms (Raynaud’s phenomenon).      
 Emotion regulation strategies of suppression and low self-compassion predicted 
scleroderma symptoms and psychosocial variables for both scleroderma and breast cancer 
participants. Limited self-compassion was predicted by limited experiences of warmth and 
safety and by elevated hyper-arousal for scleroderma participants. Hyper-arousal predicted 
elevated Raynaud’s phenomenon and scleroderma disability. This variable (hyper-arousal) 
also predicted an earlier diagnosis of scleroderma. Lower self-compassion was predicted by 
hyper-arousal in breast cancer participants; while hyper-arousal predicted fatigue related to  
breast cancer and was associated with nausea.             
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  Findings suggest that individuals with scleroderma experienced heightened states of 
arousal that are associated with a number of physiological and psychological factors. These 
individuals reported lower early life experience of warmth and safety than community and 
breast cancer (not significant) participants. These findings may explain the difference in 
predictor variables for hyper-arousal for breast cancer and scleroderma participants. Lower 
self-compassion predicted elevated hyper-arousal in scleroderma and breast cancer 
participants, suggesting that these emotion regulation strategies were likely to increase 
physiological responses to threat that increase arousal levels. Breast cancer participants who 
engaged in strategies high in self-compassion reported experiencing breast cancer at an older 
age, indicating more positive physiological outcomes for individuals diagnosed with breast  
cancer who engaged in self-compassion.               
  There were no positive outcomes between self-compassion and scleroderma. 
Significantly lower experiences of self-compassion, EMWS, insecure attachment, and 
significantly elevated levels of suppression and hyper-arousal tended to indicate more 
negative illness related and psychological health outcomes for scleroderma participants; 
whereas significant variables insecure attachment, low self-compassion and suppression 
predicted negative psychological outcomes and hyper-arousal predicted negative physical  
(elevated fatigue) outcomes for breast cancer participants.                                                                         
  The findings support Gilbert’s Social Mentalities theory, in that individuals with 
scleroderma were likely to engage in emotion regulation strategies that increased arousal. This 
inadequate approach to managing negative emotions and reducing arousal may have developed 
as a consequence of being exposed to early social experiences limited in nurturing and feelings 
around safety and security. These experiences may have also contributed to the development of 
an insecure attachment style that predicted an early onset of Raynaud’s phenomenon (the first 
symptom of scleroderma diagnosed up to decades before the onset of scleroderma, in 
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individuals with limited sclerosis). Findings suggest that scleroderma participants may engage 
the threat mentality due to limited early social experiences of soothing (under-developed self-
soothing mentality), necessary to develop effective emotion regulation strategies such as self-
compassion. These inadequate emotion regulation strategies that generally do not reduce 
arousal and the subsequent social behaviours (insecurity in attachment relationships) may 
explain more negative health outcomes for scleroderma participants, when compared with 
individuals experiencing breast cancer.           
 Individuals with scleroderma and individuals with breast cancer who engaged strategies 
low in self-compassion and/or fail to rely on significant others in times of distress, may be 
likely to increase physiological arousal through the activation of avoidance behaviours, such as 
utilizing a dismissive style of relating or through suppressing distressing emotions, or over-
identifying with negative experiences (variables found to be higher in scleroderma participants 
than breast cancer and community participants). Actions that may influence negative 
psychological and physiological health comes. An earlier onset of scleroderma was predicted 
by hyper-arousal, while lower experiences of self-compassion were significantly related to 
elevated hyper-arousal for both scleroderma and breast cancer individuals. Therefore the 
under-utilization of effective emotion regulation strategies, such as being open to one’s 
experiences without over-identifying, suppressing or avoiding, through the use of 
compassionate mindful awareness; may reduce the capacity of individuals with scleroderma or 
breast cancer to self-sooth and reduce arousal levels; returning the body to a state of 
equilibrium, and subsequently lessening  
the impact on the immune system.                 
  Findings suggest that the utilization of a well-developed self-soothing social mentality 
through the engagement of self-compassion strategies may reduce arousal and provide better 
health outcomes; in that individuals with breast cancer in the third study reporting higher self-
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compassion experienced breast cancer at an older age. Therefore a well-developed self-
soothing social mentality that provides opportunities to utilize strategies high in self-
compassion and engage support and care from significant others, may reduce arousal and the 
impact on immune system functioning. The capacity to engage in these strategies may explain 
the different outcomes experienced by breast cancer and scleroderma participants. Breast 
cancer participant’s self-compassion may provide beneficial outcomes in that it predicts a 
diagnosis of breast cancer at a later age. This suggests that engaging in strategies that are high 
in self-compassion may effectively reduce physiological arousal when stressed or distressed, 
delaying the onset of disease.               
  Conclusion: The findings support the psychosocial scleroderma model proposed 
earlier in this research project, that suggests early environments that involve a lack of warmth 
and safeness, influence the development of the threat mentality (e.g., Gilbert et al., 2006), 
inadequate emotion regulation strategies (such as suppression and low self-compassion) and 
insecure attachment styles (dismissive and fearful); ways of relating to the self and others that 
are likely to be inadequate in reducing arousal and are risk factors in the development of 
psychological disorders (depression and anxiety) and hyper-arousal associated with an earlier 
onset of scleroderma. Engaging in strategies high in self-compassion appears to provide 
protective mechanisms for down regulating the stress/threat response (levels of hyper-
arousal); as found in the third study with individuals diagnosed with breast cancer. In this 
study individuals who engaged in higher levels of self-compassion reported a diagnosis of 
breast cancer at an older age. Whereas low self-compassion was related to a diagnosis of 
Raynaud’s phenomenon at a younger age for individuals diagnosed with scleroderma in the 
first study. Suggesting that this way of relating to self has negative consequence as it is linked 
to an earlier onset of Raynaud’s, the first symptom of scleroderma. As low-self compassion 
was also related to hyper-arousal (hyper-arousal predicted a diagnosis of scleroderma at a 
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younger age) and a number of psychological (e.g., depression and stress) and scleroderma 
symptoms (e.g., Raynaud’s phenomenon); providing education and treatment in the 
development of self-compassion, may enable individuals with scleroderma and breast cancer 
to engage in more effective emotion regulation strategies, to reduce arousal and improve  
psychological and physical disease symptomology.                                                   
Implications and Recommendations             
  As genetic and environmental factors are well known risks in the development of 
many diseases; experiencing early environments that provide limited experiences of feeling 
nurtured and safe are likely to create distress and physiological arousal associated with the 
threat system and the development of the threat mentality. Parents who fail to provide their 
children with opportunities to develop emotion regulation strategies, involved in the self-
soothing social mentality and associated resources to seek help from others (as external 
regulators); may leave their children vulnerable to more negative health outcomes in later life. 
Utilizing emotion regulation strategies that reduce arousal and the impact on the immune 
system may provide opportunities to delay the onset of a disease an individual may otherwise  
be predisposed to.                    
  Engaging in effective emotion regulation strategies such as self-compassion would not 
only provide personal benefits to the individual but financial benefits to the health system. A 
delay in onset may lessen the burden on families as children would be older and therefore the 
illness would be less likely to impact on the responsibilities associated with caring for a young 
family, managing a career and general life activities associated with these factors. Individuals 
with incurable diseases would have a better quality of life for a longer period of time (having 
the disease later in life) and would most likely require fewer visits for medical treatment, than 
if diagnosed with the illness at a younger age. The benefits of engaging in self-compassionate 
emotion regulation strategies would therefore provide advantages not only for the individual 
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inflicted by the disease and their family but would also reduce the financial cost to the health 
system and the general community. Providing opportunities for individuals diagnosed with 
scleroderma and breast cancer (by providing information about this study to scleroderma 
patients through Scleroderma association’s newsletters and publications for psychologist about 
the relevance of the significant variables to specific symptomology and onset found in this 
study) to develop self-compassion strategies to effectively manage emotions and reduce 
arousal. Psychologist with an understanding of the findings in this study would become more 
aware of screening for negative childhood experiences of threat, levels of self-compassion and 
emotion regulation strategies such as suppression and physiological experiences of hyper-
arousal to inform treatment. As a great number of people with scleroderma are members of 
Scleroderma associations the development of strategies to manage the experiences reported in 
the current study could be delivered in either a group or individually setting, in order to deliver 
information and strategies to a greater number of people more quickly through these 
associations and possibly improve current psychological and scleroderma symptoms and 
improve quality of life.         
 Breast cancer and scleroderma participants may benefit from education around the 
implications of engaging in adequate emotion regulation strategies that provide positive 
soothing experiences to reduce emotional distress and physically calm the body. These 
individuals may also benefit from information about reducing the fight and flight response and 
the consequential chronic states of arousal that impede the functioning of the immune system. 
Compassion focused therapies and emotion regulation strategies that provide opportunities to 
develop the self-soothing social mentality would also assist individuals with scleroderma and 
breast cancer.                
  Improving understanding that some coping styles are not helpful in reducing 
physiological and psychologically stress and providing individuals with opportunities to 
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become mindfully aware of difficult thoughts and memories without using over-identification 
or suppression techniques; while managing these experiences with self-kindness, rather than 
self-judgment would almost certainly assist many individuals with scleroderma and breasts 
cancer to live more healthier, happier, less painful and more relaxed lives than may otherwise 
occur, without the opportunity to improve the relationship with one’s self.      
  General community health outcomes may also improve if education were available to 
the public (perhaps through literature resources and health programs on television) that 
informed parents and caregivers of the psychological and physiological health implications of 
providing, or not providing children opportunities to develop emotion regulation strategies that 
facilitate self-soothing thinking processes. Parents therefore would become more aware of the 
impacts these experiences may have on their children and implement more appropriate 
parenting strategies that reduce distress and arousal and provide a greater likelihood of 
positively influencing the future health of their children.                                                                 
Future Research                                                  
 The current study forms the basis for future research. Individuals diagnosed with 
Raynaud’s disease could be assessed for emotion regulation strategies (such as low self-
compassion) and other stress related factors that create hyper-arousal. Individuals would be 
offered compassion focused therapy and monitored for development of scleroderma. 
Participants would be compared to individuals that elected not to engage in therapy. This study 
may identify potential risk factors in the development of scleroderma; and a therapy that may 
increase the age of onset or provide possible preventative outcomes. For those individuals with 
a current diagnosis of scleroderma and breast cancer, research that involves interviewing this 
population regarding their childhood history and engaging these groups in emotion regulation 
strategies such as self-compassion and reduction in emotional suppression to reduce negative 
arousal may provide opportunities to improve psychological and physiological disease related 
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health outcomes. Research involving other autoimmune diseases (as well as scleroderma) with 
a larger sample size could also be conducted (in Australia, the USA and UK) to determine 
whether similar experiences are reported by these populations; and whether these experiences 
are related to onset and severity of disease symptoms. If future research exploring these 
populations, report similar findings, a treatment model could be formulated for individuals 
experiencing stress related arousal associated with elevated symptomology; to improve 
psychological and physiological well-being.                                                                                                        
Final Note               
 For parents with young children: engaging in activities that encourage feelings of 
warmth and safety to reduce distress and arousal could help reduce the occurrence and 
experience of pain, associated with some of our more serious illnesses such as scleroderma. For 
those in psychological practice: this research (scleroderma and scleroderma/breast cancer 
models) may provide guidelines to assist clients who have negative early life experiences and 
suffer a disease in later life. Assessing clients’ experiences of compassion (self and others) and 
emotion regulation strategies (involving arousal and immune system functioning); and 
engaging clients in therapies that address these problems, may provide dramatically improved 
physiological and psychological outcomes for these individuals.                                                                         
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Scleroderma Study 
 
     My name is Karen Kearney I am currently undertaking research with Dr. Dee Bartrum, as part of a 
PhD (Psychology) at Bond University.  The focus of this study is to investigate the relationship between 
early experiences, cognitive and emotional aspects and scleroderma. Research has shown an association 
between scleroderma, anxiety, depression and stress prior to the onset of this disease. The current study 
will consider issues associated with the emotions and cognitions that may underlie the development of 
psychological conditions, such as depression, anxiety and physiological symptoms (e.g., Raynaud’s, pain 
and inflammatory conditions) associated with scleroderma. The findings of this research will contribute to 
the body of literature in the area of scleroderma, and aid in the development of suitable psychological 
treatments and interventions for those diagnosed with this medical condition.  
 
     I conducted research in 2008 in relation to stressful life events and scleroderma. The results of this 
study can be found on the websites of the Scleroderma Australia, Scleroderma Qld, the U.K. Scleroderma 
Society and the International Scleroderma Network U.S.A.  To undertake the current research I require 
people who have been diagnosed with scleroderma to complete a questionnaire.   The questionnaire will 
contain statements from which the participants can choose a response.   Confidentiality is assured by our 
procedure, in which only the combined results of all participants will be published.  You may withdraw 
from the study at any time. We invite you to complete the questionnaire which will take approximately 
30-40 minutes.  Minimal research has been conducted in this area in relation to scleroderma, with your 
assistance we aim to add to existing research and our understanding of this disease.  
 
If you have any questions concerning this study please contact either Dr. Dee Bartrum or myself.  
 
Thank you in advance 
 
Kind Regards, 
 
Karen Kearney                  Email:  kakearne@student.bond.edu.au   
Dr. Dee Bartrum               Email: dbartrum@bond.edu.au   
                                          Clinic Director, Bond University Psychology Clinic 
                                          School of Psychology Faculty of Humanities and Social Sciences 
                                          Bond University, Gold Coast, Qld, 4229, Australia   
Ethics Officer                    Email: buhrec@bond.edu.au   
 
In the event that undue distress has been experienced or you identify that you require psychological 
support, we consider it appropriate to offer you the following referral services.  
 
 Lifeline Provides a free 24-hour, telephone counseling service. Phone:  13 11 14.  Bond 
University Clinic, Gold Coast, Queensland. Phone: (07) 5595 2527 
 Email: psych_clinic@bond.edu.auAustralian Psychological Society. 
ww.psychology.org.au/ReferralService/About/  
 
                             
 
                                                          Survey Instructions    
 
Please read each statement carefully. Please tick the response that best represents your opinion. 
 If you want to change your response to an item, please place a cross through the initial response 
 and tick the correct response. Please give your most honest answer to assist us with our data. 
 
                                                  
 
Appendix A 
Important:  Please complete all questions in the questionnaire.  Incomplete questionnaires may be 
removed from the study.  The questionnaire should take about 30 – 40 minutes to complete. 
 
Country:   Australia        United Kingdom   
 
 United States of America     Other: country             
.                                                  please state ___________ 
 
Please state your ethnic background 
___________________________________                                                                
  
 
  Yes   Are you of Aboriginal  
  No    or Torres Strait Islander descent?                                        
 
  Yes   Is any biologically related relative of 
  No    Aboriginal or Torres Strait Island descent?      
 
Please state biological relatives ethnic background 
__________________________________ 
 
Age:         __________years __________ months 
 
 
Age at which you were diagnosed with Scleroderma                    
__________ years   _________ months 
 
What type of Scleroderma do you have?  
 
   Diffused 
   Limited/ CREST 
   Other  Please Specify ___________________ 
Have you been diagnosed/exposed to any of the following   
 
   Raynauds      Age diagnosed _________        
   Exposure to Toxins associated onset scleroderma  
 Please state type of toxin    _____________________ 
 
        Please rate     No Problem   Mild     Moderate    Severe 
 Skin involvement                                                                                            
   Swollen/inflamed          Age diagnosed _________ 
   Thick skin                      Age diagnosed _________ 
   Tight skin                       Age diagnosed _________ 
   Skin softening                Age diagnosed _________ 
Please state body  areas  affected  by the following                                                    
skin conditions
 Swollen/inflamed    ________________________       
 Thick skin                ________________________              
 Tight skin                 ________________________              
 Skin softening          ________________________               
How would you rate your scleroderma symptoms  
                           No  problem Mild  Moderate Severe   Age 
   
When first diagnosed                      ______ 
When least severe                           ______ 
When most severe                          ______ 
 Overall would you rate your current  
scleroderma symptoms as  
   Less Severe  
   More Severe  
, Remained Constant 
 
 
Do you take medication for any of the indicated conditions?     
 Yes      No     
 
How would you rate the severity of your symptoms before using  
medication?          Mild     Moderate    Severe 
 
 
Gender            Female       Male  
 
Education       Primary      Secondary     Tertiary 
 
Current relationship status 
   Single          Defacto Relationship  
                                Time in relationship ___________ 
   Divorced     Married:  
                                 Time in relationship ___________ 
 
Occupation 
Current  occupation ________________________  
Before diagnosis scleroderma_________________ 
When first diagnosis scleroderma_________________ 
Have you or a (genetically related) family member been diagnosed with any of the following: 
Biological                                                                Age 
Relative    You                                                   Diagnosed 
Please indicate if diagnosed before or after                                   
you were diagnosed with scleroderma.  
               Other autoimmune disease             ______  Before    After   
                Pituitary adenoma                          ______  Before    After   
                Elevated prolactin levels                ______ 
                Bulemia/Anorexia  (Circle one)         ______ 
                Autism/ Aspergers  Circle one)         ______ 
 Before    After   
 Before    After                                                                                     
 Before    After 
                Anxiety                                          ______  Before    After 
                Depression                                     ______  Before    After 
                Post Traumatic Stress Disorder      ______ 
                Other psychological condition       ______                          
                         Please state ________________________ 
 Before    After                                                                       
 Before    After    
          
Please state relative eg., parent, sibling, etc __________ Counselling: Before or after diagnosed with scleroderma. 
Have you received counselling for any psychological 
condition?     No    Yes   Please specify _________ 
 Before    After 
Have you been tested for elevated prolactin   No    Yes 
 Scleroderma Health Assessment Questionnaire (SHAQ) 
 
In this section we are interested in learning how your illness 
affects your ability to function in daily life.  
Please feel free to add any comments. 
Please circle the response that best describes your usual abilities   .             
IN THE PAST SEVEN DAYS.  
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Are you able to:     
Dress yourself including tying shoelaces and doing buttons 0 1 2 3 
Shampoo your hair 
Arising 
0 1 2 3 
Are you able to:      
Stand up from an armless straight chair 0 1 2 3 
Get in and out of bed 0 1 2 3 
Eating     
Are you able to:     
Cut your meat 0 1 2 3 
Lift a full glass to your mouth 0 1 2 3 
Open a new milk carton 0 1 2 3 
Walking     
Are you able to:     
Walk outdoors on flat ground 0 1 2 3 
Climb up five stairs 0 1 2 3 
 
     
 
 
Please check any AIDS or DEVICES that you usually use for any of 
these activities? 
 
 
 
    Other     (Specify______________________ 
   Cane 
   Walker 
   Crutches  
   Wheelchair 
   Devices used for   
      dressing (button hook,    
       zipper pull, long   
       handled shoe horn etc) 
      Built up or special    
        utensil 
   Special or built up   
        chair     
 
 
Please check any categories for which you usually need 
ASSISTANCE FROM ANOTHER PERSON. 
 
 
 
 
   Dressing & Grooming 
   Arising 
   Eating  
   Walking 
  
 Please circle the response that best describes your usual 
abilities IN THE PAST SEVEN DAYS. 
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Are you able to:     
Wash and dry your body 0 1 2 3 
Take a tub bath 0 1 2 3 
Get on and off the toilet 0 1 2 3 
Reach     
Are you able to:     
Reach and get down a 5 lb (approx 2 kg) object from above your head 
(e.g. sugar) 
0 1 2 3 
Bend down to pick clothing off the floor 0 1 2 3 
 
 
Are you able to: 
             
Open  car doors:  0 1 2 3 
Open jars that have been previously opened  0 1 2 3 
Turn faucets (taps) on and off 0 1 2 3 
Activities     
Are you able to:     
Run errands and shop    0 1 2 3 
Get in and out of a car 0 1 2 3 
Do chores such as vacuuming or yard work 0 1 2 3 
 
 
 
Please check any of the following AIDs or Devices that you usually 
use for any of these activities?  
 
   Other:   Please specify         _________________________ 
 
 
 
 
 
 
   Raised toilet seat                   
   Bathtub seat   
   Bathtub bar  
Long handled appliances          
   For reach  
 Long handled appliances 
   In the bathroom  
   Jar opener (for jars    
        previously opened) 
 
 
Please check any categories for which you usually need HELP FROM 
ANOTHER PERSON.  
                             
 
  
    Hygiene    
    Reach                               
    Gripping and opening  
         things    
    Errands and chores 
 
 
 
 
 
 
 
 
Grip 
 We are also interested in learning whether or not you are affected by pain because of your illness. 
 
How much pain have you had because of your illness IN THE PAST WEEK ? 
PLACE A MARK ON THE LINE TO INDICATE THE SEVERITY OF THE PAIN. 
NO PAIN          VERY SEVERE 
PAIN 
├──────────────────────────────────────────────────┤ 
0             100 
 
IN THE PAST WEEK, how much have your intestinal problems interfered with 
your daily activities? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
INTESTINAL PROBLEMS      VERY SEVERE 
DO NOT LIMIT ACTIVITIES      LIMITATION 
├──────────────────────────────────────────────────┤ 
0             100 
 
IN THE PAST WEEK, how much have your breathing problems interfered with your daily activities? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
BREATHING PROBLEMS      VERY SEVERE 
DO NOT LIMIT ACTIVITIES      LIMITATION 
├──────────────────────────────────────────────────┤ 
0             100 
 
IN THE PAST WEEK, how much has Raynaud’s interfered with your daily activities? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
RAYNAUD’S          
DOES NOT LIMIT ACTIVITIES     VERY SEVERE     
                                                                                                                       LIMITATION 
├──────────────────────────────────────────────────┤ 
0             100 
 
IN THE PAST WEEK, how much have your finger ulcers interfered with your daily activities? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
FINGER ULCERS      VERY SEVERE 
DO NOT LIMIT ACTIVITIES      LIMITATION 
├──────────────────────────────────────────────────┤ 
0              100 
 
Overall, considering how much pain, discomfort, limitations in your daily life and other changes in your 
body and life, how severe would you rate your disease today? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
NO DISEASE      VERY SEVERE 
LIMITATION 
├──────────────────────────────────────────────────┤ 
0              100 
 
                                            
                                           Depression Anxiety and Stress Scale (DASS)                                                                                                         
In this section we are interested in your experiences of stress. 
 
Please read each statement and circle a number 0, 1, 2, or 3, which indicates how much the statement applied to you  
OVER THE PAST WEEK.  There are no right or wrong answers.  Do not spend too much time on any statement. 
 Not at 
all 
Sometimes Frequently Most of 
the time 
1. I Found It hard to wind down 0 1 2 3 
2. I was aware of dryness of my mouth 0 1 2 3 
3. I couldn’t seem to experience any positive feeling at all 0 1 2 3 
4. I experienced breathing difficulty (eg. Excessively rapid breathing, 
breathlessness in the absence of physical exertion). 
0 1 2 3 
5. I found it difficult to work up the initiative to do things 0 1 2 3 
6. I tend to over-react to situations 0 1 2 3 
7. I experienced trembling (eg. In the hands) 0 1 2 3 
8. I felt that I was using a lot of nervous energy 0 1 2 3 
9. I was worried about situations in which I might panic and make a 
fool of myself 
0 1 2 3 
10. I felt that I had nothing to look forward to 0 1 2 3 
11. I found myself getting agitated 0 1 2 3 
12. I found it difficult to relax 0 1 2 3 
13. I felt down-hearted and blue 0 1 2 3 
14. I was intolerant of anything that kept me from getting on with 
what I was doing 
0 1 2 3 
15. I felt I was close to panic 0 1 2 3 
16. I was unable to become enthusiastic about anything 0 1 2 3 
17. I felt I wasn’t worth much as a person 0 1 2 3 
18. I felt that I was rather touchy 0 1 2 3 
19. I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat). 
0 1 2 3 
20. I felt scared without good reason 0 1 2 3 
21. I felt that life was meaningless 0 1 2 3 
 
 
 
 
Relationship Scales Questionnaire (RSQ) 
 
In this section we are interested in your interpersonal experiences. 
Please read each of the following statements and rate the extent to which you believe each statement best describes 
your feelings about close relationships. 
  Not at all   
like me  
 Somewhat   
like me  
 Very much   
like me  
1. I find it difficult to depend on other people. 1  2  3  4  5  
2. It is very important to me to feel independent. 1  2  3  4  5  
3. I find it easy to get emotionally close to others. 1  2  3  4  5  
4. I want to merge completely with another person. 1  2  3  4  5  
5. I worry that I will be hurt if I allows myself to become 
too close to others. 
1  2  3  4  5  
6. I am comfortable without close emotional relationships. 1  2  3  4  5  
7. I am not sure that I can always depend on others to be 
there when I need them. 
1  2  3  4  5  
8. I want to be completely emotionally intimate with 
others. 
1  2  3  4  5  
9. I worry about being alone. 1  2  3  4  5  
10. I am comfortable depending on other people. 1  2  3  4  5  
11. I often worry that romantic partners don't really love me. 1  2  3  4  5  
12. I find it difficult to trust others completely. 1  2  3  4  5  
13. I worry about others getting too close to me. 1  2  3  4  5  
14. I want emotionally close relationships. 1  2  3  4  5  
15. I am comfortable having other people depend on me. 1  2  3  4  5  
16. I worry that others don't value me as much as I value 
them. 
1  2  3  4  5  
17. People are never there when you need them. 1  2  3  4  5  
18. My desire to merge completely sometimes scares people 
away. 
1  2  3  4  5  
19. It is very important to me to feel self-sufficient. 1  2  3  4  5 
20. I am nervous when anyone gets too close to me. 1  2  3  4  5  
21. I often worry that romantic partners won't want to stay 
with me. 
1  2  3  4  5  
22. I prefer not to have other people depend on me. 1  2  3  4  5  
23. I worry about being abandoned. 1  2  3  4  5  
24. I am somewhat uncomfortable being close to others. 1  2  3  4  5  
25. I find that others are reluctant to get as close as I would 
like. 
1  2  3  4  5  
26. I prefer not to depend on others. 1  2  3  4  5  
27. I know that others will be there when I need them. 1  2  3  4  5  
28. I worry about having others not accept me. 1  2  3  4  5  
29. Romantic partners often want me to be closer than I feel 
comfortable being. 
1  2  3  4  5  
30. I find it relatively easy to get close to others. 1  2  3  4  5  
   
                                     
                                  Early Memories of Warmth and Safety Scale (EMWS) 
 
In this section we are interested in your emotional memories 
 
Below is a set of questions that tap various feelings you may have experienced when you were young. 
Please read each item carefully and circle the number to the right of the statement that best describes 
your feelings during childhood.  Use the scale below. 
 
0 = No, never     1 = Yes, but            
rarely 
2 = Yes, 
sometimes 
3 = Yes, often     4 = Yes, most 
of the time 
 
1.  I felt secure and safe.        0   1   2   3   4 
2.  I felt appreciated the way I was.                             0   1   2   3   4 
3.  I felt understood.        0   1   2   3   4   
4.  I felt a sense of warmth with those around me.    0   1   2   3   4  
5.  I felt comfortable sharing my feelings and thoughts.                                0   1   2   3   4                                          
with those around me 
6.  I felt people enjoyed my company.           0   1   2   3   4 
7.  I knew that I could count on empathy and understanding   0   1   2   3   4 
    from people close to me when I was unhappy. 
8.  I felt peaceful and calm.       0   1   2   3   4 
9.  I felt that I was a cherished member of my family.   0   1   2   3   4 
10. I could easily be soothed by people close to me when I was unhappy. 0   1   2   3   4 
11. I felt loved.        0   1   2   3   4 
12. I felt comfortable turning to people important to me for help and           0   1   2   3   4                            
advice 
13. I felt part of those around me.      0   1   2   3   4 
14. I felt loved even when people were upset about something I had done. 0   1   2   3   4 
15. I felt happy.        0   1   2   3   4  
16. I had feelings of connectedness.      0   1   2   3   4  
17. I knew I could rely on people close to me to console me when.  0   1   2   3   4                                            
I was upset 
18. I felt cared about.        0   1   2   3   4  
19. I had a sense of belonging.       0   1   2   3   4  
20. I knew that I could count on help from people close to me when. 0   1   2   3   4                                      
I was unhappy 
21. I felt at ease.        0   1   2   3   4  
                                   
 
 Emotion Regulation Questionnaire (ERQ) 
 
 
In this section we would like to ask you some questions about your emotional life.                                 
For each answer please use the following scale 
 
         1--------------------2--------------------3----------------4----------------5----------------6-----------------7                                       
Strongly Disagree                                                  Neutral                                                  Agree Strongly 
 
 
1.   When I want to feel more positive emotion (such as joy amusement) I    
change what I am thinking about.  
 
  
1    2     3      4     5    6     7 
2.    I keep my emotion to myself.         
 
 1    2      3     4     5    6     7 
 
3.    When I want to feel less negative emotions (such as sadness or anger), I 
change what I am thinking about.   
 1    2      3     4     5    6     7 
4.   When I am feeling positive emotions, I am careful not to express them   
 
 1    2     3     4     5     6     7 
5.   When I am faced with a stressful situation, I make myself think about it in a 
way that helps me stay calm.  
 1    2     3     4     5     6     7 
6.  I control my emotions by not expressing them.  
 
 1    2     3     4     5     6     7 
7.  When I want to feel more positive emotions, I change the way I’m thinking 
about the situation  
 1    2     3     4     5     6     7 
8.   I control my emotions by changing the way I think about the situation 
 
 1    2     3     4     5     6     7 
9.   When I am feeling negative emotions, I make sure not to express them  
 
 1    2     3     4     5     6     7 
10. When I want to feel less negative emotion, I change the way I’m thinking 
about the situation. 
 1    2     3     4     5     6     7 
 
              
 
 
 
 
 
 
 
 
 
 
 
 
 Hyper-arousal Scale (HS) 
 
 
In this section we would like to ask you how you generally respond in the following situations 
 
Please rate the following experiences from 
not at all true to completely true 
Not at 
all true 
 A little 
   true 
Moderately 
     true 
  Quite 
   true 
Completely  
    true 
1. I am well organized      
2. I am slow to awaken in the morning      
3. I am a very careful worker      
4. My mind is always going      
5. I think a lot about feelings      
6. Bright lights, crowds, noise or traffic 
bother me 
     
7. Evenings are my best time      
8. I cannot take naps even when I try      
9. I tend to anticipate problems      
10. My bedroom is a mess      
11. I take things personally      
12. I get rattled when a lot happens at once      
13. I am good at details      
14. I have trouble falling asleep      
15. I am a cautious person      
16. In bed at night my thoughts keep going      
17. A sudden loud noise could cause me a 
prolonged reaction 
     
18. I am overly conscientious      
19. Caffeine affects me strongly      
20. When things go wrong, I tend to get 
depressed 
     
21. My routine is predictable      
22. Some thoughts return too often      
23. I take a long time to make decisions      
24. Alcohol makes me sleepy      
25. I get tearful easily      
26. I keep thinking about the same things 
long after they happened 
     
 
 
 Self-Compassion Scale (SCS) 
 
In this section we would like to ask you how you typically act towards yourself in difficult times 
 
Please read each statement carefully before answering. To the left of each item, indicate how often you 
behave in the stated manner, using the following scale:  
                 
            Almost never                                                                                    Almost always                                          
                        1                         2                         3                         4                         5 
_____ 1.  I’m disapproving and judgmental about my own flaws and inadequacies. 
_____ 2.  When I’m feeling down I tend to obsess and fixate on everything that’s wrong. 
_____ 3.  When things are going badly for me, I see the difficulties as part of life that everyone goes 
through. 
_____ 4.  When I think about my inadequacies, it tends to make me feel more separate and cut off from 
the rest of the world. 
_____ 5.  I try to be loving towards myself when I’m feeling emotional pain. 
_____ 6.  When I fail at something important to me I become consumed by feelings of inadequacy. 
_____ 7. When I'm down and out, I remind myself that there are lots of other people in the world feeling 
like I am. 
_____ 8.  When times are really difficult, I tend to be tough on myself. 
_____ 9.  When something upsets me I try to keep my emotions in balance.   
_____ 10. When I feel inadequate in some way, I try to remind myself that feelings of inadequacy are 
shared by most people. 
_____ 11. I’m intolerant and impatient towards those aspects of my personality I don't like. 
_____ 12. When I’m going through a hard time, I give myself caring and tenderness I need. 
_____ 13. When I’m feeling down, I tend to feel like most other people are probably happier than I am. 
_____ 14. When something painful happens I try to take a balanced view of the situation. 
_____ 15. I try to see my failings as part of the human condition. 
_____ 16. When I see aspects of myself that I don’t like, I get down on myself. 
_____ 17. When I fail at something important to me I try to keep things in perspective. 
_____ 18. When I’m really struggling, I tend to feel like other people must be having an easier time of it. 
_____ 19. I’m kind to myself when I’m experiencing suffering. 
_____ 20. When something upsets me I get carried away with my feelings. 
_____ 21. I can be a bit cold-hearted towards myself when I'm experiencing suffering. 
_____ 22. When I'm feeling down I try to approach my feelings with curiosity and openness. 
_____ 23. I’m tolerant of my own flaws and inadequacies. 
_____ 24. When something painful happens I tend to blow the incident out of proportion. 
_____ 25. When I fail at something that's important to me, I tend to feel alone in my failure. 
_____ 26. I try to be understanding and patient towards those aspects of my personality I don't like. 
 
  
 
                                  List of Referral Counselling Services  
 
In the event that undue distress has been experienced, or you identify that you require 
psychological support, we consider it appropriate to offer you the following counselling referral 
services:  
 
Australia 
 
 Lifeline  
 Provides a free 24-hour, telephone counseling service.   
 Phone:  13 11 14.  from any state or territory in Australia. 
 
 Bond University Clinic, Gold Coast, Queensland. 
 Phone: (07) 5595 2527 
 Email: psych_clinic@bond.edu.au 
 
 Australian Psychological Society.  
 Find a Psychologist Service  
 Covering every state and territory. 
www.psychology.org.au/ReferralService/About/  
 
 
The United States of America 
 
 U.S. listing for psychologists  http://locator.apa.org/ .  
  
The International Scleroderma Network also offers free general well-moderated 
support services online, 24 hours a day, through Sclero Forums, at 
http://www.sclero.org/forums/  
 Toll-free helpline number for U.S. residents is 1-800-564-7099. 
 
 Resources for Emotional Adjustment and Scleroderma are at: 
http://www.sclero.org/support/emotional-adj/a-to-z.html 
 
 
United Kingdom 
 The British Psychological Society 
 The Directory of Chartered Psychologists   
 http://www.bps.org.uk/findpsychologist/psychoindex.cfm  
  
 The Samaritans, 24 hour a day 
 Confidential emotional support for anyone in a crisis 
 Phone: 08457 909090 
 www.samaritans.org    
                                                               
 
                                                                 
 
 
                                                                                              
Breast Cancer Study 
 
     My name is Karen Kearney I am currently undertaking research with Dr. Richard Hicks and Dr. Peta 
Stapleton, as part of a PhD (Psychology) at Bond University.  The focus of this study is to investigate the 
relationship between psychological stress and breast cancer. Research has shown an association between 
stress and suppression of the immune system and breast cancer.  Breast cancer is an immune related 
disease and is associated with anxiety, depression and stress. The current study will consider early stress 
experiences, emotions and cognitions that may generate stress/distress and the association between these 
aspects and breast cancer. Furthermore these aspects will also be investigated in relation to depression 
and anxiety associated with breast cancer. The findings of this research will contribute to the body of 
literature in the area of breast cancer and aid in the development of suitable psychological treatments and 
interventions for those diagnosed with this medical condition.  
 
     To undertake the current research we require individuals who have been diagnosed with breast cancer 
to complete a questionnaire.   The questionnaire will contain statements from which the participants can 
choose a response. Confidentiality is assured by our procedure, in which only the combined results of all 
participants will be published. We invite you to complete the questionnaire which will take approximately 
30 minutes.   
 
       Minimal research has been conducted in this area in relation to breast cancer, with your assistance we 
aim to add to existing research and our understanding of this disease.  
 
If you have any questions concerning this study please contact either Dr. Richard Hicks Dr. Peta 
Stapleton or myself.  
 
Thank you in advance                
 
Kind Regards, 
 
Karen Kearney                  Email:  kakearne@student.bond.edu.au   
 
Dr. Richard Hicks             Email: rhicks@bond.edu.au   
                                          Professor; School of Psychology  
Dr Peta Stapleton              Email: pstapleton@bond.edu.au 
                                          Assistant Professor, School of Psychology           
                                          Faculty of Humanities and Social Sciences 
                                          Bond University, Robina, QLD, 4229, Australia   
 
Ethics Officer                   Email: buhrec@bond.edu.au   
 
 
                                                             Survey Instructions    
 
Please read each statement carefully. Please cross the response that best represents your opinion. 
If you want to change your response to an item, please place a line through the initial response and                 
cross the correct response. Please give your most honest answer to assist us with our data.  We invite you 
to complete the questionnaire which will take approximately 30 minutes. There is an attachment that 
describes the types, stages and categories of breast cancer to assist you with these specific questions. 
 
In the event that undue distress is experienced after completing this survey, or you identify that you 
require psychological support, we have listed counseling referral services on the last page of this survey 
and you are invited to contact them if needed.  
                                                                              
                             Important:  Please complete all questions in the questionnaire.  
 
 Please refer to appendix A for information to help you answer the breast cancer questions                
 
 
Country:   Australia         
.                 Other Country                                                 
Please state    ___________ 
 
 
 Yes   Are you of Aboriginal or 
  No   Torres Strait Island descent?                                        
 
 
Gender            Female       Male  Education       Primary      Secondary     
                         Tertiary       Post Grad 
 
Current relationship status 
   Single           Defacto Relationship  
                                 Time in relationship ___________ 
   Divorced     Married:  
                                Time in relationship ___________ 
 
Occupation 
Current  occupation _________________________  
Before diagnosis breast cancer _________________ 
When first diagnosis breast cancer ______________ 
   Widowed        Time in relationship ___________ 
 
 
* What type of breast cancer do you have? 
_______________________________________ 
 
Please state if benign Yes  No 
 
Have you had surgery/treatment for your breast 
cancer  Yes  No 
 
If yes please state type of treatment/surgery and                                
date surgery/treatment(s) was received 
____________________________________          
 
How would you rate              How would you rate your      
your breast cancer                 breast cancer when most   
when first diagnosed?            severe? 
 
   Mild                                       Mild 
   Moderate                               Moderate 
   Severe                                    Severe 
  
 
Other Health Information 
Have you been diagnosed with scleroderma                                         
Yes  No 
 
 
Age:         __________years __________ months 
Age first diagnosed with breast cancer                                                                 
__________ years   _________ months 
(currently means within in the last month) 
*What stage of breast cancer do you currently have ________  
*What stage when first diagnosed  ___________________ 
*What stage when most severe       ___________________ 
 
*What category of breast cancer do you currently have ______ 
*What category when first diagnosed  ________________ 
*What category when most severe       ________________ 
 
         
 How would you currently rate your 
 breast cancer?  
 
     No longer experiencing symptoms 
     Mild  
     Moderate  
  ,  Severe 
           
 
   Have you been diagnosed with any other                                                                     
   health condition/disease   Yes  No                                                                                             
    
    Please state condition/disease ________________                                                   
.   __________________ ______________________ 
Have you been diagnosed with any of the following: 
Please indicate if diagnosed before or after                                   
you were diagnosed with breast cancer? 
 
 
 
Before      After                                                  
                      Depression               
                       Posttraumatic Stress Disorder (PTSD)      
                       Anxiety 
                       Other psychological condition   
                                     Please state ______________                    
 
                       Have you received counseling for                                     
.                                    any of the stated conditions     
  
Please state condition if you have received counseling  
_____________________________________________                                                               
We are also interested in learning whether or not you are affected by pain and other changes in your body 
due to your breast cancer.  Please indicate severity on the scale below from… 0 to 100.  
How much pain have you had because of your illness IN THE PAST WEEK? 
PLACE A MARK ON THE LINE TO INDICATE THE SEVERITY OF THE PAIN. 
NO PAIN          VERY SEVERE 
PAIN 
├──────────────────────────────────────────────────┤ 
0             100 
How much nausea do you have because of your illness IN THE PAST WEEK? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
NO DISEASE      VERY SEVERE 
LIMITATION 
├──────────────────────────────────────────────────┤ 
0              100 
How much fatigue do you have because of your illness IN THE PAST WEEK? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
NO DISEASE      VERY SEVERE 
LIMITATION 
├──────────────────────────────────────────────────┤ 
0              100 
Overall, considering how much pain, fatigue, nausea and discomfort, limits your daily life and other 
changes in your body and life, how severe would you rate your disease today? 
PLACE A MARK ON THE LINE TO INDICATE THE LIMITATION OF ACTIVITY. 
 
NO DISEASE      VERY SEVERE 
LIMITATION 
├──────────────────────────────────────────────────┤ 
0              100 
 
 
 
The Breast Cancer Survey also included all psychosocial questionnaires in the scleroderma study  
   
 
                       
                 
                                                    
 
 
 
 
 
 
 
 
 
 
 
   Thank you for completing the survey 
 
 Counseling Services  
 
In the event that undue distress has been experienced, or you identify that you require psychological 
support, we have listed the following counseling referral services:  
 
 
 Lifeline  
 Provides a free 24-hour, telephone counseling service.   
 Phone:  13 11 14 from any state or territory in Australia. 
 
 Bond University Clinic, Gold Coast, Queensland. 
 Phone: (07) 5595 2527 
 Email: psych_clinic@bond.edu.au 
 
 Australian Psychological Society.  
 Find a Psychologist Service  
 Covering every state and territory. 
www.psychology.org.au/ReferralService/About/  
 
 
 
 
 
 
 
                                                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       
                                                           
 
 
 
 
 
 
                                                                   
 
                                                                        Appendix 1 
Types of Breast Cancer 
 
o Ductal carcinoma in situ (DCIS) is a non-invasive breast cancer confined to the ducts of the 
breast. 
o Lobular carcinoma in situ (LCIS) is a non-invasive breast cancer confined to the lobules of the 
breast.  
o Early breast cancer is an invasive breast cancer that is contained in the breast and may or may not 
have spread to lymph nodes in the breast or armpit. Some cancer cells may have spread outside the 
breast and armpit area but cannot be detected.  
o Locally advanced breast cancer is an invasive breast cancer that has spread to areas near the 
breast, such as the chest wall.  
o Secondary breast cancer (also called metastatic or advanced breast cancer) is an invasive breast 
cancer that has spread from the breast to other parts of the body. 
o Paget’s disease of the nipple is a rare form of invasive breast cancer that affects the nipple and the 
area around the nipple (the areola).  
o Inflammatory breast cancer is a rare form of invasive breast cancer that affects the blood vessels 
in the skin of the breast, causing the breast to become red and inflamed.  
Stages of Breast Cancer  
o Stage 0:  pre-invasive’ breast cancer such as ductal carcinoma in situ (DCIS) or lobular carcinoma 
in situ (LCIS) 
o Stage I:  early breast cancer 
o Stage II: early breast cancer   
o Stage IIB and III: advanced breast cancer  
o Stage IV: advanced breast cancer (locally advanced breast cancer or secondary breast cancer). 
Categories of Breast Cancer 
o Category 1:  breast cancer cells in one to three lymph nodes in the armpit. 
o Category 2: breast cancer cells in 4–9 lymph nodes in the armpit, and lymph nodes are  enlarged, 
and/or attached to each other or to nearby tissue; or 1 or more lymph nodes under the breastbone 
not in the armpit lymph nodes 
Category 3: breast cancer cells in 10 or more lymph nodes in the armpit or 1 or more lymph nodes above 
or below the collarbone or 1 or more lymph nodes under the breastbone and 1 or more lymph nodes in the 
armpit. 
 
 
 
Community Sample 
     
                                                                 Bond University 
                                         Faculty of Humanities and Social Sciences 
 
Psychosocial Stressors and Emotional Regulation in a Community Sample 
 
      My name is Karen Kearney I am currently undertaking research with Dr. Dee Bartrum, as part of a 
PhD (Psychology) at Bond University.  The focus of this study is to investigate issues associated with 
early life memories and the emotions and cognitions that may underlie the development of psychological 
conditions, such as depression, anxiety and stress in people who have not been diagnosed with 
scleroderma (an autoimmune disease).  To undertake the current research, I require people who have not 
been diagnosed with scleroderma to complete a questionnaire.  The questionnaire will contain statements 
from which participants can choose a response.  Anonymity is assured by our procedure, in which only 
the combined results of all participants will be published.  You may withdraw from the study at any time. 
We invite you to complete the questionnaire which will take approximately 30 minutes. Minimal research 
has been conducted in this area in relation to scleroderma, with your assistance we aim to add to existing 
research and our understanding of this disease.  
 
If you have any questions concerning this study please contact either Dr. Dee Bartrum or myself.  
Thankyou in advance 
Kind Regards, 
Karen Kearney                 Email:  kakearne@student.bond.edu.au  
Dr. Dee Bartrum               Email: dbartrum@bond.edu.au   
                                          Clinic Director, Bond University Psychology Clinic 
                                          School of Psychology Faculty of Humanities and Social Sciences 
                                          Bond University, Gold Coast, Qld, 4229, Australia   
Ethics Officer:                  Email: buhrec@bond.edu.au 
In the event that undue distress has been experienced or you identify that you require psychological support, we 
consider it appropriate to offer you the following referral services.  
 Lifeline Provides a free 24-hour, telephone counseling service. Phone:  13 11 14.  Bond University Clinic, 
Gold Coast, Queensland. Phone: (07) 5595 2527 
 Email: psych_clinic@bond.edu.au 
 Australian Psychological Society. ww.psychology.org.au/ReferralService/About/  
 
                                                 
 
 
 
 
                                                                                                               
                                                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                  
Instructions 
 
Please read each statement carefully. Please tick the response that best represents your opinion.  If you 
want to change your response to an item, please place a cross through the initial response  and tick the 
correct response. Please give your most honest answer to assist us with our data. 
 
Important:  Please complete all questions in the questionnaire.  Incomplete questionnaires may be 
removed from the study.  The questionnaire should take about 30 minutes to complete. 
 
 
Country: 
 
 Other: please state country _______________ 
 
  Australia        United Kingdom   
 
 United States of America 
 
 
Age:     
 
      __________years __________ months 
 
Gender   Female       Male 
  
Education    Primary      Secondary     Tertiary 
 
Current Occupation _______________________ 
 
Previous Occupation/s _____________________ 
 
Are you currently 
 
   Single          Defacto Relationship  
                               Length of time in relationship ____ 
   Divorced      Married:  
                               Length of time married ______ 
 
Have you been diagnosed with Scleroderma.  
 
No  Yes      Age diagnosed  _____ years   _____ months  
 
If yes please do not continue completing this 
questionnaire?                                                                   
You may like to complete the questionnaire for 
participants diagnosed with scleroderma. 
 
 
Please state your ethnic background 
___________________________________ 
 
Please state biological relatives ethnic background 
__________________________________ 
 
Have you or a (genetically related) family member                     
been diagnosed with any of the following: 
 You      Relative                                      Age Diagnosed 
           Scleroderma                                   ______ 
          Other autoimmune disease             ______ 
            Pituitary adenoma                          ______ 
Have you received counselling for any other 
psychological condition?    No   Yes    
           Elevated prolactin levels                ______ 
           Anorexia                                        ______ 
           Bulemia                                         ______ 
If yes please specify condition__________________            Anxiety                                          ______ 
            Depression                                     ______ 
            Autism                                           ______ 
 
 
 
           Aspergers                                       ______                              
           Post Traumatic Stress Disorder    ______ 
           Acute Stress Disorder                    ______ 
           Other psychological condition      ______                          
                     Please state _____________ 
 
 
 
The Community Survey also included all psychosocial questionnaires in the scleroderma study  
   
 
                                                                                                                                                                                                                                                                                                                                                      1 
 
 
Appendix B  
 
Scleroderma Study 1 -Statistical Analysis  
Frequencies - Demographic and Health Information  
Age Statistics 
 AgeDiagRaynds AgeDiagSclero CurrentAGE 
N Valid 38 76 76 
Missing 80 42 42 
Mean 46.68 47.18 55.74 
Median 48.50 50.00 57.50 
Range 52 52 54 
Minimum 20 20 26 
Maximum 72 72 80 
Sclero Limited Diffuse 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1.00 43 33.3 55.1 55.1 
2.00 35 27.1 44.9 100.0 
Total 78 60.5 100.0  
Missing System 51 39.5   
Total 129 100.0   
Raynauds 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid   41 34.7 34.7 34.7 
1 72 61.0 61.0 95.8 
2 5 4.2 4.2 100.0 
Total 118 100.0 100.0  
Education 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 3 2.3 2.9 2.9 
2 46 35.7 44.2 47.1 
3 34 26.4 32.7 79.8 
4 21 16.3 20.2 100.0 
Total 104 80.6 100.0  
Missing System 25 19.4   
Total 129 100.0   
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Country 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid   24 18.6 18.6 18.6 
1 34 26.4 26.4 45.0 
3 69 53.5 53.5 98.4 
5 2 1.6 1.6 100.0 
Total 129 100.0 100.0  
Gender 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid   24 18.6 18.6 18.6 
         1 96 74.4 74.4 93.0 
         2 9 7.0 7.0 100.0 
Total 129 100.0 100.0  
 
Reliability Statistics - Scleroderma and Psychosocial Variables 
Stress 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.814 .825 7 
 
Anxiety 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.699 .717 7 
 
Depression 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.927 .927 7 
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EMWS 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.981 .981 21 
 
RQ Dismissive Attachment 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.651 .655 5 
 
Item Statistics 
 Mean Std. Deviation N 
RQ2 3.90 1.192 73 
RQ6 2.47 1.405 73 
RQ19 3.86 1.273 73 
RQ22 2.04 1.285 73 
RQ26 3.30 1.440 73 
Summary Item Statistics 
 Mean Minimum Maximum Range Maximum / Minimum Variance N of Items 
Inter-Item Correlations .275 .039 .650 .611 16.728 .033 5 
 
Fearful Attachment 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.714 .717 4 
 
ER Re-apppraisal 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.882 .884 6 
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ER Suppression 
 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.742 .731 4 
 
Hyper-arousal 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.855 .853 26 
Reactive Hyper-arousal 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.518 .513 3 
 
Item Statistics 
 Mean Std. Deviation N 
HYP6 2.64 1.393 69 
HYP12 2.83 1.200 69 
HYP17 1.94 1.199 69 
Summary Item Statistics 
 Mean Minimum Maximum Range Maximum / Minimum Variance N of Items 
Inter-Item Correlations .260 .136 .322 .186 2.371 .009 3 
 
Self-Compassion 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.761 .766 26 
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Self-judgment 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.845 .849 5 
 
 
 
Isolation 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.775 .774 4 
 
Over-identification 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.732 .731 4 
 
Self-kindness 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.914 .914 5 
 
Common Humanity 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.808 .805 4 
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Mindfulness 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.812 .818 4 
 
SHAQ 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.957 .958 18 
 
Multiple Regression Analysis - Pain 
Pain and Psychosocial Variables - Total Scleroderma Sample 
Descriptive Statistics 
Mean Std. Deviation N 
30.49 25.797 75 
70.24 24.431 72 
15.5753 4.27173 73 
 
Correlations 
 PAIN Total EMWS 1 Total Dismissive RQ! 
Pearson Correlation PAIN 1.000 -.366 .281 
Total EMWS 1 -.366 1.000 -.120 
Total Dismissive RQ! .281 -.120 1.000 
Sig. (1-tailed) PAIN . .001 .008 
Total EMWS 1 .001 . .160 
Total Dismissive RQ! .008 .160 . 
N PAIN 75 71 72 
Total EMWS 1 71 72 71 
Total Dismissive RQ! 72 71 73 
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Variables Entered/Removedb 
Variables Entered 
Variables 
Removed Method 
Total Dismissive 
RQ!, Total EMWS 
1 
. Enter 
a. All requested variables entered. 
b. Dependent Variable: PAIN 
 
Model Summaryb 
 
Model R R Square Adjusted R Square Std. Error of the Estimate 
1 .437a .191 .167 23.537 
a. Predictors: (Constant), Total Dismissive RQ!, Total EMWS 1 b. Dependent Variable: PAIN 
 
ANOVAb 
df Mean Square F Sig. 
2 4455.121 8.042 .001a 
68 554.009   
70    
a. Predictors: (Constant), Total Dismissive RQ!, Total EMWS 1  b. Dependent Variable: PAIN 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 (Constant) 32.908 14.182  2.320 .023 4.609 61.208      
Total EMWS 1 -.356 .116 -.338 -3.073 .003 -.588 -.125 -.366 -.349 -.335 .986 1.015 
Total Dismissive RQ! 1.452 .663 .241 2.190 .032 .129 2.776 .281 .257 .239 .986 1.015 
a. Dependent Variable: PAIN 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Total EMWS 1 Total Dismissive RQ! 
1 1 2.875 1.000 .00 .01 .01 
2 .100 5.362 .01 .61 .27 
3 .025 10.676 .99 .38 .72 
a. Dependent Variable: PAIN 
                                                                                                                                                               Residual Statistics 
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 Minimum Maximum Mean Std. Deviation N 
Predicted Value 9.98 59.93 30.34 11.355 71 
Std. Predicted Value -1.818 2.609 -.013 1.006 71 
Standard Error of Predicted Value 2.823 8.894 4.686 1.314 71 
Deleted Residual -35.425 61.307 .390 24.372 70 
Stud. Deleted Residual -1.464 2.700 .020 1.025 70 
Mahal. Distance .021 9.010 2.003 1.764 71 
Cook's Distance .000 .234 .016 .031 70 
Centered Leverage Value .000 .129 .029 .025 71 
 
MANOVA – Scleroderma Pain/No Pain Groups   
Psychosocial Variables                                                                                                                            Descriptive Statistics 
 N 
Pain No/Yes 0 32 
1 38 
 
  
 
PainNoYes Mean Std. Deviation N 
Total EMWS 1 0 78.28 18.488 32 
1 63.04 26.611 38 
Total 70.01 24.327 70 
Total Dismissive RQ! 0 14.1563 4.48013 32 
1 16.5789 3.90863 38 
Total 15.4714 4.32291 70 
 
 Box's Test of Equality of Covariance Matricesa 
Box's M 6.000 
F 1.936 
df1 3 
df2 72879047.111 
Sig. .121 
Tests the null hypothesis that 
variables are equal across 
groups. a. Design: Intercept + 
PainNoYes 
 
Multivariate Testsb 
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Box's M 6.000 
F 1.936 
df1 3 
df2 72879047.111 
Sig. .121 
Tests the null hypothesis that 
variables are equal across 
groups. a. Design: Intercept + 
PainNoYes 
Effect Value F Hypothesis df Error df Sig. Partial Eta Squared 
Intercept Pillai's Trace .961 828.711a 2.000 67.000 .000 .961 
Wilks' Lambda .039 828.711a 2.000 67.000 .000 .961 
Hotelling's Trace 24.738 828.711a 2.000 67.000 .000 .961 
Roy's Largest Root 24.738 828.711a 2.000 67.000 .000 .961 
PainNoYes Pillai's Trace .156 6.175a 2.000 67.000 .003 .156 
Wilks' Lambda .844 6.175a 2.000 67.000 .003 .156 
Hotelling's Trace .184 6.175a 2.000 67.000 .003 .156 
Roy's Largest Root .184 6.175a 2.000 67.000 .003 .156 
 
 a. Exact statistic 
b. Design: Intercept + PainNoYes 
Levene's Test of Equality of Error Variancesa 
 F df1 df2 Sig. 
Total EMWS 1 5.984 1 68 .017 
Total Dismissive RQ! .769 1 68 .384 
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Tests of Between-Subjects Effects 
Source Dependent Variable Type III Sum of Squares df Mean Square F Sig. Partial Eta Squared 
Corrected Model Total EMWS 1 4035.587a 1 4035.587 7.457 .008 .099 
Total Dismissive RQ! 101.961b 1 101.961 5.839 .018 .079 
Intercept Total EMWS 1 346934.301 1 346934.301 641.098 .000 .904 
Total Dismissive RQ! 16409.961 1 16409.961 939.701 .000 .933 
PainNoYes Total EMWS 1 4035.587 1 4035.587 7.457 .008 .099 
Total Dismissive RQ! 101.961 1 101.961 5.839 .018 .079 
Error Total EMWS 1 36798.660 68 541.157    
Total Dismissive RQ! 1187.482 68 17.463    
Total Total EMWS 1 383904.250 70     
Total Dismissive RQ! 18045.000 70     
Corrected Total Total EMWS 1 40834.246 69     
Total Dismissive RQ! 1289.443 69     
a. R Squared = .099 (Adjusted R Squared = .086) 
b. R Squared = .079 (Adjusted R Squared = .066) 
 
   PainNoYes 
Dependent Variable PainNoYes Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Total EMWS 1 0 78.281 4.112 70.075 86.487 
1 63.039 3.774 55.509 70.570 
Total Dismissive RQ! 0 14.156 .739 12.682 15.630 
1 16.579 .678 15.226 17.932 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 48.77 78.29 64.26 6.893 68 
Std. Predicted Value -2.295 2.060 -.009 1.017 68 
Standard Error of Predicted Value 4.356 12.416 7.187 2.130 68 
Adjusted Predicted Value 45.42 79.00 63.90 7.176 68 
Residual -66.328 66.445 7.387 36.273 68 
Std. Residual -1.870 1.873 .208 1.023 68 
Stud. Residual -1.899 1.934 .213 1.044 68 
Deleted Residual -68.395 70.826 7.742 37.815 68 
Stud. Deleted Residual -1.939 1.977 .215 1.053 68 
Mahal. Distance .025 7.225 2.003 1.816 68 
Cook's Distance .000 .083 .016 .019 68 
Centered Leverage Value .000 .108 .030 .027 68 
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Multiple Regression Analysis: Raynaud’s and Psychosocial Variables - Total Sample  
Descriptive Statistics 
 Mean Std. Deviation N 
Raynauds 29.49 26.279 75 
Self Kindness Transformed  Log 1.1056 .17510 69 
Hyperarousal Reactive 7.4058 2.71336 69 
 
                                                                                                                                                                      Correlations 
 Raynaud Self Kindness Transformed  Log Hyperarousal Reactive 
Pearson Correlation Raynauds 1.000 -.354 .361 
Self Kindness Transformed  Log -.354 1.000 -.232 
Hyperarousal Reactive .361 -.232 1.000 
Sig. (1-tailed) Raynauds . .002 .001 
Self Kindness Transformed  Log .002 . .028 
Hyperarousal Reactive .001 .028 . 
N Raynauds 75 68 68 
Self Kindness Transformed  Log 68 69 69 
Hyperarousal Reactive 68 69 69 
 
   
 
 
Variables Entered 
Model Variables Entered Variables Removed Method 
1 Hyperarousal Reactive, Self Kindness Transformed  Log . Enter 
a. All requested variables entered. 
b. Dependent Variable: Raynauds 
 
 Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the Estimate 
1 .455a .207 .183 23.757 
a. Predictors: (Constant), Hyperarousal Reactive, Self Kindness Transformed  Log  b. Dependent Variable: Raynauds 
  
ANOVA 
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Model Sum of Squares df Mean Square F Sig. 
1 Regression 9583.254 2 4791.627 8.490 .001a 
Residual 36685.449 65 564.392   
Total 46268.703 67    
a. Predictors: (Constant), Hyperarousal Reactive, Self Kindness Transformed  Log 
b. Dependent Variable: Raynauds 
 
Coefficients 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 (Constant) 55.700 22.374  2.489 .015 11.015 100.384      
Self Kindness Transformed  
Log 
-42.815 17.039 -.285 -2.513 .014 -76.845 -8.785 -.354 -.298 -.278 .946 1.057 
Hyperarousal Reactive 2.853 1.100 .295 2.595 .012 .657 5.049 .361 .306 .287 .946 1.057 
a. Dependent Variable: Raynauds 
 
 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Self Kindness Transformed  Log Hyperarousal Reactive 
1 1 2.896 1.000 .00 .00 .01 
2 .094 5.548 .01 .06 .77 
3 .010 17.204 .98 .93 .22 
a. Dependent Variable: Raynauds 
 
Residuals Statisticsa Minimum Maximum Mean Std. Deviation N 
Predicted Value 10.50 68.57 29.49 11.960 69 
Std. Predicted Value -1.588 3.267 .000 1.000 69 
Standard Error of Predicted Value 2.914 9.961 4.779 1.448 69 
Adjusted Predicted Value 9.93 72.53 29.32 12.188 68 
Residual -48.047 49.917 -.360 23.234 68 
Std. Residual -2.022 2.101 -.015 .978 68 
Stud. Residual -2.079 2.246 -.014 1.001 68 
Deleted Residual -50.770 57.020 -.322 24.345 68 
Stud. Deleted Residual -2.135 2.320 -.012 1.012 68 
Mahal. Distance .023 10.793 1.971 1.988 69 
Cook's Distance .000 .239 .016 .032 68 
Centered Leverage Value .000 .161 .029 .030 69 
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MANOVA: Skin Severity - Mild Moderate Severe Groups 
Between-Subjects Factors N 
Tight Skin Severity Groups 1.00 12 
2.00 23 
3.00 25 
 
  Descriptive Statistics 
Tight Skin Severity Groups Mean Std. Deviation N 
Total EMWS 1 1.00 70.83 23.866 12 
2.00 77.22 18.940 23 
3.00 61.72 28.926 25 
Total 69.48 25.091 60 
Total Dismissive RQ! 1.00 13.8333 5.00606 12 
2.00 14.1739 4.23891 23 
3.00 17.6000 3.93700 25 
Total 15.5333 4.56021 60 
Transformed Log Fear RQ 1.00 .8167 .14774 12 
2.00 .9241 .16153 23 
3.00 .9963 .17349 25 
Total .9327 .17469 60 
Transformed Sqare Root Suppression ERQ1 1.00 3.0673 .90941 12 
2.00 3.8759 .58318 23 
3.00 3.7824 .87386 25 
Total 3.6752 .82908 60 
 
 
Box's Test of Equality of Covariance Matricesa 
Box's M 30.338 
F 1.336 
df1 20 
df2 4988.845 
Sig. .144 
a. Design: Intercept  TightSkinSvgps 
 
Multivariate Testsc 
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Effect Value F Hypothesis df Error df Sig. Partial Eta Squared 
Intercept Pillai's Trace .982 753.612a 4.000 54.000 .000 .982 
Wilks' Lambda .018 753.612a 4.000 54.000 .000 .982 
Hotelling's Trace 55.823 753.612a 4.000 54.000 .000 .982 
Roy's Largest Root 55.823 753.612a 4.000 54.000 .000 .982 
TightSkinSvgps Pillai's Trace .387 3.299 8.000 110.000 .002 .194 
Wilks' Lambda .650 3.240a 8.000 108.000 .002 .194 
Hotelling's Trace .480 3.180 8.000 106.000 .003 .194 
Roy's Largest Root .249 3.428b 4.000 55.000 .014 .200 
a. Exact statistic b. The statistic is an upper bound on F that yields a lower bound on the significance level. c. Design: Intercept + TightSkinSvgps 
 
Levene's Test of Equality of Error Variancesa 
 F df1 df2 Sig. 
Total EMWS 1 3.773 2 57 .029 
Total Dismissive RQ! 1.676 2 57 .196 
Transformed Log Fear RQ .458 2 57 .635 
Transformed Sqare Root 
Suppression ERQ1 
2.275 2 57 .112 
. a. Design: Intercept + TightSkinSvgps 
 
 
 
 
 
 
 
 
 
 
 
Tests of Between-Subjects Effects 
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Source Dependent Variable Type III Sum of Squares df Mean Square F Sig. Partial Eta Squared 
Corrected Model Total EMWS 1 2904.364a 2 1452.182 2.418 .098 .078 
Total Dismissive RQ! 183.962b 2 91.981 5.027 .010 .150 
Transformed Log Fear RQ .264c 2 .132 4.897 .011 .147 
Transformed Sqare Root 
Suppression ERQ1 
5.648d 2 2.824 4.611 .014 .139 
Intercept Total EMWS 1 263793.156 1 263793.156 439.159 .000 .885 
Total Dismissive RQ! 12469.283 1 12469.283 681.466 .000 .923 
Transformed Log Fear RQ 44.912 1 44.912 1666.144 .000 .967 
Transformed Sqare Root 
Suppression ERQ1 
689.641 1 689.641 1126.128 .000 .952 
TightSkinSvgps Total EMWS 1 2904.364 2 1452.182 2.418 .098 .078 
Total Dismissive RQ! 183.962 2 91.981 5.027 .010 .150 
Transformed Log Fear RQ .264 2 .132 4.897 .011 .147 
Transformed Sqare Root 
Suppression ERQ1 
5.648 2 2.824 4.611 .014 .139 
Error Total EMWS 1 34238.620 57 600.678    
Total Dismissive RQ! 1042.971 57 18.298    
Transformed Log Fear RQ 1.536 57 .027    
Transformed Sqare Root 
Suppression ERQ1 
34.907 57 .612 
   
Total Total EMWS 1 326819.000 60     
Total Dismissive RQ! 15704.000 60     
Transformed Log Fear RQ 53.997 60     
Transformed Sqare Root 
Suppression ERQ1 
851.000 60 
    
Corrected Total Total EMWS 1 37142.983 59     
Total Dismissive RQ! 1226.933 59     
Transformed Log Fear RQ 1.800 59     
Transformed Sqare Root 
Suppression ERQ1 
40.555 59 
    
a. R Squared = .078 (Adjusted R Squared = .046) b. R Squared = .150 (Adjusted R Squared = .120) c. R Squared = .147 (Adjusted R Squared = .117) d. R 
Squared = .139 (Adjusted R Squared = .109) 
 
 
 
 
 
 
Residuals Statisticsa 
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 Minimum Maximum Mean Std. Deviation N 
Predicted Value 44.03 91.49 69.05 11.253 64 
Std. Predicted Value -2.224 1.995 .000 1.000 64 
Standard Error of Predicted Value 8.145 19.956 13.750 2.532 64 
Adjusted Predicted Value 40.04 109.18 69.41 13.628 64 
Residual -69.327 63.663 .000 34.826 64 
Std. Residual -1.860 1.708 .000 .934 64 
Stud. Residual -2.202 1.783 -.004 1.010 64 
Deleted Residual -97.185 73.623 -.363 40.801 64 
Stud. Deleted Residual -2.285 1.820 -.006 1.021 64 
Mahal. Distance 2.024 17.074 7.875 3.226 64 
Cook's Distance .000 .217 .020 .032 64 
Centered Leverage Value .032 .271 .125 .051 64 
a. Dependent Variable: ID 
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Statistical Analysis – Scleroderma: Depression, Anxiety and Stress 
Multiple Regression Analysis - Depression  
Scleroderma: Depression and Psychosocial Variables - Total Sample 
Descriptive Statistics 
 Mean Std. Deviation N 
Transform Inverse Depression 
DASS 1 
.0975 .03081 75 
Total EMWS 1 70.24 24.431 72 
Raynauds 1.06 .248 77 
Transformed Log Fear RQ .9310 .16629 73 
 
Correlations 
 Transform Inverse 
Depression DASS 
1 
Total EMWS 1 Raynauds Transformed Log 
Fear RQ 
Pearson Correlation 
Transform Inverse Depression 
DASS 1 
1.000 .391 .136 -.361 
Total EMWS 1 .391 1.000 .099 -.279 
Raynauds .136 .099 1.000 .068 
Transformed Log Fear RQ -.361 -.279 .068 1.000 
Sig. (1-tailed) 
Transform Inverse Depression 
DASS 1 
. .000 .123 .001 
Total EMWS 1 .000 . .205 .009 
Raynauds .123 .205 . .286 
Transformed Log Fear RQ .001 .009 .286 . 
N 
Transform Inverse Depression 
DASS 1 
75 72 74 72 
Total EMWS 1 72 72 72 71 
Raynauds 74 72 77 72 
Transformed Log Fear RQ 72 71 72 73 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Transformed Log 
Fear RQ, 
Raynauds , Total 
EMWS 1b 
. Enter 
a. Dependent Variable: Transform Inverse Depression DASS 1 
b. All requested variables entered. 
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Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .488a .238 .204 .02750 
a. Predictors: (Constant), Transformed Log Fear RQ, Raynauds , Total EMWS  
b. Dependent Variable: Transform Inverse Depression DASS 1 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .016 3 .005 6.968 .000b 
Residual .051 67 .001 
  
Total .066 70 
   
a. Dependent Variable: Transform Inverse Depression DASS 1 
b. Predictors: (Constant), Transformed Log Fear RQ, Raynauds , Total EMWS 1 
Coefficientsa 
 
 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .104 .027 
 
3.913 .000 .051 .157 
     
Total EMWS 1 .000 .000 .299 2.673 .009 .000 .001 .391 .310 .285 .909 1.101 
Raynauds .016 .013 .126 1.172 .245 -.011 .042 .136 .142 .125 .980 1.020 
Transformed Log Fear RQ -.053 .021 -.287 -2.568 .012 -.094 -.012 -.361 -.299 -.274 .913 1.095 
a. Dependent Variable: Transform Inverse Depression DASS 1 
 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Total EMWS 1 Raynauds Transformed Log 
Fear RQ 
1 
1 3.855 1.000 .00 .01 .00 .00 
2 .096 6.341 .00 .73 .03 .06 
3 .039 9.985 .02 .02 .87 .19 
4 .010 19.217 .98 .24 .10 .75 
a. Dependent Variable: Transform Inverse Depression DASS 1 
 
 
 
Residuals Statisticsa 
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 Minimum Maximum Mean Std. Deviation N 
Predicted Value .0583 .1284 .0978 .01516 71 
Std. Predicted Value -2.612 2.057 .016 1.009 71 
Standard Error of Predicted 
Value 
.003 .015 .006 .003 71 
Adjusted Predicted Value .0597 .1411 .0978 .01564 71 
Residual -.05144 .06964 -.00014 .02662 71 
Std. Residual -1.871 2.533 -.005 .968 71 
Stud. Residual -1.888 2.609 -.006 1.000 71 
Deleted Residual -.05240 .07391 -.00022 .02849 71 
Stud. Deleted Residual -1.926 2.732 -.006 1.012 71 
Mahal. Distance .105 20.667 3.065 4.014 71 
Cook's Distance .000 .214 .018 .037 71 
Centered Leverage Value .002 .295 .044 .057 71 
a. Dependent Variable: Transform Inverse Depression DASS 1 
 
Multiple Regression Analysis: Depression and Psychosocial/ 
Scleroderma Variables – Limited Sclerosis                                          
   Descriptive Statistics 
Sclero Limited Mean Std. Deviation N 
1.00 Transform Inverse Depression 
DASS 1 
.0963 .02934 42 
Total EMWS 1 73.03 21.888 40 
Transformed Sqare Root 
Suppression ERQ1 
3.6629 .71952 38 
Correlations 
Sclero Limited 
Transform Inverse 
Depression DASS 
1 Total EMWS 1 
Transformed 
Sqare Root 
Suppression 
ERQ1 
1.00 Pearson Correlation Transform Inverse Depression 
DASS 1 
1.000 .496 -.478 
Total EMWS 1 .496 1.000 -.098 
Transformed Sqare Root 
Suppression ERQ1 
-.478 -.098 1.000 
Sig. (1-tailed) Transform Inverse Depression 
DASS 1 
. .001 .001 
Total EMWS 1 .001 . .283 
Transformed Sqare Root 
Suppression ERQ1 
.001 .283 . 
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N Transform Inverse Depression 
DASS 1 
42 40 38 
Total EMWS 1 40 40 37 
Transformed Sqare Root 
Suppression ERQ1 
38 37 38 
Variables Entered/Removedb 
Sclero Limited Model Variables Entered 
Variables 
Removed Method 
1.00 1 Transformed 
Sqare Root 
Suppression 
ERQ1, Total 
EMWS 1 
. Enter 
 
Model Summaryb 
Sclero Limited Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1.00 1 .658a .433 .399 .02274 
a. Predictors: (Constant), Transformed Sqare Root Suppression ERQ1, Total EMWS 1 
b. Dependent Variable: Transform Inverse Depression DASS 1 
ANOVAb 
Sclero Limited Model Sum of Squares df Mean Square F Sig. 
1.00 1 Regression .013 2 .007 12.970 .000a 
Residual .018 34 .001   
Total .031 36    
a. Predictors: (Constant), Transformed Sqare Root Suppression ERQ1, Total EMWS 1 
b. Dependent Variable: Transform Inverse Depression DASS 1 
Coefficientsa 
 
 
Sclero Limited Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1.00 1 (Constant) .117 .024  4.765 .000 .067 .166      
Total EMWS 1 .001 .000 .454 3.499 .001 .000 .001 .496 .515 .452 .990 1.010 
Transformed Square Root 
Suppression ERQ1 
-.018 .005 -.434 -3.342 .002 -.028 -.007 -.478 -.497 -.432 .990 1.010 
a. Dependent Variable: Transform Inverse Depression DASS 1 
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Collinearity Diagnosticsa 
Sclero Limited Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Total EMWS 1 
Transformed 
Sqare Root 
Suppression 
ERQ1 
1.00 1 1 2.918 1.000 .00 .01 .00 
2 .067 6.586 .01 .74 .18 
3 .015 14.100 .98 .25 .82 
a. Dependent Variable: Transform Inverse Depression DASS 1 
Residuals Statisticsa 
Sclero Limited Minimum Maximum Mean Std. Deviation N 
1.00 Predicted Value .0471 .1361 .0964 .01931 37 
Std. Predicted Value -2.551 2.059 .003 1.001 37 
Standard Error of Predicted 
Value 
.004 .011 .006 .002 37 
Adjusted Predicted Value .0499 .1345 .0967 .01908 37 
Residual -.04905 .06378 -.00039 .02167 37 
Std. Residual -2.157 2.805 -.017 .953 37 
Stud. Residual -2.207 2.903 -.023 .986 37 
Deleted Residual -.05136 .06831 -.00069 .02321 37 
Stud. Deleted Residual -2.350 3.298 -.015 1.033 37 
Mahal. Distance .009 6.890 1.949 1.760 37 
Cook's Distance .000 .199 .023 .036 37 
Centered Leverage Value .000 .191 .054 .049 37 
a. Dependent Variable: Transform Inverse Depression DASS 1 
 
 
Multiple Regression Analysis: Diffuse - Depression 
 
Descriptive Statisticsa 
 Mean Std. Deviation N 
Transform Inverse Depression 
DASS 1 
.0990 .03299 33 
OverIdentification SC 10.9677 3.70121 31 
Raynaud 31.88 29.099 34 
a. Diffuse Limited Sclerodema = Diffuse 
                                                                                                                                                                                                                                                                                                                                                      22 
 
 
 
 
 
Correlationsa 
Correlations Transform Inverse 
Depression DASS 
1 
OverIdentification 
SC 
Raynaud 
Pearson Correlation 
Transform Inverse Depression 
DASS 1 
1.000 -.549 -.513 
OverIdentification SC -.549 1.000 -.321 
Raynaud -.513 -.321 1.000 
Sig. (1-tailed) 
Transform Inverse Depression 
DASS 1 
. .001 .001 
OverIdentification SC .001 . .039 
Raynaud .001 .039 . 
N 
Transform Inverse Depression 
DASS 1 
33 30 33 
OverIdentification SC 30 31 31 
Raynaud 33 31 34 
a. Diffuse Limited Sclerodema = Diffuse 
 
Variables Entered/Removeda,b 
Model Variables Entered Variables 
Removed 
Method 
1 
Raynaud, 
OverIdentification 
SCc 
. Enter 
a. Diffuse Limited Sclerodema = Diffuse 
b. Dependent Variable: Transform Inverse Depression DASS 1 
c. All requested variables entered. 
Model Summarya,c 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .654b .428 .386 .02586 
a. Diffuse Limited Sclerodema = Diffuse 
b. Predictors: (Constant), Raynaud, OverIdentification SC 
c. Dependent Variable: Transform Inverse Depression DASS 1 
ANOVAa,b 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .014 2 .007 10.106 .001c 
Residual .018 27 .001 
  
Total .032 29 
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a. Diffuse Limited Sclerodema = Diffuse 
b. Dependent Variable: Transform Inverse Depression DASS 1 
c. Predictors: (Constant), Raynaud, OverIdentification SC 
 
Coefficientsa,b 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .155 .015 
 
10.297 .000 .124 .185 
     
OverIdentification SC -.004 .001 -.429 -2.792 .009 -.007 -.001 -.549 -.473 -.406 .897 1.115 
Raynaud .000 .000 -.375 -2.441 .021 -.001 .000 -.513 -.425 -.355 .897 1.115 
a. Diffuse Limited Sclerodema = Diffuse 
b. Dependent Variable: Transform Inverse Depression DASS 1 
 
Collinearity Diagnosticsa,b 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) OverIdentification 
SC 
Raynaud 
1 
1 2.648 1.000 .01 .01 .05 
2 .302 2.961 .06 .03 .93 
3 .050 7.307 .93 .95 .03 
a. Diffuse Limited Sclerodema = Diffuse 
b. Dependent Variable: Transform Inverse Depression DASS 1 
Residuals Statisticsa,b 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .0440 .1354 .0981 .02170 31 
Std. Predicted Value -2.548 1.685 -.045 1.005 31 
Standard Error of Predicted 
Value 
.005 .013 .008 .002 31 
Adjusted Predicted Value .0340 .1342 .0966 .02284 30 
Residual -.04769 .04698 .00023 .02553 30 
Std. Residual -1.844 1.817 .009 .988 30 
Stud. Residual -1.918 2.034 .022 1.048 30 
Deleted Residual -.05159 .05889 .00098 .02884 30 
Stud. Deleted Residual -2.026 2.169 .020 1.075 30 
Mahal. Distance .077 6.800 1.965 1.760 31 
Cook's Distance .000 .350 .047 .073 30 
Centered Leverage Value .003 .234 .068 .061 31 
a. Diffuse Limited Sclerodema = Diffuse 
b. Dependent Variable: Transform Inverse Depression DASS 1 
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Mann Witney U-Test: Finger Ulcers - Depression 
Depression - Finger Ulcers and No Finger Ulcer Groups  
Descriptive Statistics 
 N Mean Std. Deviation Minimum Maximum 
Transform Inverse Depression 
DASS 1 
75 .0975 .03081 .04 .14 
FingerUlcrNY 76 .5921 .49471 .00 1.00 
 
Ranks 
 FingerUlcrNY N Mean Rank Sum of Ranks 
Transform Inverse Depression 
DASS 1 
.00 30 45.45 1363.50 
1.00 45 33.03 1486.50 
Total 75 
  
 
Test Statisticsa 
 Transform 
Inverse 
Depression DASS 
1 
Mann-Whitney U 451.500 
Wilcoxon W 1486.500 
Z -2.438 
Asymp. Sig. (2-tailed) .015 
a. Grouping Variable: FingerUlcrNY 
Medium Scores 
Case Processing Summary 
 Cases 
Included Excluded Total 
N Percent N Percent N Percent 
Transform Inverse Depression 
DASS 1  * FingerUlcrNY 
75 58.1% 54 41.9% 129 100.0% 
 
Report 
Transform Inverse Depression DASS 1 
FingerUlcrNY N Median 
.00 30 .1250 
1.00 45 .0909 
Total 75 .1000 
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Multiple Regression Analysis - Anxiety 
Anxiety and Psychosocial and Scleroderma Variables - Total Sample  
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed Log Anxiety 1.0175 .13186 76 
Total EMWS 1 70.24 24.431 72 
Transformed Sqare Root Suppression ERQ1 3.7001 .80731 69 
Transformed SQRT Breathing 1SHAQ 3.6189 2.92497 76 
 
Correlations 
 
Transformed Log 
Anxiety Total EMWS 1 
Transformed Sqare 
Root Suppression 
ERQ1 
Transformed SQRT 
Breathing 1SHAQ 
Pearson Correlation Transformed Log Anxiety 1.000 -.468 .325 .418 
Total EMWS 1 -.468 1.000 .068 -.067 
Transformed Sqare Root 
Suppression ERQ1 
.325 .068 1.000 -.078 
Transformed SQRT Breathing 
1SHAQ 
.418 -.067 -.078 1.000 
Sig. (1-tailed) Transformed Log Anxiety . .000 .003 .000 
Total EMWS 1 .000 . .292 .288 
Transformed Sqare Root 
Suppression ERQ1 
.003 .292 . .263 
Transformed SQRT Breathing 
1SHAQ 
.000 .288 .263 . 
N Transformed Log Anxiety 76 72 69 76 
Total EMWS 1 72 72 66 72 
Transformed Sqare Root 
Suppression ERQ1 
69 66 69 69 
Transformed SQRT Breathing 
1SHAQ 
76 72 69 76 
 
 
 
Variables Entered/Removedb 
Model Variables Entered Variables Removed Method 
1 Transformed SQRT Breathing 1SHAQ, Total EMWS 1, Transformed 
Sqare Root Suppression ERQ1 
. Enter 
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a. b. Dependent Variable: Transformed Log Anxiety 
Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .721a .520 .496 .09359 
a. Predictors: (Constant), Transformed SQRT Breathing 1SHAQ, Total 
EMWS 1, Transformed Sqare Root Suppression ERQ1 b. Dependent 
Variable: Transformed Log Anxiety 
b.  
ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .587 3 .196 22.345 .000a 
Residual .543 62 .009   
Total 1.130 65    
a. Predictors: (Constant), Transformed SQRT Breathing 1SHAQ, Total EMWS 1, Transformed Sqare Root 
Suppression ERQ1 b. Dependent Variable: Transformed Log Anxiety 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 (Constant) .891 .065  13.640 .000 .761 1.022      
Total EMWS 1 -.003 .000 -.467 -5.279 .000 -.003 -.002 -.468 -.557 -.465 .991 1.009 
Transformed Sqare Root 
Suppression ERQ1 
.064 .014 .389 4.398 .000 .035 .092 .325 .488 .387 .990 1.010 
Transformed SQRT Breathing 
1SHAQ 
.019 .004 .417 4.718 .000 .011 .027 .418 .514 .415 .990 1.010 
a. Dependent Variable: Transformed Log Anxiety 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Total EMWS 1 
Transformed Sqare 
Root Suppression ERQ1 
Transformed SQRT 
Breathing 1SHAQ 
1 1 3.563 1.000 .00 .01 .00 .02 
2 .341 3.235 .00 .03 .01 .90 
3 .077 6.822 .03 .85 .18 .02 
4 .020 13.414 .96 .11 .81 .06 
a. Dependent Variable: Transformed Log Anxiety 
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Residuals Statisticsa 
 
Minimum Maximum Mean Std. Deviation N 
Predicted Value .8104 1.2682 1.0146 .09615 66 
Std. Predicted Value -2.179 2.638 -.030 1.012 66 
Standard Error of Predicted Value .012 .037 .023 .006 66 
Adjusted Predicted Value .8060 1.2576 1.0143 .09638 66 
Residual -.18428 .18756 -.00126 .09082 66 
Std. Residual -1.969 2.004 -.013 .970 66 
Stud. Residual -2.013 2.063 -.012 .997 66 
Mahal. Distance .127 9.429 3.020 2.106 66 
Cook's Distance .000 .063 .014 .015 66 
Centered Leverage Value .002 .145 .046 .032 66 
a. Dependent Variable: Transformed Log Anxiety 
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Multiple Regression Analysis: Limited and Diffuse - Anxiety and Psychosocial and Scleroderma Variables  
Limited Sclerosis 
Descriptive Statistics 
Sclero Limited Mean Std. Deviation N 
1.00 Transformed Log Anxiety 1.0025 .13589 42 
Total EMWS 1 73.03 21.888 40 
Transformed SQRT Breathing 
1SHAQ 
3.5047 2.90966 42 
Transformed Sqare Root 
Suppression ERQ1 
3.6629 .71952 38 
Correlations 
Sclero Limited 
Transformed Log 
Anxiety Total EMWS 1 
Transformed 
SQRT Breathing 
1SHAQ 
Transformed 
Sqare Root 
Suppression 
ERQ1 
1.00 Pearson Correlation Transformed Log Anxiety 1.000 -.510 .464 .446 
Total EMWS 1 -.510 1.000 .129 -.098 
Transformed SQRT Breathing 
1SHAQ 
.464 .129 1.000 .223 
Transformed Sqare Root 
Suppression ERQ1 
.446 -.098 .223 1.000 
Sig. (1-tailed) Transformed Log Anxiety . .000 .001 .002 
Total EMWS 1 .000 . .213 .283 
Transformed SQRT Breathing 
1SHAQ 
.001 .213 . .089 
Transformed Sqare Root 
Suppression ERQ1 
.002 .283 .089 . 
N Transformed Log Anxiety 42 40 42 38 
Total EMWS 1 40 40 40 37 
Transformed SQRT Breathing 
1SHAQ 
42 40 42 38 
Transformed Sqare Root 
Suppression ERQ1 
38 37 38 38 
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Variables Entered/Removedb 
Sclero Limited Model Variables Entered 
Variables 
Removed Method 
1.00 1 Transformed 
Sqare Root 
Suppression 
ERQ1, Total 
EMWS 1, 
Transformed 
SQRT Breathing 
1SHAQ 
. Enter 
a. All requested variables entered. 
b. Dependent Variable: Transformed Log Anxiety 
 
Model Summaryb 
Sclero Limited Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1.00 1 .790a .623 .589 .08709 
a. Predictors: (Constant), Transformed Sqare Root Suppression ERQ1, Total EMWS 1, Transformed 
SQRT Breathing 1SHAQ b. Dependent Variable: Transformed Log Anxiety 
ANOVAb 
Sclero Limited Model Sum of Squares df Mean Square F Sig. 
1.00 1 Regression .414 3 .138 18.216 .000a 
Residual .250 33 .008   
Total .665 36    
a. Predictors: (Constant), Transformed Sqare Root Suppression ERQ1, Total EMWS 1, Transformed SQRT Breathing 1SHAQ 
b. Dependent Variable: Transformed Log Anxiety 
Coefficientsa 
Sclero Limited Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1.00 1 (Constant) .972 .094  10.330 .000 .780 1.163      
Total EMWS 1 -.003 .001 -.543 -4.993 .000 -.005 -.002 -.510 -.656 -.533 .966 1.035 
Transformed SQRT Breathing 
1SHAQ 
.022 .005 .470 4.235 .000 .011 .032 .464 .593 .452 .927 1.079 
Transformed Sqare Root 
Suppression ERQ1 
.055 .021 .289 2.611 .013 .012 .097 .446 .414 .279 .934 1.071 
a. Dependent Variable: Transformed Log Anxiety 
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Collinearity Diagnosticsa 
Sclero Limited Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Total EMWS 1 
Transformed 
SQRT Breathing 
1SHAQ 
Transformed 
Sqare Root 
Suppression 
ERQ1 
1.00 1 1 3.609 1.000 .00 .01 .02 .00 
2 .310 3.414 .01 .02 .95 .01 
3 .067 7.336 .02 .71 .00 .17 
4 .014 15.884 .98 .26 .03 .82 
a. Dependent Variable: Transformed Log Anxiety 
 
Residuals Statisticsa 
Sclero Limited Minimum Maximum Mean Std. Deviation N 
1.00 Predicted Value .7997 1.3102 .9977 .10778 37 
Std. Predicted Value -1.890 2.867 -.044 1.004 37 
Standard Error of Predicted 
Value 
.016 .045 .028 .007 37 
Adjusted Predicted Value .7891 1.2984 .9973 .10729 37 
Residual -.19437 .17341 -.00531 .08371 37 
Std. Residual -2.232 1.991 -.061 .961 37 
Stud. Residual -2.328 2.050 -.059 1.006 37 
Deleted Residual -.21155 .18381 -.00485 .09179 37 
Stud. Deleted Residual -2.508 2.161 -.068 1.040 37 
Mahal. Distance .179 8.617 2.942 2.130 37 
Cook's Distance .000 .120 .024 .031 37 
Centered Leverage Value .005 .239 .082 .059 37 
a. Dependent Variable: Transformed Log Anxiety 
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Multiple Regression Analysis: Diffuse Sclerosis – Anxiety  
 
Descriptive Statistics 
Sclero Diffuse Mean Std. Deviation N 
1.00 Transformed Log Anxiety 1.0360 .12623 34 
Total EMWS 1 66.77 27.237 32 
SC Isolation 10.3226 4.36186 31 
 
 
Correlations 
Sclero Diffuse Transformed Log Anxiety Total EMWS 1 SC Isolation 
1.00 Pearson Correlation Transformed Log Anxiety 1.000 -.415 .383 
Total EMWS 1 -.415 1.000 .097 
SC Isolation .383 .097 1.000 
Sig. (1-tailed) Transformed Log Anxiety . .009 .017 
Total EMWS 1 .009 . .309 
SC Isolation .017 .309 . 
N Transformed Log Anxiety 34 32 31 
Total EMWS 1 32 32 29 
SC Isolation 31 29 31 
 
Variables Entered/Removedb 
 
Sclero Diffuse Model Variables Entered Variables Removed Method 
1.00 1 SC Isolation, Total EMWS 1 . Enter 
a. All requested variables entered. b. Dependent Variable: Transformed Log Anxiety 
 
Model Summaryb 
R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
.594a .352 .303 .10541 
 
ANOVA 
 
Sclero Diffuse Model Sum of Squares df Mean Square F Sig. 
1.00 1 Regression .157 2 .079 7.074 .004a 
Residual .289 26 .011   
Total .446 28    
a. Predictors: (Constant), SC Isolation, Total EMWS 1 b. Dependent Variable: Transformed Log Anxiety 
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                                                                                                                                                                              Coefficients 
 
 
Sclero Diffuse Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1.00 1 (Constant) 1.049 .068  15.499 .000 .910 1.189      
Total EMWS 1 -.002 .001 -.456 -2.874 .008 -.004 -.001 -.415 -.491 -.454 .991 1.009 
SC Isolation .012 .005 .427 2.692 .012 .003 .022 .383 .467 .425 .991 1.009 
a. Dependent Variable: Transformed Log Anxiety 
 
 
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed Log Anxiety 1.0175 .13186 76 
Total EMWS 1 70.24 24.431 72 
Transformed Sqare Root Suppression ERQ1 3.7001 .80731 69 
Transformed SQRT Breathing 1SHAQ 3.6189 2.92497 76 
 
 
Sclero Diffuse Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Total EMWS 1 SC Isolation 
1.00 1 1 2.815 1.000 .01 .02 .02 
2 .129 4.670 .00 .51 .59 
3 .055 7.123 .99 .48 .39 
a. Dependent Variable: Transformed Log Anxiety 
 
 
Sclero Diffuse Minimum Maximum Mean Std. Deviation N 
1.00 Predicted Value .9163 1.1744 1.0388 .07576 29 
Std. Predicted Value -1.597 1.847 .037 1.011 29 
Standard Error of Predicted 
Value 
.020 .049 .033 .008 29 
Adjusted Predicted Value .9135 1.1578 1.0370 .07523 29 
Residual -.16886 .20977 .00135 .09026 29 
Std. Residual -1.602 1.990 .013 .856 29 
Stud. Residual -1.657 2.096 .021 .904 29 
Deleted Residual -.18074 .23261 .00315 .10070 29 
Stud. Deleted Residual -1.718 2.254 .024 .925 29 
Mahal. Distance .013 5.023 1.974 1.373 29 
Cook's Distance .000 .159 .031 .041 29 
Centered Leverage Value .000 .179 .070 .049 29 
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Sclero Diffuse Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Total EMWS 1 SC Isolation 
1.00 1 1 2.815 1.000 .01 .02 .02 
2 .129 4.670 .00 .51 .59 
3 .055 7.123 .99 .48 .39 
a. Dependent Variable: Transformed Log Anxiety 
 
 
T-Tests - Anxiety 
Anxiety – Pain and No Pain Groups  
Group Statistics 
 PainNoYes N Mean Std. Deviation Std. Error Mean 
Transformed Log Anxiety 
0 35 .9782 .11509 .01945 
1 40 1.0494 .13863 .02192 
Independent Samples Test 
 Levene's Test for Equality of Variances t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) Mean Difference Std. Error Difference 95% Confidence Interval of the 
Difference 
Lower Upper 
Transformed Log 
Anxiety 
Equal variances assumed 2.275 .136 -2.401 73 .019 -.07123 .02967 -.13037 -.01209 
Equal variances not assumed 
  
-2.431 72.815 .018 -.07123 .02931 -.12965 -.01282 
 
 
Multiple Regression Analysis: Scleroderma - Stress 
Stress and Psychosocial and Scleroderma Variables - Total Sample 
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed Logarithm Stress 
DASS 1 
1.0585 .12737 75 
Total EMWS 1 70.24 24.431 72 
Total Self Compassion 79.3871 17.40770 62 
AgeDiagRaynds 46.68 11.529 38 
 
 
 
Correlations 
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Correlations Transformed 
Logarithm Stress 
DASS 1 
Total EMWS 1 Total Self 
Compassion 
AgeDiagRaynds 
Pearson Correlation 
Transformed Logarithm Stress 
DASS 1 
1.000 -.364 -.382 -.365 
Total EMWS 1 -.364 1.000 .292 -.099 
Total Self Compassion -.382 .292 1.000 .204 
AgeDiagRaynds -.365 -.099 .204 1.000 
Sig. (1-tailed) 
Transformed Logarithm Stress 
DASS 1 
. .001 .001 .013 
Total EMWS 1 .001 . .012 .283 
Total Self Compassion .001 .012 . .140 
AgeDiagRaynds .013 .283 .140 . 
N 
Transformed Logarithm Stress 
DASS 1 
75 72 61 37 
Total EMWS 1 72 72 60 36 
Total Self Compassion 61 60 62 30 
AgeDiagRaynds 37 36 30 38 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
AgeDiagRaynds, 
Total EMWS 1, 
Total Self 
Compassionb 
. Enter 
a. Dependent Variable: Transformed Logarithm Stress DASS 1 
b. All requested variables entered. 
Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .577a .333 .256 .10983 
a. Predictors: (Constant), AgeDiagRaynds, Total EMWS 1, Total Self 
Compassion 
b. Dependent Variable: Transformed Logarithm Stress DASS 1 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .157 3 .052 4.335 .013b 
Residual .314 26 .012 
  
Total .470 29 
   
a. Dependent Variable: Transformed Logarithm Stress DASS 1 
b. Predictors: (Constant), AgeDiagRaynds, Total EMWS 1, Total Self Compassion 
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Coefficientsa 
 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) 1.488 .124 
 
12.045 .000 1.234 1.742 
     
Total EMWS 1 -.002 .001 -.337 -1.986 .058 -.004 .000 -.364 -.363 -.318 .889 1.125 
Total Self Compassion -.002 .001 -.211 -1.223 .232 -.004 .001 -.382 -.233 -.196 .860 1.162 
AgeDiagRaynds -.004 .002 -.356 -2.145 .042 -.008 .000 -.365 -.388 -.343 .931 1.074 
a. Dependent Variable: Transformed Logarithm Stress DASS 1 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Total EMWS 1 Total Self 
Compassion 
AgeDiagRaynds 
1 
1 3.857 1.000 .00 .01 .00 .00 
2 .092 6.484 .01 .66 .00 .18 
3 .033 10.863 .01 .27 .69 .49 
4 .019 14.217 .99 .07 .31 .32 
a. Dependent Variable: Transformed Logarithm Stress DASS 1 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .9172 1.2094 1.0768 .06549 29 
Std. Predicted Value -1.922 2.052 .249 .890 29 
Standard Error of Predicted 
Value 
.023 .083 .037 .012 29 
Adjusted Predicted Value .8861 1.2925 1.0716 .07492 29 
Residual -.30633 .16223 .00533 .10592 29 
Std. Residual -2.789 1.477 .048 .964 29 
Stud. Residual -3.145 1.611 .068 1.058 29 
Deleted Residual -.38940 .21203 .01052 .12924 29 
Stud. Deleted Residual -3.917 1.665 .046 1.158 29 
Mahal. Distance .267 15.488 2.595 2.936 29 
Cook's Distance .000 .670 .065 .154 29 
Centered Leverage Value .009 .534 .089 .101 29 
a. Dependent Variable: Transformed Logarithm Stress DASS 1 
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T-Tests - Stress  
Stress – Intestinal and No Intestinal Groups  
Group Statistics 
 IntestinalNY N Mean Std. Deviation Std. Error Mean 
Transformed Logarithm Stress 
DASS 1 
.00 24 1.0135 .12569 .02566 
1.00 51 1.0797 .12374 .01733 
 
Independent Samples Test 
 Levene's Test for Equality of Variances t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) Mean Difference Std. Error Difference 95% Confidence Interval of the Difference 
Lower Upper 
Transformed Logarithm Stress DASS 
1 
Equal variances assumed .041 .840 -2.150 73 .035 -.06619 .03078 -.12754 -.00483 
Equal variances not assumed 
  
-2.138 44.506 .038 -.06619 .03096 -.12856 -.00381 
 
T-Tests and MANOVA – Depression, Anxiety and Stress 
Depression, Anxiety and Stress – Raynaud’s and No Raynaud’s Groups 
T-Tests 
T-Test  
Group Statistics 
 RaynaudsNY N Mean Std. Deviation Std. Error Mean 
Transform Inverse Depression 
DASS 1 
.00 14 .1172 .02238 .00598 
1.00 60 .0930 .03109 .00401 
Transformed Logarithm Stress 
DASS 1 
.00 15 .9670 .11570 .02987 
1.00 59 1.0809 .12140 .01580 
Transformed Log Anxiety 
.00 15 .9521 .13236 .03417 
1.00 60 1.0328 .12868 .01661 
Independent Samples Test 
 
 Levene's Test for Equality of Variances t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) Mean Difference Std. Error Difference 95% Confidence Interval of the Difference 
Lower Upper 
Transform Inverse Depression DASS 
1 
Equal variances assumed 2.567 .113 2.746 72 .008 .02422 .00882 .00664 .04180 
Equal variances not assumed 
  
3.362 26.181 .002 .02422 .00720 .00942 .03902 
Transformed Logarithm Stress DASS 
1 
Equal variances assumed .179 .674 -3.274 72 .002 -.11392 .03479 -.18327 -.04457 
Equal variances not assumed 
  
-3.371 22.508 .003 -.11392 .03380 -.18392 -.04392 
Transformed Log Anxiety 
Equal variances assumed .030 .863 -2.159 73 .034 -.08063 .03735 -.15508 -.00619 
Equal variances not assumed 
  
-2.122 21.118 .046 -.08063 .03800 -.15963 -.00164 
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MANOVA - Depression Anxiety Stress: Raynaud’s/No Raynaud’s 
 N 
RaynaudsNY .00 14 
1.00 59 
 
 
RaynaudsNY Mean Std. Deviation N 
Transformed Logarithm Stress 
DASS 1 
.00 .9589 .11566 14 
1.00 1.0809 .12140 59 
Total 1.0575 .12893 73 
Transform Inverse Depression 
DASS 1 
.00 .1172 .02238 14 
1.00 .0931 .03136 59 
Total .0977 .03122 73 
Transformed Log Anxiety .00 .9288 .10037 14 
1.00 1.0303 .12839 59 
Total 1.0109 .12929 73 
 
Box's Test of Equality of Covariance Matricesa 
Box's M 11.567 
F 1.757 
df1 6 
df2 3199.205 
Sig. .104 
a. Design: Intercept + RaynaudsNY 
Multivariate Testsb 
Effect Value F Hypothesis df Error df Sig. 
Partial Eta 
Squared 
Intercept Pillai's Trace .993 3391.910a 3.000 69.000 .000 .993 
Wilks' Lambda .007 3391.910a 3.000 69.000 .000 .993 
Hotelling's Trace 147.474 3391.910a 3.000 69.000 .000 .993 
Roy's Largest Root 147.474 3391.910a 3.000 69.000 .000 .993 
RaynaudsNY Pillai's Trace .160 4.367a 3.000 69.000 .007 .160 
Wilks' Lambda .840 4.367a 3.000 69.000 .007 .160 
Hotelling's Trace .190 4.367a 3.000 69.000 .007 .160 
Roy's Largest Root .190 4.367a 3.000 69.000 .007 .160 
a. Exact statistic b. Design: Intercept + RaynaudsNY 
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Source Dependent Variable 
Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Corrected Model Transformed Logarithm Stress 
DASS 1 
.168a 1 .168 11.611 .001 .141 
Transform Inverse Depression 
DASS 1 
.007b 1 .007 7.393 .008 .094 
Transformed Log Anxiety .117c 1 .117 7.619 .007 .097 
Intercept Transformed Logarithm Stress 
DASS 1 
47.080 1 47.080 3249.470 .000 .979 
Transform Inverse Depression 
DASS 1 
.500 1 .500 559.027 .000 .887 
Transformed Log Anxiety 43.431 1 43.431 2836.854 .000 .976 
RaynaudsNY Transformed Logarithm Stress 
DASS 1 
.168 1 .168 11.611 .001 .141 
Transform Inverse Depression 
DASS 1 
.007 1 .007 7.393 .008 .094 
Transformed Log Anxiety .117 1 .117 7.619 .007 .097 
Error Transformed Logarithm Stress 
DASS 1 
1.029 71 .014 
   
Transform Inverse Depression 
DASS 1 
.064 71 .001 
   
Transformed Log Anxiety 1.087 71 .015    
Total Transformed Logarithm Stress 
DASS 1 
82.832 73 
    
Transform Inverse Depression 
DASS 1 
.767 73 
    
Transformed Log Anxiety 75.800 73     
Corrected Total Transformed Logarithm Stress 
DASS 1 
1.197 72 
    
Transform Inverse Depression 
DASS 1 
.070 72 
    
Transformed Log Anxiety 1.204 72     
a. R Squared = .141 (Adjusted R Squared = .128) 
b. R Squared = .094 (Adjusted R Squared = .082) 
c. R Squared = .097 (Adjusted R Squared = .084) 
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RaynaudsNY 
Dependent Variable RaynaudsNY Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Transformed Logarithm Stress 
DASS 1 
.00 .959 .032 .895 1.023 
1.00 1.081 .016 1.050 1.112 
Transform Inverse Depression 
DASS 1 
.00 .117 .008 .101 .133 
1.00 .093 .004 .085 .101 
Transformed Log Anxiety .00 .929 .033 .863 .995 
1.00 1.030 .016 .998 1.062 
 
 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 61.63 67.20 64.32 1.255 74 
Std. Predicted Value -2.161 2.308 -.003 1.006 74 
Standard Error of Predicted 
Value 
4.692 16.890 8.123 2.190 74 
Adjusted Predicted Value 52.42 70.19 63.69 2.835 74 
Residual -62.102 61.962 4.977 36.051 74 
Std. Residual -1.710 1.706 .137 .993 74 
Stud. Residual -1.764 1.731 .145 1.021 74 
Deleted Residual -66.105 65.298 5.604 38.154 74 
Stud. Deleted Residual -1.792 1.757 .146 1.027 74 
Mahal. Distance .232 14.801 2.927 2.358 74 
Cook's Distance .000 .098 .016 .019 74 
Centered Leverage Value .003 .203 .040 .032 74 
 
 
Multiple Regression Analysis: Scleroderma – Hyper-arousal  
Hyper-arousal and Psychosocial and Scleroderma Variables - Total Sample 
 
Descriptive Statistics 
 Mean Std. Deviation N 
Hyperarousal 74.0152 15.83617 66 
Transformed Reflect Log Age Diag Scleroderma 1.3372 .20475 75 
Transformed Sqrt Self Compassion 8.8541 1.00415 62 
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Correlations 
Hyperarousal 
Transformed 
Reflect Log Age 
Diag Scleroderma 
Transformed Sqrt 
Self Compassion 
Pearson Correlation Hyperarousal 1.000 .368 -.383 
Transformed Reflect Log Age 
Diag Scleroderma 
.368 1.000 -.137 
Transformed Sqrt Self 
Compassion 
-.383 -.137 1.000 
Sig. (1-tailed) Hyperarousal . .002 .001 
Transformed Reflect Log Age 
Diag Scleroderma 
.002 . .150 
Transformed Sqrt Self 
Compassion 
.001 .150 . 
N Hyperarousal 66 63 59 
Transformed Reflect Log Age 
Diag Scleroderma 
63 75 59 
Transformed Sqrt Self 
Compassion 
59 59 62 
 
Variables Entered/Removedb 
Model Variables Entered Variables Removed Method 
1 Transformed Sqrt Self Compassion, Transformed Reflect Log Age Diag Scleroderma . Enter 
a. All requested variables entered. 
b. Dependent Variable: Hyperarousal 
 
Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the Estimate 
1 .498a .248 .221 13.97809 
a. Predictors: (Constant), Transformed Sqrt Self Compassion, Transformed Reflect Log Age Diag Scleroderma b. Dependent Variable: Hyperarousal 
 
ANOVA 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 3603.827 2 1801.914 9.222 .000a 
Residual 10941.667 56 195.387   
Total 14545.494 58    
a. Predictors: (Constant), Transformed Sqrt Self Compassion, Transformed Reflect Log Age Diag Scleroderma  b. Dependent Variable: Hyperarousal 
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Coefficients 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 (Constant) 88.129 21.702  4.061 .000 44.655 131.604      
Transformed Reflect Log Age 
Diag Scleroderma 
24.830 9.050 .321 2.744 .008 6.701 42.959 .368 .344 .318 .981 1.019 
Transformed Sqrt Self 
Compassion 
-5.344 1.845 -.339 -2.896 .005 -9.041 -1.647 -.383 -.361 -.336 .981 1.019 
a. Dependent Variable: Hyperarousal 
 
Collinearity Diagnosticsa 
 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) 
Transformed 
Reflect Log Age 
Diag Scleroderma 
Transformed Sqrt 
Self Compassion 
1 1 2.975 1.000 .00 .00 .00 
2 .020 12.082 .01 .65 .23 
3 .005 25.565 .99 .35 .77 
a. Dependent Variable: Hyperarousal 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 56.6793 92.6918 74.2862 7.74018 59 
Std. Predicted Value -2.199 2.369 .034 .982 59 
Standard Error of Predicted 
Value 
1.826 5.245 2.976 .927 59 
Adjusted Predicted Value 56.4170 92.9142 74.4472 7.81997 56 
Residual -28.24400 31.27230 1.19091 13.96887 56 
Std. Residual -2.021 2.237 .085 .999 56 
Stud. Residual -2.045 2.414 .088 1.026 56 
Mahal. Distance .006 7.183 1.897 1.841 59 
Cook's Distance .000 .318 .019 .046 56 
Centered Leverage Value .000 .124 .033 .032 59 
a. Dependent Variable: Hyperarousal 
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Multiple Regression Analysis: Scleroderma - Reactive Hyper-arousal and Psychosocial and Scleroderma Variables  
 
Descriptive Statistics 
 Mean Std. Deviation N 
Hyperarousal Reactive 7.4058 2.71336 69 
SC Overidentification 11.3478 3.41634 69 
Total Dismissive RQ! 15.5753 4.27173 73 
Raynaud 29.49 26.279 75 
 
Correlations 
 Hyperarousal 
Reactive 
SC 
Overidentification 
Total Dismissive 
RQ! 
Raynaud 
Pearson Correlation 
Hyperarousal Reactive 1.000 .411 .407 .361 
SC Overidentification .411 1.000 .092 .183 
Total Dismissive RQ! .407 .092 1.000 .146 
Raynaud .361 .183 .146 1.000 
Sig. (1-tailed) 
Hyperarousal Reactive . .000 .000 .001 
SC Overidentification .000 . .227 .068 
Total Dismissive RQ! .000 .227 . .110 
Raynaud .001 .068 .110 . 
N 
Hyperarousal Reactive 69 69 68 68 
SC Overidentification 69 69 68 68 
Total Dismissive RQ! 68 68 73 72 
Raynaud 68 68 72 75 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Raynaud, Total 
Dismissive RQ!, 
SC 
Overidentificationb 
. Enter 
a. Dependent Variable: Hyperarousal Reactive 
b. All requested variables entered. 
Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .605a .366 .336 2.21122 
a. Predictors: (Constant), Raynaud, Total Dismissive RQ!, SC 
Overidentification 
b. Dependent Variable: Hyperarousal Reactive 
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ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 180.348 3 60.116 12.295 .000b 
Residual 312.927 64 4.889 
  
Total 493.275 67 
   
a. Dependent Variable: Hyperarousal Reactive  b. Predictors Raynaud, Total Dismissive Overidentification 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .275 1.303 
 
.211 .833 -2.328 2.879 
     
SC Overidentification .265 .081 .334 3.293 .002 .104 .427 .411 .381 .328 .962 1.039 
Total Dismissive RQ! .215 .064 .339 3.363 .001 .087 .343 .407 .388 .335 .974 1.026 
Raynaud .026 .011 .250 2.447 .017 .005 .047 .361 .293 .244 .950 1.053 
a. Dependent Variable: Hyperarousal Reactive 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) SC 
Overidentification 
Total Dismissive 
RQ! 
Raynaud 
1 
1 3.562 1.000 .00 .01 .00 .02 
2 .342 3.229 .01 .01 .01 .97 
3 .069 7.191 .00 .64 .43 .00 
4 .028 11.299 .98 .34 .55 .00 
a. Dependent Variable: Hyperarousal Reactive 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 4.4240 12.0477 7.4469 1.61052 67 
Std. Predicted Value -1.817 2.829 .025 .982 67 
Standard Error of Predicted 
Value 
.291 .874 .517 .135 67 
Adjusted Predicted Value 4.3398 11.7013 7.4522 1.59442 67 
Residual -5.34198 5.19745 -.05888 2.10916 67 
Std. Residual -2.416 2.350 -.027 .954 67 
Stud. Residual -2.474 2.402 -.028 .984 67 
Deleted Residual -5.60181 5.42703 -.06413 2.24696 67 
Stud. Deleted Residual -2.581 2.498 -.028 .997 67 
Mahal. Distance .177 9.471 2.927 2.123 67 
Cook's Distance .000 .158 .016 .028 67 
Centered Leverage Value .003 .141 .044 .032 67 
a. Dependent Variable: Hyperarousal Reactive 
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                                                                                         Appendix C 
 
Statistical Analysis Study 2 
Frequencies: Scleroderma, Community and Psychosocial Variables 
Demographic Information 
 
Statistics 
 Age Country Gender Education 
N 
Valid 72 75 75 75 
Missing 3 0 0 0 
Mean 47.69 
   
Minimum 18 
   
Maximum 76 
   
 
Gender 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
 1 1.3 1.3 1.3 
1 54 72.0 72.0 73.3 
2 19 25.3 25.3 98.7 
Gender 1 1.3 1.3 100.0 
Total 75 100.0 100.0 
 
 
Education 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
 3 4.0 4.0 4.0 
1 3 4.0 4.0 8.0 
2 34 45.3 45.3 53.3 
3 26 34.7 34.7 88.0 
4 7 9.3 9.3 97.3 
8 1 1.3 1.3 98.7 
Education 1 1.3 1.3 100.0 
Total 75 100.0 100.0 
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Reliability Statistics 
Scleroderma, Community and Psychosocial Variables 
Stress DASS 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.818 .824 7 
Anxiety 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.722 .738 7 
 
Depression 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.911 .912 7 
 
Dismissive Attachment 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.996 .996 5 
 
Fearful Attachment 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.996 .996 4 
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EMWS 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha Based 
on Standardized Items 
N of Items 
.982 .982 21 
 
Re-appraisal 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.875 .878 6 
 
Suppression 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.739 .735 4 
 
Reactive Hyperarousal 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.619 .621 3 
Item Statistics 
 Mean Std. Deviation N 
HYP6 2.59 1.340 139 
HYP12 2.66 1.183 139 
HYP17 1.84 1.118 139 
 
Summary Item Statistics 
 Mean Minimum Maximum Range Maximum / Minimum Variance N of Items 
Inter-Item Correlations .353 .332 .365 .033 1.099 .000 3 
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Hyper-arousal 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.854 .853 26 
 
 
Self-Compassion 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.779 .780 26 
 
Self-Judgment 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.838 .838 5 
 
Isolation 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.814 .813 4 
 
Over-identification 
 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.783 .783 4 
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Self Kindness 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.897 .898 5 
 
 
 
Common Humanity 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.806 .805 4 
 
 
Mindfulness 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.805 .811 4 
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T-Tests and MANOVA- Scleroderma and Community Groups 
Psychosocial Variables – Scleroderma and No Scleroderma Groups  
Group Statistics 
 
ScleroNoYes N Mean Std. Deviation Std. Error Mean 
Total EMWS No Scleroderma 62 78.6452 20.21531 2.56735 
Yes Scleroderma 88 70.0284 23.94298 2.55233 
ERQ Reappraisal No Scleroderma 58 30.3103 6.07615 .79784 
Yes Scleroderma 81 27.9630 7.99131 .88792 
Hyperarousal No Scleroderma 57 71.4211 13.81891 1.83036 
Yes Scleroderma 78 73.6410 15.92513 1.80317 
Self Compassion Self Kindness No Scleroderma 58 15.8103 4.45821 .58539 
Yes Scleroderma 81 13.6049 4.80021 .53336 
Self Compassion Mindfulness No Scleroderma 58 13.9483 2.95238 .38767 
Yes Scleroderma 81 12.8025 3.36311 .37368 
Independent Samples Test 
 
Levene's Test for Equality of 
Variances t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) Mean Difference 
Std. Error 
Difference 
95% Confidence Interval of the 
Difference 
Lower Upper 
Total EMWS Equal variances assumed 3.300 .071 2.312 148 .022 8.61675 3.72765 1.25046 15.98305 
Equal variances not assumed   2.380 143.132 .019 8.61675 3.62017 1.46084 15.77267 
ERQ Reappraisal Equal variances assumed 2.070 .153 1.881 137 .062 2.34738 1.24812 -.12070 4.81546 
Equal variances not assumed   1.966 136.472 .051 2.34738 1.19371 -.01319 4.70795 
Hyperarousal Equal variances assumed 1.175 .280 -.845 133 .400 -2.21997 2.62674 -7.41556 2.97561 
Equal variances not assumed   -.864 129.045 .389 -2.21997 2.56936 -7.30350 2.86356 
Self Compassion Self Kindness Equal variances assumed .389 .534 2.751 137 .007 2.20541 .80173 .62005 3.79077 
Equal variances not assumed   2.785 128.045 .006 2.20541 .79193 .63844 3.77237 
Self Compassion Mindfulness Equal variances assumed 1.105 .295 2.083 137 .039 1.14581 .55019 .05784 2.23378 
Equal variances not assumed   2.128 131.341 .035 1.14581 .53844 .08066 2.21095 
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MANOVA: Scleroderma/No Scleroderma Groups 
Between-Subjects Factors 
 N 
SclerodNoYs 1.00 57 
2.00 78 
 
Descriptive Statistics 
 
SclerodNoYs Mean Std. Deviation N 
Self Compassion Self Kindness 
dimens
ion1 
1.00 15.6491 4.32390 57 
2.00 13.6410 4.80253 78 
Total 14.4889 4.69656 135 
Self Compassion Mindfulness 
dimens
ion1 
1.00 13.8421 2.86475 57 
2.00 12.7436 3.34756 78 
Total 13.2074 3.18836 135 
Total EMWS 
dimens
ion1 
1.00 77.7368 20.23745 57 
2.00 69.6731 23.90292 78 
Total 73.0778 22.70355 135 
 
Box's Test of Equality of 
Covariance Matricesa 
Box's M 6.570 
F 1.067 
df1 6 
df2 100229.431 
Sig. .380 
Tests the null hypothesis that 
the observed covariance 
matrices of the dependent 
variables are equal across 
groups. 
a. Design: Intercept + 
SclerodNoYs 
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Multivariate Testsb 
Effect 
Value F Hypothesis df Error df Sig. 
Partial Eta 
Squared 
Intercept Pillai's Trace .959 1030.406a 3.000 131.000 .000 .959 
Wilks' Lambda .041 1030.406a 3.000 131.000 .000 .959 
Hotelling's Trace 23.597 1030.406a 3.000 131.000 .000 .959 
Roy's Largest Root 23.597 1030.406a 3.000 131.000 .000 .959 
SclerodNoYs Pillai's Trace .060 2.802a 3.000 131.000 .042 .060 
Wilks' Lambda .940 2.802a 3.000 131.000 .042 .060 
Hotelling's Trace .064 2.802a 3.000 131.000 .042 .060 
Roy's Largest Root .064 2.802a 3.000 131.000 .042 .060 
a. Exact statistic b. Design: Intercept + SclerodNoYs 
Levene's Test of Equality of Error Variancesa 
 F df1 df2 Sig. 
Self Compassion Self Kindness .654 1 133 .420 
Self Compassion Mindfulness 1.407 1 133 .238 
Total EMWS 3.054 1 133 .083 
Tests the null hypothesis that the error variance of the dependent variable is equal across 
groups. a. Design: Intercept + SclerodNoYs 
 
Tests of Between-Subjects Effects 
Source Dependent Variable Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Corrected Model Self Compassion Self Kindness 132.802a 1 132.802 6.257 .014 .045 
Self Compassion Mindfulness 39.742b 1 39.742 3.997 .048 .029 
Total EMWS 2141.467c 1 2141.467 4.255 .041 .031 
Intercept Self Compassion Self Kindness 28253.928 1 28253.928 1331.160 .000 .909 
Self Compassion Mindfulness 23277.253 1 23277.253 2341.013 .000 .946 
Total EMWS 715630.934 1 715630.934 1422.089 .000 .914 
SclerodNoYs Self Compassion Self Kindness 132.802 1 132.802 6.257 .014 .045 
Self Compassion Mindfulness 39.742 1 39.742 3.997 .048 .029 
Total EMWS 2141.467 1 2141.467 4.255 .041 .031 
Error Self Compassion Self Kindness 2822.931 133 21.225    
Self Compassion Mindfulness 1322.451 133 9.943    
Total EMWS 66928.966 133 503.225    
Total Self Compassion Self Kindness 31296.000 135     
Self Compassion Mindfulness 24911.000 135     
Total EMWS 790019.250 135     
Corrected Total Self Compassion Self Kindness 2955.733 134     
Self Compassion Mindfulness 1362.193 134     
Total EMWS 69070.433 134     
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SclerodNoYs 
Dependent Variable SclerodNoYs 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Self Compassion Self Kindness dimens
ion1 
1.00 15.649 .610 14.442 16.856 
2.00 13.641 .522 12.609 14.673 
Self Compassion Mindfulness dimens
ion1 
1.00 13.842 .418 13.016 14.668 
2.00 12.744 .357 12.037 13.450 
Total EMWS dimens
ion1 
1.00 77.737 2.971 71.860 83.614 
2.00 69.673 2.540 64.649 74.697 
 
Mann Witney U-Test – Scleroderma and No Scleroderma Groups 
(Psychosocial (skewed) Variables: Over-identification – Anxiety – Depression) 
  
Over-identification– Scleroderma and No Scleroderma Groups 
 
Mann-Whitney Test 
Ranks 
 
ScleroNoYes N Mean Rank Sum of Ranks 
Self Compassion Over 
Identification 
No Scleroderma 58 56.09 3253.50 
Yes Scleroderma 80 79.22 6337.50 
Total 138   
Test Statisticsa 
 
Self Compassion 
Over Identification 
Mann-Whitney U 1542.500 
Wilcoxon W 3253.500 
Z -3.367 
Asymp. Sig. (2-tailed) .001 
a. Grouping Variable: ScleroNoYes 
 
 
Report 
Self Compassion Over Identification 
ScleroNoYes N Median 
No Scleroderma 58 13.0000 
Yes Scleroderma 80 16.0000 
Total 138 15.0000 
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Mann Witney U-Test – Scleroderma and No Scleroderma Groups 
Depression, Anxiety and Stress – Scleroderma and No Scleroderma Groups  
Ranks 
 
ScleroNoYes N Mean Rank Sum of Ranks 
Anxiety DASS No Scleroderma 63 58.53 3687.50 
Yes Scleroderma 93 92.03 8558.50 
Total 156   
 
Test Statisticsa 
 Anxiety DASS 
Mann-Whitney U 1671.500 
Wilcoxon W 3687.500 
Z -4.604 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: ScleroNoYes 
 
Ranks 
ScleroNoYes N Mean Rank Sum of Ranks 
Depression DASS No Scleroderma 63 65.41 4121.00 
Yes Scleroderma 92 86.62 7969.00 
Total 155   
 
 
 
Test Statisticsa Depression DASS 
Mann-Whitney U 2105.000 
Wilcoxon W 4121.000 
Z -2.921 
Asymp. Sig. (2-tailed) .003 
a. Grouping Variable: ScleroNoYes 
 
Medium Anxiety Depression 
 
ScleroNoYes Anxiety DASS Depression DASS 
No Scleroderma N 63 63 
Median 8.0000 8.0000 
Yes Scleroderma N 93 92 
Median 10.0000 10.0000 
Total N 156 155 
Median 9.0000 9.0000 
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Frequencies: Diffuse and Limited Sclerosis and Community Groups - Depression Anxiety and Stress   
 
No Sclero Dif Lim Stress DASS Anxiety DASS Depression DASS 
No Sclero N Valid 63 63 63 
Missing 0 0 0 
Mean 11.4603 8.5397 9.4921 
Range 13.00 6.00 10.00 
Minimum 7.00 7.00 7.00 
Maximum 20.00 13.00 17.00 
Diffuse Sclero N Valid 34 34 33 
Missing 1 1 2 
Mean 11.7353 11.3235 11.6364 
Range 13.00 12.00 18.00 
Minimum 7.00 7.00 7.00 
Maximum 20.00 19.00 25.00 
Limited Sclero N Valid 49 50 50 
Missing 2 1 1 
Mean 12.4082 10.9400 11.7000 
Range 14.00 15.00 20.00 
Minimum 7.00 7.00 7.00 
Maximum 21.00 22.00 27.00 
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Frequencies: Stress – DASS             
No Sclero Dif Lim Frequency Percent Valid Percent Cumulative Percent 
No Sclero Valid 7.00 6 9.5 9.5 9.5 
8.00 5 7.9 7.9 17.5 
9.00 5 7.9 7.9 25.4 
10.00 5 7.9 7.9 33.3 
11.00 9 14.3 14.3 47.6 
12.00 13 20.6 20.6 68.3 
13.00 7 11.1 11.1 79.4 
14.00 7 11.1 11.1 90.5 
15.00 2 3.2 3.2 93.7 
16.00 1 1.6 1.6 95.2 
17.00 1 1.6 1.6 96.8 
18.00 1 1.6 1.6 98.4 
20.00 1 1.6 1.6 100.0 
Total 63 100.0 100.0  
Diffuse Sclero Valid 7.00 4 11.4 11.8 11.8 
8.00 2 5.7 5.9 17.6 
9.00 4 11.4 11.8 29.4 
10.00 2 5.7 5.9 35.3 
11.00 6 17.1 17.6 52.9 
12.00 5 14.3 14.7 67.6 
13.00 2 5.7 5.9 73.5 
14.00 2 5.7 5.9 79.4 
15.00 1 2.9 2.9 82.4 
16.00 3 8.6 8.8 91.2 
17.00 1 2.9 2.9 94.1 
19.00 1 2.9 2.9 97.1 
20.00 1 2.9 2.9 100.0 
Total 34 97.1 100.0  
Missing System 1 2.9   
Total 35 100.0   
Limited Sclero Valid 7.00 2 3.9 4.1 4.1 
8.00 4 7.8 8.2 12.2 
9.00 6 11.8 12.2 24.5 
10.00 8 15.7 16.3 40.8 
11.00 4 7.8 8.2 49.0 
12.00 4 7.8 8.2 57.1 
13.00 5 9.8 10.2 67.3 
14.00 4 7.8 8.2 75.5 
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15.00 2 3.9 4.1 79.6 
16.00 3 5.9 6.1 85.7 
18.00 1 2.0 2.0 87.8 
19.00 3 5.9 6.1 93.9 
20.00 1 2.0 2.0 95.9 
21.00 2 3.9 4.1 100.0 
Total 49 96.1 100.0  
Missing System 2 3.9   
Total 51 100.0   
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Anxiety DASS 
No Sclero Dif Lim Frequency Percent Valid Percent Cumulative Percent 
No Sclero Valid 7.00 23 36.5 36.5 36.5 
8.00 13 20.6 20.6 57.1 
9.00 9 14.3 14.3 71.4 
10.00 10 15.9 15.9 87.3 
11.00 5 7.9 7.9 95.2 
12.00 2 3.2 3.2 98.4 
13.00 1 1.6 1.6 100.0 
Total 63 100.0 100.0  
Diffuse Sclero Valid 7.00 4 11.4 11.8 11.8 
8.00 4 11.4 11.8 23.5 
9.00 4 11.4 11.8 35.3 
10.00 5 14.3 14.7 50.0 
11.00 1 2.9 2.9 52.9 
12.00 5 14.3 14.7 67.6 
13.00 3 8.6 8.8 76.5 
14.00 3 8.6 8.8 85.3 
16.00 2 5.7 5.9 91.2 
17.00 1 2.9 2.9 94.1 
19.00 2 5.7 5.9 100.0 
Total 34 97.1 100.0  
Missing System 1 2.9   
Total 35 100.0   
Limited Sclero Valid 7.00 11 21.6 22.0 22.0 
8.00 5 9.8 10.0 32.0 
9.00 6 11.8 12.0 44.0 
10.00 6 11.8 12.0 56.0 
11.00 3 5.9 6.0 62.0 
12.00 3 5.9 6.0 68.0 
13.00 5 9.8 10.0 78.0 
14.00 2 3.9 4.0 82.0 
15.00 4 7.8 8.0 90.0 
17.00 1 2.0 2.0 92.0 
18.00 2 3.9 4.0 96.0 
19.00 1 2.0 2.0 98.0 
22.00 1 2.0 2.0 100.0 
Total 50 98.0 100.0  
Missing System 1 2.0   
Total 51 100.0   
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Depression DASS 
No Sclero Dif Lim Frequency Percent Valid Percent 
Cumulative 
Percent 
No Sclero Valid 7.00 17 27.0 27.0 27.0 
8.00 15 23.8 23.8 50.8 
9.00 7 11.1 11.1 61.9 
10.00 5 7.9 7.9 69.8 
11.00 5 7.9 7.9 77.8 
12.00 4 6.3 6.3 84.1 
13.00 4 6.3 6.3 90.5 
14.00 3 4.8 4.8 95.2 
16.00 2 3.2 3.2 98.4 
17.00 1 1.6 1.6 100.0 
Total 63 100.0 100.0  
Diffuse Sclero Valid 7.00 5 14.3 15.2 15.2 
8.00 9 25.7 27.3 42.4 
9.00 1 2.9 3.0 45.5 
10.00 3 8.6 9.1 54.5 
11.00 3 8.6 9.1 63.6 
12.00 1 2.9 3.0 66.7 
13.00 2 5.7 6.1 72.7 
14.00 2 5.7 6.1 78.8 
15.00 1 2.9 3.0 81.8 
16.00 1 2.9 3.0 84.8 
17.00 1 2.9 3.0 87.9 
21.00 2 5.7 6.1 93.9 
24.00 1 2.9 3.0 97.0 
25.00 1 2.9 3.0 100.0 
Total 33 94.3 100.0  
Missing System 2 5.7   
Total 35 100.0   
Limited Sclero Valid 7.00 4 7.8 8.0 8.0 
8.00 10 19.6 20.0 28.0 
9.00 6 11.8 12.0 40.0 
10.00 5 9.8 10.0 50.0 
11.00 5 9.8 10.0 60.0 
12.00 6 11.8 12.0 72.0 
13.00 5 9.8 10.0 82.0 
14.00 1 2.0 2.0 84.0 
15.00 1 2.0 2.0 86.0 
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16.00 1 2.0 2.0 88.0 
17.00 1 2.0 2.0 90.0 
18.00 1 2.0 2.0 92.0 
24.00 2 3.9 4.0 96.0 
26.00 1 2.0 2.0 98.0 
27.00 1 2.0 2.0 100.0 
Total 50 98.0 100.0  
Missing System 1 2.0   
Total 51 100.0   
 
Kruskal-Wallis Test: No Scleroderma/Diffuse/Limited  
Depression, Anxiety and Stress  
Ranks 
 
No Sclero Dif Lim N Mean Rank 
Stress DASS di
m
e
n
si
o
n
1 
No Sclero 63 71.02 
Diffuse Sclero 34 71.69 
Limited Sclero 49 77.95 
Total 146 
 
Anxiety DASS di
m
e
n
si
o
n
1 
No Sclero 63 55.56 
Diffuse Sclero 34 92.82 
Limited Sclero 50 84.44 
Total 147 
 
Depression DASS di
m
e
n
si
o
n
1 
No Sclero 63 61.89 
Diffuse Sclero 33 78.95 
Limited Sclero 50 84.53 
Total 146 
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Test Statisticsa,b 
 Stress DASS Anxiety DASS Depression DASS 
Chi-square .831 22.057 8.890 
df 2 2 2 
Asymp. Sig. .660 .000 .012 
a. Kruskal Wallis Test   b. Grouping Variable: No Sclero Dif Lim 
 
Case Processing Summary 
 
Cases 
Included Excluded Total 
N Percent N Percent N Percent 
Stress DASS  * No Sclero Dif 
Lim 
146 67.6% 70 32.4% 216 100.0% 
Anxiety DASS  * No Sclero Dif 
Lim 
147 68.1% 69 31.9% 216 100.0% 
Depression DASS  * No Sclero 
Dif Lim 
146 67.6% 70 32.4% 216 100.0% 
Report 
No Sclero Dif Lim Stress DASS Anxiety DASS Depression DASS 
No Sclero N 63 63 63 
Median 12.0000 8.0000 8.0000 
Diffuse Sclero N 34 34 33 
Median 11.0000 10.5000 10.0000 
Limited Sclero N 49 50 50 
Median 12.0000 10.0000 10.5000 
Total N 146 147 146 
Median 12.0000 9.0000 9.0000 
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Kruskal Wallis: No Scleroderma/Diffuse/Limited 
 Psychosocial variables (skewed) 
 
Ranks 
 
No Sclero Dif Lim N Mean Rank 
Hyperarousal Reactive di
m
e
n
si
o
n
1 
No Sclero 58 60.59 
Diffuse Sclero 31 81.48 
Limited Sclero 43 63.66 
Total 132 
 
Self Compassion Over 
Identification 
di
m
e
n
si
o
n
1 
No Sclero 58 53.31 
Diffuse Sclero 31 79.39 
Limited Sclero 42 73.64 
Total 131 
 
Test Statisticsa,b 
 
Hyperarousal Reactive 
Self Compassion Over 
Identification 
Chi-square 6.464 12.137 
df 2 2 
Asymp. Sig. .039 .002 
a. Kruskal Wallis Test 
a. Grouping Variable: No Sclero Dif Lim 
 
No Sclero Dif Lim Hyperarousal 
Reactive 
Self Compassion 
Over Identification 
No Sclero N 58 58 
Median 6.0000 13.0000 
Diffuse Sclero N 31 31 
Median 8.0000 16.0000 
Limited Sclero N 43 42 
Median 6.0000 15.5000 
Total N 132 131 
Median 7.0000 15.0000 
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T-Tests Community Diffuse groups 
 
 
Group Statistics 
 No Sclero Dif Lim N Mean Std. Deviation Std. Error Mean 
Total EMWS 
dimension1 
No Sclero 62 78.6452 20.21531 2.56735 
Diffuse Sclero 32 66.7656 27.23701 4.81487 
ERQ Reappraisal 
dimension1 
No Sclero 58 30.3103 6.07615 .79784 
Diffuse Sclero 31 28.7742 8.76246 1.57378 
Hyperarousal 
dimension1 
No Sclero 57 71.4211 13.81891 1.83036 
Diffuse Sclero 30 75.8667 15.87176 2.89777 
Self Compassion Self 
Kindness 
dimension1 
No Sclero 58 15.8103 4.45821 .58539 
Diffuse Sclero 31 15.3548 5.59493 1.00488 
Self Compassion 
Mindfulness 
dimension1 
No Sclero 58 13.9483 2.95238 .38767 
Diffuse Sclero 31 14.2903 3.50422 .62938 
 
Independent Samples Test 
 
Levene's Test for Equality of 
Variances t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence Interval of the 
Difference 
Lower Upper 
Total EMWS Equal variances assumed 8.476 .005 2.391 92 .019 11.87954 4.96802 2.01262 21.74645 
Equal variances not 
assumed 
  
2.177 49.116 .034 11.87954 5.45658 .91479 22.84428 
ERQ Reappraisal Equal variances assumed 3.543 .063 .970 87 .335 1.53615 1.58363 -1.61148 4.68378 
Equal variances not 
assumed 
  
.871 45.809 .389 1.53615 1.76447 -2.01593 5.08824 
Hyperarousal Equal variances assumed 1.471 .229 -1.354 85 .179 -4.44561 3.28232 -10.97174 2.08051 
Equal variances not 
assumed 
  
-1.297 52.434 .200 -4.44561 3.42743 -11.32191 2.43068 
Self Compassion Self 
Kindness 
Equal variances assumed 3.590 .061 .420 87 .676 .45551 1.08577 -1.70257 2.61358 
Equal variances not 
assumed 
  
.392 50.741 .697 .45551 1.16296 -1.87951 2.79053 
Self Compassion 
Mindfulness 
Equal variances assumed 3.975 .049 -.488 87 .627 -.34205 .70163 -1.73661 1.05251 
Equal variances not 
assumed 
  
-.463 53.062 .645 -.34205 .73919 -1.82463 1.14054 
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T-Tests Community Limited groups 
Group Statistics 
 No Sclero Dif Lim N Mean Std. Deviation Std. Error Mean 
Total EMWS 
dimension1 
No Sclero 62 78.6452 20.21531 2.56735 
Limited Sclero 47 72.7234 21.73827 3.17085 
ERQ Reappraisal 
dimension1 
No Sclero 58 30.3103 6.07615 .79784 
Limited Sclero 43 27.5581 7.25489 1.10636 
Hyperarousal 
dimension1 
No Sclero 57 71.4211 13.81891 1.83036 
Limited Sclero 41 72.0244 15.62128 2.43963 
Self Compassion Self 
Kindness 
dimension1 
No Sclero 58 15.8103 4.45821 .58539 
Limited Sclero 43 12.4186 3.97152 .60565 
Self Compassion 
Mindfulness 
dimension1 
No Sclero 58 13.9483 2.95238 .38767 
Limited Sclero 43 12.0000 3.08607 .47062 
 
Independent Samples Test 
 
Levene's Test for Equality of 
Variances t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence Interval of the 
Difference 
Lower Upper 
Total EMWS Equal variances assumed .376 .541 1.466 107 .146 5.92176 4.03901 -2.08511 13.92862 
Equal variances not 
assumed 
  
1.451 95.221 .150 5.92176 4.07990 -2.17762 14.02114 
ERQ Reappraisal Equal variances assumed .240 .625 2.072 99 .041 2.75221 1.32858 .11602 5.38839 
Equal variances not 
assumed 
  
2.018 80.917 .047 2.75221 1.36403 .03817 5.46624 
Hyperarousal Equal variances assumed .054 .816 -.202 96 .840 -.60334 2.98914 -6.53674 5.33006 
Equal variances not 
assumed 
  
-.198 79.673 .844 -.60334 3.04992 -6.67326 5.46659 
Self Compassion Self 
Kindness 
Equal variances assumed .919 .340 3.958 99 .000 3.39174 .85698 1.69130 5.09218 
Equal variances not 
assumed 
  
4.027 95.631 .000 3.39174 .84232 1.71967 5.06381 
Self Compassion 
Mindfulness 
Equal variances assumed .396 .531 3.217 99 .002 1.94828 .60569 .74645 3.15010 
Equal variances not 
assumed 
  
3.195 88.359 .002 1.94828 .60973 .73664 3.15992 
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MANOVA : No Scleroderma/Diffuse/Limited  
Psychosocial variables 
MANOVA Removal of EMWS (significant Levine’s) 
 
Between-Subjects Factors 
 Value Label N 
No Sclero Dif Lim 1 No Sclero 58 
2 Diffuse Sclero 31 
3 Limited Sclero 43 
 
 
 
Descriptive Statistics 
 
No Sclero Dif Lim Mean Std. Deviation N 
Self Compassion Self Kindness di
m
e
n
si
o
n
1 
No Sclero 15.8103 4.45821 58 
Diffuse Sclero 15.3548 5.59493 31 
Limited Sclero 12.4186 3.97152 43 
Total 14.5985 4.81863 132 
Self Compassion Mindfulness di
m
e
n
si
o
n
1 
No Sclero 13.9483 2.95238 58 
Diffuse Sclero 14.2903 3.50422 31 
Limited Sclero 12.0000 3.08607 43 
Total 13.3939 3.25918 132 
ERQ Reappraisal di
m
e
n
si
o
n
1 
No Sclero 30.3103 6.07615 58 
Diffuse Sclero 28.7742 8.76246 31 
Limited Sclero 27.5581 7.25489 43 
Total 29.0530 7.20932 132 
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Box's Test of Equality of 
Covariance Matricesa 
Box's M 20.762 
F 1.667 
df1 12 
df2 48238.089 
Sig. .067 
Tests the null hypothesis 
that the observed 
covariance matrices of the 
dependent variables are 
equal across groups. 
a. Design: Intercept + 
ScleroNoDL 
 
 
Multivariate Testsc 
Effect 
Value F Hypothesis df Error df Sig. 
Partial Eta 
Squared 
Intercept Pillai's Trace .958 975.065a 3.000 127.000 .000 .958 
Wilks' Lambda .042 975.065a 3.000 127.000 .000 .958 
Hotelling's Trace 23.033 975.065a 3.000 127.000 .000 .958 
Roy's Largest Root 23.033 975.065a 3.000 127.000 .000 .958 
ScleroNoDL Pillai's Trace .132 3.004 6.000 256.000 .007 .066 
Wilks' Lambda .871 3.026a 6.000 254.000 .007 .067 
Hotelling's Trace .145 3.048 6.000 252.000 .007 .068 
Roy's Largest Root .121 5.153b 3.000 128.000 .002 .108 
a. Exact statistic 
b. The statistic is an upper bound on F that yields a lower bound on the significance level. 
c. Design: Intercept + ScleroNoDL 
 
                                                                                                                                                                                                                                                                                                                                                      66 
 
 
Levene's Test of Equality of Error Variancesa 
 F df1 df2 Sig. 
Self Compassion Self Kindness 3.612 2 129 .030 
Self Compassion Mindfulness 2.012 2 129 .138 
ERQ Reappraisal 1.656 2 129 .195 
Tests the null hypothesis that the error variance of the dependent variable is equal across 
groups. a. Design: Intercept + ScleroNoDL 
Tests of Between-Subjects Effects 
Source Dependent Variable Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Corrected Model Self Compassion Self Kindness 307.244a 2 153.622 7.247 .001 .101 
Self Compassion Mindfulness 126.283b 2 63.142 6.438 .002 .091 
ERQ Reappraisal 190.191c 2 95.095 1.854 .161 .028 
Intercept Self Compassion Self Kindness 26108.719 1 26108.719 1231.689 .000 .905 
Self Compassion Mindfulness 22254.678 1 22254.678 2269.033 .000 .946 
ERQ Reappraisal 103180.909 1 103180.909 2011.100 .000 .940 
ScleroNoDL Self Compassion Self Kindness 307.244 2 153.622 7.247 .001 .101 
Self Compassion Mindfulness 126.283 2 63.142 6.438 .002 .091 
ERQ Reappraisal 190.191 2 95.095 1.854 .161 .028 
Error Self Compassion Self Kindness 2734.476 129 21.197    
Self Compassion Mindfulness 1265.232 129 9.808    
ERQ Reappraisal 6618.438 129 51.306    
Total Self Compassion Self Kindness 31173.000 132     
Self Compassion Mindfulness 25072.000 132     
ERQ Reappraisal 118227.000 132     
Corrected Total Self Compassion Self Kindness 3041.720 131     
Self Compassion Mindfulness 1391.515 131     
ERQ Reappraisal 6808.629 131     
a. R Squared = .101 (Adjusted R Squared = .087) 
b. R Squared = .091 (Adjusted R Squared = .077) 
c. R Squared = .028 (Adjusted R Squared = .013) 
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No Sclero Dif Lim 
Dependent Variable No Sclero Dif Lim 
Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
Self Compassion Self Kindness di
m
e
n
si
o
n
1 
No Sclero 15.810 .605 14.614 17.006 
Diffuse Sclero 15.355 .827 13.719 16.991 
Limited Sclero 12.419 .702 11.029 13.808 
Self Compassion Mindfulness di
m
e
n
si
o
n
1 
No Sclero 13.948 .411 13.135 14.762 
Diffuse Sclero 14.290 .562 13.177 15.403 
Limited Sclero 12.000 .478 11.055 12.945 
ERQ Reappraisal di
m
e
n
si
o
n
1 
No Sclero 30.310 .941 28.449 32.171 
Diffuse Sclero 28.774 1.286 26.229 31.320 
Limited Sclero 27.558 1.092 25.397 29.719 
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                                                                                                           Appendix D 
Statistical Analysis Study 3 
Frequencies: Scleroderma, Breast Cancer, Community and Psychosocial Variables 
Demographic and Health Information 
 
Frequencies Breast Cancer 
 
Statistics 
 AgeCurrent AgeDBC 
N 
Valid 23 23 
Missing 7 7 
Mean 53.57 50.35 
Minimum 37 36 
Maximum 76 69 
Country 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
 2 6.5 6.5 6.5 
1 23 74.2 74.2 80.6 
2 1 3.2 3.2 83.9 
3 1 3.2 3.2 87.1 
4 2 6.5 6.5 93.5 
5 1 3.2 3.2 96.8 
6 1 3.2 3.2 100.0 
Total 31 100.0 100.0 
 
Gender 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
 2 6.5 6.5 6.5 
1 28 90.3 90.3 96.8 
2 1 3.2 3.2 100.0 
Total 31 100.0 100.0 
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Education 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
 2 6.5 6.5 6.5 
1 1 3.2 3.2 9.7 
2 7 22.6 22.6 32.3 
3 16 51.6 51.6 83.9 
4 5 16.1 16.1 100.0 
Total 31 100.0 100.0 
 
  
 
TypeBC 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
 3 9.7 9.7 9.7 
1. DCIS 1 3.2 3.2 12.9 
3 3 9.7 9.7 22.6 
3 Early Breast Cancer 1 3.2 3.2 25.8 
benign 1 3.2 3.2 29.0 
Bi-lateral mastectomy for stage 
3 BC at 60; currently diagnosed 
with bony metasteses left rib 
1 3.2 3.2 32.3 
DCIS 1 3.2 3.2 35.5 
DCIS with possible 
microinvasion, but no lymph 
node involvement - large 
tumour 55 mm 
1 3.2 3.2 38.7 
DCIS, Stage IIB and III, 
Category 1 
1 3.2 3.2 41.9 
dddd 1 3.2 3.2 45.2 
early breast cancer 2 6.5 6.5 51.6 
Early breast cancer 1 3.2 3.2 54.8 
early breast cancer stage 2 
category 1 
1 3.2 3.2 58.1 
Early breast cancer, stage 1, 0 
lymph nodes affected 
1 3.2 3.2 61.3 
fgdfgdg 1 3.2 3.2 64.5 
invasive ductal carcinoma 1 3.2 3.2 67.7 
Invasive Ductal Carcinoma 1 3.2 3.2 71.0 
NA 1 3.2 3.2 74.2 
Open-Ended Response 1 3.2 3.2 77.4 
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Please state what type of breast 
cancer you have 
1 3.2 3.2 80.6 
Stage 0 1 3.2 3.2 83.9 
Stage 1 1 3.2 3.2 87.1 
Stage 11 mixed invasive lobular 
and ductal 
1 3.2 3.2 90.3 
Stage II - Category 2: 6 lymph 
nodes surgically removed 
1 3.2 3.2 93.5 
stage IV, catergory 3 
inflammatory breast cancer 
1 3.2 3.2 96.8 
Type 3 - Stage IIB and category 
3 
1 3.2 3.2 100.0 
Total 31 100.0 100.0 
 
 
Diagnosed with Scleroderma or Breast Cancer 
ScleroBCancer 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
 3 2.0 2.0 2.0 
Scleroderma 122 79.7 79.7 81.7 
Breast Cancer 28 18.3 18.3 100.0 
Total 153 100.0 100.0 
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  Reliability Statistics 
Scleroderma, Breast Cancer, Community and Psychosocial Variables 
Anxiety 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.704 .720 7 
 
Depression DASS 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.915 .916 7 
 
Stress DASS 
 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.819 .824 7 
 
Dismissive Attachment RQ 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.996 .996 5 
Fearful Attachment 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.996 .996 4 
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EMWS 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.984 .984 21 
 
 
Self-kindness SCS 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.889 .890 5 
 
Mindfulness SCS 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.797 .802 4 
 
Overidentification SCS 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.796 .796 4 
 
 
Self-Compassion Scale 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.798 .799 26 
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Hyper-arousal 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.855 .853 26 
 
 
Suppression ERQ 
Reliability Statistics 
Cronbach's Alpha Cronbach's Alpha 
Based on 
Standardized 
Items 
N of Items 
.753 .749 4 
 
Study 3(a) Multiple Regression Analysis – Differences in Predictor Variables 
Breast Cancer and Scleroderma - Pain and Psychosocial Variables  
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed SQRT Pain 4.6072 3.00576 115 
Total EMWS 70.4045 24.49157 110 
RQ Insecure Dismissive 15.3761 4.20271 109 
Correlations 
 Transformed 
SQRT Pain 
Total EMWS RQ Insecure 
Dismissive 
Pearson Correlation 
Transformed SQRT Pain 1.000 -.249 .228 
Total EMWS -.249 1.000 -.149 
RQ Insecure Dismissive .228 -.149 1.000 
Sig. (1-tailed) 
Transformed SQRT Pain . .005 .009 
Total EMWS .005 . .063 
RQ Insecure Dismissive .009 .063 . 
N 
Transformed SQRT Pain 115 109 108 
Total EMWS 109 110 107 
RQ Insecure Dismissive 108 107 109 
 
 
Variables Entered/Removeda 
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Model Variables Entered Variables 
Removed 
Method 
1 
RQ Insecure 
Dismissive, Total 
EMWSb 
. Enter 
a. Dependent Variable: Transformed SQRT Pain 
b. All requested variables entered. 
Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .315a .099 .082 2.88024 
a. Predictors: (Constant), RQ Insecure Dismissive, Total EMWS 
b. Dependent Variable: Transformed SQRT Pain 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 94.910 2 47.455 5.720 .004b 
Residual 862.759 104 8.296 
  
Total 957.670 106 
   
a. Dependent Variable: Transformed SQRT Pain 
b. Predictors: (Constant), RQ Insecure Dismissive, Total EMWS 
 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) 4.362 1.436 
 
3.039 .003 1.516 7.209 
     
Total EMWS -.027 .012 -.220 -2.336 .021 -.050 -.004 -.249 -.223 -.217 .978 1.023 
RQ Insecure Dismissive .139 .067 .195 2.072 .041 .006 .273 .228 .199 .193 .978 1.023 
a. Dependent Variable: Transformed SQRT Pain 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Total EMWS RQ Insecure 
Dismissive 
1 
1 2.873 1.000 .00 .01 .01 
2 .103 5.290 .01 .59 .27 
3 .024 10.838 .99 .40 .73 
a. Dependent Variable: Transformed SQRT Pain 
 
Residuals Statisticsa 
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 Minimum Maximum Mean Std. Deviation N 
Predicted Value 2.8926 7.1158 4.5979 .94583 107 
Std. Predicted Value -1.812 2.651 -.010 1.000 107 
Standard Error of Predicted 
Value 
.280 .895 .466 .127 107 
Adjusted Predicted Value 2.8438 6.9887 4.6016 .94707 106 
Residual -6.01837 6.43710 -.03744 2.84197 106 
Std. Residual -2.090 2.235 -.013 .987 106 
Stud. Residual -2.122 2.264 -.013 1.001 106 
Deleted Residual -6.20666 6.60366 -.03849 2.92450 106 
Stud. Deleted Residual -2.159 2.310 -.014 1.007 106 
Mahal. Distance .011 9.256 1.983 1.674 107 
Cook's Distance .000 .084 .010 .014 106 
Centered Leverage Value .000 .087 .019 .016 107 
a. Dependent Variable: Transformed SQRT Pain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                      76 
 
 
Multiple Regression Analysis: Breast Cancer - Pain 
 
Descriptive Statistics 
BreastCancerScleroderma Mean Std. Deviation N 
BreastCancer 
Transformed SQRT Pain 3.4926 3.65834 23 
Total EMWS 71.9091 27.12038 22 
RQ Insecure Dismissive 15.2727 4.10785 22 
Scleroderma 
Transformed SQRT Pain 4.8859 2.77309 92 
Total EMWS 70.0284 23.94298 88 
RQ Insecure Dismissive 15.4023 4.24938 87 
 
Correlations 
BreastCancerScleroderma Transformed 
SQRT Pain 
Total EMWS RQ Insecure 
Dismissive 
BreastCancer 
Pearson Correlation 
Transformed SQRT Pain 1.000 -.005 .032 
Total EMWS -.005 1.000 -.025 
RQ Insecure Dismissive .032 -.025 1.000 
Sig. (1-tailed) 
Transformed SQRT Pain . .491 .444 
Total EMWS .491 . .457 
RQ Insecure Dismissive .444 .457 . 
N 
Transformed SQRT Pain 23 22 22 
Total EMWS 22 22 22 
RQ Insecure Dismissive 22 22 22 
Scleroderma 
Pearson Correlation 
Transformed SQRT Pain 1.000 -.335 .294 
Total EMWS -.335 1.000 -.183 
RQ Insecure Dismissive .294 -.183 1.000 
Sig. (1-tailed) 
Transformed SQRT Pain . .001 .003 
Total EMWS .001 . .047 
RQ Insecure Dismissive .003 .047 . 
N 
Transformed SQRT Pain 92 87 86 
Total EMWS 87 88 85 
RQ Insecure Dismissive 86 85 87 
 
 
 
 
 
 
 
Variables Entered/Removeda 
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Scleroderma Model Variables Entered Variables 
Removed 
Method 
. 1 
RQ Insecure 
Dismissive, Total 
EMWSb 
. Enter 
Scleroderma 1 
RQ Insecure 
Dismissive, Total 
EMWSb 
. Enter 
a. Dependent Variable: Transformed SQRT Pain 
b. All requested variables entered. 
 
Model Summaryb 
BreastCancerScl
eroderma 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
.BreastCancer 1 .032a .001 -.104 3.84406 
Scleroderma 2 .410a .168 .148 2.55948 
a. Predictors: (Constant), RQ Insecure Dismissive, Total EMWS 
b. Dependent Variable: Transformed SQRT Pain 
 
ANOVAa 
BreastCancerScl
eroderma 
Model Sum of Squares df Mean Square F Sig. 
.BreastCancer 1 
Regression .294 2 .147 .010 .990b 
Residual 280.759 19 14.777 
  
Total 281.053 21 
   
Scleroderma 2 
Regression 108.784 2 54.392 8.303 .001b 
Residual 537.178 82 6.551 
  
Total 645.962 84 
   
a. Dependent Variable: Transformed SQRT Pain 
b. Predictors: (Constant), RQ Insecure Dismissive, Total EMWS 
 
Coefficientsa 
BreastCancer 
Scleroderma 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
BreastCancer 1 
(Constant) 3.100 3.962 
 
.782 .444 -5.192 11.392 
     
Total EMWS -.001 .031 -.004 -.019 .985 -.065 .064 -.005 -.004 -.004 .999 1.001 
RQ Insecure Dismissive .028 .204 .032 .139 .891 -.399 .456 .032 .032 .032 .999 1.001 
Scleroderma 2 
(Constant) 4.832 1.463 
 
3.303 .001 1.922 7.743 
     
Total EMWS -.034 .012 -.291 -2.845 .006 -.057 -.010 -.335 -.300 -.286 .966 1.035 
RQ Insecure Dismissive .157 .067 .240 2.347 .021 .024 .290 .294 .251 .236 .966 1.035 
a. Dependent Variable: Transformed SQRT Pain 
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Collinearity Diagnosticsa 
BreastCancer 
Scleroderma 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Total EMWS RQ Insecure 
Dismissive 
BreastCancer 1 
1 2.874 1.000 .01 .01 .01 
2 .099 5.397 .02 .75 .22 
3 .027 10.277 .98 .24 .77 
Scleroderma 2 
1 2.873 1.000 .00 .01 .01 
2 .104 5.262 .00 .55 .27 
3 .023 11.059 .99 .44 .72 
a. Dependent Variable: Transformed SQRT Pain 
 
Residuals Statisticsa 
Breast Cancer Minimum Maximum Mean Std. Deviation N 
. 
Predicted Value 3.2943 3.7072 3.4926 .11832 22 
Std. Predicted Value -1.676 1.814 .000 1.000 22 
Standard Error of Predicted 
Value 
.850 1.866 1.384 .322 22 
Adjusted Predicted Value 2.3612 4.3964 3.4727 .62875 22 
Residual -3.64442 6.56099 .15876 3.66053 22 
Std. Residual -.948 1.707 .041 .952 22 
Stud. Residual -1.037 1.807 .044 1.025 22 
Deleted Residual -4.39641 7.35439 .17871 4.24954 22 
Stud. Deleted Residual -1.039 1.933 .052 1.039 22 
Mahal. Distance .072 3.996 1.909 1.245 22 
Cook's Distance .000 .134 .055 .039 22 
Centered Leverage Value .003 .190 .091 .059 22 
Scleroderma 
Predicted Value 2.8359 7.8560 4.8724 1.13605 85 
Adjusted Predicted Value 2.7901 7.7731 4.8792 1.13708 84 
Residual -4.91140 4.81736 -.07583 2.51764 84 
Std. Residual -1.919 1.882 -.030 .984 84 
Stud. Residual -1.947 1.917 -.030 1.001 84 
Deleted Residual -5.05613 4.99519 -.07732 2.60847 84 
Stud. Deleted Residual -1.981 1.949 -.030 1.008 84 
Mahal. Distance .013 9.712 1.976 1.779 85 
Cook's Distance .000 .120 .012 .018 84 
Centered Leverage Value .000 .116 .024 .021 85 
a. Dependent Variable: Transformed SQRT Pain 
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Multiple Regression: Breast Cancer Variables and Psychosocial Variables 
Fatigue: Hyper-arousal and Fearful Attachment 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Transformed 
Total 
Hyperarousal, 
Transformed 
SQRT Fearful 
Attachmentb 
. Enter 
a. Dependent Variable: Fatigue 
b. All requested variables entered. 
 
Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .626a .392 .324 25.718 
a. Predictors: (Constant), Transformed Total Hyperarousal, Transformed SQRT 
Fearful Attachment 
b. Dependent Variable: Fatigue 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 7675.539 2 3837.770 5.802 .011b 
Residual 11905.413 18 661.412 
  
Total 19580.952 20 
   
a. Dependent Variable: Fatigue 
b. Predictors: (Constant), Transformed Total Hyperarousal, Transformed SQRT Fearful Attachment 
 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) -148.154 55.003 
 
-2.694 .015 -263.710 -32.597 
     
Transformed SQRT Fearful 
Attachment 
15.105 8.480 .344 1.781 .092 -2.711 32.922 .476 .387 .327 .905 1.105 
Transformed Total Hyperarousal 14.479 6.541 .428 2.214 .040 .737 28.221 .534 .463 .407 .905 1.105 
a. Dependent Variable: Fatigue 
 
 
Collinearity Diagnosticsa 
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Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Transformed 
SQRT Fearful 
Attachment 
Transformed 
Total 
Hyperarousal 
1 
1 2.970 1.000 .00 .00 .00 
2 .025 10.918 .08 .99 .06 
3 .005 23.397 .92 .01 .94 
a. Dependent Variable: Fatigue 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value -18.68 61.76 27.38 19.590 21 
Std. Predicted Value -2.351 1.755 .000 1.000 21 
Standard Error of Predicted 
Value 
5.920 14.690 9.412 2.488 21 
Adjusted Predicted Value -27.72 54.61 26.10 20.287 21 
Residual -48.403 39.999 .000 24.398 21 
Std. Residual -1.882 1.555 .000 .949 21 
Stud. Residual -1.997 1.724 .023 1.022 21 
Deleted Residual -54.501 49.168 1.282 28.401 21 
Stud. Deleted Residual -2.200 1.834 .016 1.055 21 
Mahal. Distance .107 5.573 1.905 1.523 21 
Cook's Distance .000 .227 .056 .063 21 
Centered Leverage Value .005 .279 .095 .076 21 
a. Dependent Variable: Fatigue 
 
Multiple Regression: Nausea Breast Cancer – Model Significant -Variables Not Significant 
 
Descriptive Statistics 
 Mean Std. Deviation N 
Nausea 5.65 15.323 23 
Dissmisive Attachment Log 
Transformed 
1.1680 .12290 22 
Transformed SQRT Fearful 
Attachment 
3.3305 .72292 22 
 
 
 
 
 
 
 
Correlations 
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 Nausea Dissmisive 
Attachment Log 
Transformed 
Transformed 
SQRT Fearful 
Attachment 
Pearson Correlation 
Nausea 1.000 .464 .461 
Dissmisive Attachment Log 
Transformed 
.464 1.000 .493 
Transformed SQRT Fearful 
Attachment 
.461 .493 1.000 
Sig. (1-tailed) 
Nausea . .015 .015 
Dissmisive Attachment Log 
Transformed 
.015 . .010 
Transformed SQRT Fearful 
Attachment 
.015 .010 . 
N 
Nausea 23 22 22 
Dissmisive Attachment Log 
Transformed 
22 22 22 
Transformed SQRT Fearful 
Attachment 
22 22 22 
 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Transformed 
SQRT Fearful 
Attachment, 
Dissmisive 
Attachment Log 
Transformedb 
. Enter 
a. Dependent Variable: Nausea 
b. All requested variables entered. 
 
Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .535a .286 .211 13.608 
a. Predictors: (Constant), Transformed SQRT Fearful Attachment, Dissmisive 
Attachment Log Transformed 
b. Dependent Variable: Nausea 
 
 
 
 
 
ANOVAa 
                                                                                                                                                                                                                                                                                                                                                      82 
 
 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 1411.905 2 705.952 3.812 .041b 
Residual 3518.530 19 185.186 
  
Total 4930.435 21 
   
a. Dependent Variable: Nausea 
b. Predictors: (Constant), Transformed SQRT Fearful Attachment, Dissmisive Attachment Log Transformed 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) -61.526 28.371 
 
-2.169 .043 -120.907 -2.145 
     
Dissmisive Attachment Log 
Transformed 
38.983 27.773 .313 1.404 .177 -19.147 97.113 .464 .307 .272 .757 1.321 
Transformed SQRT Fearful 
Attachment 
6.499 4.722 .307 1.376 .185 -3.383 16.382 .461 .301 .267 .757 1.321 
a. Dependent Variable: Nausea 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Dissmisive 
Attachment Log 
Transformed 
Transformed 
SQRT Fearful 
Attachment 
1 
1 2.971 1.000 .00 .00 .00 
2 .024 11.082 .11 .03 .88 
3 .005 25.037 .88 .97 .12 
a. Dependent Variable: Nausea 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value -9.13 19.89 5.65 8.200 22 
Std. Predicted Value -1.802 1.736 .000 1.000 22 
Standard Error of Predicted 
Value 
3.033 9.188 4.786 1.568 22 
Adjusted Predicted Value -12.46 17.08 5.16 8.330 22 
Residual -15.190 30.867 .257 13.207 22 
Std. Residual -1.116 2.268 .019 .970 22 
Stud. Residual -1.184 2.503 .036 1.051 22 
Mahal. Distance .088 8.619 1.909 2.013 22 
Cook's Distance .001 .473 .063 .132 22 
Centered Leverage Value .004 .410 .091 .096 22 
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a. Dependent Variable: Nausea 
 
 
Multiple Regression: Breast Cancer Depression –Nausea -Fatigue 
 
Descriptive Statistics 
 Mean Std. Deviation N 
Depression Log Transformed 1.0347 .17745 21 
Nausea 6.19 15.961 21 
Fatigue 27.38 31.290 21 
 
Correlations 
 Depression Log 
Transformed 
Nausea Fatigue 
Pearson Correlation 
Depression Log Transformed 1.000 .442 .616 
Nausea .442 1.000 .715 
Fatigue .616 .715 1.000 
Sig. (1-tailed) 
Depression Log Transformed . .022 .001 
Nausea .022 . .000 
Fatigue .001 .000 . 
N 
Depression Log Transformed 21 21 21 
Nausea 21 21 21 
Fatigue 21 21 21 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 Fatigue, Nauseab . Enter 
a. Dependent Variable: Depression Log Transformed 
b. All requested variables entered. 
 
Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .616a .379 .310 .14738 
a. Predictors: (Constant), Fatigue, Nausea 
b. Dependent Variable: Depression Log Transformed 
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ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .239 2 .119 5.496 .014b 
Residual .391 18 .022 
  
Total .630 20 
   
a. Dependent Variable: Depression Log Transformed 
b. Predictors: (Constant), Fatigue, Nausea 
 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .939 .045 
 
21.046 .000 .845 1.033 
     
Nausea 4.262E-005 .003 .004 .014 .989 -.006 .006 .442 .003 .003 .489 2.045 
Fatigue .003 .002 .613 2.308 .033 .000 .007 .616 .478 .429 .489 2.045 
a. Dependent Variable: Depression Log Transformed 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Nausea Fatigue 
1 
1 2.198 1.000 .07 .06 .05 
2 .633 1.863 .47 .28 .00 
3 .168 3.617 .47 .66 .95 
a. Dependent Variable: Depression Log Transformed 
 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .9392 1.2890 1.0347 .10926 21 
Std. Predicted Value -.874 2.328 .000 1.000 21 
Standard Error of Predicted 
Value 
.035 .097 .052 .020 21 
Adjusted Predicted Value .9184 1.2632 1.0330 .10574 21 
Residual -.24474 .35440 .00000 .13982 21 
Std. Residual -1.661 2.405 .000 .949 21 
Stud. Residual -1.896 2.491 .004 1.025 21 
Deleted Residual -.31919 .38045 .00170 .16445 21 
Stud. Deleted Residual -2.060 2.991 .018 1.116 21 
Mahal. Distance .154 7.797 1.905 2.367 21 
Cook's Distance .000 .365 .062 .103 21 
Centered Leverage Value .008 .390 .095 .118 21 
a. Dependent Variable: Depression Log Transformed 
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Multiple Regression Analysis: Scleroderma and Breast Cancer – Anxiety Depression Stress - Biopsychosocial   
Anxiety Breast Cancer and Scleroderma - Split File 
 
Descriptive Statistics 
SclerodermaBreastCancer Mean Std. Deviation N 
 
Transformed Inverse Anxiety .0000 . 0 
Transformed SQRT Pain .0000 . 0 
ERQ Suppresion .0000 . 0 
Total EMWS .0000 . 0 
Hyperarousal .0000 . 0 
Scleroderma 
Transformed Inverse Anxiety .0995 .02873 93 
Transformed SQRT Pain 4.8859 2.77309 92 
ERQ Suppresion 14.5062 5.56130 81 
Total EMWS 70.0284 23.94298 88 
Hyperarousal 73.6410 15.92513 78 
BreastCancer 
Transformed Inverse Anxiety .1063 .02470 22 
Transformed SQRT Pain 3.4926 3.65834 23 
ERQ Suppresion 14.5909 5.36886 22 
Total EMWS 71.9091 27.12038 22 
Hyperarousal 74.9091 15.35581 22 
 
 
Variables Entered/Removeda,b 
 
Scleroderma 
BreastCancer 
Model Variables Entered Variables 
Removed 
Method 
Scleroderma 1 
Hyperarousal, 
Transformed 
SQRT Pain, ERQ 
Suppresion, Total 
EMWSc 
. Enter 
BreastCancer 2 
Hyperarousal, 
Transformed 
SQRT Pain, Total 
EMWS, ERQ 
Suppresionc 
. Enter 
a. There are no valid cases in one or more split files. Statistics cannot be computed. 
b. Dependent Variable: Transformed Inverse Anxiety 
c. All requested variables entered. 
 
Model Summarya,c 
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Scleroderma 
BreastCancer 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
Scleroderma 1 .666b .444 .413 .02202 
Breast Cancer 2 .615d .378 .232 .02165 
a. There are no valid cases in one or more split files. Statistics cannot be computed. 
b. Predictors: (Constant), Hyperarousal, Transformed SQRT Pain, ERQ Suppresion, Total EMWS 
c. Dependent Variable: Transformed Inverse Anxiety 
d. Predictors: (Constant), Hyperarousal, Transformed SQRT Pain, Total EMWS, ERQ Suppresion 
 
ANOVAa,b 
Scleroderma 
BreastCancer 
Model Sum of Squares df Mean Square F Sig. 
Scleroderma 1 
Regression .027 4 .007 14.180 .000c 
Residual .034 71 .000 
  
Total .062 75 
   
BreastCancer 2 
Regression .005 4 .001 2.586 .074d 
Residual .008 17 .000 
  
Total .013 21 
   
a. There are no valid cases in one or more split files. Statistics cannot be computed. 
b. Dependent Variable: Transformed Inverse Anxiety 
c. Predictors: (Constant), Hyperarousal, Transformed SQRT Pain, ERQ Suppresion, Total EMWS 
d. Predictors: (Constant), Hyperarousal, Transformed SQRT Pain, Total EMWS, ERQ Suppresion 
 
Coefficientsa,b 
ScleroBC Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. Correlations Collinearity Statistics 
B Std. Error Beta Zero-order Partial Part Tolerance VIF 
Scleroderma 1 
(Constant) .153 .020 
 
7.781 .000 
     
Transformed SQRT Pain -.003 .001 -.262 -2.774 .007 -.344 -.313 -.245 .879 1.138 
Total EMWS .000 .000 .269 2.709 .008 .443 .306 .240 .793 1.261 
ERQ Suppresion -.002 .000 -.336 -3.773 .000 -.354 -.409 -.334 .986 1.014 
Hyperarousal -.001 .000 -.284 -3.012 .004 -.408 -.337 -.266 .883 1.132 
Breast Cancer 2 
(Constant) .182 .033 
 
5.501 .000 
     
Transformed SQRT Pain -.001 .001 -.130 -.613 .548 -.356 -.147 -.117 .812 1.232 
Total EMWS .000 .000 -.119 -.601 .556 .019 -.144 -.115 .928 1.077 
ERQ Suppresion -.002 .001 -.527 -2.408 .028 -.538 -.504 -.461 .763 1.311 
Hyperarousal .000 .000 -.244 -1.265 .223 -.206 -.293 -.242 .986 1.014 
a. There are no valid cases in one or more split files. Statistics cannot be computed. 
b. Dependent Variable: Transformed Inverse Anxiety 
 
Collinearity Diagnosticsa,b 
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Scleroderma 
BreastCancer 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Transformed SQRT 
Pain 
ERQ Suppresion Total EMWS Hyperarousal 
Scleroderma 1 
1 4.555 1.000 .00 .01 .01 .00 .00 
2 .249 4.280 .00 .63 .02 .07 .00 
3 .113 6.348 .00 .03 .63 .28 .00 
4 .072 7.966 .01 .16 .31 .17 .31 
5 .012 19.582 .98 .17 .03 .48 .69 
BreastCancer 2 
1 4.360 1.000 .00 .01 .00 .01 .00 
2 .435 3.166 .00 .76 .00 .02 .00 
3 .130 5.799 .00 .13 .29 .44 .00 
4 .062 8.403 .01 .07 .45 .30 .29 
5 .014 17.970 .98 .02 .25 .23 .70 
a. There are no valid cases in one or more split files. Statistics cannot be computed. 
b. Dependent Variable: Transformed Inverse Anxiety 
 
 
Residuals Statisticsa,b 
SclerodermaBreastCancer Minimum Maximum Mean Std. Deviation N 
Scleroderma 
Predicted Value .0360 .1340 .0995 .01932 75 
Std. Predicted Value -3.317 1.801 -.002 1.009 75 
Standard Error of Predicted 
Value 
.003 .009 .005 .001 75 
Adjusted Predicted Value .0339 .1353 .0994 .01948 75 
Residual -.04411 .05902 .00171 .02137 75 
Std. Residual -2.004 2.681 .077 .971 75 
Stud. Residual -2.058 2.736 .078 1.000 75 
Deleted Residual -.04654 .06145 .00174 .02270 75 
Stud. Deleted Residual -2.107 2.872 .081 1.013 75 
Mahal. Distance .432 12.650 3.921 2.295 75 
Cook's Distance .000 .085 .012 .016 75 
Centered Leverage Value .006 .169 .052 .031 75 
BreastCancer 
Predicted Value .0814 .1350 .1061 .01520 22 
Std. Predicted Value -1.638 1.888 -.009 1.000 22 
Standard Error of Predicted 
Value 
.008 .013 .010 .002 22 
Adjusted Predicted Value .0816 .1359 .1054 .01622 22 
Residual -.03448 .03168 .00014 .01948 22 
Std. Residual -1.593 1.463 .006 .900 22 
Stud. Residual -1.711 1.660 .021 1.018 22 
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Deleted Residual -.03979 .04279 .00083 .02505 22 
Stud. Deleted Residual -1.824 1.760 .030 1.050 22 
Mahal. Distance 1.672 6.578 3.823 1.543 22 
Cook's Distance .000 .230 .058 .059 22 
Centered Leverage Value .080 .313 .182 .073 22 
a. There are no valid cases in one or more split files. Statistics cannot be computed. 
b. Dependent Variable: Transformed Inverse Anxiety 
 
Multiple Regression Analysis: Anxiety - Breast Cancer 
 
Descriptive Statisticsa 
 Mean Std. Deviation N 
Transformed Inverse Anxiety .1063 .02470 22 
Transformed SQRT Pain 3.4926 3.65834 23 
ERQ Suppresion 14.5909 5.36886 22 
a. ScleroBC = Breast Cancer 
 
Correlationsa 
 Transformed 
Inverse Anxiety 
Transformed 
SQRT Pain 
ERQ Suppresion 
Pearson Correlation 
Transformed Inverse Anxiety 1.000 -.356 -.538 
Transformed SQRT Pain -.356 1.000 .419 
ERQ Suppresion -.538 .419 1.000 
Sig. (1-tailed) 
Transformed Inverse Anxiety . .052 .005 
Transformed SQRT Pain .052 . .026 
ERQ Suppresion .005 .026 . 
N 
Transformed Inverse Anxiety 22 22 22 
Transformed SQRT Pain 22 23 22 
ERQ Suppresion 22 22 22 
a. ScleroBC = Breast Cancer 
 
Variables Entered/Removeda,b 
Model Variables Entered Variables 
Removed 
Method 
1 
ERQ Suppresion, 
Transformed 
SQRT Painc 
. Enter 
a. ScleroBC = Breast Cancer 
b. Dependent Variable: Transformed Inverse Anxiety 
c. All requested variables entered. 
 
Model Summarya,c 
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Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .557b .311 .238 .02156 
a. ScleroBC = Breast Cancer 
b. Predictors: (Constant), ERQ Suppresion, Transformed SQRT Pain 
c. Dependent Variable: Transformed Inverse Anxiety 
 
ANOVAa,b 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .004 2 .002 4.281 .029c 
Residual .009 19 .000 
  
Total .013 21 
   
a. ScleroBC = Breast Cancer 
b. Dependent Variable: Transformed Inverse Anxiety 
c. Predictors: (Constant), ERQ Suppresion, Transformed SQRT Pain 
 
 
Coefficientsa,b 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. Correlations Collinearity Statistics 
B Std. Error Beta Zero-order Partial Part Tolerance VIF 
1 
(Constant) .142 .014 
 
10.401 .000 
     
Transformed SQRT Pain -.001 .001 -.159 -.756 .459 -.356 -.171 -.144 .824 1.213 
ERQ Suppresion -.002 .001 -.472 -2.250 .037 -.538 -.459 -.428 .824 1.213 
a. ScleroBC = Breast Cancer 
b. Dependent Variable: Transformed Inverse Anxiety 
 
Collinearity Diagnosticsa,b 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Transformed 
SQRT Pain 
ERQ Suppresion 
1 
1 2.604 1.000 .02 .05 .01 
2 .342 2.760 .07 .86 .02 
3 .054 6.930 .91 .09 .96 
a. ScleroBC = Breast Cancer 
b. Dependent Variable: Transformed Inverse Anxiety 
 
 
 
 
 
Residuals Statisticsa,b 
                                                                                                                                                                                                                                                                                                                                                      90 
 
 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .0856 .1330 .1061 .01377 22 
Std. Predicted Value -1.499 1.942 -.012 1.000 22 
Standard Error of Predicted 
Value 
.005 .011 .008 .002 22 
Adjusted Predicted Value .0809 .1396 .1057 .01440 22 
Residual -.03235 .03479 .00017 .02051 22 
Std. Residual -1.500 1.613 .008 .951 22 
Stud. Residual -1.583 1.737 .016 1.025 22 
Deleted Residual -.03603 .04031 .00056 .02391 22 
Stud. Deleted Residual -1.654 1.843 .027 1.049 22 
Mahal. Distance .118 4.920 1.914 1.385 22 
Cook's Distance .000 .278 .057 .067 22 
Centered Leverage Value .006 .234 .091 .066 22 
a. ScleroBC = Breast Cancer 
b. Dependent Variable: Transformed Inverse Anxiety 
 
Multiple Regression Analysis: Total Illness (Scleroderma/BC) - Anxiety  
 
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed Inverse Anxiety .1008 .02803 115 
Transformed SQRT Pain 4.6072 3.00576 115 
ERQ Suppresion 14.5243 5.49482 103 
Total EMWS 70.4045 24.49157 110 
Hyperarousal 73.9200 15.73369 100 
 
Correlations 
 Transformed 
Inverse Anxiety 
Transformed SQRT 
Pain 
ERQ Suppresion Total EMWS Hyperarousal 
Pearson Correlation 
Transformed Inverse Anxiety 1.000 -.351 -.384 .361 -.365 
Transformed SQRT Pain -.351 1.000 .075 -.249 .014 
ERQ Suppresion -.384 .075 1.000 -.048 .072 
Total EMWS .361 -.249 -.048 1.000 -.251 
Hyperarousal -.365 .014 .072 -.251 1.000 
Sig. (1-tailed) 
Transformed Inverse Anxiety . .000 .000 .000 .000 
Transformed SQRT Pain .000 . .226 .005 .446 
ERQ Suppresion .000 .226 . .318 .239 
Total EMWS .000 .005 .318 . .006 
Hyperarousal .000 .446 .239 .006 . 
N 
Transformed Inverse Anxiety 115 114 103 110 100 
Transformed SQRT Pain 114 115 102 109 99 
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ERQ Suppresion 103 102 103 100 100 
Total EMWS 110 109 100 110 98 
Hyperarousal 100 99 100 98 100 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Hyperarousal, 
Transformed 
SQRT Pain, ERQ 
Suppresion, Total 
EMWSb 
. Enter 
a. Dependent Variable: Transformed Inverse Anxiety 
b. All requested variables entered. 
 
Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .634a .402 .376 .02214 
a. Predictors: (Constant), Hyperarousal, Transformed SQRT Pain, ERQ 
Suppresion, Total EMWS 
b. Dependent Variable: Transformed Inverse Anxiety 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .031 4 .008 15.611 .000b 
Residual .046 93 .000 
  
Total .076 97 
   
a. Dependent Variable: Transformed Inverse Anxiety 
b. Predictors: (Constant), Hyperarousal, Transformed SQRT Pain, ERQ Suppresion, Total EMWS 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .158 .016 
 
9.702 .000 .126 .191 
     
Transformed SQRT Pain -.003 .001 -.270 -3.252 .002 -.004 -.001 -.351 -.320 -.261 .931 1.074 
ERQ Suppresion -.002 .000 -.333 -4.135 .000 -.003 -.001 -.384 -.394 -.332 .989 1.011 
Total EMWS .000 .000 .206 2.403 .018 .000 .000 .361 .242 .193 .876 1.141 
Hyperarousal -.001 .000 -.286 -3.438 .001 -.001 .000 -.365 -.336 -.276 .930 1.075 
a. Dependent Variable: Transformed Inverse Anxiety 
 
 
Collinearity Diagnosticsa 
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Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Transformed SQRT 
Pain 
ERQ Suppresion Total EMWS Hyperarousal 
1 
1 4.517 1.000 .00 .01 .01 .00 .00 
2 .279 4.023 .00 .77 .01 .06 .00 
3 .116 6.243 .00 .07 .61 .31 .00 
4 .075 7.758 .02 .07 .33 .24 .28 
5 .013 18.389 .98 .08 .05 .39 .71 
a. Dependent Variable: Transformed Inverse Anxiety 
 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .0420 .1404 .1009 .01792 97 
Std. Predicted Value -3.312 2.231 .003 1.009 97 
Standard Error of Predicted 
Value 
.003 .008 .005 .001 97 
Adjusted Predicted Value .0414 .1402 .1008 .01804 97 
Residual -.04435 .05568 .00148 .02161 97 
Std. Residual -2.003 2.515 .067 .976 97 
Stud. Residual -2.039 2.556 .068 1.000 97 
Deleted Residual -.04594 .05752 .00152 .02268 97 
Stud. Deleted Residual -2.075 2.637 .070 1.008 97 
Mahal. Distance .385 13.021 3.963 2.354 97 
Cook's Distance .000 .083 .010 .013 97 
Centered Leverage Value .004 .134 .041 .024 97 
a. Dependent Variable: Transformed Inverse Anxiety 
 
Multiple Regression - Total Illness Sample (Scleroderma/BC) - Depression  
 
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed Inverse 
Depression 
.0978 .03075 114 
Hyperarousal 73.9200 15.73369 100 
Self Compassion 82.7059 17.28308 102 
ERQ Suppresion 14.5243 5.49482 103 
Transformed SQRT Fearful 
Attachment 
3.0525 .63150 108 
RQ Insecure Dismissive 15.3761 4.20271 109 
Total EMWS 70.4045 24.49157 110 
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Correlations 
 Transformed Inverse 
Depression 
Hyperarousal Self Compassion ERQ Suppresion Transformed SQRT 
Fearful Attachment 
RQ Insecure 
Dismissive 
Total EMWS 
Pearson Correlation 
Transformed Inverse Depression 1.000 -.410 .397 -.279 -.343 -.337 .370 
Hyperarousal -.410 1.000 -.437 .072 .311 .264 -.251 
Self Compassion .397 -.437 1.000 -.072 -.243 -.125 .320 
ERQ Suppresion -.279 .072 -.072 1.000 .353 .219 -.048 
Transformed SQRT Fearful 
Attachment 
-.343 .311 -.243 .353 1.000 .536 -.321 
RQ Insecure Dismissive -.337 .264 -.125 .219 .536 1.000 -.149 
Total EMWS .370 -.251 .320 -.048 -.321 -.149 1.000 
Sig. (1-tailed) 
Transformed Inverse Depression . .000 .000 .002 .000 .000 .000 
Hyperarousal .000 . .000 .239 .001 .004 .006 
Self Compassion .000 .000 . .235 .007 .105 .001 
ERQ Suppresion .002 .239 .235 . .000 .014 .318 
Transformed SQRT Fearful 
Attachment 
.000 .001 .007 .000 . .000 .000 
RQ Insecure Dismissive .000 .004 .105 .014 .000 . .063 
Total EMWS .000 .006 .001 .318 .000 .063 . 
N 
Transformed Inverse Depression 114 99 101 102 107 108 110 
Hyperarousal 99 100 99 100 98 99 98 
Self Compassion 101 99 102 102 101 102 100 
ERQ Suppresion 102 100 102 103 101 102 100 
Transformed SQRT Fearful 
Attachment 
107 98 101 101 108 108 106 
RQ Insecure Dismissive 108 99 102 102 108 109 107 
Total EMWS 110 98 100 100 106 107 110 
 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Total EMWS, ERQ 
Suppresion, 
Hyperarousal, RQ 
Insecure 
Dismissive, Self 
Compassion, 
Transformed 
SQRT Fearful 
Attachmentb 
. Enter 
a. Dependent Variable: Transformed Inverse Depression 
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b. All requested variables entered. 
Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .601a .361 .319 .02537 
a. Predictors: (Constant), Total EMWS, ERQ Suppresion, Hyperarousal, RQ 
Insecure Dismissive, Self Compassion, Transformed SQRT Fearful Attachment 
b. Dependent Variable: Transformed Inverse Depression 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .033 6 .006 8.580 .000b 
Residual .059 91 .001 
  
Total .092 97 
   
a. Dependent Variable: Transformed Inverse Depression 
b. Predictors: (Constant), Total EMWS, ERQ Suppresion, Hyperarousal, RQ Insecure Dismissive, Self 
Compassion, Transformed SQRT Fearful Attachment 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .114 .028 
 
4.129 .000 .059 .169 
     
Hyperarousal .000 .000 -.207 -2.131 .036 -.001 .000 -.410 -.218 -.179 .745 1.343 
Self Compassion .000 .000 .201 2.085 .040 .000 .001 .397 .214 .175 .757 1.322 
ERQ Suppresion -.001 .001 -.203 -2.255 .027 -.002 .000 -.279 -.230 -.189 .868 1.152 
Transformed SQRT Fearful 
Attachment 
.001 .005 .013 .116 .908 -.010 .011 -.343 .012 .010 .579 1.728 
RQ Insecure Dismissive -.001 .001 -.187 -1.866 .065 -.003 .000 -.337 -.192 -.156 .698 1.433 
Total EMWS .000 .000 .220 2.389 .019 .000 .001 .370 .243 .200 .825 1.212 
a. Dependent Variable: Transformed Inverse Depression 
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Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Hyperarousal Self Compassion ERQ Suppresion Transformed SQRT 
Fearful Attachment 
RQ Insecure 
Dismissive 
Total EMWS 
1 
1 6.643 1.000 .00 .00 .00 .00 .00 .00 .00 
2 .148 6.694 .00 .01 .02 .12 .01 .02 .33 
3 .093 8.436 .00 .04 .00 .78 .01 .05 .04 
4 .046 12.071 .00 .11 .41 .00 .00 .01 .43 
5 .043 12.444 .01 .26 .00 .00 .00 .62 .06 
6 .020 18.162 .00 .18 .06 .09 .82 .29 .06 
7 .007 31.707 .98 .40 .50 .00 .16 .01 .08 
a. Dependent Variable: Transformed Inverse Depression 
 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .0296 .1280 .0977 .01876 97 
Std. Predicted Value -3.690 1.635 -.007 1.015 97 
Standard Error of Predicted 
Value 
.004 .012 .007 .002 97 
Adjusted Predicted Value .0282 .1336 .0978 .01907 97 
Residual -.04854 .07458 -.00026 .02401 97 
Std. Residual -1.913 2.940 -.010 .946 97 
Stud. Residual -1.965 3.139 -.012 .986 97 
Deleted Residual -.05122 .08502 -.00036 .02606 97 
Stud. Deleted Residual -1.997 3.305 -.010 .997 97 
Mahal. Distance 1.227 20.161 6.092 3.479 97 
Cook's Distance .000 .197 .012 .024 97 
Centered Leverage Value .013 .208 .063 .036 97 
a. Dependent Variable: Transformed Inverse Depression 
 
Multiple Regression Analysis: Scleroderma - Depression  
 
 
Descriptive Statisticsa 
 Mean Std. Deviation N 
Transformed Inverse 
Depression 
.0977 .03012 92 
Total EMWS 70.0284 23.94298 88 
Self Compassion 83.1500 17.94725 80 
RQ Insecure Dismissive 15.4023 4.24938 87 
ERQ Suppresion 14.5062 5.56130 81 
Trnasform SQRT RQ Fear 2.9814 .58973 86 
a. Scleroderma = Scleroderma 
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Correlationsa 
 Transformed 
Inverse Depression 
Total EMWS Self Compassion RQ Insecure 
Dismissive 
ERQ Suppresion Trnasform SQRT 
RQ Fear 
Pearson Correlation 
Transformed Inverse Depression 1.000 .374 .372 -.278 -.262 -.364 
Total EMWS .374 1.000 .340 -.183 .007 -.360 
Self Compassion .372 .340 1.000 -.102 -.096 -.260 
RQ Insecure Dismissive -.278 -.183 -.102 1.000 .247 .580 
ERQ Suppresion -.262 .007 -.096 .247 1.000 .309 
Trnasform SQRT RQ Fear -.364 -.360 -.260 .580 .309 1.000 
Sig. (1-tailed) 
Transformed Inverse Depression . .000 .000 .005 .010 .000 
Total EMWS .000 . .001 .047 .475 .000 
Self Compassion .000 .001 . .185 .198 .010 
RQ Insecure Dismissive .005 .047 .185 . .014 .000 
ERQ Suppresion .010 .475 .198 .014 . .003 
Trnasform SQRT RQ Fear .000 .000 .010 .000 .003 . 
N 
Transformed Inverse Depression 92 88 79 86 80 85 
Total EMWS 88 88 78 85 78 84 
Self Compassion 79 78 80 80 80 79 
RQ Insecure Dismissive 86 85 80 87 80 86 
ERQ Suppresion 80 78 80 80 81 79 
Trnasform SQRT RQ Fear 85 84 79 86 79 86 
a. Scleroderma = Scleroderma 
Variables Entered/Removeda,b 
Model Variables Entered Variables 
Removed 
Method 
1 
Trnasform SQRT 
RQ Fear, Self 
Compassion, 
ERQ Suppresion, 
Total EMWS, RQ 
Insecure 
Dismissivec 
. Enter 
a. Scleroderma = Scleroderma 
b. Dependent Variable: Transformed Inverse Depression 
c. All requested variables entered. 
Model Summarya,c 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .540b .291 .242 .02622 
a. Scleroderma = Scleroderma 
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b. Predictors: (Constant), Trnasform SQRT RQ Fear, Self Compassion, ERQ 
Suppresion, Total EMWS, RQ Insecure Dismissive 
c. Dependent Variable: Transformed Inverse Depression 
ANOVAa,b 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .020 5 .004 5.916 .000c 
Residual .050 72 .001 
  
Total .070 77 
   
a. Scleroderma = Scleroderma 
b. Dependent Variable: Transformed Inverse Depression 
c. Predictors: (Constant), Trnasform SQRT RQ Fear, Self Compassion, ERQ Suppresion, Total EMWS, RQ 
Insecure Dismissive 
Coefficientsa,b 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .085 .026 
 
3.210 .002 .032 .137 
     
Total EMWS .000 .000 .240 2.147 .035 .000 .001 .374 .245 .213 .789 1.268 
Self Compassion .000 .000 .237 2.209 .030 .000 .001 .372 .252 .219 .857 1.167 
RQ Insecure Dismissive -.001 .001 -.109 -.888 .378 -.003 .001 -.278 -.104 -.088 .656 1.525 
ERQ Suppresion -.001 .001 -.184 -1.737 .087 -.002 .000 -.262 -.201 -.172 .879 1.138 
Trnasform SQRT RQ Fear -.005 .007 -.096 -.722 .473 -.019 .009 -.364 -.085 -.072 .551 1.814 
a. Scleroderma = Scleroderma b. Dependent Variable: Transformed Inverse Depression 
 
Collinearity Diagnosticsa,b 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Total EMWS Self Compassion RQ Insecure 
Dismissive 
ERQ Suppresion Trnasform SQRT 
RQ Fear 
1 
1 5.693 1.000 .00 .00 .00 .00 .00 .00 
2 .142 6.325 .00 .27 .03 .03 .17 .01 
3 .090 7.950 .00 .08 .01 .09 .74 .02 
4 .041 11.715 .01 .50 .43 .25 .03 .00 
5 .025 15.217 .07 .02 .24 .58 .06 .32 
6 .009 25.466 .92 .13 .29 .04 .00 .65 
a. Scleroderma = Scleroderma b. Dependent Variable: Transformed Inverse Depression 
 
 
 
 
 
Residuals Statisticsa,b 
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 Minimum Maximum Mean Std. Deviation N 
Predicted Value .0438 .1260 .0974 .01642 77 
Std. Predicted Value -3.314 1.745 -.015 1.010 77 
Standard Error of Predicted 
Value 
.004 .013 .007 .002 77 
Adjusted Predicted Value .0451 .1280 .0975 .01676 77 
Residual -.05309 .07845 -.00019 .02442 77 
Std. Residual -2.025 2.992 -.007 .931 77 
Stud. Residual -2.070 3.190 -.009 .974 77 
Deleted Residual -.05550 .08917 -.00029 .02674 77 
Stud. Deleted Residual -2.120 3.418 -.006 .991 77 
Mahal. Distance .702 19.402 4.986 3.293 77 
Cook's Distance .000 .232 .015 .031 77 
Centered Leverage Value .009 .252 .065 .043 77 
a. Scleroderma = Scleroderma 
b. Dependent Variable: Transformed Inverse Depression 
 
 
Multiple Regression Analysis: Breast Cancer - Depression  
 
Descriptive Statistics 
 Mean Std. Deviation N 
Depression Log Transformed 1.0367 .17343 22 
Dissmisive Attachment Log 
Transformed 
1.1680 .12290 22 
Self Compassion SQRT 
Transformed 
8.9676 .84018 22 
 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Self Compassion 
SQRT 
Transformed, 
Dissmisive 
Attachment Log 
Transformedb 
. Enter 
a. Dependent Variable: Depression Log Transformed 
b. All requested variables entered. 
 
 
Model Summaryb 
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Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .667a .445 .386 .13589 
a. Predictors: (Constant), Self Compassion SQRT Transformed, Dissmisive 
Attachment Log Transformed 
b. Dependent Variable: Depression Log Transformed 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression .281 2 .140 7.604 .004b 
Residual .351 19 .018 
  
Total .632 21 
   
a. Dependent Variable: Depression Log Transformed 
b. Predictors: (Constant), Self Compassion SQRT Transformed, Dissmisive Attachment Log Transformed 
 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) .974 .477 
 
2.041 .055 -.025 1.973 
     
Dissmisive Attachment Log 
Transformed 
.663 .247 .470 2.687 .015 .147 1.180 .551 .525 .459 .956 1.046 
Self Compassion SQRT Transformed -.079 .036 -.385 -2.199 .040 -.155 -.004 -.483 -.450 -.376 .956 1.046 
a. Dependent Variable: Depression Log Transformed 
 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Dissmisive 
Attachment Log 
Transformed 
Self Compassion 
SQRT 
Transformed 
1 
1 2.986 1.000 .00 .00 .00 
2 .011 16.195 .00 .47 .32 
3 .002 34.958 1.00 .53 .68 
a. Dependent Variable: Depression Log Transformed 
 
 
 
 
 
Residuals Statisticsa 
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 Minimum Maximum Mean Std. Deviation N 
Predicted Value .8198 1.2322 1.0367 .11564 22 
Std. Predicted Value -1.875 1.691 .000 1.000 22 
Standard Error of Predicted 
Value 
.029 .074 .049 .013 22 
Adjusted Predicted Value .7894 1.2789 1.0387 .11931 22 
Residual -.19084 .31744 .00000 .12925 22 
Std. Residual -1.404 2.336 .000 .951 22 
Stud. Residual -1.567 2.400 -.007 1.013 22 
Deleted Residual -.23747 .33497 -.00201 .14713 22 
Stud. Deleted Residual -1.634 2.798 .006 1.070 22 
Mahal. Distance .027 5.269 1.909 1.468 22 
Cook's Distance .000 .200 .046 .051 22 
Centered Leverage Value .001 .251 .091 .070 22 
a. Dependent Variable: Depression Log Transformed 
 
Multiple Regression Analysis: Total sample (Scleroderma/BC) - Stress  
 
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed SQRT Stress 3.4450 .50685 114 
Hyperarousal 73.9200 15.73369 100 
Total EMWS 70.4045 24.49157 110 
Transformed SQRT Fearful 
Attachment 
3.0525 .63150 108 
Self Compassion 82.7059 17.28308 102 
RQ Insecure Dismissive 15.3761 4.20271 109 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
RQ Insecure 
Dismissive, Self 
Compassion, Total 
EMWS, 
Hyperarousal, 
Transformed 
SQRT Fearful 
Attachmentb 
. Enter 
a. Dependent Variable: Transformed SQRT Stress 
b. All requested variables entered. 
 
Model Summaryb 
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Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .594a .353 .317 .41873 
a. Predictors: (Constant), RQ Insecure Dismissive, Self Compassion, Total 
EMWS, Hyperarousal, Transformed SQRT Fearful Attachment 
b. Dependent Variable: Transformed SQRT Stress 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 8.788 5 1.758 10.024 .000b 
Residual 16.131 92 .175 
  
Total 24.919 97 
   
a. Dependent Variable: Transformed SQRT Stress 
 
 
 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) 3.252 .455 
 
7.142 .000 2.348 4.157 
     
Hyperarousal .012 .003 .388 3.991 .000 .006 .019 .518 .384 .335 .746 1.340 
Total EMWS -.002 .002 -.097 -1.049 .297 -.006 .002 -.285 -.109 -.088 .829 1.207 
Transformed SQRT Fearful 
Attachment 
.070 .085 .087 .823 .413 -.098 .238 .240 .085 .069 .633 1.579 
Self Compassion -.007 .003 -.248 -2.567 .012 -.013 -.002 -.455 -.259 -.215 .757 1.321 
RQ Insecure Dismissive -.013 .012 -.109 -1.083 .282 -.037 .011 .085 -.112 -.091 .699 1.431 
a. Dependent Variable: Transformed SQRT Stress 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Hyperarousal Total EMWS Transformed SQRT 
Fearful Attachment 
Self Compassion RQ Insecure 
Dismissive 
1 
1 5.746 1.000 .00 .00 .00 .00 .00 .00 
2 .138 6.463 .00 .02 .37 .02 .02 .05 
3 .046 11.223 .00 .12 .42 .00 .40 .01 
4 .043 11.558 .01 .27 .07 .00 .01 .60 
5 .022 16.290 .00 .19 .06 .78 .07 .34 
6 .007 29.465 .99 .40 .08 .19 .50 .01 
a. Dependent Variable: Transformed SQRT Stress 
 
Residuals Statisticsa 
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 Minimum Maximum Mean Std. Deviation N 
Predicted Value 2.8169 4.4524 3.4500 .30450 97 
Std. Predicted Value -2.087 3.347 .017 1.012 97 
Standard Error of Predicted 
Value 
.062 .186 .102 .025 97 
Adjusted Predicted Value 2.8158 4.4489 3.4485 .30944 97 
Residual -.97835 .97811 .01568 .40808 97 
Std. Residual -2.336 2.336 .037 .975 97 
Stud. Residual -2.393 2.444 .039 1.010 97 
Deleted Residual -1.02625 1.07075 .01723 .43854 97 
Stud. Deleted Residual -2.458 2.514 .040 1.020 97 
Mahal. Distance 1.157 18.171 5.114 3.153 97 
Cook's Distance .000 .169 .013 .024 97 
Centered Leverage Value .012 .187 .053 .033 97 
a. Dependent Variable: Transformed SQRT Stress 
 
 
Multiple Regression Analysis: Scleroderma – Stress 
 
Descriptive Statistics 
 Mean Std. Deviation N 
Transformed SQRT Stress 3.4489 .52086 92 
Total EMWS 70.0284 23.94298 88 
Transformed SQRT Fearful 
Attachment 
2.9814 .58973 86 
Hyperarousal 73.6410 15.92513 78 
Self Compassion 83.1500 17.94725 80 
 
Model Variables Entered Variables 
Removed 
Method 
1 
Self Compassion, 
Transformed 
SQRT Fearful 
Attachment, Total 
EMWS, 
Hyperarousalb 
. Enter 
a. Dependent Variable: Transformed SQRT Stress 
b. All requested variables entered. 
Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .577a .333 .296 .43715 
a. Predictors: (Constant), Self Compassion, Transformed SQRT Fearful 
Attachment, Total EMWS, Hyperarousal 
                                                                                                                                                                                                                                                                                                                                                      103 
 
 
b. Dependent Variable: Transformed SQRT Stress 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 6.779 4 1.695 8.869 .000b 
Residual 13.568 71 .191 
  
Total 20.347 75 
   
a. Dependent Variable: Transformed SQRT Stress 
b. Predictors: (Constant), Self Compassion, Transformed SQRT Fearful Attachment, Total EMWS, 
Hyperarousal 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) 3.414 .549 
 
6.221 .000 2.319 4.508 
     
Total EMWS -.003 .002 -.155 -1.426 .158 -.008 .001 -.345 -.167 -.138 .791 1.265 
Transformed SQRT Fearful 
Attachment 
.000 .095 .000 -.002 .998 -.189 .189 .231 .000 .000 .816 1.226 
Hyperarousal .011 .004 .351 3.149 .002 .004 .019 .500 .350 .305 .757 1.321 
Self Compassion -.007 .003 -.237 -2.143 .036 -.013 .000 -.439 -.246 -.208 .767 1.304 
a. Dependent Variable: Transformed SQRT Stress 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Total EMWS Transformed SQRT 
Fearful Attachment 
Hyperarousal Self Compassion 
1 
1 4.802 1.000 .00 .00 .00 .00 .00 
2 .123 6.252 .00 .36 .04 .06 .02 
3 .044 10.461 .00 .42 .00 .14 .44 
4 .025 13.816 .00 .08 .68 .44 .11 
5 .007 27.164 1.00 .13 .28 .36 .43 
a. Dependent Variable: Transformed SQRT Stress 
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Multiple Regression Analysis: Breast Cancer – Stress - Model Significant (Variables Not Significant) 
 
Descriptive Statistics 
 Mean Std. Deviation N 
Total Stress DASS 11.9545 3.18445 22 
RSQ Dismissing attachment 
subscale 
15.2727 4.10785 22 
Total Hyperarousal 74.9091 15.35581 22 
Self Compassion SQRT 
Transformed 
8.9676 .84018 22 
 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Self Compassion 
SQRT 
Transformed, 
RSQ Dismissing 
attachment 
subscale, Total 
Hyperarousalb 
. Enter 
a. Dependent Variable: Total Stress DASS 
b. All requested variables entered. 
 
Model Summaryb 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .717a .515 .434 2.39611 
a. Predictors: (Constant), Self Compassion SQRT Transformed, RSQ 
Dismissing attachment subscale, Total Hyperarousal 
b. Dependent Variable: Total Stress DASS 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 109.611 3 36.537 6.364 .004b 
Residual 103.344 18 5.741 
  
Total 212.955 21 
   
a. Dependent Variable: Total Stress DASS 
b. Predictors: (Constant), Self Compassion SQRT Transformed, RSQ Dismissing attachment subscale, Total 
Hyperarousal 
 
 
 
 
Coefficientsa 
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Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) 12.375 8.425 
 
1.469 .159 -5.325 30.075 
     
RSQ Dismissing attachment 
subscale 
.190 .138 .244 1.372 .187 -.101 .480 .467 .308 .225 .849 1.179 
Total Hyperarousal .083 .041 .398 2.012 .059 -.004 .169 .629 .429 .330 .688 1.454 
Self Compassion SQRT Transformed -1.060 .716 -.280 -1.480 .156 -2.565 .445 -.536 -.329 -.243 .755 1.325 
a. Dependent Variable: Total Stress DASS 
 
 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) RSQ Dismissing 
attachment 
subscale 
Total Hyperarousal Self Compassion 
SQRT 
Transformed 
1 
1 3.918 1.000 .00 .00 .00 .00 
2 .050 8.823 .01 .60 .01 .04 
3 .029 11.563 .00 .38 .63 .02 
4 .002 41.193 .99 .02 .36 .94 
a. Dependent Variable: Total Stress DASS 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 8.7457 16.1741 11.9545 2.28464 22 
Std. Predicted Value -1.405 1.847 .000 1.000 22 
Standard Error of Predicted 
Value 
.609 1.378 1.001 .211 22 
Adjusted Predicted Value 7.9903 15.6565 11.9067 2.35354 22 
Residual -4.24944 4.22849 .00000 2.21836 22 
Std. Residual -1.773 1.765 .000 .926 22 
Stud. Residual -1.920 2.157 .008 1.044 22 
Deleted Residual -4.98103 6.32011 .04780 2.83483 22 
Stud. Deleted Residual -2.093 2.435 .010 1.093 22 
Mahal. Distance .401 5.995 2.864 1.535 22 
Cook's Distance .000 .576 .074 .123 22 
Centered Leverage Value .019 .285 .136 .073 22 
a. Dependent Variable: Total Stress DASS 
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Multiple Regression Analysis: Scleroderma and Breast Cancer – Age Diagnosed - Psychosocial Variables  
Total Illness Sample (Scleroderma and Breast Cancer) 
Descriptive Statistics 
 Mean Std. Deviation N 
AgeDiagBCSclero 47.60 11.119 114 
Hyperarousal 73.9200 15.73369 100 
Self Compassion 82.7059 17.28308 102 
Transformed SQRT Stress 3.4450 .50685 114 
 
Correlations 
 AgeDiagBCSclero Hyperarousal Self Compassion Transformed 
SQRT Stress 
Pearson Correlation 
AgeDiagBCSclero 1.000 -.300 .221 -.248 
Hyperarousal -.300 1.000 -.437 .518 
Self Compassion .221 -.437 1.000 -.455 
Transformed SQRT Stress -.248 .518 -.455 1.000 
Sig. (1-tailed) 
AgeDiagBCSclero . .002 .015 .005 
Hyperarousal .002 . .000 .000 
Self Compassion .015 .000 . .000 
Transformed SQRT Stress .005 .000 .000 . 
N 
AgeDiagBCSclero 114 95 97 109 
Hyperarousal 95 100 99 99 
Self Compassion 97 99 102 102 
Transformed SQRT Stress 109 99 102 114 
 
Variables Entered/Removeda 
Model Variables Entered Variables 
Removed 
Method 
1 
Transformed 
SQRT Stress, 
Self Compassion, 
Hyperarousalb 
. Enter 
a. Dependent Variable: AgeDiagBCSclero 
b. All requested variables entered. 
 
Model Summaryb 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .327a .107 .077 10.681 
a. Predictors: (Constant), Transformed SQRT Stress, Self Compassion, 
Hyperarousal 
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b. Dependent Variable: AgeDiagBCSclero 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 1239.362 3 413.121 3.621 .016b 
Residual 10381.233 91 114.079 
  
Total 11620.595 94 
   
a. Dependent Variable: AgeDiagBCSclero 
b. Predictors: (Constant), Transformed SQRT Stress, Self Compassion, Hyperarousal 
 
Coefficientsa 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
1 
(Constant) 61.770 13.049 
 
4.734 .000 35.850 87.690 
     
Hyperarousal -.149 .085 -.211 -1.760 .082 -.318 .019 -.300 -.181 -.174 .680 1.470 
Self Compassion .054 .074 .083 .723 .472 -.094 .201 .221 .076 .072 .738 1.356 
Transformed SQRT Stress -2.196 2.662 -.100 -.825 .412 -7.484 3.092 -.248 -.086 -.082 .667 1.500 
a. Dependent Variable: AgeDiagBCSclero 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Hyperarousal Self Compassion Transformed SQRT 
Stress 
1 
1 3.913 1.000 .00 .00 .00 .00 
2 .067 7.650 .00 .14 .27 .02 
3 .015 15.956 .02 .83 .11 .42 
4 .005 27.977 .98 .03 .61 .56 
a. Dependent Variable: AgeDiagBCSclero 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 35.76 54.59 47.53 3.639 99 
Std. Predicted Value -3.261 1.927 -.018 1.002 99 
Standard Error of Predicted 
Value 
1.164 3.935 2.117 .592 99 
Adjusted Predicted Value 34.52 54.46 47.50 3.761 94 
Residual -26.178 19.897 -.596 10.274 94 
Std. Residual -2.451 1.863 -.056 .962 94 
Stud. Residual -2.487 1.897 -.059 .983 94 
Deleted Residual -26.943 20.631 -.664 10.724 94 
Stud. Deleted Residual -2.561 1.925 -.062 .992 94 
Mahal. Distance .127 11.768 2.989 2.352 99 
                                                                                                                                                                                                                                                                                                                                                      108 
 
 
Cook's Distance .000 .119 .011 .017 94 
Centered Leverage Value .001 .125 .032 .025 99 
a. Dependent Variable: AgeDiagBCSclero 
 
Multiple Regression Analysis: Split File - Scleroderma and Breast Cancer – Age Diagnosed - Psychosocial Variables 
Descriptive Statistics 
BreastCancerScleroderma Mean Std. Deviation N 
.BreastCancer 
AgeDiagBCSclero 50.35 8.637 23 
Hyperarousal 74.9091 15.35581 22 
Self Compassion 81.0909 14.88019 22 
Transformed SQRT Stress 3.4289 .45433 22 
Scleroderma 
AgeDiagBCSclero 46.90 11.600 91 
Hyperarousal 73.6410 15.92513 78 
Self Compassion 83.1500 17.94725 80 
Transformed SQRT Stress 3.4489 .52086 92 
Correlations 
BreastCancerScleroderma AgeDiagBCSclero Hyperarousal Self Compassion Transformed SQRT 
Stress 
.BreastCancer 
Pearson Correlation 
AgeDiagBCSclero 1.000 -.121 .603 -.424 
Hyperarousal -.121 1.000 -.492 .609 
Self Compassion .603 -.492 1.000 -.557 
Transformed SQRT Stress -.424 .609 -.557 1.000 
Sig. (1-tailed) 
AgeDiagBCSclero . .301 .002 .028 
Hyperarousal .301 . .010 .001 
Self Compassion .002 .010 . .004 
Transformed SQRT Stress .028 .001 .004 . 
N 
AgeDiagBCSclero 23 21 21 21 
Hyperarousal 21 22 22 22 
Self Compassion 21 22 22 22 
Transformed SQRT Stress 21 22 22 22 
Scleroderma 
Pearson Correlation 
AgeDiagBCSclero 1.000 -.346 .163 -.225 
Hyperarousal -.346 1.000 -.425 .500 
Self Compassion .163 -.425 1.000 -.439 
Transformed SQRT Stress -.225 .500 -.439 1.000 
Sig. (1-tailed) 
AgeDiagBCSclero . .001 .080 .017 
Hyperarousal .001 . .000 .000 
Self Compassion .080 .000 . .000 
Transformed SQRT Stress .017 .000 .000 . 
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N 
AgeDiagBCSclero 91 74 76 88 
Hyperarousal 74 78 77 77 
Self Compassion 76 77 80 80 
Transformed SQRT Stress 88 77 80 92 
 
Variables Entered/Removeda 
BreastCancer 
Scleroderma 
Model Variables Entered Variables 
Removed 
Method 
BreastCancer 1 
Transformed 
SQRT Stress, Self 
Compassion, 
Hyperarousalb 
. Enter 
Scleroderma 2 
Transformed 
SQRT Stress, Self 
Compassion, 
Hyperarousalb 
. Enter 
a. Dependent Variable: AgeDiagBCSclero 
b. All requested variables entered. 
Model Summaryb 
BreastCancer 
Scleroderma 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
BreastCancer 1 .674a .454 .358 6.922 
Scleroderma 2 .352a .124 .086 11.089 
a. Predictors: (Constant), Transformed SQRT Stress, Self Compassion, Hyperarousal 
b. Dependent Variable: AgeDiagBCSclero 
 
ANOVAa 
BreastCancer 
Scleroderma 
Model Sum of Squares df Mean Square F Sig. 
BreastCancer 1 
Regression 677.500 3 225.833 4.713 .014b 
Residual 814.515 17 47.913 
  
Total 1492.016 20 
   
Scleroderma 2 
Regression 1214.670 3 404.890 3.293 .025b 
Residual 8607.975 70 122.971 
  
Total 9822.645 73 
   
a. Dependent Variable: AgeDiagBCSclero 
b. Predictors: (Constant), Transformed SQRT Stress, Self Compassion, Hyperarousal 
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Coefficientsa 
Breast 
Cancer 
Sclero 
derma 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
Breast 
Cancer 
1 
(Constant) 26.004 22.043 
 
1.180 .254 -20.503 72.511 
     
Hyperarousal .206 .131 .366 1.577 .133 -.070 .481 -.121 .357 .283 .596 1.679 
Self Compassion .355 .129 .612 2.761 .013 .084 .627 .603 .556 .495 .653 1.532 
Transformed SQRT Stress -5.805 4.628 -.305 -1.254 .227 -15.570 3.960 -.424 -.291 -.225 .542 1.846 
Sclero 
derma 
2 
(Constant) 68.984 14.812 
 
4.657 .000 39.442 98.526 
     
Hyperarousal -.227 .098 -.312 -2.327 .023 -.422 -.032 -.346 -.268 -.260 .698 1.434 
Self Compassion .000 .083 .000 -.002 .998 -.167 .166 .163 .000 .000 .751 1.332 
Transformed SQRT Stress -1.549 3.006 -.070 -.515 .608 -7.544 4.445 -.225 -.061 -.058 .687 1.455 
a. Dependent Variable: AgeDiagBCSclero 
Collinearity Diagnosticsa 
BreastCancer  
Scleroderma 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Hyperarousal Self Compassion Transformed SQRT 
Stress 
BreastCancer 1 
1 3.928 1.000 .00 .00 .00 .00 
2 .057 8.276 .00 .13 .20 .01 
3 .011 18.779 .03 .86 .14 .35 
4 .003 34.934 .97 .00 .65 .64 
Scleroderma 2 
1 3.909 1.000 .00 .00 .00 .00 
2 .069 7.516 .00 .14 .29 .02 
3 .016 15.406 .02 .82 .11 .43 
4 .005 26.931 .98 .04 .60 .55 
a. Dependent Variable: AgeDiagBCSclero 
 
Residuals Statisticsa 
BreastCancerScleroderma Minimum Maximum Mean Std. Deviation N 
. 
 
 
 
 
BreastCancer 
Predicted Value 40.55 60.62 50.35 5.820 22 
Std. Predicted Value -1.683 1.765 .000 1.000 22 
Standard Error of Predicted 
Value 
2.079 4.194 2.971 .572 22 
Adjusted Predicted Value 40.35 60.58 50.12 5.986 21 
Residual -10.812 18.357 .143 6.769 21 
Std. Residual -1.562 2.652 .021 .978 21 
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Stud. Residual -1.721 2.794 .025 1.058 21 
Deleted Residual -13.123 20.372 .214 7.936 21 
Stud. Deleted Residual -1.837 3.685 .056 1.203 21 
Mahal. Distance .852 6.388 2.864 1.465 22 
Cook's Distance .000 .214 .047 .062 21 
Centered Leverage Value .043 .319 .143 .073 22 
Scleroderma 
Predicted Value 34.34 54.59 46.82 4.089 77 
Std. Predicted Value -3.079 1.885 -.019 1.002 77 
Standard Error of Predicted 
Value 
1.367 4.506 2.491 .716 77 
Adjusted Predicted Value 32.43 56.03 46.80 4.291 73 
Residual -25.739 17.400 -.865 10.535 73 
Std. Residual -2.321 1.569 -.078 .950 73 
Stud. Residual -2.361 1.607 -.082 .977 73 
Deleted Residual -26.641 18.254 -.963 11.144 73 
Stud. Deleted Residual -2.444 1.626 -.087 .987 73 
Mahal. Distance .123 11.069 2.997 2.377 77 
Cook's Distance .000 .162 .014 .022 73 
Centered Leverage Value .002 .152 .041 .033 77 
a. Dependent Variable: AgeDiagBCSclero 
 
 
 
Multiple Regression Analysis: Scleroderma/Breast Cancer - Differences in Predictor Variables-Self-Compassion  
 
Descriptive Statistics 
BreastCancerScleroderma Mean Std. Deviation N 
BreastCancer 
Self Compassion 81.0909 14.88019 22 
Hyperarousal 74.9091 15.35581 22 
Total EMWS 71.9091 27.12038 22 
Scleroderma 
Self Compassion 83.1500 17.94725 80 
Hyperarousal 73.6410 15.92513 78 
Total EMWS 70.0284 23.94298 88 
 
     
 
 
 
 
Correlations 
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BreasCancerScleroderma Self Compassion Hyperarousal Total EMWS 
. 
 
 
 
BreastCancer 
Pearson Correlation 
Self Compassion 1.000 -.492 .264 
Hyperarousal -.492 1.000 -.058 
Total EMWS .264 -.058 1.000 
Sig. (1-tailed) 
Self Compassion . .010 .118 
Hyperarousal .010 . .400 
Total EMWS .118 .400 . 
N 
Self Compassion 22 22 22 
Hyperarousal 22 22 22 
Total EMWS 22 22 22 
Scleroderma 
Pearson Correlation 
Self Compassion 1.000 -.425 .340 
Hyperarousal -.425 1.000 -.312 
Total EMWS .340 -.312 1.000 
Sig. (1-tailed) 
Self Compassion . .000 .001 
Hyperarousal .000 . .003 
Total EMWS .001 .003 . 
N 
Self Compassion 80 77 78 
Hyperarousal 77 78 76 
Total EMWS 78 76 88 
 
 
 
Variables Entered/Removeda 
BreastCancerScl
eroderma 
Model Variables Entered Variables 
Removed 
Method 
BreastCancer 1 
Total EMWS, 
Hyperarousalb 
. Enter 
Scleroderma 2 
Total EMWS, 
Hyperarousalb 
. Enter 
a. Dependent Variable: Self Compassion b. All requested variables entered. 
 
Model Summaryb 
BreastCancerScl
eroderma 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
BreastCancer. 1 .545a .297 .223 13.11445 
Scleroderma 2 .478a .228 .207 15.98074 
a. Predictors: (Constant), Total EMWS, Hyperarousal b. Dependent Variable: Self Compassion 
 
 
ANOVAa 
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BreastCancerScl
eroderma 
Model Sum of Squares df Mean Square F Sig. 
BreastCancer 1 
Regression 1382.032 2 691.016 4.018 .035b 
Residual 3267.786 19 171.989 
  
Total 4649.818 21 
   
Scleroderma 2 
Regression 5514.738 2 2757.369 10.797 .000b 
Residual 18643.047 73 255.384 
  
Total 24157.785 75 
   
a. Dependent Variable: Self Compassion 
c. Predictors: (Constant), Total EMWS, Hyperarousal 
 
 
Coefficientsa 
BreastCancer 
Scleroderma 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
BreastCancer. 1 
(Constant) 106.472 16.534 
 
6.440 .000 71.866 141.077 
     
Hyperarousal -.463 .187 -.478 -2.481 .023 -.854 -.072 -.492 -.495 -.477 .997 1.003 
Total EMWS .130 .106 .236 1.226 .235 -.092 .351 .264 .271 .236 .997 1.003 
Scleroderma 2 
(Constant) 100.444 12.173 
 
8.251 .000 76.182 124.705 
     
Hyperarousal -.398 .122 -.354 -3.266 .002 -.641 -.155 -.425 -.357 -.336 .902 1.108 
Total EMWS .172 .081 .229 2.120 .037 .010 .334 .340 .241 .218 .902 1.108 
a. Dependent Variable: Self Compassion 
 
Collinearity Diagnosticsa 
BreastCancer 
Scleroderma 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) Hyperarousal Total EMWS 
BreastCancer 1 
1 2.890 1.000 .00 .00 .01 
2 .093 5.588 .02 .11 .84 
3 .017 12.973 .97 .88 .14 
Scleroderma 2 
1 2.886 1.000 .00 .00 .01 
2 .099 5.396 .01 .14 .58 
3 .014 14.163 .99 .85 .41 
a. Dependent Variable: Self Compassion 
 
Residuals Statisticsa 
BreastCancerScleroderma Minimum Maximum Mean Std. Deviation N 
BreastCancer 
Predicted Value 69.6172 95.5846 81.0909 8.11240 22 
Std. Predicted Value -1.414 1.787 .000 1.000 22 
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Standard Error of Predicted 
Value 
3.151 6.382 4.746 .986 22 
Adjusted Predicted Value 70.9355 99.1591 81.5163 8.17858 22 
Residual -23.90904 26.34596 .00000 12.47433 22 
Std. Residual -1.823 2.009 .000 .951 22 
Stud. Residual -1.929 2.072 -.015 1.013 22 
Deleted Residual -26.75850 28.02523 -.42541 14.17540 22 
Stud. Deleted Residual -2.093 2.292 -.018 1.063 22 
Mahal. Distance .258 4.019 1.909 1.137 22 
Cook's Distance .000 .267 .046 .066 22 
Centered Leverage Value .012 .191 .091 .054 22 
Scleroderma 
Predicted Value 55.6232 100.8019 82.9936 8.65402 76 
Std. Predicted Value -3.210 2.059 -.018 1.009 76 
Standard Error of Predicted 
Value 
1.864 6.243 3.096 .790 76 
Adjusted Predicted Value 58.7977 101.0118 82.9608 8.65818 76 
Residual -42.95408 44.46497 -.16465 15.79726 76 
Std. Residual -2.688 2.782 -.010 .989 76 
Stud. Residual -2.716 2.905 -.009 1.012 76 
Deleted Residual -43.87169 48.48402 -.13189 16.56391 76 
Stud. Deleted Residual -2.845 3.068 -.008 1.032 76 
Mahal. Distance .033 10.461 2.010 1.663 76 
Cook's Distance .000 .254 .017 .039 76 
Centered Leverage Value .000 .139 .027 .022 76 
a. Dependent Variable: Self Compassion 
 
Multiple Regression Analysis: Scleroderma Predictor Variables for Hyper-arousal – Self-Compassion/Age Diagnosed Scleroderma 
 
 
Descriptive Statistics 
Scleroderma Mean Std. Deviation N 
. Hyperarousal 72.3924 14.24998 79 
Self Compassion 84.9625 15.69362 80 
Total EMWS 76.8810 22.25558 84 
AgeDiagBCSclero 50.35 8.637 23 
1.00 Hyperarousal 73.6410 15.92513 78 
Self Compassion 83.1500 17.94725 80 
Total EMWS 70.0284 23.94298 88 
AgeDiagBCSclero 46.90 11.600 91 
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Correlations 
Scleroderma Hyperarousal Self Compassion Total EMWS 
AgeDiagBCScler
o 
. Pearson Correlation Hyperarousal 1.000 -.605 -.383 -.121 
Self Compassion -.605 1.000 .432 .603 
Total EMWS -.383 .432 1.000 -.228 
AgeDiagBCSclero -.121 .603 -.228 1.000 
Sig. (1-tailed) Hyperarousal . .000 .000 .301 
Self Compassion .000 . .000 .002 
Total EMWS .000 .000 . .160 
AgeDiagBCSclero .301 .002 .160 . 
N Hyperarousal 79 79 78 21 
Self Compassion 79 80 79 21 
Total EMWS 78 79 84 21 
AgeDiagBCSclero 21 21 21 23 
   1.00 Pearson Correlation Hyperarousal 1.000 -.425 -.312 -.346 
Self Compassion -.425 1.000 .340 .163 
Total EMWS -.312 .340 1.000 -.023 
AgeDiagBCSclero -.346 .163 -.023 1.000 
Sig. (1-tailed) Hyperarousal . .000 .003 .001 
Self Compassion .000 . .001 .080 
Total EMWS .003 .001 . .418 
AgeDiagBCSclero .001 .080 .418 . 
N Hyperarousal 78 77 76 74 
Self Compassion 77 80 78 76 
Total EMWS 76 78 88 84 
AgeDiagBCSclero 74 76 84 91 
 
                                     
Model Summaryb 
Scleroderma Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
Change Statistics 
R Square Change F Change df1 df2 Sig. F Change 
. 1 .685a .469 .375 11.26709 .469 4.997 3 17 .012 
1.00 1 .549a .301 .271 13.59802 .301 10.041 3 70 .000 
a. Predictors: (Constant), AgeDiagBCSclero, Total EMWS, Self Compassion 
b. Dependent Variable: Hyperarousal 
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Variables Entered/Removeda 
Scleroderma Model 
Variables 
Entered 
Variables 
Removed Method 
. 1 AgeDiagBCScle
ro, Total EMWS, 
Self 
Compassionb 
. Enter 
1.00 1 AgeDiagBCScle
ro, Total EMWS, 
Self 
Compassionb 
. Enter 
a. Dependent Variable: Hyperarousal 
b. All requested variables entered. 
ANOVAa 
Scleroderma Model Sum of Squares df Mean Square F Sig. 
. 1 Regression 1903.136 3 634.379 4.997 .012b 
Residual 2158.104 17 126.947   
Total 4061.240 20    
1.00 1 Regression 5570.079 3 1856.693 10.041 .000b 
Residual 12943.431 70 184.906   
Total 18513.510 73    
a. Dependent Variable: Hyperarousal 
b. Predictors: (Constant), AgeDiagBCSclero, Total EMWS, Self Compassion 
 
Coefficientsa 
Scleroderma Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
95.0% Confidence Interval for B Correlations Collinearity Statistics 
B Std. Error Beta Lower Bound Upper Bound Zero-order Partial Part Tolerance VIF 
. 1 (Constant) 98.494 19.892  4.951 .000 56.525 140.463      
Self Compassion -.880 .296 -.969 -2.973 .009 -1.504 -.255 -.605 -.585 -.526 .294 3.398 
Total EMWS .096 .171 .149 .559 .583 -.265 .457 -.383 .134 .099 .438 2.284 
AgeDiagBCSclero .820 .498 .497 1.646 .118 -.231 1.871 -.121 .371 .291 .343 2.915 
1.00 1 (Constant) 125.493 9.619  13.046 .000 106.307 144.678      
Self Compassion -.268 .096 -.302 -2.798 .007 -.460 -.077 -.425 -.317 -.280 .855 1.169 
Total EMWS -.144 .071 -.216 -2.030 .046 -.285 -.003 -.312 -.236 -.203 .878 1.139 
AgeDiagBCSclero -.415 .140 -.302 -2.973 .004 -.693 -.137 -.346 -.335 -.297 .967 1.035 
a. Dependent Variable: Hyperarousal 
 
 
Collinearity Diagnosticsa 
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Scleroderma Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Self Compassion Total EMWS 
AgeDiagBCScler
o 
. 1 1 3.914 1.000 .00 .00 .00 .00 
2 .065 7.731 .01 .00 .33 .04 
3 .016 15.577 .57 .22 .00 .01 
4 .004 30.247 .42 .78 .67 .94 
1.00 1 1 3.860 1.000 .00 .00 .01 .00 
2 .086 6.716 .01 .00 .67 .21 
3 .035 10.501 .02 .56 .31 .51 
4 .019 14.212 .96 .43 .02 .27 
a. Dependent Variable: Hyperarousal 
 
Study 3(b) Kruskal-Wallis Test: Scleroderma/Breast Cancer/Community  
Psychosocial Variables (includes Depression and Anxiety) 
Ranks 
 ScleroBCCom N Mean Rank 
Self Compassion Self Kindness 
Community 58 93.21 
Scleroderma 81 72.30 
Breast Cancer 22 80.86 
Total 161 
 
Self Compassion Over 
Identification 
Community 58 67.74 
Scleroderma 80 94.18 
Breast Cancer 22 64.39 
Total 160 
 
Self Compassion Mindfulness 
Community 58 92.66 
Scleroderma 81 73.91 
Breast Cancer 22 76.36 
Total 161 
 
Stress DASS 
Community 63 85.44 
Scleroderma 92 91.11 
Breast Cancer 22 90.36 
Total 177 
 
Anxiety DASS 
Community 63 65.72 
Scleroderma 93 104.66 
Breast Cancer 22 93.50 
Total 178 
 
Depression DASS 
Community 63 73.86 
Scleroderma 92 97.86 
Breast Cancer 22 95.32 
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Total 177 
 
Total EMWS 
Community 62 97.29 
Scleroderma 88 79.19 
Breast Cancer 22 85.32 
Total 172 
 
RQ Insecure Dismissive 
Community 63 88.75 
Scleroderma 87 86.11 
Breast Cancer 22 81.59 
Total 172 
 
RQ Insecure Fear 
Community 63 87.33 
Scleroderma 86 79.47 
Breast Cancer 22 107.73 
Total 171 
 
ERQ Reappraisal 
Community 58 88.90 
Scleroderma 81 75.83 
Breast Cancer 22 79.23 
Total 161 
 
ERQ Suppresion 
Community 58 76.08 
Scleroderma 81 83.58 
Breast Cancer 22 84.48 
Total 161 
 
Hyperarousal 
Community 57 74.78 
Scleroderma 78 80.28 
Breast Cancer 22 85.39 
Total 157 
 
Hyperarousal Introspect 
Community 58 79.66 
Scleroderma 80 78.83 
Breast Cancer 22 88.80 
Total 160 
 
Hyperarousal Reactive 
Community 58 72.33 
Scleroderma 81 84.57 
Breast Cancer 22 90.70 
Total 161 
 
Self Compassion 
Community 58 86.85 
Scleroderma 80 78.37 
Breast Cancer 22 71.50 
Total 160 
 
Self Compassion Self 
Judgement 
Community 58 82.41 
Scleroderma 81 80.22 
Breast Cancer 22 80.18 
Total 161 
 
Self Compassion Common 
Humanity 
Community 58 85.30 
Scleroderma 81 77.25 
Breast Cancer 22 83.45 
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Total 161 
 
Self Compassion Isolation 
Community 58 87.07 
Scleroderma 81 79.30 
Breast Cancer 22 71.27 
Total 161 
 
Test Statisticsa,b 
 Self Compassion 
Self Kindness 
Self Compassion 
Over Identification 
Total DASS Anxiety DASS Depression DASS Total EMWS RQ Insecure Fear 
Chi-Square 6.836 14.147 9.535 22.159 8.770 4.821 5.830 
df 2 2 2 2 2 2 2 
Asymp. Sig. .033 .001 .009 .000 .012 .090 .054 
a. Kruskal Wallis Test 
b. Grouping Variable: ScleroBCCom 
 
Report 
ScleroBCCom Anxiety DASS Depression DASS Total EMWS RQ Insecure Fear Self Compassion 
Over Identification 
Self Compassion 
Self Kindness 
Community 
N 63 63 62 62 58 58 
Median 8.0000 8.0000 82.0000 9.0000 13.0000 15.0000 
Scleroderma 
N 93 92 88 86 80 81 
Median 10.0000 10.0000 71.5000 9.0000 16.0000 14.0000 
Breast Cancer 
N 22 22 22 22 22 22 
Median 9.5000 10.0000 80.0000 12.0000 13.0000 15.0000 
Total 
N 178 177 172 170 160 161 
Median 9.0000 9.0000 76.0000 9.0000 15.0000 14.0000 
 
 
Kruskal-Wallis Test: Diffuse/ Limited Sclerosis, Breast Cancer and Community Groups 
Comparison - Psychosocial Variables 
Ranks 
 No Sclero Dif Lim N Mean Rank 
Total DASS 
No Sclero 63 68.90 
Diffuse Sclero 33 93.92 
Limited Sclero 49 92.90 
Breast Cancer 22 92.52 
Total 167 
 
Stress DASS 
No Sclero 63 81.52 
Diffuse Sclero 34 82.21 
Limited Sclero 49 89.22 
Breast Cancer 22 86.05 
Total 168 
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Anxiety DASS      
No Sclero 63 62.75 
Diffuse Sclero 34 106.38 
Limited Sclero 50 96.68 
Breast Cancer 22 89.14 
Total 169 
 
Depression DASS 
No Sclero 63 70.33 
Diffuse Sclero 33 89.83 
Limited Sclero 50 96.13 
Breast Cancer 22 90.64 
Total 168 
 
Self Compassion Over 
Identification 
No Sclero 58 64.96 
Diffuse Sclero 31 95.02 
Limited Sclero 42 88.36 
Breast Cancer 22 61.68 
Total 153 
 
Self Compassion Self Kindness 
No Sclero 58 88.59 
Diffuse Sclero 31 85.05 
Limited Sclero 43 57.41 
Breast Cancer 22 76.89 
Total 154 
 
Self Compassion Mindfulness 
No Sclero 58 87.17 
Diffuse Sclero 31 87.48 
Limited Sclero 43 60.35 
Breast Cancer 22 71.45 
Total 154 
 
 
Test Statisticsa,b 
 Total DASS Stress DASS Anxiety DASS Depression DASS Self Compassion 
Over Identification 
Self Compassion 
Self Kindness 
Self Compassion 
Mindfulness 
Chi-Square 9.896 .805 23.120 9.136 14.918 13.277 11.148 
df 3 3 3 3 3 3 3 
Asymp. Sig. .019 .848 .000 .028 .002 .004 .011 
a. Kruskal Wallis Test 
b. Grouping Variable: No Sclero Dif Lim 
 
Report 
No Sclero Dif Lim Anxiety DASS Depression DASS Total EMWS Self Compassion 
Over Identification 
Self Compassion 
Self Kindness 
Self Compassion 
Mindfulness 
No Sclero 
N 63 63 62 58 58 58 
Median 8.0000 8.0000 82.0000 13.0000 15.0000 14.0000 
Diffuse Sclero 
N 34 33 32 31 31 31 
Median 10.5000 10.0000 71.5000 16.0000 16.0000 13.0000 
Limited Sclero N 50 50 47 42 43 43 
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Median 10.0000 10.5000 72.0000 15.5000 13.0000 12.0000 
Breast Cancer 
N 22 22 22 22 22 22 
Median 9.5000 10.0000 80.0000 13.0000 15.0000 13.5000 
Total 
N 169 168 163 153 154 154 
Median 9.0000 9.0000 76.0000 15.0000 14.0000 13.0000 
 
 
 
 
 
 
Mann Witney U-Test: Scleroderma/Breast Cancer -– Scleroderma/Community – Breast Cancer/Community (not significant and not presented) Groups 
Comparison - Psychosocial Variables – Scleroderma and Breast Cancer Groups  
Ranks 
 ScleroBCCom N Mean Rank Sum of Ranks 
RQ Insecure Fear 
Scleroderma 86 51.08 4393.00 
Breast Cancer 22 67.86 1493.00 
Total 108 
  
Self Compassion Over 
Identification 
Scleroderma 80 55.46 4437.00 
Breast Cancer 22 37.09 816.00 
Total 102 
  
Stress DASS 
Scleroderma 92 57.51 5291.00 
Breast Cancer 22 57.45 1264.00 
Total 114 
  
Anxiety DASS 
Scleroderma 93 59.63 5546.00 
Breast Cancer 22 51.09 1124.00 
Total 115 
  
Depression DASS 
Scleroderma 92 57.74 5312.00 
Breast Cancer 22 56.50 1243.00 
Total 114 
  
Total EMWS 
Scleroderma 88 54.90 4831.50 
Breast Cancer 22 57.89 1273.50 
Total 110 
  
RQ Insecure Dismissive 
Scleroderma 87 55.53 4831.00 
Breast Cancer 22 52.91 1164.00 
Total 109 
  
ERQ Reappraisal 
Scleroderma 81 51.53 4174.00 
Breast Cancer 22 53.73 1182.00 
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Total 103 
  
ERQ Suppresion 
Scleroderma 81 52.00 4212.00 
Breast Cancer 22 52.00 1144.00 
Total 103 
  
Hyperarousal 
Scleroderma 78 49.72 3878.00 
Breast Cancer 22 53.27 1172.00 
Total 100 
  
Hyperarousal Reactive 
Scleroderma 81 51.15 4143.50 
Breast Cancer 22 55.11 1212.50 
Total 103 
  
Self Compassion 
Scleroderma 80 52.46 4197.00 
Breast Cancer 22 48.00 1056.00 
Total 102 
  
Self Compassion Self 
Judgement 
Scleroderma 81 51.96 4209.00 
Breast Cancer 22 52.14 1147.00 
Total 103 
  
Self Compassion Isolation 
Scleroderma 81 53.10 4301.00 
Breast Cancer 22 47.95 1055.00 
Total 103 
  
Self Compassion Self Kindness 
Scleroderma 81 50.77 4112.00 
Breast Cancer 22 56.55 1244.00 
Total 103 
  
Self Compassion Common 
Humanity 
Scleroderma 81 50.95 4127.00 
Breast Cancer 22 55.86 1229.00 
Total 103 
  
Self Compassion Mindfulness 
Scleroderma 81 51.46 4168.50 
Breast Cancer 22 53.98 1187.50 
Total 103 
  
 
 
Mann Witney U Test: Scleroderma/BC - Fearful Attachment and Over-identification (only significant variables)  
 
Test Statisticsa 
 RQ Insecure Fear Self Compassion 
Over Identification 
Anxiety DASS Depression DASS Total EMWS 
Mann-Whitney U 652.000 563.000 871.000 990.000 915.500 
Wilcoxon W 4393.000 816.000 1124.000 1243.000 4831.500 
Z -2.251 -2.592 -1.089 -.159 -.392 
Asymp. Sig. (2-tailed) .024 .010 .276 .873 .695 
a. Grouping Variable: ScleroBCCom 
 
Report 
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BCScleroComm Self Compassion 
Over Identification 
RQ Insecure Fear 
       1 
N 58 62 
Median 13.0000 9.0000 
Scleroderma 
N 80 86 
Median 16.0000 9.0000 
Breast Cancer 
N 22 22 
Median 13.0000 12.0000 
Total 
N 160 170 
Median 15.0000 9.0000 
 
 
 
Mann-Whitney U– Scleroderma and Community Groups - Psychosocial Variables  
Ranks 
 ScleroBCCom N Mean Rank Sum of Ranks 
Self Compassion Over 
Identification 
Community 58 56.09 3253.50 
Scleroderma 80 79.22 6337.50 
Total 138 
  
Depression DASS 
Community 63 65.41 4121.00 
Scleroderma 92 86.62 7969.00 
Total 155 
  
Total EMWS 
Community 62 85.02 5271.50 
Scleroderma 88 68.79 6053.50 
Total 150 
  
Total DASS 
Community 63 64.88 4087.50 
Scleroderma 91 86.24 7847.50 
Total 154 
  
Anxiety DASS 
Community 63 58.53 3687.50 
Scleroderma 93 92.03 8558.50 
Total 156 
  
Self Compassion Self Kindness 
Community 58 80.43 4665.00 
Scleroderma 81 62.53 5065.00 
Total 139 
  
Self Compassion Mindfulness 
Community 58 79.16 4591.00 
Scleroderma 81 63.44 5139.00 
Total 139 
  
Test Statisticsa 
 Self Compassion 
Over Identification 
Depression DASS Total EMWS Total DASS Anxiety DASS Self Compassion 
Self Kindness 
Self Compassion 
Mindfulness 
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Mann-Whitney U 1542.500 2105.000 2137.500 2071.500 1671.500 1744.000 1818.000 
Wilcoxon W 3253.500 4121.000 6053.500 4087.500 3687.500 5065.000 5139.000 
Z -3.367 -2.921 -2.254 -2.925 -4.604 -2.591 -2.279 
Asymp. Sig. (2-tailed) .001 .003 .024 .003 .000 .010 .023 
a. Grouping Variable: ScleroBCCom 
Report 
SclerodNoYs Total EMWS Self Compassion 
Over Identification 
Self Compassion 
Self Kindness 
Self Compassion 
Mindfulness 
Anxiety DASS Depression DASS 
1 
N 62 58 58 58 63 63 
Median 82.0000 13.0000 15.0000 14.0000 8.0000 8.0000 
2 
N 88 80 81 81 93 92 
Median 71.5000 16.0000 14.0000 12.0000 10.0000 10.0000 
Total 
N 150 138 139 139 156 155 
Median 75.5000 15.0000 14.0000 13.0000 9.0000 9.0000 
 
Frequencies: Scleroderma, Breast Cancer and Community Groups 
Total Illness (BC/Scleroderma) - Depression, Anxiety and Stress   
 
Stress DASS 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 9 5.9 7.9 7.9 
8.00 9 5.9 7.9 15.8 
9.00 11 7.2 9.6 25.4 
10.00 14 9.2 12.3 37.7 
11.00 15 9.8 13.2 50.9 
12.00 11 7.2 9.6 60.5 
13.00 11 7.2 9.6 70.2 
14.00 7 4.6 6.1 76.3 
15.00 5 3.3 4.4 80.7 
16.00 7 4.6 6.1 86.8 
17.00 2 1.3 1.8 88.6 
18.00 4 2.6 3.5 92.1 
19.00 5 3.3 4.4 96.5 
20.00 2 1.3 1.8 98.2 
21.00 2 1.3 1.8 100.0 
Total 114 74.5 100.0 
 
Missing System 39 25.5 
  
Total 153 100.0 
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Anxiety DASS 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 22 14.4 19.1 19.1 
8.00 11 7.2 9.6 28.7 
9.00 16 10.5 13.9 42.6 
10.00 15 9.8 13.0 55.7 
11.00 7 4.6 6.1 61.7 
12.00 12 7.8 10.4 72.2 
13.00 11 7.2 9.6 81.7 
14.00 5 3.3 4.3 86.1 
15.00 6 3.9 5.2 91.3 
16.00 2 1.3 1.7 93.0 
17.00 2 1.3 1.7 94.8 
18.00 2 1.3 1.7 96.5 
19.00 3 2.0 2.6 99.1 
22.00 1 .7 .9 100.0 
Total 115 75.2 100.0 
 
Missing System 38 24.8 
  
Total 153 100.0 
  
 
 
Depression DASS 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 14 9.2 12.3 12.3 
8.00 26 17.0 22.8 35.1 
9.00 11 7.2 9.6 44.7 
10.00 8 5.2 7.0 51.8 
11.00 11 7.2 9.6 61.4 
12.00 9 5.9 7.9 69.3 
13.00 9 5.9 7.9 77.2 
14.00 5 3.3 4.4 81.6 
15.00 3 2.0 2.6 84.2 
16.00 2 1.3 1.8 86.0 
17.00 3 2.0 2.6 88.6 
18.00 2 1.3 1.8 90.4 
21.00 3 2.0 2.6 93.0 
23.00 1 .7 .9 93.9 
24.00 3 2.0 2.6 96.5 
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25.00 2 1.3 1.8 98.2 
26.00 1 .7 .9 99.1 
27.00 1 .7 .9 100.0 
Total 114 74.5 100.0 
 
Missing System 39 25.5 
  
Total 153 100.0 
  
 
Frequencies: Scleroderma, Breast Cancer and Community Groups 
Scleroderma - Depression, Anxiety and Stress   
 
Depression DASSa 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 10 8.2 10.9 10.9 
8.00 22 18.0 23.9 34.8 
9.00 8 6.6 8.7 43.5 
10.00 8 6.6 8.7 52.2 
11.00 9 7.4 9.8 62.0 
12.00 7 5.7 7.6 69.6 
13.00 7 5.7 7.6 77.2 
14.00 4 3.3 4.3 81.5 
15.00 3 2.5 3.3 84.8 
16.00 2 1.6 2.2 87.0 
17.00 3 2.5 3.3 90.2 
18.00 1 .8 1.1 91.3 
21.00 2 1.6 2.2 93.5 
24.00 3 2.5 3.3 96.7 
25.00 1 .8 1.1 97.8 
26.00 1 .8 1.1 98.9 
27.00 1 .8 1.1 100.0 
Total 92 75.4 100.0 
 
Missing System 30 24.6 
  
Total 122 100.0 
  
a. BCScleroComm = Scleroderma 
 
 
 
 
 
Anxiety DASSa 
                                                                                                                                                                                                                                                                                                                                                      127 
 
 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 17 13.9 18.3 18.3 
8.00 10 8.2 10.8 29.0 
9.00 11 9.0 11.8 40.9 
10.00 13 10.7 14.0 54.8 
11.00 4 3.3 4.3 59.1 
12.00 9 7.4 9.7 68.8 
13.00 9 7.4 9.7 78.5 
14.00 5 4.1 5.4 83.9 
15.00 5 4.1 5.4 89.2 
16.00 2 1.6 2.2 91.4 
17.00 2 1.6 2.2 93.5 
18.00 2 1.6 2.2 95.7 
19.00 3 2.5 3.2 98.9 
22.00 1 .8 1.1 100.0 
Total 93 76.2 100.0 
 
Missing System 29 23.8 
  
Total 122 100.0 
  
a. BCScleroComm = Scleroderma 
Stress DASSa 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 7 5.7 7.6 7.6 
8.00 8 6.6 8.7 16.3 
9.00 11 9.0 12.0 28.3 
10.00 10 8.2 10.9 39.1 
11.00 10 8.2 10.9 50.0 
12.00 9 7.4 9.8 59.8 
13.00 8 6.6 8.7 68.5 
14.00 6 4.9 6.5 75.0 
15.00 4 3.3 4.3 79.3 
16.00 7 5.7 7.6 87.0 
17.00 1 .8 1.1 88.0 
18.00 3 2.5 3.3 91.3 
19.00 4 3.3 4.3 95.7 
20.00 2 1.6 2.2 97.8 
21.00 2 1.6 2.2 100.0 
Total 92 75.4 100.0 
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Missing System 30 24.6 
  
Tota 122 100.0 
  
 
Frequencies: Scleroderma, Breast Cancer and Community 
Groups 
Breast Cancer - Depression, Anxiety and Stress   
 
 Depression DASSa 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 4 14.3 18.2 18.2 
8.00 4 14.3 18.2 36.4 
9.00 3 10.7 13.6 50.0 
11.00 2 7.1 9.1 59.1 
12.00 2 7.1 9.1 68.2 
13.00 2 7.1 9.1 77.3 
14.00 1 3.6 4.5 81.8 
18.00 1 3.6 4.5 86.4 
21.00 1 3.6 4.5 90.9 
23.00 1 3.6 4.5 95.5 
25.00 1 3.6 4.5 100.0 
Total 22 78.6 100.0 
 
Missing System 6 21.4 
  
Total 28 100.0 
  
 
 Anxiety DASSa 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 5 17.9 22.7 22.7 
8.00 1 3.6 4.5 27.3 
9.00 5 17.9 22.7 50.0 
10.00 2 7.1 9.1 59.1 
11.00 3 10.7 13.6 72.7 
12.00 3 10.7 13.6 86.4 
13.00 2 7.1 9.1 95.5 
15.00 1 3.6 4.5 100.0 
Total 22 78.6 100.0 
 
Missing System 6 21.4 
  
Total 28 100.0 
  
a. BCScleroComm = Breast Cancer 
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Stress DASSa 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 2 7.1 9.1 9.1 
8.00 1 3.6 4.5 13.6 
10.00 4 14.3 18.2 31.8 
11.00 5 17.9 22.7 54.5 
12.00 2 7.1 9.1 63.6 
13.00 3 10.7 13.6 77.3 
14.00 1 3.6 4.5 81.8 
15.00 1 3.6 4.5 86.4 
17.00 1 3.6 4.5 90.9 
18.00 1 3.6 4.5 95.5 
19.00 1 3.6 4.5 100.0 
Total 22 78.6 100.0 
 
Missing System 6 21.4 
  
Total 28 100.0 
  
a. BCScleroComm = Breast Cancer 
 
Frequencies: Scleroderma, Breast Cancer and Community Groups 
Community - Depression, Anxiety and Stress   
 
Depression DASSa 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 17 27.0 27.0 27.0 
8.00 15 23.8 23.8 50.8 
9.00 7 11.1 11.1 61.9 
10.00 5 7.9 7.9 69.8 
11.00 5 7.9 7.9 77.8 
12.00 4 6.3 6.3 84.1 
13.00 4 6.3 6.3 90.5 
14.00 3 4.8 4.8 95.2 
16.00 2 3.2 3.2 98.4 
17.00 1 1.6 1.6 100.0 
Total 63 100.0 100.0 
 
a. BCScleroComm =        1 
 
 
Anxiety DASSa 
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 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 23 36.5 36.5 36.5 
8.00 13 20.6 20.6 57.1 
9.00 9 14.3 14.3 71.4 
10.00 10 15.9 15.9 87.3 
11.00 5 7.9 7.9 95.2 
12.00 2 3.2 3.2 98.4 
13.00 1 1.6 1.6 100.0 
Total 63 100.0 100.0 
 
a. BCScleroComm =        1 
Stress DASSa 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
7.00 6 9.5 9.5 9.5 
8.00 5 7.9 7.9 17.5 
9.00 5 7.9 7.9 25.4 
10.00 5 7.9 7.9 33.3 
11.00 9 14.3 14.3 47.6 
12.00 13 20.6 20.6 68.3 
13.00 7 11.1 11.1 79.4 
14.00 7 11.1 11.1 90.5 
15.00 2 3.2 3.2 93.7 
16.00 1 1.6 1.6 95.2 
17.00 1 1.6 1.6 96.8 
18.00 1 1.6 1.6 98.4 
20.00 1 1.6 1.6 100.0 
Total 63 100.0 100.0 
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Mann Witney U-Tests: Scleroderma/BC/Community -  Depression, Anxiety and Stress 
Ranks 
 ScleroBCCom N Mean Rank Sum of Ranks 
Depression DASS 
Scleroderma 92 57.74 5312.00 
Breast Cancer 22 56.50 1243.00 
Total 114 
  
Anxiety DASS 
Scleroderma 93 59.63 5546.00 
Breast Cancer 22 51.09 1124.00 
Total 115 
  
Stress DASS 
Scleroderma 92 57.51 5291.00 
Breast Cancer 22 57.45 1264.00 
Total 114 
  
Test Statisticsa 
 Depression DASS Anxiety DASS Stress DASS 
Mann-Whitney U 990.000 871.000 1011.000 
Wilcoxon W 1243.000 1124.000 1264.000 
Z -.159 -1.089 -.007 
Asymp. Sig. (2-tailed) .873 .276 .994 
Ranks 
 ScleroBCCom N Mean Rank Sum of Ranks 
Depression DASS 
Community 63 65.41 4121.00 
Scleroderma 92 86.62 7969.00 
Total 155 
  
Anxiety DASS 
Community 63 58.53 3687.50 
Scleroderma 93 92.03 8558.50 
Total 156 
  
Stress DASS 
Community 63 74.93 4720.50 
Scleroderma 92 80.10 7369.50 
Total 155 
  
Test Statisticsa 
 Depression DASS Anxiety DASS Stress DASS 
Mann-Whitney U 2105.000 1671.500 2704.500 
Wilcoxon W 4121.000 3687.500 4720.500 
Z -2.921 -4.604 -.708 
Asymp. Sig. (2-tailed) .003 .000 .479 
a. Grouping Variable: ScleroBCCom 
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Mann Whitney U: Community Breast Cancer  
 
Descriptive Statistics 
 N Mean Std. Deviation Minimum Maximum 
Depression DASS 177 10.8701 4.32882 7.00 27.00 
Anxiety DASS 178 9.9944 3.02251 7.00 22.00 
ScleroBCCom 213 1.84 .634 1 3 
Ranks 
 
ScleroBCCom N Mean Rank Sum of Ranks 
Depression DASS Community 63 40.44 2548.00 
Breast Cancer 22 50.32 1107.00 
Total 85   
Anxiety DASS Community 63 39.19 2469.00 
Breast Cancer 22 53.91 1186.00 
Total 85   
Test Statisticsa 
 
Depression 
DASS Anxiety DASS 
Mann-Whitney U 532.000 453.000 
Wilcoxon W 2548.000 2469.000 
Z -1.640 -2.469 
Asymp. Sig. (2-tailed) .101 .014 
a. Grouping Variable: ScleroBCCom 
 
Mann Whitney U: Scleroderma Breast Cancer  
Descriptive Statistics 
 N Mean Std. Deviation Minimum Maximum 
Depression DASS 177 10.8701 4.32882 7.00 27.00 
Anxiety DASS 178 9.9944 3.02251 7.00 22.00 
ScleroBCCom 213 1.84 .634 1 3 
Ranks 
 
ScleroBCCom N Mean Rank Sum of Ranks 
Depression DASS Scleroderma 92 57.74 5312.00 
Breast Cancer 22 56.50 1243.00 
Total 114   
Anxiety DASS Scleroderma 93 59.63 5546.00 
Breast Cancer 22 51.09 1124.00 
Total 115   
 
 
Test Statisticsa 
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Depression 
DASS Anxiety DASS 
Mann-Whitney U 990.000 871.000 
Wilcoxon W 1243.000 1124.000 
Z -.159 -1.089 
Asymp. Sig. (2-tailed) .873 .276 
a. Grouping Variable: ScleroBCCom 
Report 
ScleroBCCom Depression DASS Anxiety DASS Stress DASS Total EMWS 
Community 
Mean 9.4921 8.5397 11.4603 78.6452 
N 63 63 63 62 
Std. Deviation 2.63275 1.58445 2.78142 20.21531 
Median 8.0000 8.0000 12.0000 82.0000 
Scleroderma 
Mean 11.5870 11.0000 12.1630 70.0284 
N 92 93 92 88 
Std. Deviation 4.77667 3.49223 3.70410 23.94298 
Median 10.0000 10.0000 11.5000 71.5000 
Breast Cancer 
Mean 11.8182 9.9091 11.9545 71.9091 
N 22 22 22 22 
Std. Deviation 5.36866 2.30753 3.18445 27.12038 
Median 10.0000 9.5000 11.0000 80.0000 
Total 
Mean 10.8701 9.9944 11.8870 73.3750 
N 177 178 177 172 
Std. Deviation 4.32882 3.02251 3.33690 23.32118 
Median 9.0000 9.0000 12.0000 76.0000 
 
 
  
 
 
 
 
 
 
 
 








Appendix H 
Means and Standard Deviations for the Three Comparison Groups 
Group   Scleroderma     Community Breast Cancer 
 Mean  SD Mean SD Mean SD 
SHAQ 14.91   6.02     -      -  
Stress 12.16   3.70 11.46   2.78 11.95   3.98 
Anxiety 11.00   3.09   8.54   1.59   9.91   2.31 
Depression  11.59   4.78   9.49   2.63 11.82   5.37 
EMWS 70.03 23.94 78.65 20.22 71.91 27.12 
Dismissive 
Attachment 
15.40    4.25  15.69   3.76 15.27   4.11 
Fearful 
Attachment 
  9.23   3.68   9.42   3.01 11.59   4.66 
Reappraisal 27.96   7.99 30.31   6.08 28.82   5.97 
Suppression 14.51   5.56 13.60   4.53 14.59   5.37 
Hyper-arousal 
Introspect 
18.20   5.13 18.00   4.44 19.32   5.25 
Hyper-arousal 73.64 15.92 71.42 13.82 74.91 15.36 
Hyper-arousal 
Reactive 
  7.40   2.79   6.67   2.66   7.64   2.68 
Self-
Compassion 
83.15 17.94 86.43 15.87 81.09 14.88 
SC Isolation 13.21   3.90 14.00   3.63 12.68   3.70 
SC Over 
Identify 
15.10   3.54 13.22   3.41 12.64   3.80 
SC Self 
Judgment 
15.67   4.56 16.16   3.74 15.50   4.74 
SC Self 
Kindness 
13.61   4.80 15.81   4.46 14.32   3.91 
SC Common 
Humanity 
12.83   3.70 13.29   3.42 13.09   2.45 
SC 
Mindfulness 
12.81   3.36 13.95   2.95 12.86   2.70 
Raynaud’s 28.21 27.86      -     -      -      - 
Breathing 19.66 25.20      -     -      -      - 
Intestinal 19.58 23.37      -      -      -      - 
Pain 28.48 26.10      -      - 25.00 25.89 
Finger Ulcers   8.78 18.40      -      -      -      - 
 
